var title_f21_30_21984="Central line suture";
var content_f21_30_21984=[" <div id=\"graphicsToolbar\">",
"  <div id=\"graphicsCopy\">",
"   &copy;2013 UpToDate",
"   <sup>",
"    &reg;",
"   </sup>",
"  </div>",
"  <div id=\"graphicsLinks\">",
"   <a href=\"?imageKey=EM%2F58552&amp;source=image_view&amp;view=print&amp;elapsedTimeMs=1\" onclick=\"\">",
"    <img alt=\"Print this page\" src=\"./../images/icn_print.myextg\" title=\"Print this page\"/>",
"   </a>",
"   <a class=\"icontxt textLink\" href=\"?imageKey=EM%2F58552&amp;source=image_view&amp;view=print&amp;elapsedTimeMs=1\" onclick=\"\" title=\"Print this page\">",
"    Print",
"   </a>",
"   <a class=\"etacLink\" href=\"#\">",
"    <img alt=\"Email graphic(s)\" src=\"./../images/icn_email.myextg\" title=\"Email graphic(s)\"/>",
"   </a>",
"   <a class=\"icontxt textLink etacLink\" href=\"#\" title=\"Email graphic(s)\">",
"    Email",
"   </a>",
"  </div>",
" </div>",
" <div class=\"graphic\">",
"  <div class=\"figure\" style=\"width: 470px\">",
"   <div class=\"ttl\">",
"    Central venous catheter sutured in place",
"   </div>",
"   <div class=\"cntnt\" style=\"width: 432px; height: 232px; background-image: url(data:image/jpeg;base64,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);\">",
"   </div>",
"   <div class=\"lgnd\">",
"    When suturing central venous catheters in place, avoid knots that place excessive pressure on the skin, which can lead to skin necrosis.",
"    <div class=\"footnotes\">",
"    </div>",
"    <div class=\"reference\">",
"     UpToDate acknowledges the invaluable assistance of the University of Massacusetts Medical School, Department of Anatomy and Department of Emergency Medicine, including Thomas Ellis, MD and Jean Marcelin, MD, for the photographs of central venous catheter placement.",
"    </div>",
"   </div>",
"  </div>",
" </div>",
"</div>"].join("\n");
var script_f21_30_21984=[""].join("\n");
var outline_f21_30_21984=null;
var title_f21_30_21985="Loopmarks acute";
var content_f21_30_21985=[" <div id=\"graphicsToolbar\">",
"  <div id=\"graphicsCopy\">",
"   &copy;2013 UpToDate",
"   <sup>",
"    &reg;",
"   </sup>",
"  </div>",
"  <div id=\"graphicsLinks\">",
"   <a href=\"?imageKey=EM%2F69125&amp;source=image_view&amp;view=print&amp;elapsedTimeMs=1\" onclick=\"\">",
"    <img alt=\"Print this page\" src=\"./../images/icn_print.myextg\" title=\"Print this page\"/>",
"   </a>",
"   <a class=\"icontxt textLink\" href=\"?imageKey=EM%2F69125&amp;source=image_view&amp;view=print&amp;elapsedTimeMs=1\" onclick=\"\" title=\"Print this page\">",
"    Print",
"   </a>",
"   <a class=\"etacLink\" href=\"#\">",
"    <img alt=\"Email graphic(s)\" src=\"./../images/icn_email.myextg\" title=\"Email graphic(s)\"/>",
"   </a>",
"   <a class=\"icontxt textLink etacLink\" href=\"#\" title=\"Email graphic(s)\">",
"    Email",
"   </a>",
"  </div>",
" </div>",
" <div class=\"graphic\">",
"  <div class=\"figure\" style=\"width: 470px\">",
"   <div class=\"ttl\">",
"    Loopmarks acute",
"   </div>",
"   <div class=\"cntnt\" style=\"width: 360px; height: 378px; background-image: url(data:image/jpeg;base64,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);\">",
"   </div>",
"   <div class=\"lgnd\">",
"    <div class=\"footnotes\">",
"    </div>",
"    <div class=\"reference\">",
"     Reproduced with permission from Stephen Ludwig, MD.",
"    </div>",
"   </div>",
"  </div>",
" </div>",
"</div>"].join("\n");
var script_f21_30_21985=[""].join("\n");
var outline_f21_30_21985=null;
var title_f21_30_21986="Bullous impetigo 2";
var content_f21_30_21986=[" <div id=\"graphicsToolbar\">",
"  <div id=\"graphicsCopy\">",
"   &copy;2013 UpToDate",
"   <sup>",
"    &reg;",
"   </sup>",
"  </div>",
"  <div id=\"graphicsLinks\">",
"   <a href=\"?imageKey=DERM%2F86956&amp;source=image_view&amp;view=print&amp;elapsedTimeMs=1\" onclick=\"\">",
"    <img alt=\"Print this page\" src=\"./../images/icn_print.myextg\" title=\"Print this page\"/>",
"   </a>",
"   <a class=\"icontxt textLink\" href=\"?imageKey=DERM%2F86956&amp;source=image_view&amp;view=print&amp;elapsedTimeMs=1\" onclick=\"\" title=\"Print this page\">",
"    Print",
"   </a>",
"   <a class=\"etacLink\" href=\"#\">",
"    <img alt=\"Email graphic(s)\" src=\"./../images/icn_email.myextg\" title=\"Email graphic(s)\"/>",
"   </a>",
"   <a class=\"icontxt textLink etacLink\" href=\"#\" title=\"Email graphic(s)\">",
"    Email",
"   </a>",
"  </div>",
" </div>",
" <div class=\"graphic\">",
"  <div class=\"figure\" style=\"width: 524px\">",
"   <div class=\"ttl\">",
"    Bullous impetigo",
"   </div>",
"   <div class=\"cntnt\" style=\"width: 504px; height: 378px; background-image: url(data:image/jpeg;base64,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);\">",
"   </div>",
"   <div class=\"lgnd\">",
"    <div class=\"footnotes\">",
"    </div>",
"    <div class=\"reference\">",
"     Reproduced with permission from: www.visualdx.com. Copyright Logical Images, Inc.",
"    </div>",
"   </div>",
"  </div>",
" </div>",
"</div>"].join("\n");
var script_f21_30_21986=[""].join("\n");
var outline_f21_30_21986=null;
var title_f21_30_21987="Total hip replacement (arthroplasty)";
var content_f21_30_21987=[" <h1 id=\"patTopicTitle\">",
"  Patient information: Total hip replacement (arthroplasty) (Beyond the Basics)",
" </h1>",
" <div id=\"patTopicContributors\">",
"  <div class=\"rcTop\">",
"   <div>",
"   </div>",
"  </div>",
"  <div class=\"rcContent\">",
"   <table>",
"    <tr>",
"     <td>",
"      <a class=\"contributor contributor_credentials patTopicContributorsType\" href=\"UTD.htm?21/30/21987/contributors\">",
"       Authors",
"      </a>",
"      <a class=\"contributor contributor_credentials\" href=\"UTD.htm?21/30/21987/contributors\" id=\"au6166\">",
"       Greg A Erens, MD",
"      </a>",
"      <a class=\"contributor contributor_credentials\" href=\"UTD.htm?21/30/21987/contributors\" id=\"au5724\">",
"       Peter H Schur, MD",
"      </a>",
"     </td>",
"     <td>",
"      <a class=\"contributor contributor_credentials patTopicContributorsType\" href=\"UTD.htm?21/30/21987/contributors\">",
"       Section Editor",
"      </a>",
"      <a class=\"contributor contributor_credentials\" href=\"UTD.htm?21/30/21987/contributors\" id=\"se4268\">",
"       Daniel E Furst, MD",
"      </a>",
"     </td>",
"     <td>",
"      <a class=\"contributor contributor_credentials patTopicContributorsType\" href=\"UTD.htm?21/30/21987/contributors\">",
"       Deputy Editor",
"      </a>",
"      <a class=\"contributor contributor_credentials\" href=\"UTD.htm?21/30/21987/contributors\" id=\"de4792\">",
"       Jerry M Greene, MD",
"      </a>",
"     </td>",
"    </tr>",
"   </table>",
"  </div>",
"  <div class=\"rcBottom\">",
"   <div>",
"   </div>",
"  </div>",
" </div>",
" <div class=\"patTopicTool\" id=\"patTopicToolTop\">",
"  <a class=\"toolbutton findicon findInPageLink\" href=\"#\" title=\"Find in Topic\">",
"   Find",
"  </a>",
"  <a class=\"toolbutton printicon\" href=\"UTD.htm?21/30/21987?view=print\" title=\"Print This Topic\">",
"   Print",
"  </a>",
"  <script src=\"file://w.sharethis.com/button/sharethis.js#publisher=357881b8-c7e3-4c31-b7d2-242aeb1528e1&amp;type=website&amp;post_services=care2%2Cfacebook%2Ctwitter%2Cmyspace%2Cdigg%2Cdelicious%2Cfaves%2Creddit%2Cxanga%2Cstumbleupon%2Cblinklist%2Csimpy%2Cyigg%2Ctechnorati%2Cmeneame%2Corkut%2Cmixx%2Cfunp%2Cfresqui%2Cmister_wong%2Cfriendster%2Cfriendfeed%2Clinkedin%2Coknotizie%2Cgoogle_bmarks%2Cyahoo_bmarks%2Cfark%2Cnewsvine%2Clivejournal%2Ctypepad%2Cbus_exchange%2Cpropeller%2Cwordpress%2Cblogger%2Cblogmarks%2Cwindows_live%2Cfurl%2Cybuzz%2Cdiigo\" type=\"text/javascript\">",
"  </script>",
" </div>",
" <div id=\"patTopicMiddle\">",
"  <div id=\"topicContent\">",
"   <div id=\"topicText\">",
"    <p class=\"headingAnchor\" id=\"H1\">",
"     <span class=\"h1\">",
"      HIP REPLACEMENT OVERVIEW",
"     </span>",
"    </p>",
"    <p>",
"     Normally, the hip functions as a &ldquo;ball-and-socket&rdquo; joint. The top of the thigh (femur) bone (ball) fits into a part of the pelvis called the acetabulum (socket), allowing the joint to move smoothly in multiple directions (",
"     <a class=\"graphic graphic_figure graphicRef70663 \" href=\"UTD.htm?42/1/43026\">",
"      figure 1",
"     </a>",
"     ). Total hip replacement is a surgical procedure that replaces the hip joint with artificial parts (called prostheses). (See",
"     <a class=\"medical medical_review\" href=\"UTD.htm?9/55/10106?source=see_link\">",
"      \"Total hip arthroplasty\"",
"     </a>",
"     .)",
"    </p>",
"    <p>",
"     The most common cause of hip joint deterioration is osteoarthritis; other possible causes include inflammatory arthritis (eg, rheumatoid or psoriatic arthritis), hip disorders of infancy and childhood, osteonecrosis (avascular necrosis), and trauma.",
"    </p>",
"    <p>",
"     This article will discuss total hip replacement surgery. A review of other treatment options for arthritis is available separately. (See",
"     <a class=\"medical medical_patient\" href=\"UTD.htm?21/29/21975?source=see_link\">",
"      \"Patient information: Osteoarthritis treatment (Beyond the Basics)\"",
"     </a>",
"     and",
"     <a class=\"medical medical_patient\" href=\"UTD.htm?23/44/24264?source=see_link\">",
"      \"Patient information: Rheumatoid arthritis treatment (Beyond the Basics)\"",
"     </a>",
"     and",
"     <a class=\"medical medical_patient\" href=\"UTD.htm?35/36/36419?source=see_link\">",
"      \"Patient information: Psoriatic arthritis (Beyond the Basics)\"",
"     </a>",
"     .)",
"    </p>",
"    <p class=\"headingAnchor\" id=\"H2\">",
"     <span class=\"h1\">",
"      REASONS FOR HIP REPLACEMENT",
"     </span>",
"    </p>",
"    <p>",
"     Total hip replacement is only considered when you have tried and failed more conservative treatments, yet you continue to have significant pain, stiffness, or problems with the function of your hip.",
"    </p>",
"    <p>",
"     Total hip replacement may be performed on adults with a deteriorated hip. However, the replacement parts can deteriorate over time, and healthcare providers generally recommend delaying hip replacement until it is absolutely necessary.",
"    </p>",
"    <p class=\"headingAnchor\" id=\"H3\">",
"     <span class=\"h1\">",
"      ALTERNATIVES TO HIP REPLACEMENT",
"     </span>",
"    </p>",
"    <p>",
"     While total hip replacement can be helpful under the right circumstances, you should only consider it after a discussion of the risks, benefits, and alternatives with a healthcare provider.",
"    </p>",
"    <p class=\"headingAnchor2\" id=\"H4\">",
"     <span class=\"h2\">",
"      Nonsurgical treatment",
"     </span>",
"     &nbsp;&mdash;&nbsp;Nonsurgical treatment methods are initially recommended for people with hip problems due to osteoarthritis or other conditions. Nonsurgical treatments for people with osteoarthritis include:",
"    </p>",
"    <p>",
"     <ul class=\"bulletCompact-block\">",
"      <li>",
"       Weight loss or maintenance of a healthy weight",
"      </li>",
"      <li>",
"       Physical therapy",
"      </li>",
"      <li>",
"       Use of an assistive device (such as a cane or walker)",
"      </li>",
"      <li>",
"       Pain-relieving medications",
"      </li>",
"      <li>",
"       Glucocorticoid (steroid) injection into the painful joint (see",
"       <a class=\"medical medical_patient\" href=\"UTD.htm?23/46/24289?source=see_link\">",
"        \"Patient information: Hip pain (Beyond the Basics)\"",
"       </a>",
"       )",
"      </li>",
"     </ul>",
"    </p>",
"    <p>",
"     People with inflammatory arthritis (such as rheumatoid arthritis) may benefit from a treatment regimen of antirheumatic or other medications. (See",
"     <a class=\"medical medical_patient\" href=\"UTD.htm?23/44/24264?source=see_link\">",
"      \"Patient information: Rheumatoid arthritis treatment (Beyond the Basics)\"",
"     </a>",
"     .)",
"    </p>",
"    <p class=\"headingAnchor2\" id=\"H5\">",
"     <span class=\"h2\">",
"      Surgical alternatives",
"     </span>",
"     &nbsp;&mdash;&nbsp;There are a few surgical alternatives to total hip replacement. Surgical alternatives to hip replacement, such as hip fusion or osteotomy, may be considered in people who are young or in whom a hip replacement may not be durable enough to last for many years",
"     <span class=\"nowrap\">",
"      and/or",
"     </span>",
"     may not withstand an active lifestyle. Total hip resurfacing is another option for younger patients. The best surgical procedure depends upon the reasons for which the joint deteriorated. More information about surgical alternatives to hip replacement is available separately. (See",
"     <a class=\"medical medical_review\" href=\"UTD.htm?9/55/10106?source=see_link\">",
"      \"Total hip arthroplasty\"",
"     </a>",
"     .)",
"    </p>",
"    <p class=\"headingAnchor\" id=\"H6\">",
"     <span class=\"h1\">",
"      TOTAL HIP REPLACEMENT PROCEDURE",
"     </span>",
"    </p>",
"    <p>",
"     Total hip replacement is performed in an operating room after you are given general or regional (epidural or spinal) anesthesia. The surgical approach used will be determined by your surgeon and is typically a single incision along the posterior (rear), lateral (side), or anterior (front) aspect of the hip. Less invasive hip replacement surgery techniques, which use smaller incisions and specialized instruments, are often used.",
"    </p>",
"    <p>",
"     The type of prosthesis used depends upon the needs of the particular patient and the surgeon performing the procedure. There are a variety of types of prosthetic surfaces, including metal-on-plastic, metal-on-metal, and ceramic-on-ceramic. An example of one type of prosthesis is shown here (",
"     <a class=\"graphic graphic_figure graphicRef65030 \" href=\"UTD.htm?16/43/17073\">",
"      figure 2",
"     </a>",
"     ). Each surface has unique advantages and disadvantages, and your surgeon can discuss which surface is appropriate for you. (See",
"     <a class=\"medical medical_review\" href=\"UTD.htm?9/55/10106?source=see_link\">",
"      \"Total hip arthroplasty\"",
"     </a>",
"     .)",
"    </p>",
"    <p class=\"headingAnchor\" id=\"H7\">",
"     <span class=\"h1\">",
"      AFTER SURGERY",
"     </span>",
"    </p>",
"    <p class=\"headingAnchor2\" id=\"H8\">",
"     <span class=\"h2\">",
"      Management",
"     </span>",
"     &nbsp;&mdash;&nbsp;After surgery, you will be given pain medication through your IV or by mouth. You will also be given an antibiotic to prevent infection. (See",
"     <a class=\"medical medical_review\" href=\"UTD.htm?27/34/28198?source=see_link\">",
"      \"Prevention of prosthetic joint infections\"",
"     </a>",
"     .)",
"    </p>",
"    <p>",
"     Most people are also given a medication to help prevent blood clots in the legs. Compression boots (devices that are worn around the legs and that inflate periodically) are often worn to prevent blood clots. Compression stockings may also be recommended. (See",
"     <a class=\"medical medical_review\" href=\"UTD.htm?40/52/41802?source=see_link\">",
"      \"Prevention of venous thromboembolic disease in surgical patients\"",
"     </a>",
"     .)",
"    </p>",
"    <p class=\"headingAnchor2\" id=\"H9\">",
"     <span class=\"h2\">",
"      Rehabilitation",
"     </span>",
"     &nbsp;&mdash;&nbsp;Physical therapy (PT) is an important part of the recovery process. Most people are able to try standing and even walking, with the help of a physical therapist, within the first 24 hours.",
"    </p>",
"    <p>",
"     Your length of stay in the hospital will depend upon a number of factors, although most people stay one to three days, during which time you will work with a physical therapist to develop an exercise and rehabilitation program. You may continue your therapy at home under the supervision of a physical therapist, or you may stay in a rehabilitation facility and continue PT until you are able to independently perform daily activities.",
"    </p>",
"    <p>",
"     The rehabilitation program generally includes exercises to stretch and strengthen the muscles surrounding the hip joint, as well as training in activities of daily life (eg, stair climbing, bending, walking). The goal of the rehabilitation is to regain strength and motion.",
"    </p>",
"    <p>",
"     After several months of rehabilitation, you will be encouraged to maintain an active lifestyle. Most people can resume their normal activities within three to six months. While high-impact sports such as running, contact sports, and skiing are not usually recommended after hip replacement, you can typically participate in activities like walking, cycling, and swimming.",
"    </p>",
"    <p>",
"     Most hip replacements last 10 to 15 years or longer, and most people are very satisfied with the outcome. Newer prosthetic types may extend the life of the hip replacement.",
"    </p>",
"    <p class=\"headingAnchor\" id=\"H10\">",
"     <span class=\"h1\">",
"      TOTAL HIP REPLACEMENT COMPLICATIONS",
"     </span>",
"    </p>",
"    <p>",
"     Serious complications after hip replacement surgery are not common and can be minimized by choosing a clinician who is experienced and who performs the procedure frequently and by choosing a hospital that is experienced in caring for patients before, during, and after surgery.",
"    </p>",
"    <p>",
"     Complications can occur during surgery, in the immediate postoperative period, or many years after surgery. It is important to understand these potential risks before deciding to undergo hip replacement. For most patients, the benefits of reduced pain and improved function outweigh the small risk of complications. (See",
"     <a class=\"medical medical_review\" href=\"UTD.htm?1/39/1658?source=see_link\">",
"      \"Complications of total hip arthroplasty\"",
"     </a>",
"     .)",
"    </p>",
"    <p class=\"headingAnchor2\" id=\"H11\">",
"     <span class=\"h2\">",
"      Complications during surgery",
"     </span>",
"     &nbsp;&mdash;&nbsp;Very rarely, complications can occur during the actual hip replacement procedure. These include fractures (typically of the femur) and injury to the surrounding nerves or blood vessels. Most of these complications can be treated during the course of the surgery.",
"    </p>",
"    <p class=\"headingAnchor2\" id=\"H12\">",
"     <span class=\"h2\">",
"      Blood clots",
"     </span>",
"     &nbsp;&mdash;&nbsp;People who undergo hip replacement are at increased risk for developing blood clots after surgery. With appropriate preventive treatments, only about 1 percent of people will develop a blood clot. (See",
"     <a class=\"medical medical_patient\" href=\"UTD.htm?12/44/12998?source=see_link\">",
"      \"Patient information: Deep vein thrombosis (DVT) (Beyond the Basics)\"",
"     </a>",
"     and",
"     <a class=\"medical medical_patient\" href=\"UTD.htm?2/29/2517?source=see_link\">",
"      \"Patient information: Pulmonary embolism (Beyond the Basics)\"",
"     </a>",
"     .)",
"    </p>",
"    <p class=\"headingAnchor2\" id=\"H13\">",
"     <span class=\"h2\">",
"      Infection",
"     </span>",
"     &nbsp;&mdash;&nbsp;Infection following hip replacement is uncommon (between 0.4 and 1.5 percent of patients). Antibiotics are routinely given to help prevent infection. (See",
"     <a class=\"medical medical_patient\" href=\"UTD.htm?18/21/18769?source=see_link\">",
"      \"Patient information: Joint infection (Beyond the Basics)\"",
"     </a>",
"     and",
"     <a class=\"medical medical_review\" href=\"UTD.htm?6/19/6457?source=see_link\">",
"      \"Treatment of prosthetic joint infections\"",
"     </a>",
"     .)",
"    </p>",
"    <p class=\"headingAnchor2\" id=\"H14\">",
"     <span class=\"h2\">",
"      Dislocation",
"     </span>",
"     &nbsp;&mdash;&nbsp;Dislocation of the artificial hip joint can occur if the ball becomes dislodged from the socket. Dislocation occurs in less than 2 percent of patients. In most cases, an orthopedic surgeon can move the joint back into place while the patient is sedated.",
"    </p>",
"    <p>",
"     To minimize the risk of dislocation, some patients are given specific precautions related to the motion of the hip. The particular precautions depend upon how your surgery is performed and should be discussed with your surgeon.",
"    </p>",
"    <p class=\"headingAnchor2\" id=\"H15\">",
"     <span class=\"h2\">",
"      Loosening",
"     </span>",
"     &nbsp;&mdash;&nbsp;Loosening of the joint implant is most often caused by wear of the prosthetic components. It is the most common long-term problem associated with total hip replacement, although the number of people who develop loosening is decreasing as prosthetic materials and surfaces are improved.",
"    </p>",
"    <p class=\"headingAnchor2\" id=\"H16\">",
"     <span class=\"h2\">",
"      Breakage",
"     </span>",
"     &nbsp;&mdash;&nbsp;Breakage of the implant itself can occur as a result of wear and tear of the prosthesis, often over the course of years. Older implants are more likely to break, while newer prostheses are stronger and more durable. This is a rare occurrence, with less than 0.5 percent of people experiencing breakage.",
"    </p>",
"    <p class=\"headingAnchor2\" id=\"H17\">",
"     <span class=\"h2\">",
"      Change in leg length",
"     </span>",
"     &nbsp;&mdash;&nbsp;Before, during, and after hip replacement surgery, a surgeon carefully measures the length of your legs in an attempt to make them equal length. However, in rare cases, the procedure results in one leg being slightly longer than the other. Some people with a significant difference in leg length find that wearing a lift in one shoe is helpful.",
"    </p>",
"    <p class=\"headingAnchor2\" id=\"H18\">",
"     <span class=\"h2\">",
"      Joint stiffening",
"     </span>",
"     &nbsp;&mdash;&nbsp;Joint stiffening caused by extra bone formation, also called heterotopic ossification, is a process in which some soft tissues around the hip harden into bone. People with this problem may experience hip stiffness or may feel no discomfort at all. If you are at risk for joint stiffening, your healthcare provider may recommend a preventive treatment.",
"    </p>",
"    <p class=\"headingAnchor\" id=\"H19\">",
"     <span class=\"h1\">",
"      SUMMARY",
"     </span>",
"    </p>",
"    <p>",
"     <ul class=\"bullet-block\">",
"      <li>",
"       Total hip replacement (THR) is a very effective surgical procedure that involves replacing the damaged \"ball and socket\" parts of the hip with replacement (prosthetic) parts, with the goal of relieving pain and improving function.",
"      </li>",
"      <li>",
"       Most patients require THR due to pain caused by arthritis. (See",
"       <a class=\"local\" href=\"#H2\">",
"        'Reasons for hip replacement'",
"       </a>",
"       above.)",
"      </li>",
"      <li>",
"       Following surgery, you will be given medications to prevent infection and control pain. Measures are also taken to prevent blood clots. (See",
"       <a class=\"local\" href=\"#H8\">",
"        'Management'",
"       </a>",
"       above.)",
"      </li>",
"      <li>",
"       You will work with a physical therapist after surgery to strengthen and stretch the muscles around the hip. (See",
"       <a class=\"local\" href=\"#H9\">",
"        'Rehabilitation'",
"       </a>",
"       above.)",
"      </li>",
"      <li>",
"       After surgery, you can usually resume your normal activities within three to six months. Newer surgical techniques may allow some patients to return to normal activities even faster. Low-impact activities such as walking, cycling, and swimming are recommended. High impact activities, such as running, are not usually recommended after hip replacement surgery.",
"      </li>",
"      <li>",
"       Complications following hip replacement surgery are uncommon, and can usually be prevented with careful post-operative management. (See",
"       <a class=\"local\" href=\"#H10\">",
"        'Total hip replacement complications'",
"       </a>",
"       above.)",
"      </li>",
"     </ul>",
"    </p>",
"    <p class=\"headingAnchor\" id=\"H20\">",
"     <span class=\"h1\">",
"      WHERE TO GET MORE INFORMATION",
"     </span>",
"    </p>",
"    <p>",
"     Your healthcare provider is the best source of information for questions and concerns related to your medical problem.",
"    </p>",
"    <p>",
"     This article will be updated as needed on our web site (",
"     <a class=\"external\" href=\"file://www.uptodate.com/patients\">",
"      www.uptodate.com/patients",
"     </a>",
"     ). Related topics for patients, as well as selected articles written for healthcare professionals, are also available. Some of the most relevant are listed below.",
"     <br/>",
"    </p>",
"    <p class=\"headingAnchor2\" id=\"H1784876161\">",
"     <span class=\"h2\">",
"      Patient level information",
"     </span>",
"     &nbsp;&mdash;&nbsp;UpToDate offers two types of patient education materials.",
"    </p>",
"    <p class=\"headingAnchor2\" id=\"H181960465\">",
"     <span class=\"h3\">",
"      The Basics",
"     </span>",
"     &nbsp;&mdash;&nbsp;The Basics patient education pieces answer the four or five key questions a patient might have about a given condition. These articles are best for patients who want a general overview and who prefer short, easy-to-read materials.",
"    </p>",
"    <p>",
"     <a class=\"medical medical_basics\" href=\"UTD.htm?42/3/43058?source=see_link\">",
"      Patient information: Osteoarthritis (The Basics)",
"     </a>",
"     <br/>",
"     <a class=\"medical medical_basics\" href=\"UTD.htm?22/34/23075?source=see_link\">",
"      Patient information: Hip replacement (The Basics)",
"     </a>",
"     <br/>",
"     <a class=\"medical medical_basics\" href=\"UTD.htm?22/46/23266?source=see_link\">",
"      Patient information: Aseptic necrosis of the hip (The Basics)",
"     </a>",
"     <br/>",
"     <a class=\"medical medical_basics\" href=\"UTD.htm?14/33/14867?source=see_link\">",
"      Patient information: Hip fracture (The Basics)",
"     </a>",
"     <br/>",
"     <a class=\"medical medical_basics\" href=\"UTD.htm?11/59/12211?source=see_link\">",
"      Patient information: Paget disease of bone (The Basics)",
"     </a>",
"    </p>",
"    <p class=\"headingAnchor2\" id=\"H181960500\">",
"     <span class=\"h3\">",
"      Beyond the Basics",
"     </span>",
"     &nbsp;&mdash;&nbsp;Beyond the Basics patient education pieces are longer, more sophisticated, and more detailed. These articles are best for patients who want in-depth information and are comfortable with some medical jargon.",
"    </p>",
"    <p>",
"     <a class=\"medical medical_patient\" href=\"UTD.htm?21/29/21975?source=see_link\">",
"      Patient information: Osteoarthritis treatment (Beyond the Basics)",
"     </a>",
"     <br/>",
"     <a class=\"medical medical_patient\" href=\"UTD.htm?23/44/24264?source=see_link\">",
"      Patient information: Rheumatoid arthritis treatment (Beyond the Basics)",
"     </a>",
"     <br/>",
"     <a class=\"medical medical_patient\" href=\"UTD.htm?35/36/36419?source=see_link\">",
"      Patient information: Psoriatic arthritis (Beyond the Basics)",
"     </a>",
"     <br/>",
"     <a class=\"medical medical_patient\" href=\"UTD.htm?23/46/24289?source=see_link\">",
"      Patient information: Hip pain (Beyond the Basics)",
"     </a>",
"     <br/>",
"     <a class=\"medical medical_patient\" href=\"UTD.htm?12/44/12998?source=see_link\">",
"      Patient information: Deep vein thrombosis (DVT) (Beyond the Basics)",
"     </a>",
"     <br/>",
"     <a class=\"medical medical_patient\" href=\"UTD.htm?2/29/2517?source=see_link\">",
"      Patient information: Pulmonary embolism (Beyond the Basics)",
"     </a>",
"     <br/>",
"     <a class=\"medical medical_patient\" href=\"UTD.htm?18/21/18769?source=see_link\">",
"      Patient information: Joint infection (Beyond the Basics)",
"     </a>",
"     <br/>",
"    </p>",
"    <p class=\"headingAnchor2\" id=\"H21\">",
"     <span class=\"h2\">",
"      Professional level information",
"     </span>",
"     &nbsp;&mdash;&nbsp;Professional level articles are designed to keep doctors and other health professionals up-to-date on the latest medical findings. These articles are thorough, long, and complex, and they contain multiple references to the research on which they are based. Professional level articles are best for people who are comfortable with a lot of medical terminology and who want to read the same materials their doctors are reading.",
"    </p>",
"    <p>",
"     <a class=\"medical medical_review\" href=\"UTD.htm?1/39/1658?source=see_link\">",
"      Complications of total hip arthroplasty",
"     </a>",
"     <br/>",
"     <a class=\"medical medical_review\" href=\"UTD.htm?42/59/43961?source=see_link\">",
"      Low molecular weight heparin for venous thromboembolic disease",
"     </a>",
"     <br/>",
"     <a class=\"medical medical_review\" href=\"UTD.htm?41/43/42680?source=see_link\">",
"      Clinical manifestations and diagnosis of prosthetic joint infections",
"     </a>",
"     <br/>",
"     <a class=\"medical medical_review\" href=\"UTD.htm?27/34/28198?source=see_link\">",
"      Prevention of prosthetic joint infections",
"     </a>",
"     <br/>",
"     <a class=\"medical medical_review\" href=\"UTD.htm?35/21/36186?source=see_link\">",
"      Prevention of venous thromboembolic disease in medical patients",
"     </a>",
"     <br/>",
"     <a class=\"medical medical_review\" href=\"UTD.htm?40/52/41802?source=see_link\">",
"      Prevention of venous thromboembolic disease in surgical patients",
"     </a>",
"     <br/>",
"     <a class=\"medical medical_review\" href=\"UTD.htm?12/9/12440?source=see_link\">",
"      Surgical therapy of osteoarthritis",
"     </a>",
"     <br/>",
"     <a class=\"medical medical_review\" href=\"UTD.htm?9/55/10106?source=see_link\">",
"      Total hip arthroplasty",
"     </a>",
"     <br/>",
"     <a class=\"medical medical_review\" href=\"UTD.htm?31/20/32073?source=see_link\">",
"      Total joint replacement for severe rheumatoid arthritis",
"     </a>",
"     <br/>",
"     <a class=\"medical medical_review\" href=\"UTD.htm?6/19/6457?source=see_link\">",
"      Treatment of prosthetic joint infections",
"     </a>",
"     <br/>",
"     <br/>",
"     The following organizations also provide reliable health information.",
"    </p>",
"    <p>",
"     <ul class=\"bullet-block\">",
"      <li>",
"       National Library of Medicine",
"       <br/>",
"       (",
"       <a class=\"external\" href=\"file://www.nlm.nih.gov/medlineplus/healthtopics.html\">",
"        www.nlm.nih.gov/medlineplus/healthtopics.html",
"       </a>",
"       )",
"      </li>",
"      <li>",
"       The Arthritis Foundation",
"       <br/>",
"       (800) 283-7800",
"       <br/>",
"       (",
"       <a class=\"external\" href=\"file://www.arthritis.org/\">",
"        www.arthritis.org",
"       </a>",
"       )",
"      </li>",
"      <li>",
"       American Academy of Orthopaedic Surgeons",
"       <br/>",
"       (",
"       <a class=\"external\" href=\"file://orthoinfo.aaos.org/\">",
"        orthoinfo.aaos.org",
"       </a>",
"       )",
"      </li>",
"      <li>",
"       The National Institute of Arthritis and Musculoskeletal and Skin Diseases",
"       <br/>",
"       (",
"       <a class=\"external\" href=\"file://www.niams.nih.gov/Health_Info/Hip_Replacement\">",
"        www.niams.nih.gov/Health_Info/Hip_Replacement",
"       </a>",
"       )",
"      </li>",
"     </ul>",
"    </p>",
"    <p>",
"     [",
"     <a class=\"abstract\" href=\"UTD.htm?21/30/21987/abstract/1-5\">",
"      1-5",
"     </a>",
"     ]",
"    </p>",
"   </div>",
"  </div>",
"  <div id=\"literatureReviewDate\">",
"   <span class=\"emphasis\">",
"    Literature review current through:",
"   </span>",
"   Oct 2013.",
"   <span class=\"pipeSpace\">",
"    |",
"   </span>",
"   <span class=\"emphasis\">",
"    This topic last updated:",
"   </span>",
"   Jun 6, 2012.",
"  </div>",
"  <div class=\"patTopicTool\" id=\"patTopicToolBottom\">",
"   <a class=\"toolbutton findicon findInPageLink\" href=\"#\" title=\"Find in Topic\">",
"    Find",
"   </a>",
"   <a class=\"toolbutton printicon\" href=\"UTD.htm?21/30/21987?view=print\" title=\"Print This Topic\">",
"    Print",
"   </a>",
"  </div>",
"  <div id=\"disclaimer\">",
"   The content on the UpToDate website is not intended nor recommended as a substitute",
"for medical advice, diagnosis, or treatment.  Always seek the advice of your own physician or",
"other qualified health care professional regarding any medical questions or conditions.  The",
"use of this website is governed by the",
"   <a href=\"/home/terms-use\" target=\"_blank\">",
"    UpToDate Terms of Use",
"   </a>",
"   &copy;2013 UpToDate, Inc.",
"  </div>",
"  <div class=\"headingAnchor\" id=\"references\">",
"   <div id=\"patTopicRefHeader\">",
"    <div id=\"patTopicRefHeaderHeader\">",
"     References",
"    </div>",
"    <div id=\"patTopicRefHeaderTop\">",
"     <a href=\"#top\">",
"      <img alt=\"\" src=\"./../images/top_arrow.myextg\">",
"       Top",
"      </img>",
"     </a>",
"    </div>",
"   </div>",
"   <ol id=\"reference\">",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?21/30/21987/abstract/1\">",
"      Mancuso CA, Salvati EA. Patients' satisfaction with the process of total hip arthroplasty. J Healthc Qual 2003; 25:12.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?21/30/21987/abstract/2\">",
"      McLaughlin JR, Lee KR. Total hip arthroplasty in young patients. 8- to 13-year results using an uncemented stem. Clin Orthop Relat Res 2000; :153.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?21/30/21987/abstract/3\">",
"      Keisu KS, Orozco F, Sharkey PF, et al. Primary cementless total hip arthroplasty in octogenarians. Two to eleven-year follow-up. J Bone Joint Surg Am 2001; 83-A:359.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?21/30/21987/abstract/4\">",
"      Ibrahim SA, Stone RA, Han X, et al. Racial/ethnic differences in surgical outcomes in veterans following knee or hip arthroplasty. Arthritis Rheum 2005; 52:3143.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?21/30/21987/abstract/5\">",
"      Saleh KJ, Kassim R, Yoon P, Vorlicky LN. Complications of total hip arthroplasty. Am J Orthop (Belle Mead NJ) 2002; 31:485.",
"     </a>",
"    </li>",
"   </ol>",
"  </div>",
" </div>",
" <!-- patTopicMiddle -->",
"</div>"].join("\n");
var script_f21_30_21987=[""].join("\n");
var outline_f21_30_21987=[" <div class=\"patTopicFancyTop\">",
"  <div class=\"rcTop\">",
"   <div>",
"   </div>",
"  </div>",
"  <div class=\"rcContent\">",
"   <p>",
"    Contents of this article",
"   </p>",
"  </div>",
" </div>",
" <div class=\"patTopicFancySpacer\">",
" </div>",
" <div class=\"patTopicOutline\">",
"  <div class=\"rcbBottom\">",
"   <div class=\"rcbLeft\">",
"    <div class=\"rcbRight\">",
"     <div class=\"rcbBottomLeft\">",
"      <div class=\"rcbBottomRight rcbBottomRightBottomOnly\">",
"       <div id=\"outline\">",
"        <ul>",
"         <li class=\"plainItem\">",
"          <a href=\"#H1\">",
"           HIP REPLACEMENT OVERVIEW",
"          </a>",
"         </li>",
"         <li class=\"plainItem\">",
"          <a href=\"#H2\">",
"           REASONS FOR HIP REPLACEMENT",
"          </a>",
"         </li>",
"         <li class=\"plainItem\">",
"          <a href=\"#H3\">",
"           ALTERNATIVES TO HIP REPLACEMENT",
"          </a>",
"         </li>",
"         <li class=\"plainItem\">",
"          <a href=\"#H6\">",
"           TOTAL HIP REPLACEMENT PROCEDURE",
"          </a>",
"         </li>",
"         <li class=\"plainItem\">",
"          <a href=\"#H7\">",
"           AFTER SURGERY",
"          </a>",
"         </li>",
"         <li class=\"plainItem\">",
"          <a href=\"#H10\">",
"           TOTAL HIP REPLACEMENT COMPLICATIONS",
"          </a>",
"         </li>",
"         <li class=\"plainItem\">",
"          <a href=\"#H19\">",
"           SUMMARY",
"          </a>",
"         </li>",
"         <li class=\"plainItem\">",
"          <a href=\"#H20\">",
"           WHERE TO GET MORE INFORMATION",
"          </a>",
"         </li>",
"         <li class=\"plainItem\">",
"          <a href=\"#references\">",
"           REFERENCES",
"          </a>",
"         </li>",
"        </ul>",
"       </div>",
"       <h1>",
"        GRAPHICS",
"       </h1>",
"       <div id=\"relatedGraphics\">",
"        <ul>",
"         <li class=\"plainItem\">",
"          FIGURES",
"         </li>",
"         <li class=\"bulletItem\">",
"          <a class=\"graphic graphic_figure\" href=\"UTD.htm?42/1/43026\" title=\"figure 1\">",
"           Hip anatomy PI",
"          </a>",
"         </li>",
"         <li class=\"bulletItem\">",
"          <a class=\"graphic graphic_figure\" href=\"UTD.htm?16/43/17073\" title=\"figure 2\">",
"           Hip prosthesis PI",
"          </a>",
"         </li>",
"        </ul>",
"       </div>",
"      </div>",
"     </div>",
"    </div>",
"   </div>",
"  </div>",
" </div>"].join("\n");
var title_f21_30_21988="Gluteal artery pseudoaneurysm";
var content_f21_30_21988=[" <div id=\"graphicsToolbar\">",
"  <div id=\"graphicsCopy\">",
"   &copy;2013 UpToDate",
"   <sup>",
"    &reg;",
"   </sup>",
"  </div>",
"  <div id=\"graphicsLinks\">",
"   <a href=\"?imageKey=NEURO%2F56082&amp;source=image_view&amp;view=print&amp;elapsedTimeMs=1\" onclick=\"\">",
"    <img alt=\"Print this page\" src=\"./../images/icn_print.myextg\" title=\"Print this page\"/>",
"   </a>",
"   <a class=\"icontxt textLink\" href=\"?imageKey=NEURO%2F56082&amp;source=image_view&amp;view=print&amp;elapsedTimeMs=1\" onclick=\"\" title=\"Print this page\">",
"    Print",
"   </a>",
"   <a class=\"etacLink\" href=\"#\">",
"    <img alt=\"Email graphic(s)\" src=\"./../images/icn_email.myextg\" title=\"Email graphic(s)\"/>",
"   </a>",
"   <a class=\"icontxt textLink etacLink\" href=\"#\" title=\"Email graphic(s)\">",
"    Email",
"   </a>",
"  </div>",
" </div>",
" <div class=\"graphic\">",
"  <div class=\"figure\" style=\"width: 470px\">",
"   <div class=\"ttl\">",
"    Gluteal artery pseudoaneurysm",
"   </div>",
"   <div class=\"cntnt\" style=\"width: 337px; height: 514px; background-image: url(data:image/jpeg;base64,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);\">",
"   </div>",
"   <div class=\"lgnd\">",
"    (A and B) Pelvic computed tomography with intravenous contrast demonstrates a large intrapelvic hematoma (arrows) and pseudoaneurysm.",
"    <div class=\"footnotes\">",
"    </div>",
"    <div class=\"reference\">",
"     Reproduced with permission from: Yurtseven T, Zileli M, Goker EN, et al. Gluteal artery pseudoaneurysm, a rare cause of sciatic pain: Case report and literature review. J Spinal Disord Tech 2002; 15:330. Copyright &copy; 2002 Lippincott Williams &amp; Wilkins.",
"    </div>",
"   </div>",
"  </div>",
" </div>",
"</div>"].join("\n");
var script_f21_30_21988=[""].join("\n");
var outline_f21_30_21988=null;
var title_f21_30_21989="Rosacea papules on face";
var content_f21_30_21989=[" <div id=\"graphicsToolbar\">",
"  <div id=\"graphicsCopy\">",
"   &copy;2013 UpToDate",
"   <sup>",
"    &reg;",
"   </sup>",
"  </div>",
"  <div id=\"graphicsLinks\">",
"   <a href=\"?imageKey=DERM%2F53889&amp;source=image_view&amp;view=print&amp;elapsedTimeMs=45\" onclick=\"\">",
"    <img alt=\"Print this page\" src=\"./../images/icn_print.myextg\" title=\"Print this page\"/>",
"   </a>",
"   <a class=\"icontxt textLink\" href=\"?imageKey=DERM%2F53889&amp;source=image_view&amp;view=print&amp;elapsedTimeMs=45\" onclick=\"\" title=\"Print this page\">",
"    Print",
"   </a>",
"   <a class=\"etacLink\" href=\"#\">",
"    <img alt=\"Email graphic(s)\" src=\"./../images/icn_email.myextg\" title=\"Email graphic(s)\"/>",
"   </a>",
"   <a class=\"icontxt textLink etacLink\" href=\"#\" title=\"Email graphic(s)\">",
"    Email",
"   </a>",
"  </div>",
" </div>",
" <div class=\"graphic\">",
"  <div class=\"figure\" style=\"width: 524px\">",
"   <div class=\"ttl\">",
"    Rosacea",
"   </div>",
"   <div class=\"cntnt\" style=\"width: 504px; height: 378px; background-image: url(data:image/jpeg;base64,/9j/4AAQSkZJRgABAQAAAQABAAD/2wBDAAYEBQYFBAYGBQYHBwYIChAKCgkJChQODwwQFxQYGBcUFhYaHSUfGhsjHBYWICwgIyYnKSopGR8tMC0oMCUoKSj/2wBDAQcHBwoIChMKChMoGhYaKCgoKCgoKCgoKCgoKCgoKCgoKCgoKCgoKCgoKCgoKCgoKCgoKCgoKCgoKCgoKCgoKCj/wAARCAF6AfgDASIAAhEBAxEB/8QAHwAAAQUBAQEBAQEAAAAAAAAAAAECAwQFBgcICQoL/8QAtRAAAgEDAwIEAwUFBAQAAAF9AQIDAAQRBRIhMUEGE1FhByJxFDKBkaEII0KxwRVS0fAkM2JyggkKFhcYGRolJicoKSo0NTY3ODk6Q0RFRkdISUpTVFVWV1hZWmNkZWZnaGlqc3R1dnd4eXqDhIWGh4iJipKTlJWWl5iZmqKjpKWmp6ipqrKztLW2t7i5usLDxMXGx8jJytLT1NXW19jZ2uHi4+Tl5ufo6erx8vP09fb3+Pn6/8QAHwEAAwEBAQEBAQEBAQAAAAAAAAECAwQFBgcICQoL/8QAtREAAgECBAQDBAcFBAQAAQJ3AAECAxEEBSExBhJBUQdhcRMiMoEIFEKRobHBCSMzUvAVYnLRChYkNOEl8RcYGRomJygpKjU2Nzg5OkNERUZHSElKU1RVVldYWVpjZGVmZ2hpanN0dXZ3eHl6goOEhYaHiImKkpOUlZaXmJmaoqOkpaanqKmqsrO0tba3uLm6wsPExcbHyMnK0tPU1dbX2Nna4uPk5ebn6Onq8vP09fb3+Pn6/9oADAMBAAIRAxEAPwDPKlkJYKEA4z1NTK8Qj++N5Axz0rPgifzB50p9qupB8u9yCc+nQVwXPZCd8gtIQQOoHAAqaOWIKF3Kc/3TUZLSERmIqByGPT/69IGjV03jLE9hUvTUF2LwnXcUA3tjg9qltY1kTIRQR27GoItrtgKVB/ixipbYABjHk4OMgf1podjSjBLACMruGOnapVGwuVUg44z0+tQmUhAT8+RtAp0zF4zldo7Z61om+grdxzgyuWkkGBx9TTXA2/dbaOS3rQj7IiDGDjAGBkmmyq02F4Yt1x/CPrQ7DTHiaIMu2PIJwDnNPXEqYB4Jx7VHKhUDkZ7kDrSbtvDE5IyRjGKHfqG42RSZMKc4OAVpzuYmwV4bqp71GjyOf3QCrg5bHpVhxGsSgtuYr37GptpdD6kTFimSeeyillTA+Y7WHOfWrEEKrAJS48xuo7imyIzM27DdOfWn0BMhZFI2k4YnORUEiuNxAO0fearMiAAsc49KRMyYXGOORU+Q7kOFeEBhtcHIJqMbdjB2wTyM+tWZYdrKSCwPp2pxUMMOFJA44przEMjjULn5kY9+w9KermNzv+f9RSBcqACwPc+ntTUBPQ8Z6Uw3HQx5VnA3AcBCf5UJKUUkFiDwOKfJG3KpgH03cUvzyBl2KvYDPP1otYV+49Itqq8jYyMgpzz7ikLqUJU5Y9ivFQPBIB8pUH+7nODUYcsGVm2hetNu3QaV+pcWSa3cOGeNhzuJxUZkcqzEAhudz1Wby2JMlwzjsCKb9oiTO9Xk7AMelIqxPIYif3rEsBwFHU+lQ5mKZEYVO5PGDUU2qQquIFUHoVHJNRJvYIbl2SM8gHkn8KPQNtxszRjI3s2eoxwKi8tWh3SyBQDjaOoFSyXaxyZs40ynJcjJBPrmqsSsh3uoOG6Hqx/woskx6sWaTbGBEuyNz36nFQwDJ8qNCzE8HsPWri2c0+XYFh1PHCitCG3hgEJ2F5A2ce2KpK+rIvbYp2tio3NKMyY+VewNWGjWPZuGR/CBxkirLeYFKtGdx5Ud8npSPG6/NcZOxdoGMgE1T0VkLcrldrooAzjgrxnNWkQbwgDEsQWI9u1JEFVVkfABHyk8ipo4ijI0bHB689PpUrYZNFCkgkMfyr1CnqTUkVuhl3s7bTwWPY+wqSCUxNhFOMD7wwc1deQxwsI9nnZJJAz+tXoxaoiuoooyESIqQOSeS34VWeVvJA2kRgYG406Bmhn3yyb888c1BfSwlR5Cvk4zn174qXLrsVGPQqFtu4hmJPfNTbAYMEAcYHP61CkLmXLqFUctuHagSr9p25yBwAB2rHY1fkRog8wbwCPel8pjkDAHt6U+4AB4GVPQelECuwLbThRjml5BbqCIFG7p6Uqgv249aUB1J3dT29qkVY9p2kgnjJouMIlA6/M54FSscKMDmhlUKNvDY5qKPMYZmJPcCgRJbeYmQzBscj2rRsnd9xlJxnt0qkGXAK4AOOK2bSUQDaEV4+uG7mtIK+5M2XLdlZigRAG74JFPu4llkRjHHHxgKg61FHHcNlpQFX+EA/d9qcLZusjM0fTIGMGtk3bY5+tyi0PlfMCQxbHXiqk5dQWAXZnANW7kbMBFYjPzF+TVaZ0jTdG2B3BrKXZmsW2U5OfmOFYeprOuCzMxKrx3NaEjFmLDHPHFUpW3MRtyRxWZoZN2m5G+U7iOntXK6gzDJZSD0rrdQDBQ3I7cdq5bVvuMDyT70xMw12gg89cYPepHA3ccY5qIsu0DIJ6DHarUHKHOCcUMxEhYhgepzRSjmQDoe9FSWdERK/KmNUyAOMmrquuFVWBJ6moAFkgUOm1QePepEiQKxCDIHArRmW5PsDMWIJbpnPSl8ndNGo2qvc4z+tNVXaNAnXoR2p8YVWKliWUZaoaLRJNF58oRW/djluOvtVuFDHCUyME4AA6CmWMokt5GzwDxgcmpJn2DEfL549PrVcq3FrsTwGOOJgxBYcEn+lISCihQTg5Bx1pkKsRkAZJ+9jvTZWfld5Vieg7+9Fx7liaR2TOVUAcADFJAZA25diR459TVVPMHysxyeSSanjiJAZEO3OC5PFF2x2sTuf8AnoMjHy5I4qN0WHarFHdxnI7D3qeRdkYRQowMljzkVVUGXdtAAzwQKbYkrklmhXAQqUJwc0SlFnK7gQpx0/rTFVuflJx/L1pYreRoi6gKoPUmlfSyK66krOsYYxgjcON9Ac7F3dehx1o25UKvzOeKHRo8gY5988/WhCJJsyRlI1YRjFMjXYXzneBxgVIJT5mwbdx5OOgNNBG997EtjOaegdLETqwXKqRnqPX6U/ynnKOsDbAOSO9WI5AGJaQOW5GB0GKTzEkhZctkH6ZppIWqKoYAAxiTfk8nnNBQqOjBW9BxmpkUNGchg4Py8dRU4QcKzBVb+EmmtQZR3ODsEWPr3pGS4YABMOvQHpirbRYJIcHPO70xQQropLk9ix7U/JgZUiyy7jHtUD7249aRLMsMNcRrgdCa0/s8ap8yuRnjtUDosgLRQygnOdxzn6VPKkNSZnGIKFXcxPIIA4FN3I0eREWI7MefyrRksp3UvISTgDnr+VH2BzHncVY5Xp94+nvQl2Q211ZRiVo4y0Yjj3HgEfMKj+y75Rsd5lC/N2rfTT0jUmSMMSRuBPI/Co7hFmmZIG8mNRhmb+Qq+XTUjm1MWC1afe5YoucEAdfaryW8MaEnJCj7zcZPpVmNkTIVticZIHXHUmopZxJMDCgZCchiM7RQrD1Y63iDWsju7RbSNkfeTNOCeRKmPmUHJ46+1XVeWYI0mEhOUGwY+pJprswaeRXwzDagI4Aq7EpkVzPG7TSyxsjgHr2PYVRLsoTDb0QglDnknrUkqocrJIzuPvEdzVpUPIC7kK7setQ22aRSS0Kz7QnloTsblgR0qzDCq4zETEOrg/d9KjVO2A69g/XHpmkuGkCtlSMcYzUN21L5b6GkIYpUUzTMVB4wOTTFdXcqFAPXrjA+lVrOaaZcy/KuPSpZExJuSMqCPlz1PvT31SFa2g65kaL5Y48qOgI4+tUQ0h42ZzznvV6YOkJQsYwfvknPPpVVLho5S0eHIGBkcCpe5UVoKysYSzzY3HaVXriq6x7CGTaCTgY6/jVhhJ5X7x1VQP4e9RRwymISqpUDgE+tS9ykMIQt+8J9venwMSAVXheuegpqx7WCv87dSewp2SiYJxntStYehIzYbAOSajk27eMkelEhJjBHA9TSxZaLBIH+FIEuwyYySBNhC89aniUB1BPzdDTdoQD0xx71IJYwC3U47etMGi1BEFYtgbh0q5Cp8wqq5yMnmqlu2WDE846DrVuE5dlBCADNXFmUia2cmceZGWI6hTVy1M0zEGFpNoz15/WoYJV8tgpOB14pbedwSFUq7AjPqPStIoxeoSI/Em0hzxtPPFZ14Y2UggbvbtWjm4jiVptrAdiayr91MxZCFB6ilNlU9WU9xRduASeSapXYZGLKcqetW12sCCcEd6q3CbRy2Qf0rGxs9yrLtMOCuCe/WuK12Nln3KflzyPeuyfcq8ENWBq9uJBkpyCfrS3DZnI87mDD5jVqNgOg4HU1DOhV+RzSrnAA5LdaroYPRlkBjIRx68UVXhcrOF9exoqfUtLTQ7CJTMsbAsAD1HFSooRlDPgtzz1NIdqlUXcVI49KnSBfMMkgBYDrnpWzRkKvmLEFAABJwT708RblYSADAwNtHzk/vBx94Ad6czM0eVCknpjtWbRS0FiiIjMYbAU5XnFTKCWKqSTt+8envUKAIGZz0OMmrcBMsWV6HvQuwwDO0PlR9AMlv8KURuSqKN7Acn+tTQLmUjO4f3qtROcsUQYPy7iaq19xXtsVIYn3KTgnt6ircsUwQRsNxx1J6U5QsfyvHuYrkbDTdhS3JySx6k9qaWg7kc3m4VE2nHBJ7fSoNgBKsx2jpx1q6nMWXfC9BTHG4qIRtOMFj1NJjRXb7oDkgnIKjuKmVvLIXarEjvUscKRqcA/Nwd3X86ryh49u3GM4B70aoLpgN+/G1g3bj9ac8bjBwZPYnAHvTi5jKlGy3IJFRxl9uSruM9z0oukMdHGkeJHIDN1X0qRF8yf9yoKDjkcn8KaHRiGlyMHHIzmnxmQgLGCFB7cGhPoGrHLEQ2MDcWwAvWpWVoi4jVSoGGJ9/SmgBGZnYM5Axg9KRHRUZYtwyckk55qr9xPXYfArAYDgLnBB4BHtToYGlUrbbWZDnL01Y2kX9/Lk/wAJK5ANTx+aihldTuyvyjkfWml3JYkMBV2aVhIQOY84waljilaJpVtQsOBnZ+uKdG8f2OSNV81zwTt5A9c02G4nhXZ5mMcheSFB960VkQ7sh80BgGVmQj5WI4+pHrSyku4YqpYDCEHA4p0DsrvCXdFLfPhcAfjVj7LbYbcpZzkjByB7mjfYG7FVAFO/cuOmD1Bo87aEIkPmqTsG3I/DFTSyraiOPYHDqVcRrgKe2e9SwATWzkQTB2yNyLkIB6egoQXtqzOlNwYXeJ1R/wCPb1Oaje1byI452KseQDU06wsIngMrQ7PmL9c98eoos3e4LJksxB2K/wApx60lZsq4i2qF12rsVVAZnxyT/SiWOzjSWCIiMAdV5z6moEESgyRTcxnJjY56dqqsGucSW67ZM/mtDlZaIFG+7CTzpZkHzi2AACt6CrWID5SREJMv3mfO386mKyS7Y3y4B59fyqebccLPCcRrtXAwAfekkUUXhEs2Gw5B++BUiWxUtsJ2A4O3qf8A61XIxEV3rG4k4AROnvmrMkdw05UxbBgbk28gUWRSkUvK8oZWNgx6EjIxU8CKXI+yhpT8uXPy/WnTx+VuTdkNjA9Af5Ut1FK8K+VuI+7nd09aFEWhW/0iRfKxGADgYFRXkcpcefuZx8qqD6VfMT21uHDtuYggNxx7UxS0knOFMvWRucD2oavuXzdjJnRYY/8ASGLTMflTr+dVDKFIBOM9MDOa1LuATSbPlG3qR3rSgsrQWdvlBJOTwrcdff04pKndl86itSlBaNLbu0+wRgAnOAMf1qvdzFtka7RGnRasXjSPLIWCbEAOOw9hVJLctCbjIJzgJ3PvilPtEUbP3mNVdyluODyKewTaDjLdeR0qGFnDYGC38RPap2j+9GAB/t+tZ2KYzg4yM+mag3BMjOakmPlpkngelQgGQgqM57dqnYqKJQolQ/NhepPpUtuqbWHReue5qFMBCx5HoaswpiPjgDkHtmi4paE0LAktgY6DNPiWQsEwOenpQhRWwxJOOg7mp4ZAzSHBBVcYHSqXQyemo+BiFAlBYA8gcA1aeaBpAyxlW7BDwKoebgbGVQccAnv61IJ2g2yIqliNp3DP44rSLJauW2lMluzHcUBxtI5/OqEkRwdyA8cgjoKlikfIKxhi3G4nv/Sho2RHMhbcDyuelJ6q4krGY6hAfl4Pp1pkiAjacfMOpq84IYA85HeqUrjcVKnjnpmpNFqZsyhHCk89sc1jakC4GAeOpFb05WQhwSo6EYxWTeKGBVHFRYbOP1JM529/zrPgcZ5OC3AzW5fQ43IwHHOfSsKRdlychTTWphPR3HSfeQknaD1oqePDDAAPY0UWKT0OuQ/vGLnbg8Y6VbjwMMMuzcbeuayLe6R5/KA/eHk+grRiQxtvyRg9c1pIzROXDSBBnJHQ0NIoUNGCOeeKlVlKsQoDNgZ9fempFvjlIbBBxz0FQUiQQggmVs7jyKsxhiQkQCqBxTbUNwcFvUnuKnZkDDbnJHJosMl8vbFwcH+Zp6SqSiKytxg46Cok3NGVfGw8j2pbYqrtlPlx24xTtfYRMNwVjvAyflx1xUqrtbdIobPAJphVARtcswGCe1WYgJAyFSWX9aqwXIiqrgEhjggr6UjhW2gBlwPpViIRqxEY6DOeuDQqrDI7r84I/j6fWp5bjKrRf89Bl8jAJ5qWRGIIIAx/eqRH3SFxxgffPJPtUQGZMqSVz1ptWDcry85Ckbc9cYpwdtv7uQgYwOOtT/IQYymcZO49zTHyrfIMZpWK1IlgypkkJBBHfqDTnby4xgkHdjOeCKmh27iJGIRuGJ9faoJJVGY4wXA4z6UAhF3IQU6YyGxzmnDCSOXCBiMkDqaMEAqGYKfmyR19qcscZAk35fHHoKSHoJ5quATG+V6KOmPpUyMXVmdhEpOCV4/Oq4kJcfNyOoUf17UoRFVsMWJ5YZp37A13LHyxvHFHKPUDOcUkkscABilWUHjaecVUAQRsFjO0jAOcEUWfkQ/M+7a3O3Ix+dNMlxLMdwrRoersMEMfunNWYWlSQkkAZyUVuTVZ87x5igoeS57L7ioZnkfMiKqIOY27kdOlXexNrsvQmOaKc/vo5OqscfN6jJpIiI1YLPMYsZkUHHHtVGZp38o3EZjTPC4xlfUU4wABQcm127gV6t6fSnfUTj5h+8tGWWAiROmCMgD/ABoS5eRpJwibhwBnkD2qXy4IXVYpWdQvOeAaYi4ZV8obxkLJ6nPQ0FfIXZbCNQo2HkkOKF2+YCqfLjgDoKvSxJK++eNd64460wRlljCEpg91wPoKLdRLUR5SpdLUpGygZcH9KfFBcTAKrMqbc8nG6nSWoKPtCou7tyabbzhg6NvE33UOTgfhTtrqUlpdFa1uzDK6tkq2doU5INWbZJoy0jOWEnBIbr9TVqK0RHSTy3bkMzKuOfrVeSGZ7d3iKhHbDKD0I5oSaQ+ZN6D57cuzFwTFnO/ODSmDakbRytsI5HvjpVq1SNrYs8hG1COvX6UiuPOSJC2wdKrl6i5nsTwuZ023TBVVMAleceg/GqU+6ONlUgpn5mA6ewqa5SPZukUhl4Ix1Pv70+3WB3DyOoUcHByTRa+hN7alVH8iNk2FQ/Klh1/GrEyJCVd2cnbgA/3v8KiuYnnl25+VWCgE9P8AIp9/5SykjdgKNq9cHFK7SZT1M2/A8hYgP3jHLH0FQt+9VVUhGTgY7j1NWWcyOifxAfMx6D2qi42ySMOp4x7Vk+5pHsOXyiyKuUAHzFu5qK6l8gEkZL8gegp3mASqJAeMYxVO+JdyxIznp6VGti0rvUeZVxljyegPWnxKoiboGPA5rIV280Ajed2Mj0rSRMSES898A4xVJaXLaWwuMOB1UdBV2NwIgh5HpVHJLbEBLHnAqaF9inON3TjtWewpItSfM+UXGKl3KqhuD6+pNUwWwCMhWPc059quAGyBySKepDRYST955pQEk9+1WIPMkjLklUPU8dPaqjyHeGxtz0yac7koEjIVV6g1Qmi5E25QTIF5xsHWnSK2AZkLIR8uTVZGj3NJt3IB1bsatqyiMyTyBk2/KvXFUrdSHdFebbGdxwwA7ZqpcyKV+YgPU8hUj5GGCOhPQ1WkTKkFQHHA9DUMpLqV3RJFbHJrKu4ArEhRuxWgyyRyLu4UdRUFwF8zdnPGagp6HIXqEuzHnnvXPXybTls+9dtfxKWZto+bnFc7qEe4OJFUjGFAqo6aGVRXRlWkm5SOARRUETeXNjtnkUVVjFSsdRpEQW5lkZiWZskV0EUiMx/iHIIrnNNdpJJWRjtX5OnU962bOJiwVW5fv6GnfoOxfkyqps2/N1Bp8DJtIIwzMM1HJMqsqY3MOG9qjMbtIMAqPUVL3KWxoJtVWO4kg4XPYU4o7kK3c5OKiVQqBRz8uc1ahI2KFG0AZbmmAKoVlIPA+8PWkklIR1Re4zTwPMhcjgY496QnMah1IcJQND4ZFa7hjXJiUfPjofT9a0zEVaM8s5GWVT0rOtIDEXYMF46d60raQskmwbV2ct61cdVqTLTYWJo41mB9cL7U3KsZGdSR2XOOKk2xEs8YdFK5AIzz70+4MUiEBQiqAPdqdroLlViPJKr828Zx6VPHYSx2gd/mV+V2ngeman8ortQA4YYAxUvmSGKOEKAI+QpHU/1p8qW4OV9igYGxlzyGA+ppwt2cvJGrbR/FVmaFoXAU5IzkU/7WdrIo2Qbhkf3jRyrqF30M+SDAL9FA496aIsEfKCT94elXSiu7gBRHuBxnt6UXIj3yRQnAjOQSOcelTy21KUmULkbMoMbgOvpSxwDau7byDtGemKknRlWPzlG1xw1IWAicNHg9u31qWtSk9CtujjVgQA4POKWZ2eBUiABHTA5P1qWWEKu4fMp5yPSnxxsYX8pgHBz9RRZjdmrlOTNuVZJSzNxyOKnCxqrAuGGchAvAPrQsZMZEhChv4SM0ltE/K7wiA4LN1x60ttgsLDbB4mLTBMjOFHB9qY2yFkjaAEHOH9qtCB4Fw0iyKTuU9qkl3rbK8qKwbAUgdPpV2IvczmkmmcLK5GCNvoRUsqxrMGLuuTnGegHSleJ3XziB/e+btilZGaMYi3u/OfWhXHYHK3iosB+RD1YiiBopJljZQgTIYrySfxplvGsUjedEdxyNvUKPpRHbiWVPJBDHjPfk05JoaS2NF0j2sF3BU5xnGTU0sSzwLiQxY6KvT1zSmFUVYliDTjIY57ikZ4iB58hTCYwgzkjtV2tuZ37Fa2ZUZPs/zOwwynk+9WGt443+UKjt825u/tVVMBzMpKoASCMZq7aSwhA1wAQRk5OTn0oWuhcrrURbqQyNvl3heAg6CliCQRzb+Wb7gB65PSqu9XmLBUVcdDxmpo0BkZSyyFfunsR7VSFYl3OsmIk2Rt/DkEAjvUSSJ/rAQxLEZX1qCb5BtMsZTJB56VDGIHLqHYeWMjB6mkyoxVrl5leK4jEhbLjPJ4z9KsTeTDJJGVBGAAR2NV7dzdW5gdVyCMsxwc9uabJcyxtHtRZFgzjjuafoTZtjmklhhaZcAfdyefxqtM4WwZnBBJGAT1Prmp45WuUIuMImNwQDlqo31w3lpFw6E71x1FZytYqK1GIQWUv9zGOD3qORgBvA53fL9Kgtt0918nzHlm7CrEgZwQo4GDWe6NbWY1j5rsznp1/wqEooiUFd/HA75pYoQm5slieSvXmjKqpVXAfHNIEZ4gPmAx4AHLManWQzSFgTnrmlDg4UgGNB69ajDHdhQcEdfWlzGhagVnGYzjkjPfBqMnzMxoQT/EcVErcHBI56D0qUYAG1QCfwo0YhynZGQCT2BPenGQnGMZOPwpjAeW5B2qg4BqDftUCPlzzk/wAqWglqWAqtJ+8cnByfb2q2XiEeWGXP3BnoPeqkYYjA+Ynk+9Sk8jaAFx9cGmtBPUsKS5wCNp4wBU/kyxEhMsg4z1AqnHxgFygzlsdTV+S4/wBHSOKRhj+EDH5nvVpdzNt9CN3iQ+US3A4I9arvIGjKZ4J79aZcXrRybW8ssvPCj+dNRluAx3bT64qL6hYbIoIIzk9ie1U3j2ryOcYJ9allLIDkdOtQyuCg2E88kH+lS33KsZc6sTk84OKyL6FWkZcYJHSty4IBHUqT+VZmoRo2WDbv6UdSZO5xWoW5WUkdM49KK076ASBwTkAE/SitDmknfQ1YFYJuXCt6VdgLIFKNuAXDZ7ms20maa2eIKQ6/xNxWhG5+zomOeMn1ofdF+Ret5kG3JG7PO7uKsu2XYISD3BrGtrcTz+YXYjOAD2xWq8gEZYkkk4HqaXQLamhGPMjAxgDIyKW3jaDgnd7tyTVW1m8tiXOBnr/Sp5dz3G0MAqjfnNJajLzLtiA/gJpQrTAuRgYwo9BUSTG5mAUloQvLds0+PzXg8rOCSVz7VbWok9CzAE+8Xzu4wasKQjMnQA9faqOEhYLztX17nvVqSVfKAwBuGee9PoMtPKsjFUj25wwA9MUqjDuw+bODkjoagt24ViR0xmlNwfsfyZ3Z259f8iqEkXLMsJBcb8hTkjODT5HLy7t2JSeMc4FMj8rjyyAcbcH0psLbJEkYNyxAA60w8yxcndINuRkY3Hr+NQspIiEnA2k4xxUlyxmCsijBYqAeufemM+9WLD5lwqg+vfFN6MS2Gxo3kSSP94MOR29aS1RRbTM65z9056H3qIE5KKM7z39aejPGkkakqrnBXGRkVKepVnaxFuMYCSLulzn5jnB9qQFpZ/cjKirfkmZhuUF4hjIoVIxD5qBlbbye4OelHK7jTK5DSuqZw65yp6ZqJI90pycNtztHtUjKjuhLMjHq3YmlP+uVhHtTPI9PpU2uMbNG64LYZXOQfb2p6bVidgu88fUCkLeYrJkhQ3yHsPanWyESMJWCY4+Uc59PpR1B7EspT7PtVFZQMYA6Z70q232SBDO/P8I29PemgeYY0hBMo+U84GKtRK8SsJMN8uCWOQapa6kMqsiyXXzKyLIQxDcLRcxm1dlVwWT7jLyDn0q1bw3SCISRrIkhwMnKgelJLb3JUFk2xwkg/T2quVgmr2uUVEcsoCI7y4wcdR7mrq2rIY1fCA4OQcjNRWqRRMwYMsjnKkcHFJcXEk8xjVyYlGAdvOKfqPXZE0n7kLLNKkaEFcLyfxrHGpQG4Hm7UjOfu9cUmqjzcRK7BhgqPXP86y7KCN9TD342onGAMg47VEnJOyNIRXLdm21lHLCXjIw4ygJwDUULi3KsSZAVO9QM4PSp7p0Mo37Ui/gA6AelUrW6giuwrAm0diCQcfhmrskxJtrUsR3Ec21wBuUd0+97U9lcBcKC/wB75f4Qe1W9KWC1mdhIAn+sj/iwfQ+tJPOY7yQupTzBnOMYFaKPcnnu9CpDCs7vHJCUOOCPX3qoU8qVSFD8YznrWmdQjKBZbf505aRTklfeoJCksp2geX/Cw7mlKKtoXFu+qGwxR/IzB8Hll6c+1Wo/NkKrAWcSDDcYyfSo7SZBbXIkTfKo2oCegqbSS1mieYc5YYXPGKlJaCk20xb4SQS7CoVwmGHZRVJWVpmJ2iNUAGB1qy1wZ55WlXIOTtXpx/SqEUuXQlRz1zWUpa3Q4ppEIUiZimcgdOx+tMEuwFXBJY43e1S3PBOGwrtjr2qldPhjgewHtWb0NbcxZTKIWU5ZjgDPT3qO7dV4boO/qarrMCWkwTt4UdhVW4dnbfyecY/wqZOw1G71JlJLMCGCgZHHWiObfvYg7hwKI5WwqLk5BGSKeRl0GAMVLKYgUjnseSKHk3qQW6dFomkALLFg9smqrHEnzdaLivfckldygGetPh+6SRkCjZ3Zl68jPShXCEeWM5NPZhzdi0sh2Kg4TqM9qsl12goDjuScZrObfJk5OM45/lVpdiwEbwWHbuKepDsOkZ2ZTgZHakkYggADcepHNNi2sQrN8wPPPap4xmZjGASOAaEribsU5IThZFfDD+Er2pxDKBtXGeu09a0QJoUZN0ZYjPPJ/wDrVTdpZQCm446im42JUirLISGDAkA0yKQEMHw3p6ipG3g55GfmqCQS53Agk9TjFTbUpkckYclgeazbmLKkk8gZwBWkwcE4bnHJFUrk7yOxxjIqlZ6kO5zN6VxgjA6ZoqxqMLSfNtB29xRVEMfaqWmWV0AJGCo6Yq7F/rgVxsz19Ky7KV7mUiEYRRy/r7Vso6JHtkK4A5pGfN2FCvHJuYjGcDb0qwpMP3vmDcZPaoJLgIu4fMf7vr9KmZ0aNnDAKozzRaw+buXNiuUJ+71x60RzLLPNEANq8fjVaK6MkURI2BST7kVchEJVZQQWPUAc/WgZo202Y9gQDjBNEMhLMMD/AGTUcU8QzGGGWHIpYyyxMyZzuwF9Pen0QIsMuZhuYMCMA+lTxhWDIRuPAB7iqY2rEmMseufUVbjYCNHi2kckjvTQxYx5GTIrEdDjsKkXYtwuRuQ81WmlLRh/mywO8VFbtMk6CX/V8YHWhPXQq3c3I3RmKogATkH1pYXLSP5QCorZG41RhP77aB8xP3s8VLG3zurLlY+WUHrVpkcpYBdmDFcM7/NngD3pYBLEx5Dbs4zycd8U0usp27xvI4GelMEuAu/7wJ2lT1FD0GSOEWEsQYnbnLHjjtUDtu/eDdtODjuDVq5iiOJHyzMvKnoD2qFdm1XUkgDDYHFDvsC7llZYorlizlI2APzd6reaqTy+W+Ys7snvTJCJyzMMsMYx0IpvyZ25wmMj29qTkUkOLiWdyOI8YH1pUiPlrK7HByMZ5/KpIlxCDGN0ZPy46inzs9xd+Yy9QFAxj8qTBC26hZiuwuuRgev/ANepYE3XG512/OVfHP8A+umxGXAgc7eeM96sW0WY9xlXbG2Tn7xNVF3JloQS4jYpE/7sk4OMc96njhV7cM7janC4/iz0oa3a4gkaInavLDv9RSwxxyr5W7gkYx0NVre7F0JotzuLcOu0fMUxkA0kkrrI4ZWMvPQ8Coo41LupLfaFYn5T1A7UqySGSR1jzEi/eJ5P+NV0uSl1K93EUYmZXebbxt42/hUEEb7Vdm8t+ox/EPatJmQh5J3baRtJjPXPrVY2kccwkln8tB8o2nkDtS5epSlpYpyTpbyCURBpB8pDDJA9QKW3shOguiUVg3Cnv74qUW8rXkixBrhwPmZeQR6ipLG6hKyBYjLcBsKB0AHPSqiu427LQ5/XYLqdjIQzrgkt0/GsKCR3kSJkPkghjhu+a9AeWK8k2EeWCNw+vYVj3OlJPPLFbGGOdRuy5xn6e9Dpa3RUanSSLk1uYPKubGF3t0UNtfrn0p+o3cVzEWjDPMuGeRh932AqC1nuJYo7KQbvIHJUn95npWjp+nWsVwpunV1i+9GDgAe/rXRHXYyfu77mBFqdqsgdRtc53dh6Y/EVVvZVRjIj+XEpwo6MR6Vd8bWcFhelraBDE4DbR/CCP51UjeK80oLMAZkU/MB8xx0zWMlq4tm0GrKaRYD78CNlPyg56Vpxu4tWto1wXwSGHT6Gse1t/wBxHIP9U4xjrtrXAZ5I3kmVTkQgqenvUjmOmBCgMu1lBLFfyFZMoaSLfESGx0PYVoTMsVzKN+4ucZJzn3qlIpZnCEMwXK46ZrKQR0KdxcNalFXDsVON3OM1Vll8uMMzDf0HrUk4Pm5fG7GOOlZk7sZ8vxXO5dDaKLlurfZmUttBOTS2w6lcHBxk0wOrIuCBn+dKi4Unmi42WXGzoDx1qvIflIUtuPQmnmQIPmJyR09ahaTevC4PcUmJJj9mRuY4bpgU0KScnGKWIq33s5qUAMpYMAR1oVgdyuxHIwDjrS4YHGAQOSaidiWOealj3OG7f4UluOxKpLRYZiB1H1qW3iSMFlYE98nk1EsnzjjjpTZJsS8cHpx3NVYXKWIWR3YJjcvXNXUc+WFDIPXHWsrzNhygx71YjkBXnHBzk9KEyXA1IZwr8q2MYyD1qtJKEl4jIVuhziqN1MTKGY7R2CnFVvMHzM2Sn93NXzslU1uXpWIlKMACvpyKhZsMADn/AApsV6yBFGQD7CmTMzlgrBj1yP5Um09h2fUSU5z5WBg9KqXPyckc+1OErp97GemBTJizAEgEg1InEyJo2UsXXKH0oqS53bOGyc9KKq7I5SraskcaKAI+yip5olEflhuCeRUEYR1w45U5BprZkfYrBYEyzMep9qZgth9zPtEEABO85yO+KsLHLJPGs+VgHJUfxe1V9OInIlkXhWPlk+nrWmXQrnt6+tNiQ29k8pVCAYzwBT9OaWGeORo2KOCCoNNdF+XdkZ5HepbWSSMBSCQhyB7VPW5otrGmpRpC67Q2MDjtVhATmRflXGFyepqip/eDOeeRSrKDAGZjuDfdHcGhavUdiwJjEySH7nILelS28xMO/kR7uD6Vn3DAqY1ByOcZ61I9wwMZIIwOV96pOxdjWWUZZWUZB5z3HtTSwM/lhcKRlcdqqGXzIg4OQFGcc4NTQSpK6qcI23cSRxVtX0FayJ7N/wB27yhtwOMVIVYs8kfGVIahdpjGSeDnb6+tWPnjB3bUVxnJ5/Cly23C5AhzbZKEyDkHPJqa0VVw8pIYcL7UsJCQ7yPnGODVgKpTeBuYfkKVrg5dBw82UOrnG8gHaMmiK0mQspcZH8J6YqNZHFysSbQW6k1eQr52x2J46jr7VSs9ybtDYIZHlSOEruPrximvFtcrIVwpOcCiWcEJhSZMbCuP1oQtJEAOiMckjvT02DW4QXIR2X5lj24BA4xUgkjhhk8w5yQExyajkWQRlfl8s9KcIBsDxnIHr/epXY7ItWyfKFaImQ8gt0xmnQqtxcurLlgOvTJqzDMPI8twpJGCwPOPaoGjWKFJVIKhsbc8ketaNIzuysrPB5kPWIHAGOme2atSxvHG8MSAKpBJqK7RvOQK6spILYHb0qu+9iQrZjU/dpbFb6hcGASJyd5wBtOPqDTwj7d+4MuSMAfy96om3hEzyGZlfj5CPvetX7c/OBFIkaEEDI+7jt+NNavUbVloNNyttAVQrtc4Kk8r6U5rMgCXz0LldxBHBPpSoIpMxMFO0nLEc49qo391vaOByx2HAJOCF+lPS2okm3oTxzNDc4ErAkbTIOPwqe7gKEXVr8kS8ZB6epNZ6zF4yygbD8uEGSR/jU9qr3J8hnfyCcE5zx9KafQpq2pauJkuT5cUYjONxaJc5OPXtWVJbrcWMs/mBdh6k4JNXRtsi8EG4xngZGN359KpXcJ+QXDFgTkxKeB7mrTvvuJK2zMnSdQaDUY1GRgYO70roJoLRHmujLFLsYEsr+vYCub1YQ2l55sj74+NwQ8/SqI1C7uJnjh2BGHJAwMUc/J7rNvZ8/vLQs6pqNxfXLxSEmMvkD2qaC2ItsFiWU4OeOKXR7WN2+0T5CIepGcmtOJmfVW2q32dxk46EjkVKV/efUcnbSK2NS0hgNjHEcRHbkvn7x7CqF9/o0YJAbJypVcED0IrbkeCJLO4u4TBbOMgZyH9/pWHPqi3NwI3j3RqW2HPrTqWtYxpqTd0R3QWGKGVpFcSIScdvr6VQilEU+GUmMAn3596kvEjZB++yQD1GPyqi05+zqpO9lB5FcknqbJaDNQmEjtsTrVQDc2AuPWo/Obsckdaeshzn1rLd3NFoTwpkLnBx1UdqlB3KSVwc45pU2plnOBjP1qOecKhC9DVWsTqxJiqD5efShcCLJHzHtVYOQADyamchV3fxY7UimiNpAJACOR0pyytggjAaqpk3NnHSnu7M3AA7Z9KRVidSC+CMZpHcgYU0iyZfIzkUzcWJYd+OaASJyWK/KcU6IDd83Pf2quGbZk8elKkzDJbCnt71VgSLEzyMw2ABAealMysu1gNtUzN8uepzVb7Yv2kIRz3NCfcOU05GVzhSAPftUJiKpuOMHpzVZpVjbdx7ZpIpixA3GmNIshUJwJAePyppGMqQeD61YWOPZlRgioyEZjkbW+tOxNrkAJB+VNwHY02VU3bgcZ61OysVzxn8qhZEz+8XAPHXvU+RDXUozqWB2gGipmgVJMLncc9fSimkiWjAsZBcFVBOM5bFXWVJEeMIGycED0rmtOuJTKscK5G37x7VuKr225mb5j+VOzRxJotzuba0cQqqkDYvpk1ctkEMKByGOAA1ZNpI91vUDdADnPYt7VowlvNIZSEA/KkUOkbzpvJQlQh3OSMVbiXc+4ZyBgYqAMAhbGf6mnQMzMrD5eMYp7jWhecs4DLgYpUt1Viy7s9eO1Ei5ACdccn0ot53WRlADKfveuKfXUpPQgu41d1IDbv4iKRmFuyMBuRQRyetTSHbPiMDDdQTzioHiZ5SjMPLY5BPpS2ZoncppPLDtNuDlmyw7D2rcguVKh22qXO05HNZU0MyXX7lf3cn8JqxFE/lxq4zzgMfWhaMvTQ3bffKqqG5HUevpU6TB8xzDIjXGMdTWXEHMwjVgoQfexzVwN++3bvmPBB/nWrdyGrlxihcpJkAKSAOantZ45ZAAxEa9faq1ngpMyruLjaWbsParMFtHAjeXJkN94dx9KWonbVEF4mZSVbdGOA2eaS2nmtogWxKrHCE9RVy2Eb6gvmjKJwB2Bq0kUSM6KFdnYjA/h9KaWtyeboxwjQBWjjYOQBuJzg1GpAkeOJjncQd3PNSSBio8uUoVByG6GjYsQTzP8AWuMsfU/Wm0JA5mb/AI+FMUbDCKB1+hp0jGFT5jLIki446g0pluiAhfJBwoPPy0l4FVMRRlZmIx/EtJ90O/QS2ST7O7rHl4/4842j0qYBFIBdVYHgA5BJ71DKI5sEbklxzhuKhiVbSEGTMkknO4fw89Kd+nQLXLRXLPl1yvLbTktUdxJbyOgiXay/L8vVvagPtQqITvPIf0NOUS2xjd41ZuoANCEiFkUFpGj35bv95R7UeS+f3WFY/PuJ4x/jQZD9qX5hHvPOeQKvLC0CkRp5ifeKydx/9eqsm9AbsipKGiaMyqRv54Od49aZf2C3jrsZGfb8jA5IHualaWAAJtLFuRx9ypUtoZVaQTbnBz5Q6NT8gvbUy9stuzCVMKuAG6AVaRpIZ1njlUuVySp/WrSwxzwt5codmJ3J0Cgdqy7hY4ChtWznjjtQ9C0+bQkuLlbjMMQZ3kP+ucH8/ak8gGOby5SZcFHAPLD1zVixu5LYMrum1+7LnB+tU2nczMyIoKn+HvVJhbsYsmmm2JS7Odxywb72D0/Co54IYiIkhwo6yJ1+n0rrQ0X9swz3jrL5iYZWHT25qnqsgVpN0SxT4yvGAo9KpwSVio1G2jN0i4ZX+yKqpGxB8xxnFXtQjEYZjNDlQd2DyR2rIuryCQoVlbzQOoHGf8Kju3EgBWYNx8wK4qefQ05Lu+wy7vJ7uFI5Zi2zhFJ4ApqDylQ8GQ9s1UhcOxZgRGvVs4JqUXCCUxxZz1O7sK5pO5c5KOiJXd3YAFiE4JPaoJJPstmQwAaU8Gmaiy2cZAl5Y5K5rIeSe5lTzCdo4UA9KiStoZJ8xYUMHXOMnqB2rRto/MKlh8q8D61RtiFbOCRnuO9WFMhLFcjB5pRVtS3sSXbqzhA+T6A0yVS/y9QMYpYbNY2E27gdR60Mcuy8Yx2607dWERyRYUsBkng02JGlnVByx4x0zUcsxCAButTQTrCrOxXIXIyen096as2VK6VynIoy4U8qafADhueT+VRWf72WaTorH7vpVlUAXKg7agcWD4Ugg845pY/mHUf4U6IKrbnHB6ZowdwIwODTSKI5XCnCjI96qPJ85G36VZlcoSMA+tVFbLjjNA1oiaNjgYBzTLkbSMDk88UqSOr/ADKVUVN5YcfMeTzkCqSC5WjUSRMx5bsaktpFA2soyO4olt3UAIKmtrNynTn6VXKxXLkOSob/APVRI2DuONx61JbwMFCRsWCnJ9AanVh8yuEAY9KqxPXQrbD1HpkUwpLIMMnzZ6DnNaMFubi4itouHc4BPSpIbaNtT8pLxkUNiGYJ1ftn0Ge9S0S2c48Um51kypB6f0orRvYXSaZZWJm3kOT/AHs8miosJK5wenBIHRAmBjoB/WtK7TzbRhnGehqnbEADA460zUZZCnlRn55GwMdhVM4I2NTTzFFbxjgKBgirEjy7WEK7jnqelUbKD7PtEp3jFXmfLjywdvepGRT3kjziGCMMcYdyMKtWrVWXZEW3Z6t71WyZbkpGh2kckdjVqKUqynA2njnt7079QWhajnVjMjBlAHGe9RiYrCojwGJ5OKklIZlT5dxHH+NNMLMuAQpxzxzQ9S42LLnZIsjgMuOo6VJsjuUU5IKtxj+VQ2yFQqt88WcD2NXWhEaYUfMTxjtTu9zRWQgC+bn+Hpx2qQKceWBujDZGfX1qq8EhkHmHap5IHrV6FlRlHXI/Wlce4/Zi3dkH7wYA2/1pvmyowdgDtHHHWpWid2L8qcgEdN3pRMGV+hHPIPSqY0V7KUXEo8rcuG554FaG2WF1ly0iHIOeMUWtjHEsjjCBgBtHO76Gr8s0b6fgRqzjjOelNR01FKV3oQwsDKWAGXAA9jV2OORoHCiNnQ/M3r+NUAFVEjQ75W5ZumPSmtcGOVY2I/2R6+1F7bk2vsTPHvkVjIyoBjOaszMGdS2VVR1Hb/8AXUa7ig+YHrgAZ59Kbp7M5Lyr8qYOOx9qdkgJ42meRXZQjH5QOmRiphJ9ncrE7bDxnuaZIVllHmkjufb2qCALFIXnLbSCAM/w+tO1hb6k5tzFmSc+45/IU4iMLNO6mJQOF7A0/wAsOsjtnygAYyTw3tQ5iaJnB2xFgrx9efWqsk9Cb3Jt5Nqu2JSzYJJ/OnrJE+UKuSecL1qKUhQWgbK8Elf4qhWGSHa2CS7fLk8k1W2wlG5jzvI16QgJCHOD169K3pbtrmOJFkHmgdRSQqkUhZkQSqcjA6+oqG5VGgJRCs8hLdMYHbFJRtdlyadi39lU2yMzJ8x2cHlwKzbtoEkIgBTY2AMnNFtZPDbmaaUtIcmMZwc+lUS7B0AQySseD05pva1ggtXqXZBcx7QrB4GG7P1qJHt2dELOq7uWXv8AQUzM8U0jzlF2YO1TnrUxWO4ZpUKKhXJbpz7D1pW10NCa8MVlBIJIxIsnA3N8yn1rOgvDErKhZ2xgMuMGkd1jZkniM0nRXJzimSQz4WWJGiCj7g5NO7b0Gor7QTJcXsbK0wRFGd8jYPHpWJM0skhWSUnbxvLda07v9yiNNudyvAY4xWZcuHkypAzzjHFTNm0NCMKzRgbSqjowHJ/GoPMaRNpGAf4j1q6ZTJb8uwI4Cnpiq77ZV8oPiPOcqMnHtWT1G5WRFbZkGxQMpzj196S5nWNjI65YEA7e9W54BbAeUhUlOC386y5pfLtvmDZYct2zScbbmEm5FO6d7q5DlSUJwfar2xfKCJwf73rWXcyq92kMLbuOMetaSkCMJn58U09xqNkJEWDEKTge3WtSzlAVeBuFZPmFCB26e4q1uG1m3YJ6kmoskW9dCa9nIjbB6dhVdGcqpUcmq0h85gFPyg/nWhbRLGoEu4J+uKTd2NaIrSIdpJJyenPeo4VLKTIOP7tWp9pbCjJ7e1RkExlRgf0o5S+hZhRdu4DHbPtQzcsq845A7UyMMkQVjknmkQqHOc8jrTEkLb5Zfm5bvmpXIQjNRFiOh56AUhk+UluccGjQqwOA6nAqt5ZDZx06irCHkHse3pStiTI5AFO1yiJ8MxJ4FSRDDbT9096HjXYp6kVGgmlbbGpZs809wsXkTbL2we9W4grYCbhg/eqK2jddqvkqByFOPzrQii+ZSoGD/COlaoh2K0mI5AMEE9COlSCON+rEHrk9zU7xEjLFMZ3YJ5FMC7mzuLA9vSixO421MkF1E9spMqsCoxnJ9K21tJEl86PRJBcZ3KDMNit9Ov4Vn2MiW2p28hKqFYEljgCny2ELu7R6vAQxJBZmz+NS0Zz3/wCHMi8DGSUzf60ud/8AvZ5op08ZUNgh9pPPY+4orNmi8jzy0QxW4Z8EEdP8aQB3uC/lsExhc+1VluZPNgGflfkj0FayuedwG3BIqmebEaZjLiFOG6/SpEma327ieuPrUelRbT5pIDsN2T61DfAvNHnPJzn0NTsNO5tQSCYuuQpB6VOAmx2k6DgMOlVLRkP3iFYjj/aqvFHPdsRO2y3DcRg8n3Jp9Ab1NG1uI9vnDBwcZ9RVqKUS427gCeQf51VtLJLaVldgT2HQflVp5GDssQ+cAAcYFSaFhk2PGY5VYsNzADpU8BdSXLbyR0zUEhXYgGFd+CKikWWO7jaMfIPvDNNvsNGnJ8yFx97HRu/0pLVSWDLnyz2PVTT1cS/uyADngVLBE0G1S+Uzk5HSkty72GujttdcmFTtdgen0q+YsLhnDDPGe496QArvOAATz7+9SPHlCz439xmrt0FccpjlwEOwYHB7EU3aN20c7uuO1RAAjMbEKw7+tLExARTwSMZH8VDYWZYiVWcJKwUgbg3r7GoLfbcOylCQh/WpSqLMRkvgcH39KlkRI4QyIVIBLEetNC9CrLciyJYKdsnBwe4pbS9a7ZsIFYDG0enrTLi0MlsjHCtzkE561Hpts1pCTK2Pm7dcU9VLyNFytF8XB27V5jx8xNOa6V4pAqAsFIDGoXCxXCCL5w46+v4VXuZEtyq7ioOS6nufSqvbqJRuXYn8u3CySFYzhuen0Fad5CYzDhg4kjBO0fd9jWSl7azSoxhLW44KjnbV8yoBGsbl48fKwP3far922hm07jWCWsUbZZkkHIxypqY3D71lnG+EgbWAxjFEuyRQkqqETJXH8R9at24S5iSMTKkUa5K54FO2tkDdtWUblkmdN+Y+OcHOB2quJJhOFlO1Rymed4qW7kyFiWJF3Z2uOBj1qO4tnRx5xHmYGAT09KTVykRzIkchYXBkz8y4Jx9KjNrJKSYWw5GVGPzzVho9qhrgEDkKVHQimG6VvNGAzrg5A4PrQkh69Ch5pZtjYBXqcZyaRUZr1X3fKo3MBxu/Cm3kocFYYsljxx0qFB5ZCylg/wDe9PapubJaXNBDCyPNLGSgB2ruwc1Tu9QkkhWTBDD5Tg09DvnjW4IEYB5B4FUbhk3F0z5Y/vd6UrpBGKuNgEl47NI4BHJYnoKqzlVkA3bznAGOD71G12UMnlDIJwfapIYIpURyWPzYOOMehqI+9oi5Pl1YssDtGjMw8sZIx2Hekt49sYkIwg7nritO5VLO1aBD5x4YkDhfas5ZxII7eRcnrurZxsYObaIdTKiDIkJydvPPFYtxMZUWMH92nJP1q7fuDI6Ls2A4U55/Ks6bJfEYU4/KsprUm4QRKk5lTpjHPpUqOFkdiwGOB9Kr7gknGWGMc0qRlvlGSTWb8jZeZYhRrp9xPBPHvVm5t9yBVDDHUg1ZsoFigAZeBSlznoMck0mklqNa7FKBRGGGMD86u3MhCArk+9U+AT3QHqP5UNKHYgqVTPAqFoaqN2LFvkZgeWz1FXHQA7Q2Gptttd8jgDqcVZIDDcBzVpBIrk4U4Ofeo5AeQTgipWfCnnA71F985IyBRYdiPcWAOfmHWgFi6qB8vWnyhdnXDH9KrhzFyO/B75oSKRMrgtjv708yIpADE9zVUIzMCN2T19qtKnRARnrVLsPQlb5lY469qlhT5cx/eA596j3CTYD1HU1etdjqAuMjvVxIexMkW1VfdjNXLdTuzjcT37AVEEZmBZuD2q7DC+3KAgE/nVpGT0GSJbRsA5Lt1Cgfzps4kmj3RkBewQdKtwWD3EoEfD56mrqWJRwjsE2nIAPB/Gr5W0ZuSXqZttcCGPyvskEj9d0q5P0pTqQXrp9lkdvLq/IFM3K8Zx71SnhRZQrnYCfvHmpcewXi+hlSymRmfYEBJ4Hb6UVPqMMUR/czGQc9V2kUVk0aLVaHkcalJ4xIFyfmOewq6T9pO2EnaTy3YVkeeJX3SZXPA9SKt6ZOceWqFV5wT1pS7nlxZrmFtiBTwOMVFqC4RpZOdgAAHrUId0JCElhyS1STXZi25i3MWG361PU0TsiSwM10pMg2SAjAI7VsRIsC4b7ikc1nIs8hNxNIBJuyQg4A9qnLRzIIWZ+evNU9XZAu7JmkWN0lfPJyfp2xWmkoZA0jgs+DgVRO0Wka7AcfdyOtLYQOg8yZvnbovZR7VLtui1fqXi6G62yA716Z6Vd+RJCp5BHX1rPdC7ZDb2YYOewp9ygZFHmEHHak2Wlc0Y4eswbgAdO9WA5kjMmcITzkVS025UN5YJDKOM9x6Vdd0IYqPnxyO1NWY3o9SZHYlSQcAYx6+lMVWGQ3ODkDPSl3hFU4AJUcA8GoZZP9JHl4OccZpsIsusWaMlQNqfnk0qDZIu37mPrzTS488kACJxjFSR5kKqDgI2QB3pvV2BPQmDgY5wOmGHRqYu5juIbJJHXilldS8hZfvenrRMCAPLI5I/L/ABoAguATbE7v3gOV/wAKcyhrFSHBbd8wPVaW4YEkR4AOMg+tMt4G8koQ25z8oU8U1uXeyJxcQiI7FDSA8MDyB6VA9rCVBct5ikAZ9KUWL2YJK/vF+8O1Sllu4UMBPmKoDg9/TFUm1o9xKy1WxWEaCT5iEB4Yr3FajWi2VuCkgycELngj0rLtoTFK73cZZCMYHY1Zh3T28ixDIQ4Zj6dsU16Dlr10LfnpNKrnKhcYHUUrRGdy9xmOOTIG3pUJBVY4YgNpHVuv1qRZHKbZZNqjkE9qPUn0EliCxFRIzooAyBzmmw3jQM52Ge4KbeT/AKurCNuQusxbjnaf1xVf7d5DM8USNIRsY7cmr03Ba6WE1EXEcUKzH5zyig8AVWn/AHaHzFXJOCuakj81YDKZFZsY2nnbmqF07iQGQjA6jPJqXpqaR7Cs7oj/ADAKTgqo4+uaa0kgByueOAaRTkkhlaNRuJPb6UyaWABVDs7Mclv6Ur21LSI5XmVAZD8rHAA7VULGYsGY+WOgq3EhMuwkMME4JqtLHuGVYrnrt6cVmykykSjuwx5Xf8P8as2t6ixeUCWBIOCOCB/Wq5cudhQHHqKqyxlc+WwwTnjtVRlbYUlfc2bm4WFfNZgI2PQc1myM5VnLbQ3K+tUrhJUSN3BZScYq7pq+YGeVMSs+EPZRWl+Z2ZlNqK0Kk7q21Sw8wNkpjk++apTbScpyop+qo/8Aa1ysjIWU7coeOnaqrMFRgvO0cD61lJ9CI66jw4yGX6c8VesY/useQD3qlbRbsIQGzz+FasQ2qAmMAdDWexsi6JWZGA5A9qgLblyoyPSrEKgW28KBURBiQZOMnqB3oki4kPAiPGD6Cq/JYE5JzzVpuZBzyeT707YHbd9xen1pW6GkXYtwwKFGwYJGTTZZiqjy1Y8d+1K7iGAAMdxGOvSoIZAz4LHaO4rV9EC7iBCpVpByemak27YyxX5Tx+NNld3dTjCjkA96mu2GUiXnqxppJCbKEgOFLHPNRybVwdmMirjRhgSMDb1z3rOmDncM5x0qHoi46jklAfPT+tTxOAWBbk96q2yCR0yTgHJx6UA/6ZJsyseeAeeKSdtRX1saCRllyD944ArXtIkCgdSeD61UtIDLGvlknPUd607WJvMaPIXAzk1vGJEpItiLKgkAFT8uOuK0LWCS44DNt/hUd/rWfpjFbjLfMAD16V1vh2GCbz1mZkyp27fWtYLm3OarLkVyfS9LeJTI0oEjcYxwKnvrFXfbGPLYjgsMkmtbT0H2Q/aI2fBwGzg0yXTHG+dpzs6xrnketdKS2PPdX3ryZyQtB/aMIkwQW5z1NWbm0SCSIQ26SPcScxsudidwPT60+7g8y62ggMx2q9KbeL7PAxknLMxUyF/mx0FYSjqbuWzOP1NI0uXSNgUDEKfxoqO5QRXk8b7iVYqce1FYWO5bHjEO4KikKZX/AEFXlXnPGV71meaiOJFOSRjArTtp1Pylfmxk81m9jy4S10JLN2lB3dCfvVbuY2mWEj7yn86rRz7sJEpOD+FSwTje6HnZ3qdi9zQDqn7tAduMGiIhNwJAYLz60EAwD5xyM475qnGskl4XmfKqMACmVexfhLsBITgA5VTU1rdmWRiCdtVXm2sg6R5x708Wfk3KFJDtfBVPao5b/I0UrGkC5lQhh8w+6P61ox+XHFtlALMMY9KokrHiTqR1pYnD73Y7ivIxTskCdydmSJ1yASOCR2q0ZgApU4YHBBqvCEMe5v4xkehqtqGUdfMOxByAO4PSktrmi1ZdWV5I5JBgIPaktEdwJHUh2OeO1JZzo0OAdyP8pxVq2l8oFVRmAO1l9aWhW2gASE+ScknkD0rRsGYR7SSSpxnuKhtgPMGGBfGGB9an5J2jHBy5FNKzJbCWZVukhRdzOPvH+E1YLSPJtYDdnGPSiVYwjyR4LL2PWoXkIQuR2ywz2rS9hJ3JpCIgm5cOpxlhT5I8KWJCk8gj19qqW1/HeloZWUpHkqT3q5keXtfDAcgZp3UtRarcguHS5dG3HI69efrUyCOHeLSJGkOTkH7uKa6kW5w4yw+4Oufeo1me2jJMYLHoe4pJtMv0IUupTKYnL7A2W4rQmZI7UrEFJY5DLxWPezzIq+TEQGORk0ywFxJKWu5AiZyAOaqMmvdQ5RvqbNos0AX7QY5Fc8eq05oE3PLK4YdAgPNQzxdfKvEbuQwxj/69MAUMCSR6t60eQkupN9qiggCssYAORxz+NRNOjwMqMAx5BHv1qCa2VJQ+HkX0Ydag+QMzAZdv4B2FJ3RcUrXJmVoVfzWVmdQVCt0+tUZrVJRzMdgwCQeTVgwKELMm3ju3NRyl2RVSJVHbNL5Fq/cXVZLWHyYrMnywuTkdTVeMw48yYcAfLt7n0NIE2SElQxxwD2pwYuWBxkDgAU23e7BKyshrSNIdqR7I+vTFNlZooz0wegqS5d/KwpAX175qu0arwWOD0PrUtFLUogsykJwegNWbeFnIjC7+OcL1/GrsNpEwZlJCEbcd6ePMVVggGw549/aqjGxLlfQz2hHlAu65U8L2FTWk8YSSFwCpOSD298024SSNXV1G4nnAqpM6Dc6jKsu3PvVJu5jNXRg3LbZpPmyGb73rUMBDiUDJJPGetSaiu3oep79qjtfmCBDgjvWTKSNOxGFVT1A6DqTV1mwxBA3AY4HWqlnvEnIxjvVsRliT1br+FJK5okTQux2J8uByQKknOSoPJFRK2OUAII7+tOQlxjHI5Jodti0uxFMu2cEZ2gfnVhUwBjLZ5wasLblypXqBnNVSS0wVCQxySKaSQ27lPUpGZsY289KYskaSrGckD72O9SzMVWSbHI4wfX1rK0ppJr6QPkZBAYjjNHWw27K5vMhZowwOR8xA6gU64/eSL5Xy7mwM+laVilu6PKSckYOTjiqKgK48zlVcgEdxW0kkjOMr/IS7iEURwAQeOn61lzRkZIOcjJxWpdnbwCcnqCaoTMpdRjnGDWcmmaQdinCzea4Q43cc9qtwRFgOMMDxUSIAwbHQ9BV5ApTjgg1MUVqaljJ5YTaAGUc+9XY3WXLkhWOc/WsZZgq4Gd2c5q9bXMZVdoIbPzelbRkQ421NbTwsziIHD9a2IY5Y5TGspWQjgiudsZI/tDsSeOjDpWvbXqW9xG0jMU7e1axatqc9SLudro1y6iOSSZ41HyZJGCfcVZ1C/tmEyJcMLjPb7orAVleESKQV7gnge9VzdRI+wA7SwJcDOfatnJI4fZXdyy12HulUfPIOI2IwBRcfahEBHZR+YpLLlxgE9TiqqanbxTq8kQO3nk9B6gVTnkia6S6+3x+WrbsKTvb2xWU2aqDuZOs2s8U6l0wHBZmPO78RRU2qTx/2ZEiOu55GmKD/AJZg9qKyZ2Ur8up876fbyQRrPM25l42n0qeCRj5pU7WY8k9hUMUhkjab+FR8o9TTNkgMPmM2JDuJ9qnfoeMnbqdHC6pbjbw3equnSFppxyyZyD61TkmlMLMDtRyFXPerZAt0jhhGW9u1Ql1ZsnfQv2ckzO7t8sY/hNPjed5GITCDqW61HaETBlY8hsCtNIsoozjuR60rloin2RR+c7AKR3NLpss7B5p0bIOIx7U420MlwZJWMhTkJjgVPdXKpnYMkY2qPX0qG7u/U0V9i1NdeTamS4wQBnH9KbpwmizNcKB5gzgfwjsKqxyExiS8UAbsjd/DV+1m8/L7WMPQH1p3KsXFJkBjX5P7oqs0JeUJMGftj0qzCQ8uMEjGMirJVF3I5AAPWp5epalYq2cBijG4cq20gcZHrWtKytIA2EBALNUKplxt4OPl96nFuJI+u1SACPU1SXYL9wlB3edECSDjA7+9WoVBZ5TlTx8uaj2G2jOfu9DUsUkZbLjC9iOcfWm99Q6EksJ2uzZLEZ3dM0jxia3Ee8btvy5HSrLOVURECQddw9KguULYZXAK4JT1FNrsCZRstMNvvZSHYkkjpV3Z5hUMdrAdzinoyyQ5R8dytKzQXKCHcMjqe5o0asPW9yXygrLzygyQDncaddt+7DkI6uOCDyPao40McI2sxxxgjtTHmVAAy7lI4wO9VfuFrlIrFEGjILzE5H/16nt763WREnRUdeBkcD3qGUy79zLhh+dIlj9rd3eQeYefQLSTe0TVqNtS5dS21zcu65kcnA28DNSLYzSyE7sBRz6VXjsjbglSqqpwe5NSM8xCCMnBPQHrVX/mRGn2WSymRYfLiXIB7jvS2UTW/DLGWb+IdqcWKKue3G3Peo2dAOrMw7KOKNtQ1ashk+zccq8jnoOwqtdlmCL8q92J61Nc3ZC4jXCkYAFZsNtLcucyCNM4y1Nu+iLStqyxIwkJUAkkYy3aoJC0IxG6oMfM56mq094kUpiiZpDnG7HWop081zliBkZHpUSkXFD0d7o7IUbBzmQ+gqy8TxyKuNxHH50sBmMRAwiHpjip4oWXG/5QeevJp2ugbI5UdZQscgC45qaDEEMlxLuMmeCw/lUkv2eOHeDgg4GR1qmLwXchVtxVOCSOBVpq/mZWuiDVbtXYzKrMR1U8ZrLZDLbPMCFVv3nHb2xWjq0bQoTC3nMwwT6VkxwuYny4jZiMD1oe5MnojIvGBVyxBzyPpS2YDopXhuv4Ul2nlqoP3RlS3XmksGHz9QOPxrJ6DizXt8O5IOB0xVrdtcBfTH1FZ0Uhjf58nPQ+1W2OUUxNjnBrO5vFFiMbnYddo6elTxrvbcB0wOKhtMLLIMgg8A1ahxHvOOp7VQ7llX2Oo6ZGR71F5SMxlGOGytPiIeVt33WGOaR8Z5IOODWnTQnZlG9tjJEwVeAcnHeqVrbfNhlxjr6Zrcfa0ZI4bjn0qCXaC2CC3060WS1Dm6EdszxxSQBSTJ3PJq4kavGgViWA+ZSMYIqtu3bWVcEcZpZXzvYOM9aFITVyKVw3mK/DHgZqgI0ZyfTkc8VYnIf5m6DkfWqDvg7gOc5qHoUn0JZlwykjPrim+a24gE4Jqu1wW3fyqS1AKFmfDZ4Wjc0vY04SJQuEwBweetSgtAXAwUPX1FU7ebYckg8/lVtZxIW+XJx0rRbagh8UxAwTge/etCG5OxQT5mPXkis5k28FcsOajjDKVbJVl6You0DtI6aG8fZghgp6EHitJZ1EC9z1yDzXL287MQjH5QODnirkc2AGJ3Efw1cZmMqZuQGOa9t0dF2FhuX19M1aju5CkTG0jL/aDC8axDK+n0xWFZFru6iiEvlmVwD6irH9qWMEsxW5v1d/lZgyjdTbM5U76GZqKt9qmUyB2DsC3TPPpRVdpUbzFjbIySrN1oqNDZJnh9gS1wY3GIwMBauXz7FwQAq8D8aoFyL8sPu57d6t3TGdooGH3jlvpQ1fVHhRlZWZKA04WGH5hxlvQ1oFFtomkdmZjgE/4VXtZIopNsfCp1PvVwutztbBEZ4XioehtHUksi7v55xHFjJBq3bTSTyu2SIl4B9agCo+IS27yzk46GpJLuNW2IyjaOnpUSNY3NCMIkZkVtuTzk1DaOpEjH5mJzUCAPt+0y7k6hV6VZAHmGYYXZxgUNFp9C9HFFPEizqCRyBmtC2WMbkc429AO1U4Sr7WK89R71MMZfJBYUm7DsX0cLGGjUccY/rSvGZHEhPA4x2xVYOzRgqDj1HpT5rlYYN3OB7daSfcv0LEtwsEkYG7c3AxV2Fy9uQjDIPTNc7bXBupfNmUjjagx92rsM/+kNsIVsYPpVJjsa1xexo6mXhT1HY054ldA0ZOeuKy541nALMCV6itG0kkEOxCGYcjNG+jHa2xPbSSFAS5UnjJ9KndgqiPcHA/i6kCqIIlyHVgM5PsasWzbf3caY4zvPpRHsD7kqxxsUwWKE8gcVOvkEsqhU9+/wBKiRisoyPkHXnnNPWBWdjHjLfMqnsfeqV+gepOW8lQHc7jwDikQiIlvKBzwCfeljfYjGQKZR29KaQhDGVXJ/hGelVcQ9WDkCRUIIwCT0qNkWEgqRk9h0qZhGS235sDI39jUIjUnJYBjzt7fhT30GmLHAGG4sd7HkHoKeERNxeTPsnJ/wDrUwdNm9iD6dajKNHJwpVT/Ce9PRbD36gZHMY+UoueGI5NKY1D+WGLv2wetNbJVTgsRyMnio5GjHRiJe/bmhsa1GyW4DgxE+b/ABZ4A9qzbqWSU+U5wuc9avTPEWJYSY7Z7mqccgT7sZDEknjPFTJrY0jdDAwJKwIFHAz3xTjCWJkPJB+Ytx9KsK8ceWxl2HHHf2qaO1eVUMzFImPORSSvsO9iqzBdmxjuHtVuFFkWR2c+YvbsKuJLbQy/u4kwPlBNR3ABG6NQY3PJFVZbiu30sVdsc3yyMXYDCqOlWoIoVs1RFAdCS+ehFLJHEsg8ncyEYyF71ctbwWMZRoUkVv7wzzWsLLfYznqtDAupy7mGKLcXyScYGKzbJN8U1u6/M3zIx7e1dFd/PamZAoIOTtHIFY00cS3AkBfyzwQO1TJWaYrXVjl9RgaIOg6A7sj1qtENquc8nrjtXQazbLsLZBJxtA9K59RtJjzgk1nJWFFl2MsSm7liOKtwkNuHRqzA2Rtzz2qxG4Kjk5HesrGyZcjyHcjvWhbz7lBAwQMYNZSSMMBjz7UguHTggn0FGxSd9zaSXaTkDFDPufaU+YcgnvWdHdAqA2felF2hI5yT6003YHLoaLSADCjryR70wTq/+sUADoRWZcXQB++PpVNtSGSc47UX7ENm0Jcgjp3+tJK6PgqpB71hTaqiAGZipBxUB1Hfu8mVnz+GKZLmbSykjYx4/lVGaUHAyeT0qjNdyRPtIABFVvtIYgjOM8e9DuCmhbidi7FAxUdfYUWN6/mEE7gTge1NnlJMqq4UuAHUd8VDa27Fj5ZJKjOB2qbX2NI1O5vwy5RBkEKcnHetO1zI2+NeRzx6e9YVqQkYUqM9zWhYzSLKyxsQGHY1adty73NsSlj8xAJ7CkQMccnAyMetVInKowySe2R2qcNjBz9faqHsTKvy4boP5U4nIIUkAetQCZcbT1NK7qQQpzSuNXLek5bVLYSljEZBlVzn2961LibVDcuJdFgY7jk/Zi2fx71j6fHayIJLjUmt51PyhYyxA9cir0f2Xj/ioLj0+4/+NNMym7v/AIcypt3muHAjO45UDG3npiimz7fMYhy4BOGP8XPWipsa3PFgCluFzmQnIq5aTgO7TdvlBqlagb/Olb5BxUFlKLnUZOT5CnjPSt9kfNLe6LsM2+4YHIJfbx6V0scixFYsZG0Vi20SyXf2hgFCDAxV63lBEsrdM/Lz0FZtdjopy7lyWUW0bbMeoB6tS6fCjqzSxjzG5JNZ9mfNvJXfkA4UGtMTRsy4OPVR3qdTVNM1bdUYbY4/lHQkVaEaAc42kYNZ0HnTSLgNGoPfuKdc3KpJ5TNheue2alto0jZl0bk+VW5XqO4FSI/nHGCAD8xHes2O7TefLy7nvVqa5S3RSBlj2Heotc1uasMyLEIwuOc1JKeM7N0ZOBVG2uDKgJTbn9DV1pCijHzHptphcqSsIlkZMg4wVrNjvQG2A4OcEkVcvG2Sh2U/MOcdKja1SSNZcYyeTSRqtDR0+5Eo3DaR0JrQiMjSIUcY7HsayrYFIlCqCvtWh5hjhQMwwByPWjVg3rY0Y4iSG34Pr2pyeapYYIB6kVSgutoCxndk857CrpnSJV3Es56gdSaqy2I5mPd41jVGYiTt83Wp2mm+WRnDADH0posoGEcvmfvnJLA/w1JGhR2XcCBTtbQFK49CsxDPuB77aleaIMFmYOM8KDg0zZtUvlRz0FQy+SSCo+YdSaafKUkmXFeN2GQhCnp7VJIkKyiQ4KAfKCf6VSW5VFIPyx9M0NKi8qSwPrzmrTCw95XGXbK56YFODPjzHDMfQ02Ikrvb14FOlfcdgIwDnAOaVtLjEkBkKiQgZ6KOtMXyxkKnXPJ60Cdi5WIHd0BxyaZEdjlwc9sHnBp3HyiTAmJSwIXpk1WUEuI4Qx9WxVxo43Jed8Dso/iNTwzBA3koq5GGPUUW6sadhlta+S0bKpeZsghhgD3qS+Mkcm2QjKjjHPNSsNpilmcOGH3c4rMm1HZviSI7Tn5j3ptpIUU2yePazHzOGP8Ae5x+FXMTYMvlfKoxyMD6gVT08LLGjH77H+LpV6a7kVQsgLYGOPSiOq1HLexI7MFURtuB+YqRjn2quxZ1+eLgZyccmoiWRfMckIB3PP4VYuJop7WHyVkVk+8W71o3cm3YpCWOK0mikMgnLZ56YqlHp7ykS8hBwfTmr1xb/aZIvmxNgEnsaljZwjREbV/i5zmkl3B+RlT6UIdyScsACMHOK5nWbImUOgwqkgso4OO9do/7qMsCTIxwQe1UNRgIEcioPmHI6g0NXRFnc4dyQeeNvenB8DAB29c1rX+ju0RnUZTPzAdqxZlmjU7clc424/WsnC2pSl0LKTAqcjC44ps06gYyR6VS3umAc49KUkM2DkjGcGpsDkTi4KqwXJY/dwfzqzFbuw3TsVyNwVeoFVYoDIMbtozkHvmtOyiEAXeWk7HB5qlZbmbcmTW2mpIm4g5AGc1qJoUDxLIcHc2wKw5NR28i4XcPm9B3rVjvlSRSw5A6A9K0VSKF7NtlJvC0YVmdc7jtUYz0ps3hRYVDxoBkA8jtXRQ6ky3SyKwwVwVPepotQW4L4XKL1yelXzQkFpp3OYfwtG6RSOqfI3zDPJ9qjv8Aw3AI1SJAr7ucjj/Oa6uO4gmvUgAO7yy6+h9qmeNJDhzhSMr71Vo9CN3qeWapoc9gqXEYB43FevHtWTDOVeQZaN24IFepaioliOEGAMKPSvPNc01lJkRSGPp35rKok9hx5o7lYfKgLnnPTOTVlLuMviEsOOh6msyItuCuQrD5SPWpTBuCnOMDsOaxOiE7nQW1wjKMsRnpTnuB5fDZIPbrWPEXDKq8pjkZqeIM3zMc56jtT1NosvefvkG3IGRyatqwAPXGfvVVjAO0qOfQ1Oxyeeo4FTaxpc0bLTLq8h821i3JnGd4HP4mrUeianu2fZ1Az18xf8az9Ms/tmo21s7lElfDEdQOpxW1Fb6G8dtKbW4EU85gBMx4I6Z+uatIxnJr+v8AgmJNlJWjONykqw9xRTL6EQ3s6lShVyuzOcc9PeigfOeM3mFsIYwQMjJ561BYFYreQ4+diSBTjACd8pPlKMCptGVJ5mkk+6mQtbyPno+RehmaK2jjblpD071dhARSZiNi9FrIaMz3BuS2Ios4xU1rMbqfdISE649ah7WNYvU1o12y/aCcBh92rkY2xeaBtHYY5qoso8xI9oLEZB9KjaaW4doclf4crUavY2TS3NaPWAkixbXd+5AqzE5kfLw/uierDk1RsoobDaC2ZH656mtKa4jjC7snfwAOtQ7I0jd6stIFh2lFHPQAU23twZpJHIM3v0FNjkHCnr0qbADBiwBPGKm7NVYjln2HCtznGK17a4CwqZhk52hu9Z0VqjTF2UZxVlnVVBRQy9MZotYq9yfUVeW22whGJOPpTrdPk2SqMqvBHanQMVhDRDIJ5z6VIFDgk/dPb0ND7leRlC+is4kXO6UngDrViKQ3QEly/lR/3F6n61E0QjIWOLM2cBqsRaYtxb+bJOFmBx5eOtOKe4m1szShCMiiPHI6/wAqdbWgjl8yRy8mcFiaS3h8uPYhxtGNxp+WVcsMr7VLv1KSL6BfLYvuOOnPSpIWG4NyT/T0qvE+4BYwA3+0aYzhXAZ9qng1W2w1qzQO51yFxjpTo1j6Tr8304NVHkAUMrlkx0qN7zzY9rDK9gO1O9hpNlxwkaYcLtPGAaVGDWsggKxMf71NglRxynmEdPaiQjfiOLJ6nPSnfqheRBZ3LXdsFQMXBw3sasRxBGI3KXHOwcACofIeW6BtnEUzcOQQARUy2qRF97NKe+3pTSGMO9nb51VB6VJGc8RDIHpUmNytuBWMdARSx8Dai9ecdKZSehE+5ju2cnjFTW0a5EUhHJyRnGKU7jIS3HsKW7svNQMxCqP4ulNJvVA2tmJNbCKQFZQVcc47ClSzS4QOoAUfLyepqGKdElZU3ycbAT0qaZLiIlZEB6YCmmtdbD8rlmGVf9W8e0bMKQOtQ7Uktm8x8TL93FRNKVki+YqQMPx936VBNKY8vbEtATtLn19KrzYvQt2dykMMkE5DnnAYcfnThJ5zQ7SMAbSg/nVYSxqCoDOT2xwasWcA3mbcFKj7hPanZvS4Oy1EmdwvzJ+8U4BxSqzw4KkfNywI/SleRRFJNHux2571GbkzlSoCkjk+hqdCdSN3iVkkYMzsPmVhUEirdqERNgTOe2fSlk/16zM2WBwc8A1M671xCP3gHPNWgtYqRWp27TgOex6VRv8ASxJNhkQsRk44FbtrJiB1uDukA4NQQkTSNvBBBwSRwRQ+xOrOSudJk3ZiT5PcdapS6fMpBMXzHjAHWu/kjhkjd1IBHG0dKrBIWOWUuM9aTSuJJnBtFJG+HQqKWOYAANn3FdhNaLIxVojuPQntVa50iBbKV5cCReAo7modNdx89jBW73P1woq2k+5Rxxiozp/lIGZRg9h2NM27MYzkHmsJRaNoyRbe4KxfKT/Wrtnd7ELjLk8ketY3mcAtkHFVF1gQGVwAxRwoHqKcNHcU5XR20k5ubCKaGUq0fMYVeQfTNTRXhuYFY/K4G0r0KnvWJLLJBBbXlnG7RyN88OcAn2qJ9QhGpy3Sy7AUG6N+CCK6mccZ6m/NCSm4Z2Ec5OKydRiDQmSQDGeMdq047qO4s8hJFUjIJ7+49KhEcSqwkw6NxSaSL5r6Hl2ubrPVAY0kIY7t+OBU1ndeYmScjoTW74lsFkhKYYrztA659K4uOylsZfLYOir8zA9BWcoXM+dwep08cqbsEcdRiraFA3Y56jNc1b3Tqq55U/5zVlJwAuXOev0qNVozqhUizpoNhBJPAqXaCQdwrAi1HgK/Ud6sC+Tkq444x1o0Zrc3rJ5zfQJaZNz5g8vH97tWxY3twNYuLUPpsjNJ5keVPl+aP7nofrxXLaZqM1td2tzDC0mJMKApxIe6j3xWop06CZbqOx1pmVvMW2MGBkHIG/0zTS6mFSoUr65c3ErT5E+878/3s80Vzmqao813PLLmOR3ZnBGMMTz9KKqzMnVRwN/MfsZjT1xTIGFvYOyE727VTfzJYOM4B5rQtrYbSXyQBmtfU8rzRoQrs0lIwMyyDoe9JFELGBmmbLMRimCQQrExOdoP4U9f+JjIhVT5EfUnualrQuLJLa7ebU2BjA+TA9q0yosIC+R5h5y3rWc7LFd5iGZTwRWjBbfaiDeOORkKO1Zs2j36jbN/MIuLkl5Ooz2qa2eRrkz3JAC/dUHoKZNbP5wVZCI/aporaEEKz8dcZxmlZGiuWYrl5pwQu2Ned3rVw3kPDE5c9AKjkjieNSZFRFHIHes+xdPtRdcsh+6aSirF8zTVzZ+0TbMn5Af5VYgkVh8v3jwcVQmd5SQ6kA9AO9PtpJIQTsVD0+bvUW1NVPQ37eQIoB4A7CplnR3KqQazrVmlUMFPI2k1YWPyUZk+939TRZlqSZZkR2dcZX1yKTcEUM2A69feq4mm8kvIrFQOlPtkNwgll4287D2p7jehfidbhSoBUY61PGuVCh8ADrms4XREh8oKR3P9KtW0is5LoSTzgVLQJ3LyRoflOSepOe9E1ukkqqCSSOcGpFljAXaDt7ml+RgGB25PUVS7DRCYIVAXc21u2aVYREoaHaVBwc96kaAbs5HHTJ60kTb8rLFnHoeaEVclQhyVZhHjrjvUolkb5EB2Zz6Zqo5UuAIz/M1aCKir5zsqnp9KaHoPZN7HBSNcc5qW2aSIFFdVRutMSONyG/gHPNTutosPmSyB5M7RGOgq0uor9CGRmYgE7ueg6U6FRK4UhlHcLz+FJFJFhy2c5GM9Fpkt6Yn2RkyZ4yvAo03Y9ehaOLeD94sgk3Yww4prtE0G+eZsD7kYP86ja4EpJlbe2Ox6U5IIg5Iw5K5z3FPR7BsRwiMEeYPlYdPelmkeBx5pUDqgBzTEkjdGx98dx0qKJWMZb5Rg7tzcimuw13Ibq9MgCLvKk4OOKpPE1vdK6u32cfNsfoTV5GklBWFUZs4UkYpL7TyhUNMz71ycdjQk9x3SdhbSZpWZ4WQA569Kvx7jbs7qgbrgnqKqWNpb21mzbjK/oOlJ5rTqSSqr0AxVdAeuxK9z/q1OEUnGCelSvK63cBO4xkMDx7VR1ODz7UFFIMeCAOrU9DHcLD5StjBZfXPfNJEuzJIAkl02xgxjYZU9Rn2rTtbPdMzSERYbOO5FYVzZixvrfUC5ELMFmx3U9/wNb8MyCN9r5lU/u2Y8Yql5mcpX2I5wpcCDAEYPI71SgJuFLrIwAOAmMZPpU80qLPycbhkn39BUEMTpcSMsm0D5vxo63C9tCSaLCyRjGf4vaq8ZijVk5B28A1DNdqt4GMpZpBtAHJz9BTvLnaRpHVdi9yfm+lNag5WWpK0jqsaqvOc5NRz3EScM2S4+XAzk1OyAwPKZAWVSTg8DArn471PtumyTRssMu5drHFS9CeZFuZ/OYKyBEC5J9TWDqV4sV4UXGFQfKTySelaDT4ui8oYvNKfKhHOF9awPFUQtddt7luSDukMfO1e35VPQl1ELMCb6OBZCP4pSei+1c6J0kur5D8xSZcEcjGa2NLB1O/vHkLizOCkfeT/aJ9KzdizXt9b2UX7p0DMwPUA8kUKPUzlUb0ZsHUJUsZvJnLRrdAJlsjoMgVf1e1tdY8qK6lMV4VwFTqff6VxEuoyC5v7TS0320RMmWGNpxySa9A0q2tYdMS7kcTXZQM7N97/9VXFGUpXRV0bXXjlWwu5As0JCEjqfY/lXVbEeRVl+XcdyrnivL9RkH9qG/wBypev++TJyBt6q2K6HR9aTW5YZ5D5bW8RaQHj/ACKLlxk2dFdxeZMSDvCjAGOnvWVqemI5AILsw3EkVo6ddtLZ/aZ4gI+WAXuM8VoXOEHmKDGrr8oz/OkkW3zHm+p6SRIzRZVhzx0quLaaIhZcYHBxzXeXQTEhESuFwWI7E1QvLcKA8gUAj5SO9NvuRyNbM4543G8rGdh55PNMfMY28CTOPwrrRbJFb5ZQznnn0rG1myaW38y3UCQnp6il7rE3NdSpolzdXWo2dpHeXEUf2n5TF8xic8FgPWugF1BPqRsbbxnqhuWbYjNEQjN7Hd69K4nTtZk07X4XtkVLpHH7t1yHbp09+ldrc6cYFXUV8JzpqVtmWKE3iuqEcg+WPnIB7GhJGMpy3ued+KoJ7aAX8WoyX1o80lvM0sXlSwzr1Drk9c5zRWZ4m1aW60y1s3tmiZpnury4LZNxM/G7H8IA7UUWsCd9S7aQqLIMwGSc9Ke0jJEVKctwCBT2IEEUeRwR+NF/dKZUjQYboK0aurnNfoVLkpGRv544q5BcSOqw2yhSR2qrqkH7qKPIMmcn6VfsFjiZQnLYxxUS2LgrPQeIxaRNLKS8r9aqWeoSC5bktJjCj0rUlCEozrls9BUAggWQvtWPPQDrUWVjV3TsiaeeVgkSnczckjtS2cqkkXLENnAz2plsF8h2R9pY4U96lh0uISeZPIWxzyallq5qwxwzQukR3kg4qpYvstfJaM+ehxgCrsBhijDQjAAqqd09yzRAx7uNxqbmlrFyyDhxNcuP9kZ4FadokNw3mFS4J53VjrajCqrmQL941pQ3CpEAflxwB60WKizajIRfkO0D0p32iIjaCGJ7Y5rNuLtRCGT7+OAO9QxyPaxG5kX55OAewpW1NLqxsxzKZTkfIo/CqkiNdTlY5m8v/Y4oiAuIVjZwAfmPvU0WIhtiAC98VLfYtbE22KCEjdtAHBqS384nep8tMcbu/vWcAZrstPgqOFUdD9a1XdwgJPyr60MaLRlIAVipH9aN5I4IAqtG6ucgZXtTpVJXk4UdQKnUtWNC1ljZP3sgHt3NMwyXgVW+Tbn35qtGyKy4QO3amWt0/wBol3ooZPlz7VpFoTTNLzI1kwMsAMHB709njlj3tnaMAAmqcj2sQ8wk8+/elibCsw6EcAii7uNGrBLEIyr4z7GniKKRsMAUxkAVkxSclAoDHkZNSLFKFYyuRgZGD1qua/QrlLtxsuTnLJgcgdDUUcaxShQyhAP4u9KjAAtnBCgDFRyujkgoFHTJoGuxZVgUYx7OvU9TS3AjCLtdtwUlyBg/SqUcbjOCpJ+6KugxYO4/PtwTTV2S9DPsZtttlMZfPDe9JNv+VXGwYzgGmX8sdtbqDgRKQc/WqNxcm8gaO1JZP45z/D7D1otoUpF22vY3Yx24b5SQW7GnTSySKi5UHrzUEPlxwxRwAbwSAAP1NI80iITOAFGcEdc4p3bVhokun+zWchBYNtIHPH1qWJxFborEF9uST2OK5s363OnuzlgGUgAHJNavh03Vxp8PmRENHjzNw5qlrqhN23NC3kcwCdNxccAN0qvpUkrXreaCsHLK5OOe/FaetTRQWTvas2NoGMfxetYtxqDC1tBbuBd58sRnqvqTV2UbGEpOQni7UWngFlaJudSC+04AA9a3dG32ls/2oiZpACikYC8dq5BlNtc3dtuae5mdX3dx6n6V2VhKrWcTuuU7PnPNSr30IbsrMY0aOyiUFlQ7s56H0rOvzLNcSRpu34JCr/WtNJ1IMTEAv8wHdvpWa6vLrG5pPKIi5J44zQ1oCmuotnGlkkQ+TIx8x7n61ZlupyxwioQ2QT0HrVLXCi2tl825BOpJHbmrcPlm6uYGBZgoYAngZqjNyXQhnubf+z44oTnzt+89MY964vXtRWSK1CSf6lDIijrkfdFXfF+qQ6OotTuK7C8Q7hj2+hrmvDVrPLcwXl+25n+cJ/dQdBik+xHMdDbTSNEmoyzLK5iBRB/Cc8iq+uXNvc6qElYpFDHl/Rj/AHap+JblLHVpQGEQkjJVPRiOoqR7fzrGASMpvrghF29VBHJ/KlZ7C5tDnIdUu9PW4voWZbZoykG4cNk4wK6O2ePw/pdnfMvmSlCHVurOw4H0FUvF9sLfTrKxtBvkVvM2Y6KtY2q639v1HTImjIhifJHYt/8AWoXu6Et31ZHo7SLb6iiqhunnLFcnpjOCK7XRb+OTQbea5+VJGC5xwNozXL6Gnmm6l3hCZW5zg7iD+lUxqjzeELWxjkCyi68sZ64J61S01Jb0sbEUB1dbmOG22JDcGcyYyCMcL+NUtNu0uL9FlQwWaytlV++/sf8AZrqPDCHRL+exlKvE6rJvPJLHjp3rkPFUMmna3ttwnnGYmMHoVcdPwNNqyC56ZbXsepTmCBdtrGo+YHliO30qxPexHTozdSgTOCFI9Aea5rTLn7Pp9jJAqljGUZdw5f2qc2UNi0c+oSebO67leQ/KPUUNlxkb8CtcRuYsCFsY3DrgVmGNrmOW1uAVeM4JzyB2IrXstQS4s1aAMAVwCRWdqckpjE8C4dAd2R96smro6Eyq4miVPPxJHsIRumT71R1G4QWkLRP87ZBB6BhUFxqaX9vExzGQ+1lzgq1ZjPJpc8k87iazlOHGMlSe+KNLGUmxsbWcPiLT9RuYWQwSh5MLkkf3h6461oaLCsF7BqF5rmmPbQTeb9sjud0jgHONn3tx6YNU9VsLm50tZrO2urmFW+R4YmYqe4yBWRoWj3tv4nswul3Zhe4jkZpLVguNwznjFUtdWYzfK9CXxfqlpLqEs/8AZ8MsF3I0gXpgZ6DHQ0VleNJbaXVdTSxB+W5lXyzxsO88j2orfmmcsowbMidZpGjdMhCfWpmhZZTMGyVo1G78m2jiiwzHgVZtkdrdOeo5qd0K1i5Dbq8aSSt8x6mpZCttiSMdeBVO5nwY4QcY6026nEqgK447VG5rdImaeaSdfKA3HrntV1LUNEzTtmQrgCqsDF8JGNuRyfWnX7yx7EjBy3HPSlaxSkLC8cUmxsFYxnHqatRrJcTK8j7IyMhR3FV3hSztDJLhpMck1BZXbzyOyIfl4HoKhpFxbTNu8cRIkMbDLdMCrEUOIYxkhR6mqFgj+cJJvv549qumQGbGQQoy1R5G99Lly4n+zQ4ijBB6k9qitEa4Yyb8tnr6VnNdCdgWf5S2Ao9q2vNSzsDKVwcZA7k9qBruU5p5VuAiuCw5YY6VbF1LI9ssrApzxjgGqWmWksredefIrHecnrVm9P2hR5AUJG+evWixV9DVeaO3i3Pwg5zUdpdfbQRHlIz/ABkcn6VQEUt2fMmG2EdEzwa07W2LRK2SNvCgVnbU1WpaRhBDhRk54J71NDKZ3AUYVetUbl/KuEjj+dzxj+7V2CNohyQR3qdSy0xVGyp4I5HvR9q2ptIyPao8F2IX5cZOTVa0dpgRuyT6dqaXUd+hdi3tkkhR6igyxKp3H5unTrSRytt2svzjgcdaUqkg6AHPel6FoimvI5TGgjIZDux61YWU7ckls8EZxigRGEszQAq3JbPaq87q+/YMHGQBV6oqKRo28ltkGXLOPXgVYW5jlGFBUA8tntXPreT3AEaoQqjqVxWsJMxL5a7QevFUmugmrbk8dyqurb/kJ4AHpUc9y0qTXRVnhjOTgdKoX0oEQUHDnPSqsmo+XYxxRSfLLKEkUjrinHXczm7bHQm5V445Y1KKwyFPYVnalcGKNpoi0adTuPB9qbe37KsMMIXz3PAHp71EY0XzLi8IdYwcJnge9UyLtFCOxvdWAlv5tkQORGO49TWheQy2VqjRykEkKq4GD+FXdORjaR+bJh+pwOme1ZWs3B+3wJM4SNQX+p6YpWsgU+pdSKVUaRZWZ164Xqaq63cm2ty05AypGB6n0q19q+x2itKwRH25PcVh3kn268kvpRm2g/1a4x+P405KxcZ3Yvga0Ny8d1eblRVIhA5APv711a3gt9Qa1dSr7CwPbFc54U1B7Jbu1mTDN+9jGOQp61cudRjuNWZ1ZGLwKVJP3Rnv+VawsoaGc5NvU2L2cXtnHBlY3icMxx26gVjzadF/bcN8SSzqeOn41Z015rmKd96qWfqe/GBWfqt5i0tp8bZEkCSgdjnBxSfmZt9iGW7a21y8e4iCo0JSM+h61pfaDHplrYW75lmUMP8AYHdq5nWrlbnSNVmwHfzhHEPTpg0/wleO98z3r/6SkYWRCMZ9h7VNtSXLoddiU6ppgAz5WSX/AL2Bil1grAt00jkNECST0x1qK9uVfWrKWJgIZImGFPTFVPiJNLa6WLpQPIkVVlHfHrWnLo79CHK0kZ2q6l9sNlBAwFuZozI4PGa1NLutz3jq43lmZSehUcDmuO02Rj4etniiBnln3Jk87Bnk1u2tytlDZR3Ckeeu1MHqSc4paaCu2mcN4+vDqN1ZJC5acqWkHpzW7pmoC9ntUsQIxbwgSF/auJ1j934ynjgYH94QOfUVoaXA0t7PBDdZZVMkzZxnjpQtzJy1NzxlpzyaXHrDy7pWZVAPQrn+dUvDtzKPGNxJckKkUPy88Lx6VYv5ZdY8MtNO4gskby4o1POR/Ea55dRI0qOaFVmuVRzMzcHB4FJ9x31Om0OV9X1u41KdlSyQlFJ7r0rnvFQj08Q2sDbZYJy0RI+9G3IJPetj4fq0pg025i2xqBcSKTguCeBTfiN8/izTYxbhsJwhOM+gp6WsT0uXreG3i0JpIWzKY0YAj5t2ea5NLO0e9txZtIbiNy8gc8MQc8Y9q03kePwfHPGBuhcxSZ6ouaq3cllp+s2N7EdtrEoWYgZJJHWratoZ7tNHc2Nyl94ugHysIbQH8TXN+PZkj8S6e89u64OMZ+8vYimeDpEXxGszBmEib1KnOfbP0rR8eI2tam6Qxym4gCpbgdmPJzScXY0U7mXp2rINft4ndEs7ectnGT8w/pXQF4dRv5GllEunW821cfxZ615zcXkNhqlvNJFtXyzHNH3DdCfzrX8D6tHJZXWnhMsxMqHPJ5zUbuw4s9DN6dPlfJP2T/Vsw6qT0yKmiv47+3WBn8qTBSQ/1qmGg1LSjLGw81AQRjOe2D7Vx0DXPlZWQ74GO0Y6KD0PtSu1ob3RNqDst5dKoHnBcMn95R3+vel0DUIr6yNrfKXiDFC+eR6Ul5eWMmo2mpqMK37uZCeVz/Sq3iezOm6rHPZZ+y3TrkL90mhR6mTmbGm6rrVpaG00+WZBG5yqyEBh64rM1TWNas7xJV1TUFw4H2dpz8+ewrsdKsrHUQ1wb4WtxDEWkhWEuWjHUjB5x39KydY07w9NPtvPEW6N0wjCyYlPfOaqKtoyJu6ujzPXJ3S5N3EzbmkPmI/LKT1ye/NFXJLYrq81vCpuI3Vgr4++Oze2QM4orRRk/hOdzj1Eu7YJtc5yO9XdNkeQF+AoHSodfnVY0UeuKhW6CQKsIyzDHFRfQb0Fui9zcuVOFA6g1Z0q0Q5M2SR2NVrWN1wr8FjnNaHzCRUThfSkx3uy+5jj+6QoHSo7qf5ULnnqPpVHeouQHfKdhmq99K1zOUi5CUrdC+Y1bm3kngjV3HPb3qW1RbOLbnlvT1qvb211KkfmMMY4I7Vo+SkSK0hBcHrWbZrFdRzNIyB9hBxgAVLbwuLGZ5fvsDjHUVE2pRpExIGF9utWbBzNHukBCnoPWpbNY9iDS7BIzFK/DdfmrbcJcNjO7ac81E6w4xnadvSl07awAXJI7nqTU67mqS2KepS306iOGPbHnv3qXTorw7VlXG09B0rSyzEBgAM8+tTKq7wpOSe/rSv0Hy9QhtiwPnthSei1biaSAHYwAFQsSpJByPSq8sskziNflVRkmp6miLdqoRpHCbyzfeqTzQ022MH5euO1Jby7V2RqNqjv3pRIkZJCqGPPXmi6GkJcH9xIM5OPWm6dnyI2jB6dKdHZvM/mSMNg42VdTbCEWJVC4wR2o0tqNXuMFwzyqDx2zT3VsbmK7fan+SrqQAoK84zT0jjdNpJB7UJXNU0iMyEbWBcIeBkdaeQroWYKhA49TT1DJhVAK+jdqjYgrjb/AMCqrhzKw1sgJvfGe1Pju9sTqwOScYrMmnV4yYyw2ngnuaddOYLJ7ibHCnp600ZykT4jaXapIYct7VzTXUay26zviNZXdj64rb0iXzIDIAdz8lm71yMtsZvFEy3DEWsJ3bR3z2qraGMps67RWDTSXcp/euSFDfwrVS8v57p3MQ/0SSQRqMfe9T9KpahK76jb2lq2zzFwSOy96TW5JINTsNJsiqSMAQx6KO5qktCXLudNb3b3E6xwtm1h++/q3pWXq8kM/iTTUZtxAZ3XOM+lTIgsLCOyhJZmJwx7nua5idlt7qz1GRmYGYxbvReg5q/Ii9tzqL2UT3n7zmGBlXA/iY/4VpXC25doUGRt3EmuT8P3jXd1PNOy/Y7ZmIJ7ue5+lWWaW9E1xMxhtWUhdp+Z6HuNO5Be6gZ7OKSwV5dQi3htv3dvPBNV/CcX2/W0a7IYRwgLt4U+oPqa19Ckj/4R+CytosXVwWiDEfdHfPvWPou3SL20haT5orh45Fb370umonI75mEN7blAgRyQB6Guc8WyNZRvcbQYZmwyr1DDv9PWr9yRLpqyB/3skjPDg/xDtVDV5zNa6U8yBkeQxsPqMVTYLU5vSLqHN5BNKCHmjkjX+8M84qy8UKaq1zOCbO5LYIzmMjgHPoa5rxPC2l6tINjqIWHkEf3T1Br0bw3bWup2kGHD272/lsT/AAHuCKmN/hIdtzIsGnu9U06OzLFY4thc9Oepq58Q5BcaLLbxyPLMxCrk8Kg71l6LcxaFda9p7S7pEz5JP3ivbFZ8t+l9YareRFmLR7EXPKgdf1qltZGcnd3ZHpt3P9pjs4iGNvDggdBnqa6V7+G8vreUn/RLZQi5GNznqR9K848NatHBLezS7hPKm1Mnr2NeleHIol0qGWdQ7yIRGhHCL9fWhb2HGWmp5prVnL9qvtQjAZluMjsQo6mqOj3Am1YqrvGJmEbt3CHrW7NfCG3v47uPCyyOkcvZmzwDVHQ7GNNQFzdAPZRylJHXoC3Qiny2Rne71PR9RsbM2WkWCMEt5LpUbHZQMmvNPE2LbxPf2tsP3Nw4GRxx6Vp6lfXrxeStyuyxugseTy5b+L8qzbC1n1LVHLSAyQStIXI4JH9Ke+gtE7nS6JaPZ6lNBHu+1LEjCY/8szjp/wDWqp471Z7nVLC6uE2T27rG/HUDuP8AGtDQNRa507V76VdrOwVSP4T0FVPE0kGqXFhazE70JR5SMdB+tJK6KehT1LypdUuba1ctBIfMZAcjBxnNcvqNtHBqosrmRggBCtngjsa6bSNPjW1uJg7bvmiVh1zisU2y6jYzS3BZbqJMK/8AfwcYFaNNmUdNTpPB011AFl0ZVeWGJl2Mfu5GCR61p6BeR6vdzrPN5EkSmSQscN5gHArkdOvX0zSXFm7JeISsoPQqeQRXQeE7C2vraO5KNHcJGRdSFs7ix4b60PXRbii7O7M74g6fbwTw3CoQ0yBpR68dRWDoU66XfQeauGBVsj+6e1dP4llbUdEh8zLTRs0I4xkDoa5FriRbe3S4QFipCuOuP/rUrJopuzPRNNnFsyHY2128wJ0ypHWoNYEgQXtngJJlCPcdfzrK1DUpLGfS9+54SmQfVT2rTtP9J+2Q27L5TfOFY8jvj61DWtjVPQoatFa6hp6TWn7q4VQGA6OO+feqNr4gaOwit5VLzWcwmQnngHpVjRprdbi5SU4SRtrIemKwLyzYSXElucqjbWGfm29vrVLa5m3qdrMdX1KV9b0C2vZEabd5lvGSUYj5gMexwasXvhbXGsXudP0y7dZQN0LwnI+nvXPfD3xDf6PJfWMNvcXdtdxGOezj3bjnpIuOhB710GjJrtpo0lwBqsbREmSO4LgOvYjPek3d3Gl0OHnujFcyB45IZUbY6HIKkcEUV0Oo2S3q/aViAEnzMGHX8aK2jNpaM5507sw7+3+1QmQnHcCmaLFmQD+7UzEzfIpIQd6LRltdxzx3rHdFqxZvGMMxZiPQGpN5S1aQ43OOKqTJJOu+Q4XrTVmEsiQk/ItFh310IrqJ4Io5WPJ5pNIl2zszEfNyAasXrebAyKDjPHtSaWqxyLlTgDHNJ6IE9Tpop0SBdxx3xVRUa6uyzk+Tjj3qNgJZCMnaoyamuJ0htl8v7x4rO1ze424ggM3mPwi8BfWtH+0oIbZMY39lxzmstbBpQjebuI5KmrdvYsJEZkGR0zQ0VC5PZ2s08iy3TEB+i+laxf7M8aKBuyDx6VCCUQADP1qVEEZM8rgyDt6Vi3fQ6I6K5LqF4sbKkXzXEnRaksrSVdrTMCx561SgCzT+ccb+gx2FbIk2pyBjFDRSkNaUIQp+929qkjQ5wR8pqlGd0hmHzA+vapZLvyyEHzM3P0pWNEyeJg1wyZIwMZHQVBFGzXTOQTGvAJ/nVnT0ZizABtx9KnYBBJs5RetNwbWglNdSWFlwFX73Q1OrEZUquRWZHc7twRMc8E1ohh8hOCT1FTaxomixb4IO7AkPGKe6YkDFgCOo9arOBuV4ySO+O1E8wAAA3H1J6U15jv1LRnAALL8+emOtQXEgfIVSq9cVW+0bnAPUDH41VN4pdoicdt3vVpXM5SRFY7Xla3ZseSxJB7ntVbWJv7QvktFbbbR4MvufSsy91COzvrqSX5FZPkb1IqHTGeWRN5+ZiZXP8qpdjFzOi1O9WxtFK444CiubNrPaag11fttSTG9Sex6Vratc201rHcsu5F+VQvVvWuX1jUmktJUcHLHC56n0q+XTUzlO+pO2ptDqpvIV85B+7jj7lR3+lWXjKyadrDSl5ZXIkyfu+wqvpNpJpemvdXSGSaSPbFj+EGneJWht/DsEcG4PuyOO5oSsiXLW5vfb/tEF5ebgBbqY092Nc1rckQ0iWze6WKO3QP1yXkPOK586pdR+HQqLiJ5OWJySRUa6TKtvDcXYGZ5AFG7Lc+gqk/ImT0NbwnPd3dlHaQQ7wXLEZ4ds9W9q9Jjt4LC2Fzeyh3Rd7Z4CEdlFcf4Uki8Pm5tblALrcGGOSQegrR8251HVLaLVYjFa5ysQPLe59qWi9SoMuaFMv9ryajdMI4bwEwkDG0jt9a5u9vreHU9Te+kOZkzDx3BroPHt5Z22lxwROElJDR+2P8a47Q7T7ebjUNRJzbx5iU/pmjyByudb4KWZtLW6vLgvyWQdox/jVi9lB0uSe1BeO2nRo8/WsbSFvLYjSrgbZJsMF6YjPOa1/Ft5FBoAis1VZfPVGwepBFK2g1sN8aacupX+ltKQTMu6ZMdPaq3hJLjTZbkJkWJcojnp7ZqLxDrsUk0Ehl2sIlQjHO70rrPD1kF0FLO4YGSSIt83qe1W7NkbHnGts9x4mn2/urqPGXPTHrWNYXhtbbUbBuZJiW3j+LB4Aq3rRlnvnXzFjlhRo9xHJI7GsuwiBEEquu4gncf4AByTRFamUnoUtBt/7W1eG1dvLViV3Y6Y7V397rV7p2lfYnhBW2GPtEa8BfcV57oUgE15JE2JIvnSU9Bz1x710E+ued4VdZ3zdO2NuOVX1+lUtAd2ZOrXRvLa1gWbIXLbNuME+taGlXw/4R94AmWknXO4cLj1rWhs4R4Xg1N0VLj5x8w5ZSODXOaXbxyxLLPO8Fr5m1wPXHWm1qvMhN8uvQgvUEuryM0p2B/4AfTr+FbvhhBPptw0EhEkcTiRv7xLf4VgXw22UUkMpAbeSRyc5wKv+CllgS6KHJkiZdp/ixyalaSK+zqdHaSLa3bafDGrxzToSAemBzkVDrFjPfeIbtIyoggkDuVP3Qe2ay9E1OIa+LqdWPmFiQOoHQVueFpFs/GF3Y3IYx3KEEsc7ie/5UJ6Ib7Atxb2WgSxxCSWc7klAXPlsOhzWXI9rB4S025kXeDKS2OCeuagm1GfTZtRsY95iLkbm5w1ZXh22bWLkWVxOUgXJTccLuNW5EqOmp1GnaTpus+H7IbkttUefasjnCyRnOAfcVf8Pztot9fR+WWLj7G+4ZUMBww/GuZjuoYryKxu2EcVorK3ruHQirfhkSahfb3ndVRTcSKedwUcGrunYyty+gmtX3l6q0EinPGQOhPTisS5tRLC+W2rGMjPYk9KteLFF9cQPZbmkK5YjuSe1FxbXENg1xzsYCKUMP4s9B71O6Y3o1fc0tMUaposkl2CvkxCGJh/fFLYzSjU4XePy5GiyxHSQjrWhpWm/Zb2CK4ciyfGSp/jxn+tdD4h8PmZ7ebTyBLECQM9RU8jvbsac948yOI1GSCTVY1OxAc78dx2/GppbNIpombLGQgpzgkehqvp1mtwNRSVlW/ViViYcEe1N0S/aeSC0vmP7mT5Xzyh96BLc7e3sL+Dw+reGLqGC/a58y6TzBFLNDtwFDHsDnjNReHdP8UaZqTalJqMmn2McwaVb67DxtFn5htyc5GcUwmGw8M3N7rGnyaqk9yY4khkMYRVXJcsOc89Kp2eg2c8+nX+jI9/4fvLmOGaKVsy2jk/Mjex7HvQ7BsZsWvRi9vhEpi0uad2gZhwgLHAorA1K4+xalqmnRr/AKKtzKiIwzgBiAP0opK62KbRbQiOMKAAxHFUJN6zhW7nBrQB3XKkgEY4qW9Ee1WIAI/WltozJWtcmTa6IhHBGKx9RhMN78ucZ6VoxSjy1kAOKR1+0kyYBFJDZFMoFuv8JPWp7ZAYwDgYHJpQqeSFxuYDmi1tJDJ877VNDY0i1dzqlugQgFiASKo6tOR5Coehq1eRKkgjU59/Ssi6nEswibcAp60krlNtHT2Uvl+Winc5GSa1rWcST7ewHNcnaXXkNsiUsxwM9xXR2v8AokBa4++4zUSRtCd0XVfzd+QAq1RnlMzojKVi789amtLuOQbYQSWOSfUUlrsn1OWMYYJwKzcbG3M3sXY2VQsdtESMZ3U+czPH5AB3HqasrmMxjZ8pPPHSi6YxjOOO2D0qbGitYUI8EComAMc4HWqCXEKvM8jDd0HPNXYd5GS3BFVv7NSWfoFA7+tDRSY/TpLsyBoz5cI6Dua1GVyuM7SefrTbe3VMBeSo4yetPjkAOJD9CafM9hpLcapS2bL5IPU06WYxbPL6MOPaqk58yRiWIgUZ6dTT43jUeZI3BGAKajcHLU0ITvK7m2n2NNuJfIDBmBGM1li4keZYIhgtk5z0q/GkaQt9pYN2yT3q4wvoTKZRu7wQQo0fzPIehrOLmJ4yX3O7Zb2pLgk6nvJzHAvA9T6Vj6neG2F3LgqGOEJ6A1aXQ55T6lLxrdrLfwwW+PlxuPWraXiWOlNM0u6edtpPoK5cebdTzRxEvkbnc9/ahrtrsJBtILMFOOdop2MnI15dXkdXMeTChwma1NFtWvJBqOoALEv3FPCk1llInvoLAlFhX77L2FaYvftweziYLZwnK5H3gKHG2gJ31Na/1EvLaeSxW137WOPvHHaqfiLUlNobKKFpiEJU4wUHrRcQtbtYSSBlxnYoHCjHerljE01pcXMqebd3ClY0A6Af5600m9EVJ6HFWoN6LHTdgTY+8sTn862ZLc3Orw/Z2adYTsDkcF8dqzX2w3dlbwApPIGEjdyTXX6UEs7lFmKxqvKqOmfWnKFnYinPm1Kt3pp0nW9OvLtzIxBExYcD0qzLrQWW71aZMWu3y4iep+n41meLtSk1CZIAT5W7zGUjkKO9RrZS6xZiZsx6fCMIh43YqJabGifQl0OwOoxS61rBaQAZhQ9F9Kz9czZ39ukb5WZN7IBjPfFdNqt4mn6BbQIFLyhVAFcdPHc39+11bMG8hxGrN0J70JX0FJ2Ol06+dfFFpPqBKl4cY/uqBxSanDNd25vIwzQW8xmf/a5/wrAsLqO61YQXc+FjfLPnqBwQDXSaxrKRaTcW+mROLM/L5x4yD1p2ve4XMGzMOseIrx5YikSIJEQHO0+td9p1wsqNMXIis/kAznLY5NeR6JcmK21KczOj7AuVHLc13Hhq6ij0j7TqE4JlyojXrk/zq7aIzUrNnPeOZkkuri4t1P2aYqWccYf/APVXOvmFtkLJLHgbsf3frWnfTLqBuoZiyKjk47cDArAt4rm58yNCqRgbnAGDgdKi42rjtNiea+nSFgIxzIc8Aew710EWl/2lcGLT4T9kj4acj7x6msu00eS3S1kl4D84JwGFejeG7mS10UGOAFGYKsa9Q3vRfoUo66EviQ21x4QRLdRhIwqqvY1wSrLcTWywqUtpz5e7HGeh/Gu60OzeTVbm2uQyKitIiOONxrmIGOn68LO8+eyhkM4CDv8A/rqua+5Mo22OauLVodXWyU5MchUe4rtdQ0z7NeCO2QLcOqyR45B+X5qwtatJ7fULfVtn7uWUkcfzro7jxKjXUEksAzCoTcndT1xRG19QktLFDwfZwnV764uowot08vnpuNZ+6+laa/gTLafNzL6D0rpNIZm/ty8SLbazktGW7EdBj3q54OhDR3FrJAskV7Hvnx/ASetK/ctQ7GTBBDf6Pqst2MmdfPR+h3DqBWJpdslppV006ttdczDbyg/hcVtXqT6TMlqjD7H5hjkUjPynuKdrtiDFHZ28krSocGRRwYT/ADourXBxdzlfCFomreJhHctuDKzD/bKjvXUyxRadZ6zJablSK3EK56lieTWV/YyaU9yYGkDRBXimU9Ae/wCdWLG2vNZ0yeISF2IZ5SPRR1NaRMpdUZ2jT7EspblC0cO54gOsje/tVS3up5kuoCTJ5riTHYHNTxaa6xksskYWIlCDkE46iqcaTRJBcMpG44DdORQpNKxDir6nZWVtfTazqMUyr+78t/LIxzjt+FdJpS3Es008Cfuoh5Z3H17VzUusQ6744NxFK9uk8CoXA6Oq+lbqQTwWEstjdTM8qENGPmBaplK0rm1KN4WOS8Uaeba6kuI3ZWb7rg/dPpXNJbObiZmYxybd4z0au7kjnfT7m01WFEwB++HXPasNNOnkAingYhFJVxyCtJyT1QnBo6TwZ4je10u50a9Ma2typYfaE3bWIxken1qHR7yXQrr7Roc8MV4hxNbSfNFcpnIyPbsetbHgjRo9Y05Vvbe3mvR5i2zTqdkccYG+Rl/ixkACs7R3OoS3UHiCGyuYLaRYXMUAhmgRjtWZCoAZQxAKmqlK6uKMGmYt5Gl9dXOqPZlrd5GknCDmNmJOfpmiulvvD32VtthK/mqxjmCHIZQccjvRSVRIr2En0OEgOFU5zn1pdWiBtlxyaIvup9Kfe/8AHqv4/wA6e7OeK0KtvMCEjYEL61oW7ph9v3aypuif7tXbX/UtUy0Gh6s0QdiCVB4OKWznaWYM33Qatt/yC2+lZunf8ex/36S1KehoNullZlG7HSoooY1uMsg55ORV/Tf9Q341kzk+fJzSGTxSIbzZCoIzxWjf3oCxwHBduOBnFUdKA3Dio5v+QslDHF2R1MKrBbgwoPu4pmlpHAzSM2HbmrVr/wAeK/Ws0/6+49hUSjZnRFmwuoJtYuQRjgHrVX7YZH3yDaitjms7Rvmuxu5+tXNQ/wBWv/XSpKuy/BPuLZIIPIXvVuOQABo2O9uCPSsjTObt8+laOnf8fcv+9SbtY0WrL0AwMufmrOmlM+oJCCAMZNX2+8f96udc41IkdcGpRb2NrV7hbe1WMEDcQB9Kz7Zvtk4+95cI59zUGuciPPPAq1H8unuV4+laLczbuLaTFZHuDli7bVA7Cs7XdVYXUUMBG4NgrnjPrV3S/wDjwX/eNciOddmzzy1WzKWiuaCavHb3LRXDjKsWJ65NQTLc6pMhXabeL5ih6H3rmrf5tTm3c/vO/wBa9BjAFhLgAfuz0qosxavuef3N8wvJnh4diVAUfhTtLQQWczsSJ3fYKq2HNyfo3861NM+acBuQFbg0Xd7CtaI66WOwQpHIDK6ZJ+tbXgi0OqXRXhbaEZc/3sdq43ViTcS5PpXoXg75dEfbx+77fjRu7Djtct6/qaPoeqvDgNBIsat6A9cVmWGvy2tjK7RbZJYvLiz1RMc/ia5qV2P2hSzbTMuRnir0/wA07bucKMZrenqrnPUm7klpp1xqJW8toyiwjcZnOMeo9625Jbeyt1m+0eYxIyXPJ/Cs29dk023VGZVx0BwK5u5JOpYJOM9KU3yscdtDubf7LqE8cSW52SEtNK3Vx2+gq9csos57a3k/0aMb8gdP9kVmaRxYEjrnGatNxpF3jj98f5VnJ3NobXMLxBNJeatY2dhhm2ADuAT1NP1uzh0nw+iJcy+c0u3Cnkms/wAHE/25cHPITik8QktdRBjkDBwf96oRT1NbwtpkGJlmixcMAwJ+8PWsnxJNLA81qZcw7h8o6+9dHYf8hq6/69v6Vw2rEm6uSTk+tW9rmfkZiyKLiVZPMEbspGB1Ga7LRILvVr8fZIiLaMbFYdEHqK4qYkqM/wCzXr3w9+Xw+CvB56fSpS1NNzjNb00Q6xJb2jM/lALkt94jk5rJ0zy3lERG0FmfPcHsK7fUgP7ElbA3eeee9c1oyL/aAO1c+d1xSY4pM6bT9Hu721itiRvWPe7SDIRQcgAV2XhnSoEhiup5C8xPLAcL9BTNM4m1D/cFWtMJGh3hBwQxx+VJ7XNopJ2MzxRPHbayLqBtxhwSqjqO5rg9QLHXhqciNHbSsUKgcgMOK6O5+YhjyxiOSepqfxBGh8J2xKKT50fOPalux2JrODz9S07TrqSGSC2QTZBzvJ6flVm68KxHV/tVvFHhcSnzBgN6j+tVNFjQafvCLvyfmxz1ruhylvnn90KG2i4wTOS0XSV+ySW+T5dzIXXjARx/D7jFa/h7Txa3P2gAKvl+Wyg4yQTya3BGm+2+RerHp7VcCqI4flHOc8VN76G0aaTOa1zw7Hq10J0Cohi2gAdD6mnWGgQmNZJCIrmOMR8Nx+XvXVXny2644+XtVSwAMCEgE7jzTtrYORHnl9oBjvLxnWRLdhhT14HOMemah0VRbW2p2cKLvuUxvHHHoPrXdvzEc88nrWYY0EwIRQcDnFJTcVoS6MZPU5HTdNlt9Jbzh5wQYKnrGc1XjtEEIDwK8UcikqThgx/pXS6pxqsIHRl5HrTtQRRGcKo5HQU1VZDw8XqYWneHUtWe4YxtIZC6FOq+xrY8LmJY5UwY50kJGe4NXrZV2IdoyUHaqd0oXULcqAMselKc23c1p0YxReurezluGeVSY3GJFYcE1AlvCjBLRdsKHjevFXx0/CrEABsJsgcGkpMr2SC3SOaJEXyLW8hZvJZ8+VIrgB42xyAcA59RRJoNrb3KSPFa2sThTKIZzPJOVOVQHoqZAJNSQAbV4HT+lXIANltwOhoUmTKjHcpKoVJCygXEjMzY6Ek54oq9ZgFlJGSCetFMeiP/2Q==);\">",
"   </div>",
"   <div class=\"lgnd\">",
"    Erythematous papules and centrofacial erythema are present in this patient with rosacea.",
"    <div class=\"footnotes\">",
"    </div>",
"    <div class=\"reference\">",
"     Reproduced with permission from: www.visualdx.com. Copyright Logical Images, Inc.",
"    </div>",
"   </div>",
"  </div>",
" </div>",
"</div>"].join("\n");
var script_f21_30_21989=[""].join("\n");
var outline_f21_30_21989=null;
var title_f21_30_21990="Cyclophosphamide pulmonary toxicity";
var content_f21_30_21990=[" <noscript>",
"  <div id=\"javascriptDisabled\">",
"   It seems to us that you have your JavaScript turned off on your browser. JavaScript is required in order for our site to behave correctly.  Please enable your JavaScript to continue use our site.",
"  </div>",
" </noscript>",
" <div id=\"printHeader\">",
"  <div id=\"printHeaderLogo\">",
"   <img alt=\"UpToDate\" src=\"./../images/wk_utd-rgb.myextg\" width=\"220px\">",
"   </img>",
"  </div>",
"  <div id=\"printHeaderText\">",
"   Official reprint from  UpToDate",
"   <sup>",
"    &reg;",
"   </sup>",
"   <a href=\"file://www.uptodate.com\">",
"    www.uptodate.com",
"   </a>",
"   <br>",
"    &copy;2013 UpToDate",
"    <sup>",
"     &reg;",
"    </sup>",
"   </br>",
"  </div>",
"  <div id=\"printHeaderLinks\">",
"   <a class=\"TOPIC\" href=\"#\" id=\"printHeaderPrint\" rel=\"3\" title=\"Click here to print\">",
"    Print",
"   </a>",
"   <span class=\"pipeSpace\">",
"    |",
"   </span>",
"   <a href=\"#\" id=\"printHeaderBack\" title=\"Back to normal view\">",
"    Back",
"   </a>",
"  </div>",
" </div>",
" <!-- TC:TOPIC_PAGE -->",
" <div id=\"topicContent\">",
"  <div id=\"topicTitle\">",
"   Cyclophosphamide pulmonary toxicity",
"  </div>",
"  <div id=\"topicContributors\">",
"   <div>",
"    <a id=\"authors\">",
"    </a>",
"    <a class=\"contributor contributor_credentials contributorType\" href=\"UTD.htm?21/30/21990/contributors\">",
"     Author",
"    </a>",
"    <br/>",
"    <a class=\"contributor contributor_credentials\" href=\"UTD.htm?21/30/21990/contributors\">",
"     Ulrich Specks, MD",
"    </a>",
"    <br/>",
"   </div>",
"   <div>",
"    <a class=\"contributor contributor_credentials contributorType\" href=\"UTD.htm?21/30/21990/contributors\">",
"     Section Editors",
"    </a>",
"    <br/>",
"    <a class=\"contributor contributor_credentials\" href=\"UTD.htm?21/30/21990/contributors\">",
"     Kevin R Flaherty, MD, MS",
"    </a>",
"    <br/>",
"    <a class=\"contributor contributor_credentials\" href=\"UTD.htm?21/30/21990/contributors\">",
"     James R Jett, MD",
"    </a>",
"    <br/>",
"   </div>",
"   <div>",
"    <a class=\"contributor contributor_credentials contributorType\" href=\"UTD.htm?21/30/21990/contributors\">",
"     Deputy Editors",
"    </a>",
"    <br/>",
"    <a class=\"contributor contributor_credentials\" href=\"UTD.htm?21/30/21990/contributors\">",
"     Helen Hollingsworth, MD",
"    </a>",
"    <br/>",
"    <a class=\"contributor contributor_credentials\" href=\"UTD.htm?21/30/21990/contributors\">",
"     Diane MF Savarese, MD",
"    </a>",
"    <br/>",
"   </div>",
"  </div>",
"  <div id=\"disclosures\">",
"   <a href=\"UTD.htm?21/30/21990/contributor-disclosure\" target=\"_blank\">",
"    Disclosures",
"   </a>",
"  </div>",
"  <div id=\"reviewProcess\">",
"   <span>",
"    All topics are updated as new evidence becomes available and our",
"   </span>",
"   <a href=\"/home/editorial-policy\" target=\"_blank\">",
"    peer review process",
"   </a>",
"   <span>",
"    is complete.",
"   </span>",
"  </div>",
"  <div id=\"literatureReviewDate\">",
"   <span class=\"emphasis\">",
"    Literature review current through:",
"   </span>",
"   Oct 2013.",
"   <span class=\"pipeSpace\">",
"    |",
"   </span>",
"   <span class=\"emphasis\">",
"    This topic last updated:",
"   </span>",
"   Oct 18, 2012.",
"  </div>",
"  <div id=\"topicText\">",
"   <p class=\"headingAnchor\" id=\"H1\">",
"    <span class=\"h1\">",
"     INTRODUCTION",
"    </span>",
"    &nbsp;&mdash;&nbsp;",
"    <a class=\"drug drug_general\" href=\"UTD.htm?9/20/9546?source=see_link\">",
"     Cyclophosphamide",
"    </a>",
"    is an alkylating agent that is used in combination with other chemotherapeutic agents for the treatment of a variety of malignant processes. It also has immunosuppressive properties and is increasingly used for the treatment of certain autoimmune diseases, either as a sole agent or in combination with glucocorticoids. Long-term use of cyclophosphamide is associated with a multitude of significant side effects, such as hair loss, leukopenia, hemorrhagic cystitis, infertility, the development of secondary malignancies, and pulmonary toxicity.",
"   </p>",
"   <p>",
"    The pathogenesis, clinical manifestations, diagnosis, and treatment of",
"    <a class=\"drug drug_general\" href=\"UTD.htm?9/20/9546?source=see_link\">",
"     cyclophosphamide",
"    </a>",
"    pulmonary toxicity will be presented here. Other toxicities of cyclophosphamide are discussed separately. (See",
"    <a class=\"medical medical_review\" href=\"UTD.htm?24/32/25098?source=see_link\">",
"     \"General toxicity of cyclophosphamide and chlorambucil in inflammatory diseases\"",
"    </a>",
"    and",
"    <a class=\"medical medical_review\" href=\"UTD.htm?15/40/16008?source=see_link\">",
"     \"General principles of the use of cyclophosphamide in rheumatic and renal disease\"",
"    </a>",
"    and",
"    <a class=\"medical medical_review\" href=\"UTD.htm?22/39/23161?source=see_link\">",
"     \"Cystitis in patients with cancer\"",
"    </a>",
"    and",
"    <a class=\"medical medical_review\" href=\"UTD.htm?1/26/1447?source=see_link\">",
"     \"Ovarian failure due to anticancer drugs and radiation\"",
"    </a>",
"    and",
"    <a class=\"medical medical_review\" href=\"UTD.htm?13/24/13706?source=see_link\">",
"     \"Effects of cytotoxic agents on gonadal function in adult men\"",
"    </a>",
"    .)",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H2\">",
"    <span class=\"h1\">",
"     CLINICAL FEATURES",
"    </span>",
"    &nbsp;&mdash;&nbsp;",
"    <a class=\"drug drug_general\" href=\"UTD.htm?9/20/9546?source=see_link\">",
"     Cyclophosphamide",
"    </a>",
"    -induced pulmonary injury appears to be",
"    <strong>",
"     rare; the frequency is &lt;1 percent",
"    </strong>",
"    [",
"    <a class=\"abstract\" href=\"UTD.htm?21/30/21990/abstract/1\">",
"     1",
"    </a>",
"    ]",
"    <strong>",
"    </strong>",
"    . However, the risk may be increased by the concomitant use of radiation therapy, oxygen therapy, or other drugs with potential pulmonary toxicity; these factors also may confound attempts to estimate the true incidence of cyclophosphamide-induced lung injury, and to recognize cyclophosphamide-induced pulmonary toxicity when it develops.",
"   </p>",
"   <p>",
"    There are two distinct clinical patterns of pulmonary toxicity associated with",
"    <a class=\"drug drug_general\" href=\"UTD.htm?9/20/9546?source=see_link\">",
"     cyclophosphamide",
"    </a>",
"    : an acute pneumonitis that occurs early in the course of treatment; and a chronic, progressive, fibrotic process that may occur after prolonged therapy [",
"    <a class=\"abstract\" href=\"UTD.htm?21/30/21990/abstract/2\">",
"     2",
"    </a>",
"    ]. A single case of acute pulmonary edema after intravenous cyclophosphamide also has been reported [",
"    <a class=\"abstract\" href=\"UTD.htm?21/30/21990/abstract/3\">",
"     3",
"    </a>",
"    ].",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H3\">",
"    <span class=\"h2\">",
"     Early-onset pneumonitis",
"    </span>",
"    &nbsp;&mdash;&nbsp;Affected patients present with cough and dyspnea within one to six months of starting therapy; fever and fatigue also may be present [",
"    <a class=\"abstract\" href=\"UTD.htm?21/30/21990/abstract/2,4\">",
"     2,4",
"    </a>",
"    ]. Chest radiographs and CT scans can show reticular markings",
"    <span class=\"nowrap\">",
"     and/or",
"    </span>",
"    a ground glass appearance. Discontinuation of the drug and institution of glucocorticoids usually result in complete resolution of this syndrome.",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H4\">",
"    <span class=\"h2\">",
"     Late-onset pneumonitis and fibrosis",
"    </span>",
"    &nbsp;&mdash;&nbsp;Late-onset pulmonary toxicity develops in patients who have received prolonged treatment over several months to years with relatively low doses of",
"    <a class=\"drug drug_general\" href=\"UTD.htm?9/20/9546?source=see_link\">",
"     cyclophosphamide",
"    </a>",
"    (typically in the setting of immunosuppressive therapy) [",
"    <a class=\"abstract\" href=\"UTD.htm?21/30/21990/abstract/2,5\">",
"     2,5",
"    </a>",
"    ]. As an example, five patients with late onset pneumonitis received one to four years of cyclophosphamide therapy and developed lung disease six months to six years after stopping cyclophosphamide [",
"    <a class=\"abstract\" href=\"UTD.htm?21/30/21990/abstract/2\">",
"     2",
"    </a>",
"    ].",
"   </p>",
"   <p>",
"    The clinical picture is one of relentlessly progressive lung fibrosis. The onset of symptoms is insidious, with slowly progressive dyspnea and a nonproductive cough. This disorder differs from usual interstitial pneumonitis (UIP) in that clubbing of the fingers and \"velcro-type\" inspiratory crackles are lacking, and the diffuse reticular or nodular opacities that are observed on chest radiographs do not have the typical bibasilar predominance seen in UIP. (See",
"    <a class=\"medical medical_review\" href=\"UTD.htm?22/20/22856?source=see_link\">",
"     \"Approach to the adult with interstitial lung disease: Clinical evaluation\"",
"    </a>",
"    .)",
"   </p>",
"   <p>",
"    Some patients develop combined pleural and pulmonary fibrosis; these patients are at risk for pneumothorax [",
"    <a class=\"abstract\" href=\"UTD.htm?21/30/21990/abstract/5-7\">",
"     5-7",
"    </a>",
"    ]. (See",
"    <a class=\"local\" href=\"#H5\">",
"     'Pathology'",
"    </a>",
"    below.)",
"   </p>",
"   <p>",
"    Late-onset pneumonitis and fibrosis associated with long-term",
"    <a class=\"drug drug_general\" href=\"UTD.htm?9/20/9546?source=see_link\">",
"     cyclophosphamide",
"    </a>",
"    use is minimally responsive to glucocorticoids and to discontinuation of the drug. It almost inevitably leads to terminal respiratory failure.",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H5\">",
"    <span class=\"h1\">",
"     PATHOLOGY",
"    </span>",
"    &nbsp;&mdash;&nbsp;Histopathologic findings observed in patients with",
"    <a class=\"drug drug_general\" href=\"UTD.htm?9/20/9546?source=see_link\">",
"     cyclophosphamide",
"    </a>",
"    pulmonary toxicity are nonspecific. The characteristic picture is the presence of atypical cells in the alveolar and bronchiolar epithelium, hyperplasia of type II pneumocytes, and interstitial and alveolar edema and fibrosis [",
"    <a class=\"abstract\" href=\"UTD.htm?21/30/21990/abstract/4\">",
"     4",
"    </a>",
"    ]. Diffuse alveolar damage, organizing pneumonia (also known as bronchiolitis obliterans organizing pneumonia or BOOP), and alveolar hemorrhage have been reported [",
"    <a class=\"abstract\" href=\"UTD.htm?21/30/21990/abstract/8\">",
"     8",
"    </a>",
"    ], and a pattern indistinguishable from UIP also can be seen [",
"    <a class=\"abstract\" href=\"UTD.htm?21/30/21990/abstract/2\">",
"     2",
"    </a>",
"    ]. (See",
"    <a class=\"medical medical_review\" href=\"UTD.htm?0/26/424?source=see_link\">",
"     \"Role of lung biopsy in the diagnosis of interstitial lung disease\"",
"    </a>",
"    .)",
"   </p>",
"   <p>",
"    Among patients with late onset pulmonary toxicity, a pattern of pleuropulmonary fibrosis or fibroelastosis can be seen, affecting the upper and lateral aspects of the pleura [",
"    <a class=\"abstract\" href=\"UTD.htm?21/30/21990/abstract/6,7\">",
"     6,7",
"    </a>",
"    ].",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H6\">",
"    <span class=\"h1\">",
"     PATHOGENESIS",
"    </span>",
"    &nbsp;&mdash;&nbsp;The parent drug",
"    <a class=\"drug drug_general\" href=\"UTD.htm?9/20/9546?source=see_link\">",
"     cyclophosphamide",
"    </a>",
"    is nontoxic to the lung but it is metabolized in the liver, and to a lesser extent in the lung, to the toxic metabolites 4-hydroxycyclophosphamide, acrolein, and phosphoramide mustard [",
"    <a class=\"abstract\" href=\"UTD.htm?21/30/21990/abstract/9\">",
"     9",
"    </a>",
"    ]. Lung tissue from different species varies in its ability to locally metabolize cyclophosphamide, and susceptibility to cyclophosphamide-induced lung fibrosis in humans may depend upon genetic differences in local pulmonary drug metabolism [",
"    <a class=\"abstract\" href=\"UTD.htm?21/30/21990/abstract/10\">",
"     10",
"    </a>",
"    ]. Genetic susceptibility is further supported by the absence of a clear dose-response relationship for the development of lung toxicity in humans [",
"    <a class=\"abstract\" href=\"UTD.htm?21/30/21990/abstract/2,11\">",
"     2,11",
"    </a>",
"    ].",
"   </p>",
"   <p>",
"    In vitro models also suggest the involvement of transforming growth factor-beta in",
"    <a class=\"drug drug_general\" href=\"UTD.htm?9/20/9546?source=see_link\">",
"     cyclophosphamide",
"    </a>",
"    -induced pulmonary fibrosis [",
"    <a class=\"abstract\" href=\"UTD.htm?21/30/21990/abstract/12\">",
"     12",
"    </a>",
"    ]. However, the exact mechanisms by which cyclophosphamide-induced lung injury causes the observed increase in transforming growth factor-beta (TGF-beta) expression and the associated upregulation of collagen synthesis and irreversible fibrosis remain unclear.",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H7\">",
"    <span class=\"h2\">",
"     Risk factors",
"    </span>",
"    &nbsp;&mdash;&nbsp;Animal models and clinical observations suggest that oxidative stress may contribute to",
"    <a class=\"drug drug_general\" href=\"UTD.htm?9/20/9546?source=see_link\">",
"     cyclophosphamide",
"    </a>",
"    pulmonary toxicity [",
"    <a class=\"abstract\" href=\"UTD.htm?21/30/21990/abstract/10\">",
"     10",
"    </a>",
"    ]. Concomitant radiation therapy, use of other cytotoxic agents with known lung toxicity (eg,",
"    <a class=\"drug drug_general\" href=\"UTD.htm?38/15/39159?source=see_link\">",
"     bleomycin",
"    </a>",
"    ,",
"    <a class=\"drug drug_general\" href=\"UTD.htm?10/10/10408?source=see_link\">",
"     busulfan",
"    </a>",
"    ), concomitant use of other drugs such as",
"    <a class=\"drug drug_general\" href=\"UTD.htm?22/58/23466?source=see_link\">",
"     amiodarone",
"    </a>",
"    [",
"    <a class=\"abstract\" href=\"UTD.htm?21/30/21990/abstract/13-15\">",
"     13-15",
"    </a>",
"    ] and exposure to high inspired oxygen concentrations have all been implicated as additional risk factors for the development of the syndrome [",
"    <a class=\"abstract\" href=\"UTD.htm?21/30/21990/abstract/16\">",
"     16",
"    </a>",
"    ]. (See",
"    <a class=\"medical medical_review\" href=\"UTD.htm?23/33/24090?source=see_link\">",
"     \"Radiation-induced lung injury\"",
"    </a>",
"    and",
"    <a class=\"medical medical_review\" href=\"UTD.htm?12/31/12794?source=see_link\">",
"     \"Bleomycin-induced lung injury\"",
"    </a>",
"    .)",
"   </p>",
"   <p>",
"    It is unclear whether a higher total dose of",
"    <a class=\"drug drug_general\" href=\"UTD.htm?9/20/9546?source=see_link\">",
"     cyclophosphamide",
"    </a>",
"    is a risk factor for lung toxicity, as affected patients have received doses ranging from 150 mg to 81 g [",
"    <a class=\"abstract\" href=\"UTD.htm?21/30/21990/abstract/2,15\">",
"     2,15",
"    </a>",
"    ]. On the other hand, when cyclophosphamide is given as a conditioning agent prior to bone marrow transplantation, a dose response has been reported [",
"    <a class=\"abstract\" href=\"UTD.htm?21/30/21990/abstract/15\">",
"     15",
"    </a>",
"    ].",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H8\">",
"    <span class=\"h1\">",
"     DIAGNOSIS",
"    </span>",
"    &nbsp;&mdash;&nbsp;",
"    <a class=\"drug drug_general\" href=\"UTD.htm?9/20/9546?source=see_link\">",
"     Cyclophosphamide",
"    </a>",
"    pulmonary toxicity is primarily a clinical diagnosis, based upon symptoms, history of cyclophosphamide use, compatible findings on chest imaging studies, and the absence of an alternative diagnosis (eg, infection, recurrence of underlying disease, hypersensitivity pneumonitis).",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H9\">",
"    <span class=\"h2\">",
"     Symptoms and signs",
"    </span>",
"    &nbsp;&mdash;&nbsp;Patients with early-onset pneumonitis usually seek medical attention after a short duration of cough, dyspnea, fever, and fatigue [",
"    <a class=\"abstract\" href=\"UTD.htm?21/30/21990/abstract/2\">",
"     2",
"    </a>",
"    ]. Some patients are asymptomatic, and the disease is suspected because of unexplained radiographic or lung function abnormalities. Late-onset pulmonary toxicity should be suspected when patients with prior or ongoing",
"    <a class=\"drug drug_general\" href=\"UTD.htm?9/20/9546?source=see_link\">",
"     cyclophosphamide",
"    </a>",
"    exposure for six months or longer complain of progressively worsening nonproductive cough and dyspnea. There are no specific symptoms associated with this fibrotic process. (See",
"    <a class=\"medical medical_review\" href=\"UTD.htm?22/20/22856?source=see_link\">",
"     \"Approach to the adult with interstitial lung disease: Clinical evaluation\"",
"    </a>",
"    .)",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H10\">",
"    <span class=\"h2\">",
"     Laboratory studies",
"    </span>",
"    &nbsp;&mdash;&nbsp;No specific laboratory tests help to establish the diagnosis. Laboratory testing is aimed at the exclusion of other causes for the pulmonary opacities and dyspnea, such as infection or hypersensitivity pneumonitis. (See",
"    <a class=\"medical medical_review\" href=\"UTD.htm?1/12/1225?source=see_link\">",
"     \"Diagnosis of hypersensitivity pneumonitis (extrinsic allergic alveolitis)\"",
"    </a>",
"    .)",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H11\">",
"    <span class=\"h2\">",
"     Chest imaging studies",
"    </span>",
"    &nbsp;&mdash;&nbsp;Bilateral reticular or nodular diffuse opacities are the hallmark of both early-onset and late-onset pulmonary toxicity [",
"    <a class=\"abstract\" href=\"UTD.htm?21/30/21990/abstract/2\">",
"     2",
"    </a>",
"    ]. In the case of early-onset pneumonitis, computed tomography of the chest reveals \"ground-glass\" opacities predominantly in the periphery of the upper lungs. (See",
"    <a class=\"medical medical_review\" href=\"UTD.htm?16/29/16858?source=see_link&amp;anchor=H4#H4\">",
"     \"High resolution computed tomography of the lungs\", section on 'HRCT patterns'",
"    </a>",
"    .)",
"   </p>",
"   <p>",
"    The radiographic opacities of late-onset pneumonitis have a more fibrotic appearance on CT; however, nodular opacities with volume loss have been described [",
"    <a class=\"abstract\" href=\"UTD.htm?21/30/21990/abstract/2\">",
"     2",
"    </a>",
"    ]. The honeycombing pattern characteristic of UIP is lacking, and the lower lungs are not predominantly affected. Bilateral pleural thickening of the mid- and upper lung regions is a common feature which also helps in differentiating this process from UIP [",
"    <a class=\"abstract\" href=\"UTD.htm?21/30/21990/abstract/2,17-19\">",
"     2,17-19",
"    </a>",
"    ].",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H6776609\">",
"    <span class=\"h2\">",
"     Bronchoscopy",
"    </span>",
"    &nbsp;&mdash;&nbsp;The main role of bronchoscopy and bronchoalveolar lavage (BAL) is to exclude other processes such as infection, diffuse alveolar hemorrhage, or, in patients with a malignant disease, lymphangitic tumor spread. (See",
"    <a class=\"medical medical_review\" href=\"UTD.htm?16/36/16968?source=see_link\">",
"     \"Role of bronchoalveolar lavage in diagnosis of interstitial lung disease\"",
"    </a>",
"    and",
"    <a class=\"medical medical_review\" href=\"UTD.htm?24/51/25402?source=see_link\">",
"     \"Approach to the immunocompromised patient with fever and pulmonary infiltrates\"",
"    </a>",
"    and",
"    <a class=\"medical medical_review\" href=\"UTD.htm?22/46/23270?source=see_link\">",
"     \"Pulmonary tumor embolism\"",
"    </a>",
"    .) &nbsp;",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H12\">",
"    <span class=\"h2\">",
"     Lung biopsy",
"    </span>",
"    &nbsp;&mdash;&nbsp;Thoracoscopic and open lung biopsy do not play a significant role in the evaluation of patients with possible",
"    <a class=\"drug drug_general\" href=\"UTD.htm?9/20/9546?source=see_link\">",
"     cyclophosphamide",
"    </a>",
"    pulmonary toxicity unless other conditions such as infection, hypersensitivity pneumonitis, or diffuse malignancy cannot be excluded by other means [",
"    <a class=\"abstract\" href=\"UTD.htm?21/30/21990/abstract/8\">",
"     8",
"    </a>",
"    ]. (See",
"    <a class=\"medical medical_review\" href=\"UTD.htm?0/26/424?source=see_link\">",
"     \"Role of lung biopsy in the diagnosis of interstitial lung disease\"",
"    </a>",
"    .)",
"   </p>",
"   <p>",
"    Biopsy findings in late onset pneumonitis are often nonspecific, showing interstitial thickening and an inflammatory infiltrate of lymphocytes with a few neutrophils and eosinophils [",
"    <a class=\"abstract\" href=\"UTD.htm?21/30/21990/abstract/2,4\">",
"     2,4",
"    </a>",
"    ]. Well-formed granulomas have been described, distributed along lymphatic pathways associated with nonspecific interstitial pneumonia and hemosiderin deposition [",
"    <a class=\"abstract\" href=\"UTD.htm?21/30/21990/abstract/2\">",
"     2",
"    </a>",
"    ].",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H13\">",
"    <span class=\"h2\">",
"     Pulmonary function testing",
"    </span>",
"    &nbsp;&mdash;&nbsp;Patients with",
"    <a class=\"drug drug_general\" href=\"UTD.htm?9/20/9546?source=see_link\">",
"     cyclophosphamide",
"    </a>",
"    pulmonary toxicity typically display a restrictive pattern with a reduced diffusing capacity on pulmonary function testing. Although these findings are diagnostically nonspecific, serial pulmonary function testing may be useful in following the clinical course of these patients.",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H14\">",
"    <span class=\"h1\">",
"     TREATMENT AND PROGNOSIS",
"    </span>",
"    &nbsp;&mdash;&nbsp;Early-onset pneumonitis is generally a reversible process with a good prognosis, although fatalities have been reported [",
"    <a class=\"abstract\" href=\"UTD.htm?21/30/21990/abstract/4\">",
"     4",
"    </a>",
"    ]. Most patients respond to discontinuation of",
"    <a class=\"drug drug_general\" href=\"UTD.htm?9/20/9546?source=see_link\">",
"     cyclophosphamide",
"    </a>",
"    , but the improvement may be gradual; disappearance of symptoms and clearing of chest radiographs may take weeks to months [",
"    <a class=\"abstract\" href=\"UTD.htm?21/30/21990/abstract/2\">",
"     2",
"    </a>",
"    ].",
"   </p>",
"   <p>",
"    The role of glucocorticoids in the treatment of early-onset pneumonitis remains unclear. Most, but not all, successfully treated patients described in the literature have received glucocorticoids, but the magnitude of benefit due to glucocorticoid use (versus treatment discontinuation alone) is unknown [",
"    <a class=\"abstract\" href=\"UTD.htm?21/30/21990/abstract/20\">",
"     20",
"    </a>",
"    ]. We typically prescribe systemic glucocorticoid therapy in patients with more severe initial symptoms and impairment on pulmonary function testing. The optimal dose is unknown; based on clinical experience we initiate therapy with the equivalent of",
"    <a class=\"drug drug_general\" href=\"UTD.htm?37/43/38585?source=see_link\">",
"     prednisone",
"    </a>",
"    60 mg per day, and taper slowly as tolerated.",
"   </p>",
"   <p>",
"    Late-onset pneumonitis with fibrosis is essentially irreversible and follows a chronically progressive course over months to years [",
"    <a class=\"abstract\" href=\"UTD.htm?21/30/21990/abstract/2\">",
"     2",
"    </a>",
"    ]. Treatment is largely supportive, as systemic glucocorticoids have not been beneficial in reversing fibrosis. Lung transplantation may be considered in selected cases. (See",
"    <a class=\"medical medical_review\" href=\"UTD.htm?3/25/3480?source=see_link\">",
"     \"Lung transplantation: An overview\"",
"    </a>",
"    .)",
"   </p>",
"   <p>",
"    Mortality due to progressive respiratory failure in late onset pneumonitis is estimated to be over 60 percent [",
"    <a class=\"abstract\" href=\"UTD.htm?21/30/21990/abstract/2,4,21\">",
"     2,4,21",
"    </a>",
"    ].",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H7156563\">",
"    <span class=\"h1\">",
"     SUMMARY AND RECOMMENDATIONS",
"    </span>",
"   </p>",
"   <p>",
"    <ul class=\"bullet-block\">",
"     <li>",
"      <a class=\"drug drug_general\" href=\"UTD.htm?9/20/9546?source=see_link\">",
"       Cyclophosphamide",
"      </a>",
"      -induced pulmonary injury appears to be",
"      <strong>",
"       rare; the frequency is &lt;1 percent",
"      </strong>",
"      . However, the risk may be increased by the concomitant use of radiation, oxygen therapy, or other drugs with potential pulmonary toxicity. (See",
"      <a class=\"local\" href=\"#H1\">",
"       'Introduction'",
"      </a>",
"      above.)",
"     </li>",
"     <li>",
"      Patients with early-onset",
"      <a class=\"drug drug_general\" href=\"UTD.htm?9/20/9546?source=see_link\">",
"       cyclophosphamide",
"      </a>",
"      pneumonitis develop cough and dyspnea within one to six months after the onset of cyclophosphamide therapy; fever and fatigue also may be present. Key findings on computed tomography include diffuse parenchymal lung disease (eg, areas of consolidation, ground glass opacities, nodular opacities, intralobular septal thickening). (See",
"      <a class=\"local\" href=\"#H3\">",
"       'Early-onset pneumonitis'",
"      </a>",
"      above and",
"      <a class=\"local\" href=\"#H11\">",
"       'Chest imaging studies'",
"      </a>",
"      above.)",
"     </li>",
"     <li>",
"      Late-onset",
"      <a class=\"drug drug_general\" href=\"UTD.htm?9/20/9546?source=see_link\">",
"       cyclophosphamide",
"      </a>",
"      pneumonitis occurs after prolonged (&gt;6 months) treatment with relatively low doses of cyclophosphamide. Presenting manifestations include progressive nonproductive cough and dyspnea. Key findings on computed tomography include interlobular and intralobular septal thickening and often bilateral pleural thickening of the mid- and upper lung regions, but absence of honeycombing. (See",
"      <a class=\"local\" href=\"#H4\">",
"       'Late-onset pneumonitis and fibrosis'",
"      </a>",
"      above and",
"      <a class=\"local\" href=\"#H11\">",
"       'Chest imaging studies'",
"      </a>",
"      above.)",
"     </li>",
"     <li>",
"      <a class=\"drug drug_general\" href=\"UTD.htm?9/20/9546?source=see_link\">",
"       Cyclophosphamide",
"      </a>",
"      pulmonary toxicity is primarily a clinical diagnosis based on the history of cyclophosphamide use, compatible symptoms and findings on chest imaging studies, and the absence of an alternative diagnosis (eg, infection, recurrence of underlying disease, hypersensitivity pneumonitis). (See",
"      <a class=\"local\" href=\"#H8\">",
"       'Diagnosis'",
"      </a>",
"      above.)",
"     </li>",
"     <li>",
"      Early-onset pneumonitis due to",
"      <a class=\"drug drug_general\" href=\"UTD.htm?9/20/9546?source=see_link\">",
"       cyclophosphamide",
"      </a>",
"      is generally a reversible process with a good prognosis following discontinuation of cyclophosphamide. We suggest restricting the use of systemic glucocorticoids to patients with more severe initial symptoms and pulmonary function impairment (",
"      <a class=\"grade\" href=\"._grade_6?title=Grade 2C\">",
"       Grade 2C",
"      </a>",
"      ). (See",
"      <a class=\"local\" href=\"#H14\">",
"       'Treatment and prognosis'",
"      </a>",
"      above.) &nbsp;",
"     </li>",
"     <li>",
"      Late-onset pneumonitis with fibrosis is essentially irreversible and follows a progressive course that is unresponsive to glucocorticoid therapy. Lung transplantation may be considered in selected patients. (See",
"      <a class=\"local\" href=\"#H14\">",
"       'Treatment and prognosis'",
"      </a>",
"      above and",
"      <a class=\"medical medical_review\" href=\"UTD.htm?3/25/3480?source=see_link\">",
"       \"Lung transplantation: An overview\"",
"      </a>",
"      .)",
"     </li>",
"    </ul>",
"   </p>",
"  </div>",
"  <div id=\"topicAgreement\">",
"   Use of UpToDate is subject to the",
"   <a class=\"licenseLink\" href=\"./license\" id=\"sla_in_page\" target=\"_blank\">",
"    Subscription and License Agreement",
"   </a>",
"   .",
"  </div>",
"  <div class=\"headingAnchor\" id=\"references\">",
"   <h1>",
"    REFERENCES",
"   </h1>",
"   <ol id=\"reference\">",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?21/30/21990/abstract/1\">",
"      Twohig KJ, Matthay RA. Pulmonary effects of cytotoxic agents other than bleomycin. Clin Chest Med 1990; 11:31.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?21/30/21990/abstract/2\">",
"      Malik SW, Myers JL, DeRemee RA, Specks U. Lung toxicity associated with cyclophosphamide use. Two distinct patterns. Am J Respir Crit Care Med 1996; 154:1851.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?21/30/21990/abstract/3\">",
"      Maxwell I. Letter: Reversible pulmonary edema following cyclophosphamide treatment. JAMA 1974; 229:137.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?21/30/21990/abstract/4\">",
"      Segura A, Yuste A, Cercos A, et al. Pulmonary fibrosis induced by cyclophosphamide. Ann Pharmacother 2001; 35:894.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?21/30/21990/abstract/5\">",
"      Hamada K, Nagai S, Kitaichi M, et al. Cyclophosphamide-induced late-onset lung disease. Intern Med 2003; 42:82.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?21/30/21990/abstract/6\">",
"      Becker CD, Gil J, Padilla ML. Idiopathic pleuroparenchymal fibroelastosis: an unrecognized or misdiagnosed entity? Mod Pathol 2008; 21:784.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?21/30/21990/abstract/7\">",
"      Frankel SK, Cool CD, Lynch DA, Brown KK. Idiopathic pleuroparenchymal fibroelastosis: description of a novel clinicopathologic entity. Chest 2004; 126:2007.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?21/30/21990/abstract/8\">",
"      Myers JL. Diagnosis of drug reactions in the lung. Monogr Pathol 1993; :32.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?21/30/21990/abstract/9\">",
"      Kachel DL, Martin WJ 2nd. Cyclophosphamide-induced lung toxicity: mechanism of endothelial cell injury. J Pharmacol Exp Ther 1994; 268:42.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?21/30/21990/abstract/10\">",
"      Hoyt DG, Lazo JS. Acute pneumocyte injury, poly(ADP-ribose) polymerase activity, and pyridine nucleotide levels after in vitro exposure of murine lung slices to cyclophosphamide. Biochem Pharmacol 1994; 48:1757.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?21/30/21990/abstract/11\">",
"      Trask CW, Joannides T, Harper PG, et al. Radiation-induced lung fibrosis after treatment of small cell carcinoma of the lung with very high-dose cyclophosphamide. Cancer 1985; 55:57.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?21/30/21990/abstract/12\">",
"      Hoyt DG, Lazo JS. Early increases in pulmonary mRNA encoding procollagens and transforming growth factor-beta in mice sensitive to cyclophosphamide-induced pulmonary fibrosis. J Pharmacol Exp Ther 1989; 249:38.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?21/30/21990/abstract/13\">",
"      Gupta S, Mahipal A. Fatal pulmonary toxicity after a single dose of cyclophosphamide. Pharmacotherapy 2007; 27:616.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?21/30/21990/abstract/14\">",
"      Bhagat R, Sporn TA, Long GD, Folz RJ. Amiodarone and cyclophosphamide: potential for enhanced lung toxicity. Bone Marrow Transplant 2001; 27:1109.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?21/30/21990/abstract/15\">",
"      Sampath S, Schultheiss TE, Wong J. Dose response and factors related to interstitial pneumonitis after bone marrow transplant. Int J Radiat Oncol Biol Phys 2005; 63:876.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?21/30/21990/abstract/16\">",
"      Spector JI, Zimbler H, Ross JS. Early-onset cyclophosphamide-induced interstitial pneumonitis. JAMA 1979; 242:2852.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?21/30/21990/abstract/17\">",
"      Alvarado CS, Boat TF, Newman AJ. Late-onset pulmonary fibrosis and chest deformity in two children treated with cyclophosphamide. J Pediatr 1978; 92:443.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?21/30/21990/abstract/18\">",
"      Abdel Karim FW, Ayash RE, Allam C, Salem PA. Pulmonary fibrosis after prolonged treatment with low-dose cyclophosphamide. A case report. Oncology 1983; 40:174.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?21/30/21990/abstract/19\">",
"      Tsukamoto N, Matsukuma K, Matsuyama T, et al. Cyclophosphamide-induced interstitial pneumonitis in a patient with ovarian carcinoma. Gynecol Oncol 1984; 17:41.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?21/30/21990/abstract/20\">",
"      Mark GJ, Lehimgar-Zadeh A, Ragsdale BD. Cyclophosphamide pneumonitis. Thorax 1978; 33:89.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?21/30/21990/abstract/21\">",
"      Stentoft J. Progressive pulmonary fibrosis complicating cyclophosphamide therapy. Acta Med Scand 1987; 221:403.",
"     </a>",
"    </li>",
"   </ol>",
"  </div>",
"  <div id=\"topicVersionRevision\">",
"   Topic 4349 Version 4.0",
"  </div>",
" </div>",
" <div id=\"footer\">",
"  <div id=\"supportFooter\">",
"   <span class=\"sfInfo\">",
"    &copy; 2013 UpToDate, Inc. All rights reserved.",
"   </span>",
"   <span class=\"pipeSpace\">",
"    |",
"   </span>",
"   <a class=\"licenseLink\" href=\"./license\" id=\"sla_footer\">",
"    Subscription and License Agreement",
"   </a>",
"   <span class=\"sfInfo\">",
"    <span class=\"pipeSpace\">",
"     |",
"    </span>",
"    Release: 21.3 - C21.34",
"   </span>",
"   <br/>",
"   <span class=\"sfInfo\">",
"    Licensed to:",
"    <span class=\"emphasis\">",
"     Morehouse School of Medicine",
"    </span>",
"   </span>",
"   <span class=\"sfInfo\">",
"    <span class=\"pipeSpace\">",
"     |",
"    </span>",
"    Support Tag: [1105-178.219.2.221-4EAA1F1B94-S473950.14]",
"    <br/>",
"   </span>",
"  </div>",
" </div>",
"</div>"].join("\n");
var script_f21_30_21990=[""].join("\n");
var outline_f21_30_21990=[" <div id=\"toggleOutline\">",
"  <a href=\"#\" title=\"Collapse Topic Outline\">",
"   <img alt=\"\" src=\"./../images/orange_arrow_left.myextg\"/>",
"  </a>",
" </div>",
" <div id=\"innerOutline\">",
"  <h1>",
"   TOPIC OUTLINE",
"  </h1>",
"  <div id=\"outline\">",
"   <ul>",
"    <li>",
"     <a class=\"sr_button\" href=\"#H7156563\" id=\"summRecButton\">",
"      <span>",
"       SUMMARY &amp; RECOMMENDATIONS",
"      </span>",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#H1\">",
"      INTRODUCTION",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#H2\">",
"      CLINICAL FEATURES",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H3\">",
"      Early-onset pneumonitis",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H4\">",
"      Late-onset pneumonitis and fibrosis",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#H5\">",
"      PATHOLOGY",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#H6\">",
"      PATHOGENESIS",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H7\">",
"      Risk factors",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#H8\">",
"      DIAGNOSIS",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H9\">",
"      Symptoms and signs",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H10\">",
"      Laboratory studies",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H11\">",
"      Chest imaging studies",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H6776609\">",
"      Bronchoscopy",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H12\">",
"      Lung biopsy",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H13\">",
"      Pulmonary function testing",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#H14\">",
"      TREATMENT AND PROGNOSIS",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#H7156563\">",
"      SUMMARY AND RECOMMENDATIONS",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a href=\"#references\">",
"      REFERENCES",
"     </a>",
"    </li>",
"   </ul>",
"  </div>",
"  <h1>",
"   RELATED TOPICS",
"  </h1>",
"  <div id=\"relatedTopics\">",
"   <ul>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"UTD.htm?22/20/22856?source=related_link\">",
"      Approach to the adult with interstitial lung disease: Clinical evaluation",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"UTD.htm?24/51/25402?source=related_link\">",
"      Approach to the immunocompromised patient with fever and pulmonary infiltrates",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"UTD.htm?12/31/12794?source=related_link\">",
"      Bleomycin-induced lung injury",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"UTD.htm?22/39/23161?source=related_link\">",
"      Cystitis in patients with cancer",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"UTD.htm?1/12/1225?source=related_link\">",
"      Diagnosis of hypersensitivity pneumonitis (extrinsic allergic alveolitis)",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"UTD.htm?13/24/13706?source=related_link\">",
"      Effects of cytotoxic agents on gonadal function in adult men",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"UTD.htm?15/40/16008?source=related_link\">",
"      General principles of the use of cyclophosphamide in rheumatic and renal disease",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"UTD.htm?24/32/25098?source=related_link\">",
"      General toxicity of cyclophosphamide and chlorambucil in inflammatory diseases",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"UTD.htm?16/29/16858?source=related_link\">",
"      High resolution computed tomography of the lungs",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"UTD.htm?3/25/3480?source=related_link\">",
"      Lung transplantation: An overview",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"UTD.htm?1/26/1447?source=related_link\">",
"      Ovarian failure due to anticancer drugs and radiation",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"UTD.htm?22/46/23270?source=related_link\">",
"      Pulmonary tumor embolism",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"UTD.htm?23/33/24090?source=related_link\">",
"      Radiation-induced lung injury",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"UTD.htm?16/36/16968?source=related_link\">",
"      Role of bronchoalveolar lavage in diagnosis of interstitial lung disease",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"UTD.htm?0/26/424?source=related_link\">",
"      Role of lung biopsy in the diagnosis of interstitial lung disease",
"     </a>",
"    </li>",
"   </ul>",
"  </div>",
" </div>"].join("\n");
var title_f21_30_21991="Assessment of respiratory distress in the mechanically ventilated patient";
var content_f21_30_21991=[" <noscript>",
"  <div id=\"javascriptDisabled\">",
"   It seems to us that you have your JavaScript turned off on your browser. JavaScript is required in order for our site to behave correctly.  Please enable your JavaScript to continue use our site.",
"  </div>",
" </noscript>",
" <div id=\"printHeader\">",
"  <div id=\"printHeaderLogo\">",
"   <img alt=\"UpToDate\" src=\"./../images/UTD2_masthead.myextg\">",
"    <img align=\"right\" alt=\"Wolters Kluwer Health\" height=\"40\" src=\"./../images/logoWKH.myextg\" width=\"175\">",
"     <br>",
"      <div id=\"printHeaderText\">",
"       Official reprint from  UpToDate",
"       <sup>",
"        &reg;",
"       </sup>",
"       <br>",
"        <a href=\"file://www.uptodate.com\">",
"         www.uptodate.com",
"        </a>",
"        &copy;2013 UpToDate",
"        <sup>",
"         &reg;",
"        </sup>",
"       </br>",
"      </div>",
"     </br>",
"    </img>",
"   </img>",
"  </div>",
"  <div id=\"printHeaderLinks\">",
"   <a class=\"TOPIC\" href=\"#\" id=\"printHeaderPrint\" rel=\"1\" title=\"Click here to print\">",
"    Print",
"   </a>",
"   <span class=\"pipeSpace\">",
"    |",
"   </span>",
"   <a href=\"#\" id=\"printHeaderBack\" title=\"Back to normal view\">",
"    Back",
"   </a>",
"  </div>",
" </div>",
" <!-- TC:TOPIC_PAGE -->",
" <div id=\"topicContent\">",
"  <div id=\"topicTitle\">",
"   Assessment of respiratory distress in the mechanically ventilated patient",
"  </div>",
"  <div id=\"topicContributors\">",
"   <div>",
"    <a id=\"authors\">",
"    </a>",
"    <a class=\"contributor contributor_credentials contributorType\" href=\"UTD.htm?21/30/21991/contributors\">",
"     Authors",
"    </a>",
"    <br/>",
"    <a class=\"contributor contributor_credentials\" href=\"UTD.htm?21/30/21991/contributors\">",
"     David A Kaufman, MD",
"    </a>",
"    <br/>",
"    <a class=\"contributor contributor_credentials\" href=\"UTD.htm?21/30/21991/contributors\">",
"     Barry Fuchs, MD",
"    </a>",
"    <br/>",
"    <a class=\"contributor contributor_credentials\" href=\"UTD.htm?21/30/21991/contributors\">",
"     Gregg Lipschik, MD",
"    </a>",
"    <br/>",
"   </div>",
"   <div>",
"    <a class=\"contributor contributor_credentials contributorType\" href=\"UTD.htm?21/30/21991/contributors\">",
"     Section Editor",
"    </a>",
"    <br/>",
"    <a class=\"contributor contributor_credentials\" href=\"UTD.htm?21/30/21991/contributors\">",
"     Polly E Parsons, MD",
"    </a>",
"    <br/>",
"   </div>",
"   <div>",
"    <a class=\"contributor contributor_credentials contributorType\" href=\"UTD.htm?21/30/21991/contributors\">",
"     Deputy Editor",
"    </a>",
"    <br/>",
"    <a class=\"contributor contributor_credentials\" href=\"UTD.htm?21/30/21991/contributors\">",
"     Geraldine Finlay, MD",
"    </a>",
"    <br/>",
"   </div>",
"  </div>",
"  <div id=\"disclosures\">",
"   <a href=\"UTD.htm?21/30/21991/contributor-disclosure\" target=\"_blank\">",
"    Disclosures",
"   </a>",
"  </div>",
"  <div id=\"reviewProcess\">",
"   <span>",
"    All topics are updated as new evidence becomes available and our",
"   </span>",
"   <a href=\"/home/editorial-policy\" target=\"_blank\">",
"    peer review process",
"   </a>",
"   <span>",
"    is complete.",
"   </span>",
"  </div>",
"  <div id=\"literatureReviewDate\">",
"   <span class=\"emphasis\">",
"    Literature review current through:",
"   </span>",
"   Oct 2013.",
"   <span class=\"pipeSpace\">",
"    |",
"   </span>",
"   <span class=\"emphasis\">",
"    This topic last updated:",
"   </span>",
"   Sep 14, 2012.",
"  </div>",
"  <div id=\"topicText\">",
"   <p class=\"headingAnchor\" id=\"H1\">",
"    <span class=\"h1\">",
"     INTRODUCTION",
"    </span>",
"    &nbsp;&mdash;&nbsp;Patients undergoing mechanical ventilation frequently develop respiratory distress, often referred to as \"bucking\" or \"fighting\" the ventilator [",
"    <a class=\"abstract\" href=\"UTD.htm?21/30/21991/abstract/1-4\">",
"     1-4",
"    </a>",
"    ]. The term used in the medical literature for this observation is patient-ventilator asynchrony or dyssynchrony. Clinical signs include anxiety, agitation, tachypnea, tachycardia, use of accessory muscles of breathing, uncoordinated thoracic wall or abdominal movement, and asynchrony with the ventilator [",
"    <a class=\"abstract\" href=\"UTD.htm?21/30/21991/abstract/5\">",
"     5",
"    </a>",
"    ]. Because respiratory distress may signify the onset of a life-threatening complication, a rapid, focused evaluation is required (",
"    <a class=\"graphic graphic_figure graphicRef52670 \" href=\"UTD.htm?30/43/31409\">",
"     figure 1",
"    </a>",
"    ).",
"   </p>",
"   <p>",
"    Respiratory distress that occurs soon after the initiation (or reestablishment) of mechanical ventilation is often the result of inadequate ventilator support or insufficient sedation. Errors in setting the ventilator are common, and also should be considered if respiratory distress occurs during procedures or patient transport [",
"    <a class=\"abstract\" href=\"UTD.htm?21/30/21991/abstract/6\">",
"     6",
"    </a>",
"    ]. Respiratory distress can often be managed by observing the patient's breathing pattern, and changing the ventilator settings to match respiratory rate, triggering efforts, and requirements for peak inspiratory flow. (See",
"    <a class=\"medical medical_review\" href=\"UTD.htm?13/1/13336?source=see_link\">",
"     \"Overview of mechanical ventilation\"",
"    </a>",
"    .)",
"   </p>",
"   <p>",
"    The differential diagnosis and evaluation of respiratory distress in a previously stable patient receiving mechanical ventilation will be reviewed here. The acute respiratory distress syndrome (ARDS) is discussed separately. (See",
"    <a class=\"medical medical_review\" href=\"UTD.htm?10/16/10505?source=see_link\">",
"     \"Acute respiratory distress syndrome: Clinical features and diagnosis\"",
"    </a>",
"    and",
"    <a class=\"medical medical_review\" href=\"UTD.htm?29/15/29945?source=see_link\">",
"     \"Acute respiratory distress syndrome: Epidemiology; pathophysiology; pathology; and etiology\"",
"    </a>",
"    and",
"    <a class=\"medical medical_review\" href=\"UTD.htm?2/42/2730?source=see_link\">",
"     \"Mechanical ventilation in acute respiratory distress syndrome\"",
"    </a>",
"    .)",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H2\">",
"    <span class=\"h1\">",
"     DIFFERENTIAL DIAGNOSIS",
"    </span>",
"    &nbsp;&mdash;&nbsp;Respiratory distress in mechanically ventilated patients can be classified anatomically as originating in the airway, the pulmonary parenchyma, or outside the lungs. Common causes include endotracheal tube obstruction, heart failure, pneumonia, patient-ventilator asynchrony due to inadequate sedation, and compression of the lungs by pleural fluid or ascites (",
"    <a class=\"graphic graphic_table graphicRef65177 \" href=\"UTD.htm?25/5/25692\">",
"     table 1",
"    </a>",
"    ).",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H3\">",
"    <span class=\"h2\">",
"     Airway",
"    </span>",
"    &nbsp;&mdash;&nbsp;The artificial airway is composed of the endotracheal tube (ETT) and, in many cases, a heat and moisture exchanger (HME). The artificial airway is an important cause of respiratory distress. As an example, the HME may become saturated with secretions, leading to increased airway resistance [",
"    <a class=\"abstract\" href=\"UTD.htm?21/30/21991/abstract/7-10\">",
"     7-10",
"    </a>",
"    ].",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H4\">",
"    <span class=\"h3\">",
"     Endotracheal tube",
"    </span>",
"    &nbsp;&mdash;&nbsp;Problems related to the endotracheal tube include obstruction by secretions, blood, torsion, kinking, or a foreign body [",
"    <a class=\"abstract\" href=\"UTD.htm?21/30/21991/abstract/11\">",
"     11",
"    </a>",
"    ]. In addition, the patient can bite on, or completely through, the ETT [",
"    <a class=\"abstract\" href=\"UTD.htm?21/30/21991/abstract/12\">",
"     12",
"    </a>",
"    ]. (See",
"    <a class=\"medical medical_review\" href=\"UTD.htm?15/11/15545?source=see_link\">",
"     \"Endotracheal tube management and complications\"",
"    </a>",
"    .)",
"   </p>",
"   <p>",
"    The ETT may migrate out of position, especially when it is inadequately secured. Excessive neck movement can cause significant displacement, with neck extension leading to superior migration of the ETT and neck flexion leading to inferior migration (",
"    <a class=\"graphic graphic_figure graphicRef55694 graphicRef68470 \" href=\"UTD.htm?19/4/19524\">",
"     figure 2A-B",
"    </a>",
"    )&nbsp;[",
"    <a class=\"abstract\" href=\"UTD.htm?21/30/21991/abstract/13\">",
"     13",
"    </a>",
"    ].",
"   </p>",
"   <p>",
"    <ul class=\"bullet-block\">",
"     <li>",
"      Superior migration of the ETT to a position above the vocal cords results in incomplete delivery of the set tidal volume and escape of air from the nose and mouth during the ventilator-delivered breath.",
"     </li>",
"     <li>",
"      Inferior migration of the ETT may result in unilateral intubation of a mainstem bronchus, putting the patient at risk for barotrauma and pneumothorax as the entire set tidal volume is delivered to one lung. When this occurs, the right mainstem bronchus is more frequently intubated [",
"      <a class=\"abstract\" href=\"UTD.htm?21/30/21991/abstract/14\">",
"       14",
"      </a>",
"      ]. (See",
"      <a class=\"medical medical_review\" href=\"UTD.htm?32/10/32934?source=see_link\">",
"       \"Pulmonary barotrauma during mechanical ventilation\"",
"      </a>",
"      .)",
"     </li>",
"    </ul>",
"   </p>",
"   <p>",
"    The balloon cuff at the end of the ETT may leak or rupture, leading to incomplete delivery of the set tidal volume and loss of positive end-expiratory pressure (PEEP). This usually results in an audible air leak and a deflated pilot balloon. Similarly, patients can bite through the pilot balloon tube, causing cuff deflation. Herniation of the ETT cuff over the end of the tube has been reported as a cause of respiratory distress and increased airway pressures [",
"    <a class=\"abstract\" href=\"UTD.htm?21/30/21991/abstract/15\">",
"     15",
"    </a>",
"    ].",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H5\">",
"    <span class=\"h3\">",
"     Large and medium-sized airways",
"    </span>",
"    &nbsp;&mdash;&nbsp;Respiratory distress can also be caused by abnormalities in the large and medium sized airways of the tracheobronchial tree.",
"   </p>",
"   <p>",
"    Abundant thick airway secretions may become impacted in the lower airways, causing obstruction and atelectasis. The character and volume of secretions prior to the onset of the respiratory distress can help establish this diagnosis. Excessive airway secretions can sometimes be detected by examining the flow-volume loop on the ventilator display, where a sawtooth pattern may represent intermittent changes in airway resistance [",
"    <a class=\"abstract\" href=\"UTD.htm?21/30/21991/abstract/16\">",
"     16",
"    </a>",
"    ]. Ensuring adequate humidification of the inspired gases may diminish inspissation of secretions. Frequent airway suctioning, pulmonary toilet, and bronchoscopy have also been used to facilitate clearance of secretions [",
"    <a class=\"abstract\" href=\"UTD.htm?21/30/21991/abstract/17\">",
"     17",
"    </a>",
"    ]. In some cases, unrecognized foreign body aspiration at the time of intubation can result in acute respiratory decompensation. (See",
"    <a class=\"medical medical_review\" href=\"UTD.htm?34/36/35399?source=see_link\">",
"     \"Airway foreign bodies in adults\"",
"    </a>",
"    .)",
"   </p>",
"   <p>",
"    In addition to underlying lung disease and mechanical obstruction, bronchospasm may cause acute respiratory distress, most commonly in patients with COPD, asthma, or volume overload. Bronchoscopy, airway suctioning, the use of beta-adrenergic receptor blockers, and allergic reactions can also contribute to bronchospasm and respiratory distress [",
"    <a class=\"abstract\" href=\"UTD.htm?21/30/21991/abstract/18\">",
"     18",
"    </a>",
"    ]. Conventional treatment with inhaled bronchodilators is usually sufficient; in severe cases of upper airway edema caused by the endotracheal tube, corticosteroids may be considered. (See",
"    <a class=\"medical medical_review\" href=\"UTD.htm?15/11/15545?source=see_link\">",
"     \"Endotracheal tube management and complications\"",
"    </a>",
"    .)",
"   </p>",
"   <p>",
"    Bronchospasm may also be complicated by dynamic hyperinflation (also called auto-PEEP), which will exacerbate patient distress by increasing work of breathing. In addition, auto-PEEP may cause hypotension and, in severe cases, may present as a cardiopulmonary arrest with pulseless electrical activity. Auto-PEEP usually occurs in the setting of obstructive lung disease, but it may also occur in patients with markedly increased minute ventilatory requirements, for example, acute respiratory distress syndrome (ARDS). Auto-PEEP may be precipitated by an increase in either airway resistance or minute ventilation or by a reduction in the peak inspiratory flow setting.",
"   </p>",
"   <p>",
"    Auto-PEEP may be appreciated on physical examination and confirmed by review of the flow-time waveforms. Auto-PEEP can be quantified by execution of an expiratory hold maneuver during mechanical ventilation (",
"    <a class=\"graphic graphic_figure graphicRef52820 \" href=\"UTD.htm?24/62/25582\">",
"     figure 3",
"    </a>",
"    ). (See",
"    <a class=\"medical medical_review\" href=\"UTD.htm?25/32/26119?source=see_link&amp;anchor=H5#H5\">",
"     \"Physiologic and pathophysiologic consequences of mechanical ventilation\", section on 'Auto-PEEP'",
"    </a>",
"    .)",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H6\">",
"    <span class=\"h2\">",
"     Pulmonary parenchyma and vasculature",
"    </span>",
"    &nbsp;&mdash;&nbsp;Atelectasis, pneumonia, aspiration of oropharyngeal or gastroesophageal contents, pulmonary edema, and pulmonary emboli can all cause respiratory distress in patients undergoing mechanical ventilation.",
"   </p>",
"   <p>",
"    With the exception of acute pulmonary embolism, these conditions can usually be differentiated by physical examination and plain chest radiography. Acute pulmonary embolism is notoriously difficult to diagnose, since there are no specific symptoms, signs, or chest radiograph findings, but it is even more difficult in the mechanically ventilated patient for several reasons. Ventilation scans are difficult to perform in mechanically ventilated patients. In addition, interpretation of perfusion scans in the presence of preexisting pulmonary disease, and without the benefit of a ventilation scan, is difficult [",
"    <a class=\"abstract\" href=\"UTD.htm?21/30/21991/abstract/19\">",
"     19",
"    </a>",
"    ]. CT scans and angiograms are diagnostic but require patient transport, which may be difficult in severely ill patients. Although echocardiography can be done emergently at the bedside with a high degree of diagnostic sensitivity in hemodynamically compromised patients, it is not specific. (See",
"    <a class=\"medical medical_review\" href=\"UTD.htm?5/57/6042?source=see_link\">",
"     \"Diagnosis of acute pulmonary embolism\"",
"    </a>",
"    .)",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H7\">",
"    <span class=\"h2\">",
"     Problems outside the lung",
"    </span>",
"    &nbsp;&mdash;&nbsp;Extrapulmonary processes can cause respiratory distress by restricting inspiration or increasing respiratory drive. Thoracic processes that cause restriction include pneumothorax and large pleural effusions. Abdominal problems, such as ascites, ileus, or splinting from abdominal pain, may limit chest wall expansion and lower the compliance of the respiratory system [",
"    <a class=\"abstract\" href=\"UTD.htm?21/30/21991/abstract/20\">",
"     20",
"    </a>",
"    ]. (See",
"    <a class=\"medical medical_review\" href=\"UTD.htm?20/17/20761?source=see_link\">",
"     \"Abdominal compartment syndrome\"",
"    </a>",
"    .)",
"   </p>",
"   <p>",
"    Fever, shock, pain, delirium, and anxiety can increase respiratory drive and cause apparent respiratory distress and agitation without a change in respiratory mechanics or gas exchange. These are diagnoses of exclusion, however, and life-threatening disorders must always be considered before administering sedatives, analgesics, or neuroleptics. The source of the patient's pain or discomfort should be sought and specifically treated [",
"    <a class=\"abstract\" href=\"UTD.htm?21/30/21991/abstract/21\">",
"     21",
"    </a>",
"    ]. Primary measures to prevent and treat delirium (such as minimizing sleep deprivation, reassurance, and providing orientation to time, place, and situation) may be effective. (See",
"    <a class=\"medical medical_review\" href=\"UTD.htm?36/1/36889?source=see_link\">",
"     \"Acute toxic-metabolic encephalopathy in adults\"",
"    </a>",
"    and",
"    <a class=\"medical medical_review\" href=\"UTD.htm?39/61/40920?source=see_link\">",
"     \"Pain control in the critically ill adult patient\"",
"    </a>",
"    and",
"    <a class=\"medical medical_review\" href=\"UTD.htm?15/29/15833?source=see_link\">",
"     \"Sedative-analgesic medications in critically ill patients: Selection, initiation, maintenance, and withdrawal\"",
"    </a>",
"    .)",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H8\">",
"    <span class=\"h1\">",
"     EVALUATION AND MANAGEMENT",
"    </span>",
"    &nbsp;&mdash;&nbsp;The first step in the evaluation is to perform a rapid assessment of the patient and the monitoring equipment, to determine the urgency of the situation, and to identify obvious problems, while acquiring relevant information from the bedside nurse and respiratory therapist. This quick survey should evaluate the appearance of the patient, the vital signs (including pulse oximetry), cardiac rate and rhythm, the patency of the ventilator circuit connections, and the position and condition of the artificial airway, including a check for air leaking from the nose or mouth (",
"    <a class=\"graphic graphic_figure graphicRef52670 \" href=\"UTD.htm?30/43/31409\">",
"     figure 1",
"    </a>",
"    ).",
"   </p>",
"   <p>",
"    Following this brief assessment, if the cause of patient distress is not determined, a chest radiograph, arterial blood gas, and electrocardiogram should be obtained. A chest radiograph is central to the evaluation of respiratory distress in ventilated patients. Important findings include the position of the ETT as well as signs of pneumonia, pulmonary edema, pneumothorax, pleural effusion, or atelectasis. Further diagnostic evaluation may be based on the findings of the plain chest film.",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H9\">",
"    <span class=\"h2\">",
"     Initial stabilization",
"    </span>",
"    &nbsp;&mdash;&nbsp;If respiratory distress is severe, or the patient is hemodynamically unstable, stabilization is essential and must take precedence over a detailed evaluation or diagnostic procedures. The patient should be disconnected from the ventilator and manual ventilations with 100 percent oxygen should be administered. This maneuver allows the clinician to focus on the patient and \"feel\" the mechanics of the respiratory system, while supporting oxygenation and ventilation. If the patient's status improves immediately after the institution of manual ventilations, the ventilator or the ventilator settings are the source of the problem (",
"    <a class=\"graphic graphic_figure graphicRef52670 \" href=\"UTD.htm?30/43/31409\">",
"     figure 1",
"    </a>",
"    ). (See",
"    <a class=\"medical medical_review\" href=\"UTD.htm?13/1/13336?source=see_link\">",
"     \"Overview of mechanical ventilation\"",
"    </a>",
"    .)",
"   </p>",
"   <p>",
"    If the patient's condition rapidly deteriorates despite manual ventilation, empiric treatment of immediately life-threatening conditions may be required before a definitive diagnosis is made. As an example, respiratory distress accompanied by hypotension and unilaterally decreased breath sounds may require presumptive treatment of a tension pneumothorax with needle decompression followed by placement of a thoracostomy tube. (See",
"    <a class=\"medical medical_review\" href=\"UTD.htm?1/12/1226?source=see_link\">",
"     \"Placement and management of thoracostomy tubes\"",
"    </a>",
"    .)",
"   </p>",
"   <p>",
"    If manual ventilations meet with minimal resistance, the clinician must verify that air is not escaping from the patient's nose or mouth. Air leaking from the nose and mouth suggests that the ETT has migrated superiorly (above the vocal cords) or that the cuff has ruptured or deflated. Inspection of the ETT position with respect to the incisors, and examination of the pressure within the pilot balloon are essential (",
"    <a class=\"graphic graphic_figure graphicRef55694 \" href=\"UTD.htm?29/53/30559\">",
"     figure 2A",
"    </a>",
"    ). In general, either problem requires replacement of the ETT. If an air leak is not audible, the expiratory tidal volume should be compared to the set tidal volume during mechanical ventilation; an expiratory tidal volume smaller than the set tidal volume suggests the presence of a leak in the system. (See",
"    <a class=\"medical medical_review\" href=\"UTD.htm?15/11/15545?source=see_link\">",
"     \"Endotracheal tube management and complications\"",
"    </a>",
"    .)",
"   </p>",
"   <p>",
"    If manual ventilations are difficult and do not improve the patient's condition, the patency of the ETT should be assessed using a suction catheter. Failure of the catheter to pass easily confirms obstruction of the ETT. Reversible causes of ETT obstruction should be treated empirically by repositioning the patient's head (to alleviate kinking) or inserting a bite block. If these maneuvers fail, the ETT can be replaced using a flexible exchange catheter. In select cases, the ETT can be removed, and the need for continued mechanical ventilation assessed. If the patient is unlikely to tolerate extubation, and there is no improvement after ETT replacement, urgent bronchoscopy to assess airway patency should be considered. (See",
"    <a class=\"medical medical_review\" href=\"UTD.htm?37/15/38135?source=see_link\">",
"     \"Flexible bronchoscopy: Indications and contraindications\"",
"    </a>",
"    .)",
"   </p>",
"   <p>",
"    If the suction catheter passes easily, a trial of increased sedation, with or without short-term neuromuscular paralysis, may help determine whether respiratory distress is the result of an intrinsic respiratory problem, or the consequence of an increase in the patient's respiratory efforts. If the distress resolves with sedation, active respiratory effort is the likely cause and the underlying etiology must be sought. Possibilities include hypercapnia or hypoxemia, delirium, pain, fever, shock, or a structural CNS lesion. (See",
"    <a class=\"medical medical_review\" href=\"UTD.htm?15/29/15833?source=see_link\">",
"     \"Sedative-analgesic medications in critically ill patients: Selection, initiation, maintenance, and withdrawal\"",
"    </a>",
"    and",
"    <a class=\"medical medical_review\" href=\"UTD.htm?42/44/43720?source=see_link\">",
"     \"Use of neuromuscular blocking medications in critically ill patients\"",
"    </a>",
"    .)",
"   </p>",
"   <p>",
"    Persistent difficulty with manual ventilations despite sedation or paralysis suggests the presence of a new lower airway, parenchymal, or thoracic wall problem. A rapid history, focused physical examination, measurement of respiratory mechanics, and chest radiograph will often lead to the correct diagnosis.",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H10\">",
"    <span class=\"h2\">",
"     Focused assessment",
"    </span>",
"    &nbsp;&mdash;&nbsp;Once the patient's clinical condition has stabilized, a more complete evaluation can be performed to determine the underlying cause of the distress, including (",
"    <a class=\"graphic graphic_figure graphicRef52670 \" href=\"UTD.htm?30/43/31409\">",
"     figure 1",
"    </a>",
"    ):",
"   </p>",
"   <p>",
"    <ul class=\"bulletCompact-block\">",
"     <li>",
"      Focused history and physical examination",
"     </li>",
"     <li>",
"      Assessment of gas exchange",
"     </li>",
"     <li>",
"      Review of the activated ventilator alarms",
"     </li>",
"     <li>",
"      Assessment of the respiratory mechanics",
"     </li>",
"     <li>",
"      Chest radiography",
"     </li>",
"    </ul>",
"   </p>",
"   <p>",
"    A focused history, with the patient answering \"yes\" or \"no\" questions or writing short replies, should be obtained if possible [",
"    <a class=\"abstract\" href=\"UTD.htm?21/30/21991/abstract/21\">",
"     21",
"    </a>",
"    ]. A brief discussion among those caring for the patient, including the clinician, nurse, and respiratory therapist, often reveals important clues to the cause of a patient's distress. Examples include recent chest pain, a change in the quality or quantity of respiratory secretions, administration of new medications, or changes in ventilator parameters.",
"   </p>",
"   <p>",
"    The physical examination frequently localizes the cause of respiratory distress. Trends in the vital signs and all available hemodynamic data should be reviewed. Tachypnea is almost universal in this setting. Hypotension in combination with an increase in central venous pressure may accompany excessive auto-PEEP, tension pneumothorax, or massive pulmonary embolism. Fever may complicate infection, pulmonary embolism, or allergic reaction. Hypertension and tachycardia are common during an episode of respiratory distress; in the absence of other findings, they may signify pain or anxiety.",
"   </p>",
"   <p>",
"    The cardiopulmonary examination should focus on evidence of bronchospasm, equality of breath sounds, and signs of volume overload. Bronchospasm usually presents with wheezing or rhonchi. Unequal breath sounds suggest unilateral mainstem bronchus intubation, pneumothorax, or pleural effusion. Crackles, wheezing, or rhonchi may reflect pulmonary edema. The presence of any nonpulmonary abnormalities, including abdominal distension and signs of deep venous thrombosis, should be noted.",
"   </p>",
"   <p>",
"    Most intubated patients are continuously monitored with pulse oximetry, which can detect decreases in the oxyhemoglobin saturation (SaO",
"    <sub>",
"     2",
"    </sub>",
"    ). However, there are important technical limitations to pulse oximetry. Significant drops in the arterial oxygen tension (PaO",
"    <sub>",
"     2",
"    </sub>",
"    ) may not result in a corresponding change in the SaO",
"    <sub>",
"     2",
"    </sub>",
"    , especially when they occur at high oxygen tensions (&gt;100 mmHg). Other conditions associated with inaccurate pulse oximetry include poor peripheral perfusion, excessive patient movement, abnormal hemoglobin, very low SaO",
"    <sub>",
"     2",
"    </sub>",
"    , and certain dyes. (See",
"    <a class=\"medical medical_review\" href=\"UTD.htm?9/32/9736?source=see_link\">",
"     \"Pulse oximetry\"",
"    </a>",
"    .)",
"   </p>",
"   <p>",
"    Arterial blood gases should be measured if the cause of respiratory distress is not immediately apparent, if pulse oximetry demonstrates desaturation, or if the pulse oximetry waveform is unreliable. The presence of hypoxemia or hypercapnia on blood gas analysis suggests diagnostic possibilities and indicates specific therapy [",
"    <a class=\"abstract\" href=\"UTD.htm?21/30/21991/abstract/22\">",
"     22",
"    </a>",
"    ]. (See",
"    <a class=\"medical medical_review\" href=\"UTD.htm?33/8/33925?source=see_link\">",
"     \"Oxygenation and mechanisms of hypoxemia\"",
"    </a>",
"    .)",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H11\">",
"    <span class=\"h2\">",
"     Respiratory mechanics",
"    </span>",
"    &nbsp;&mdash;&nbsp;Respiratory mechanics quantify the interrelationship of pressure, volume, and airflow within the respiratory system. Recognizing trends and acute changes in respiratory mechanics can aid in the diagnosis of respiratory distress. The peak inspiratory pressure (Ppeak), the plateau pressure (Pplat), and the difference between the two",
"    <span class=\"nowrap\">",
"     (&Delta;Ppeak",
"    </span>",
"    &ndash; Pplat) provide important information about the resistance and compliance of the respiratory system [",
"    <a class=\"abstract\" href=\"UTD.htm?21/30/21991/abstract/23,24\">",
"     23,24",
"    </a>",
"    ]. These pressures should be measured only during volume-controlled ventilation with a constant flow (ie, square wave) pattern [",
"    <a class=\"abstract\" href=\"UTD.htm?21/30/21991/abstract/25\">",
"     25",
"    </a>",
"    ]. Accurate assessment may require additional sedation (",
"    <a class=\"graphic graphic_figure graphicRef71863 \" href=\"UTD.htm?42/50/43822\">",
"     figure 4",
"    </a>",
"    ).",
"   </p>",
"   <p>",
"    The Ppeak is the highest pressure measured during the respiratory cycle, and is a function of both the resistance of the airways and the compliance of the respiratory system. Pplat is the pressure recorded during a pause at end-inspiration; because the Pplat is measured while there is no airflow, it reflects the static compliance of the respiratory system, including the lung parenchyma, chest wall, and abdomen [",
"    <a class=\"abstract\" href=\"UTD.htm?21/30/21991/abstract/26,27\">",
"     26,27",
"    </a>",
"    ].",
"   </p>",
"   <p>",
"    An increase in the Ppeak with a widening of the",
"    <span class=\"nowrap\">",
"     &Delta;Ppeak",
"    </span>",
"    &ndash; Pplat suggests that an increase in airway resistance is the cause of respiratory distress [",
"    <a class=\"abstract\" href=\"UTD.htm?21/30/21991/abstract/28\">",
"     28",
"    </a>",
"    ]. Obstruction of the ETT (eg, by inspissated secretions, a kinked tube, or the patient biting the tube) and bronchospasm can cause this change in respiratory mechanics.",
"   </p>",
"   <p>",
"    In contrast, an increase in both the Ppeak and Pplat with a",
"    <span class=\"nowrap\">",
"     &Delta;Ppeak",
"    </span>",
"    &ndash; Pplat that narrows or stays the same suggests a decrease in respiratory system compliance. Abrupt decreases in the respiratory compliance suggest unilateral mainstem bronchus intubation, pneumothorax, severe atelectasis, pneumonia, pulmonary edema, or abdominal distension.",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H12\">",
"    <span class=\"h1\">",
"     SUMMARY AND RECOMMENDATIONS",
"    </span>",
"   </p>",
"   <p>",
"    <ul class=\"bullet-block\">",
"     <li>",
"      Acute respiratory distress in patients undergoing mechanical ventilation is called patient-ventilator asynchrony or dyssynchrony. Alternatively, it is often referred to as \"bucking\" or \"fighting\" the ventilator. Signs include agitation, tachypnea, tachycardia, use of accessory muscles of breathing, uncoordinated thoracic wall or abdominal movement, asynchrony with the ventilator, and deterioration in gas exchange. (See",
"      <a class=\"local\" href=\"#H1\">",
"       'Introduction'",
"      </a>",
"      above.)",
"     </li>",
"     <li>",
"      The mechanical ventilator, endotracheal tube, airways, and lung parenchyma are all potential sources of respiratory distress, as are extrapulmonary processes. Frequent causes include endotracheal tube obstruction, mucus plugging, heart failure, pneumonia, aspiration, pulmonary embolism, and extra-pulmonary etiologies such as pleural effusion and ascites. In addition, it may reflect an increase in the respiratory drive without any change in respiratory mechanics, such as due to pain, fear, anxiety, delirium, or a new intracerebral process. (See",
"      <a class=\"local\" href=\"#H2\">",
"       'Differential diagnosis'",
"      </a>",
"      above.)",
"     </li>",
"     <li>",
"      Patients with severe respiratory distress or hemodynamic instability should be disconnected from the ventilator and manually ventilated with 100 percent oxygen. This allows the clinician to feel the mechanics of the respiratory system, while supporting oxygenation and ventilation. The resistance and response to manual ventilation provide important information regarding the etiology of the respiratory distress. (See",
"      <a class=\"local\" href=\"#H9\">",
"       'Initial stabilization'",
"      </a>",
"      above.)",
"     </li>",
"     <li>",
"      Once the clinical condition is stable, a definitive diagnostic evaluation can be initiated. This includes a focused history, physical exam, arterial blood gas analysis, and chest radiograph, as well as assessment of lung mechanics using measurements from the ventilator. The likely cause of the respiratory distress is usually identified by this evaluation. (See",
"      <a class=\"local\" href=\"#H10\">",
"       'Focused assessment'",
"      </a>",
"      above and",
"      <a class=\"local\" href=\"#H11\">",
"       'Respiratory mechanics'",
"      </a>",
"      above.)",
"     </li>",
"     <li>",
"      An algorithm for the evaluation and management of acute respiratory distress in mechanically ventilated patients is shown in the figure (",
"      <a class=\"graphic graphic_figure graphicRef52670 \" href=\"UTD.htm?30/43/31409\">",
"       figure 1",
"      </a>",
"      ).",
"     </li>",
"    </ul>",
"   </p>",
"  </div>",
"  <div id=\"topicAgreement\">",
"   Use of UpToDate is subject to the",
"   <a class=\"licenseLink\" href=\"./license\" id=\"sla_in_page\" target=\"_blank\">",
"    Subscription and License Agreement",
"   </a>",
"   .",
"  </div>",
"  <div class=\"headingAnchor\" id=\"references\">",
"   <h1>",
"    REFERENCES",
"   </h1>",
"   <ol id=\"reference\">",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?21/30/21991/abstract/1\">",
"      Glauser FL, Polatty RC, Sessler CN. Worsening oxygenation in the mechanically ventilated patient. Causes, mechanisms, and early detection. Am Rev Respir Dis 1988; 138:458.",
"     </a>",
"    </li>",
"    <li>",
"     Tobin MJ, Fahey PJ. Management of the patient who is \"fighting the ventilator\". In: Principles and Practice of Mechanical Ventilation, McGraw Hill, New York 1994. p.1149.",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?21/30/21991/abstract/3\">",
"      Marcy TW, Marini JJ. Respiratory distress in the ventilated patient. Clin Chest Med 1994; 15:55.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?21/30/21991/abstract/4\">",
"      Keith RL, Pierson DJ. Complications of mechanical ventilation. A bedside approach. Clin Chest Med 1996; 17:439.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?21/30/21991/abstract/5\">",
"      Thille AW, Rodriguez P, Cabello B, et al. Patient-ventilator asynchrony during assisted mechanical ventilation. Intensive Care Med 2006; 32:1515.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?21/30/21991/abstract/6\">",
"      Abramson NS, Wald KS, Grenvik AN, et al. Adverse occurrences in intensive care units. JAMA 1980; 244:1582.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?21/30/21991/abstract/7\">",
"      Girault C, Breton L, Richard JC, et al. Mechanical effects of airway humidification devices in difficult to wean patients. Crit Care Med 2003; 31:1306.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?21/30/21991/abstract/8\">",
"      Lellouche F, Maggiore SM, Deye N, et al. Effect of the humidification device on the work of breathing during noninvasive ventilation. Intensive Care Med 2002; 28:1582.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?21/30/21991/abstract/9\">",
"      Pelosi P, Solca M, Ravagnan I, et al. Effects of heat and moisture exchangers on minute ventilation, ventilatory drive, and work of breathing during pressure-support ventilation in acute respiratory failure. Crit Care Med 1996; 24:1184.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?21/30/21991/abstract/10\">",
"      Lawes EG. Hidden hazards and dangers associated with the use of HME/filters in breathing circuits. Their effect on toxic metabolite production, pulse oximetry and airway resistance. Br J Anaesth 2003; 91:249.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?21/30/21991/abstract/11\">",
"      Shlamovitz GZ, Halpern P. Delayed obstruction of endotracheal tubes by aspirated foreign bodies: report of two cases. Ann Emerg Med 2004; 43:630.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?21/30/21991/abstract/12\">",
"      Hosking MP, Lennon RL, Warner MA, et al. Endotracheal tube obstruction: recognition and management. Mil Med 1989; 154:489.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?21/30/21991/abstract/13\">",
"      Conrardy PA, Goodman LR, Lainge F, Singer MM. Alteration of endotracheal tube position. Flexion and extension of the neck. Crit Care Med 1976; 4:7.",
"     </a>",
"    </li>",
"    <li>",
"     McGill JW, Clinton LE. Tracheal intubation. In: Clinical Procedures in Emergency Medicine, 3rd ed, WB Saunders Company, Philadelphia 1998. p.23.",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?21/30/21991/abstract/15\">",
"      Davidson I, Zimmer S. Cuff herniation. Anaesthesia 1989; 44:938.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?21/30/21991/abstract/16\">",
"      Guglielminotti J, Alzieu M, Maury E, et al. Bedside detection of retained tracheobronchial secretions in patients receiving mechanical ventilation: is it time for tracheal suctioning? Chest 2000; 118:1095.",
"     </a>",
"    </li>",
"    <li>",
"     Fink JB. Bronchial hygiene and lung expansion. In: Clinical Practice in Respiratory Care, Lippincott, Philadelphia 1999. p.344.",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?21/30/21991/abstract/18\">",
"      Guglielminotti J, Desmonts JM, Dureuil B. Effects of tracheal suctioning on respiratory resistances in mechanically ventilated patients. Chest 1998; 113:1335.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?21/30/21991/abstract/19\">",
"      Tanios MA, Simon AR, Hassoun PM. Management of venous thromboembolic disease in the chronically critically ill patient. Clin Chest Med 2001; 22:105.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?21/30/21991/abstract/20\">",
"      Gilroy RJ Jr, Lavietes MH, Loring SH, et al. Respiratory mechanical effects of abdominal distension. J Appl Physiol 1985; 58:1997.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?21/30/21991/abstract/21\">",
"      Hansen-Flaschen JH. Dyspnea in the ventilated patient: a call for patient-centered mechanical ventilation. Respir Care 2000; 45:1460.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?21/30/21991/abstract/22\">",
"      Weinberger SE, Schwartzstein RM, Weiss JW. Hypercapnia. N Engl J Med 1989; 321:1223.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?21/30/21991/abstract/23\">",
"      Stenqvist O. Practical assessment of respiratory mechanics. Br J Anaesth 2003; 91:92.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?21/30/21991/abstract/24\">",
"      de Chazal I, Hubmayr RD. Novel aspects of pulmonary mechanics in intensive care. Br J Anaesth 2003; 91:81.",
"     </a>",
"    </li>",
"    <li>",
"     Schmidt GA. Ventilator waveforms: clinical interpretation. In: Principles of Critical Care, 3rd ed, Hall J, Schmidt GA, Wood LD (Eds), The McGraw Hill Companies, 2008.",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?21/30/21991/abstract/26\">",
"      Tobin MJ. Respiratory monitoring. JAMA 1990; 264:244.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?21/30/21991/abstract/27\">",
"      Marini, JJ. Lung mechanics determinations at the bedside: instrumentation and clinical applications. Respir Care 1990; 35:669.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?21/30/21991/abstract/28\">",
"      Tobin MJ. Advances in mechanical ventilation. N Engl J Med 2001; 344:1986.",
"     </a>",
"    </li>",
"   </ol>",
"  </div>",
"  <div id=\"topicVersionRevision\">",
"   Topic 1633 Version 6.0",
"  </div>",
" </div>",
" <div id=\"footer\">",
"  <div id=\"supportFooter\">",
"   <span class=\"sfInfo\">",
"    &copy; 2013 UpToDate, Inc. All rights reserved.",
"   </span>",
"   <span class=\"pipeSpace\">",
"    |",
"   </span>",
"   <a class=\"licenseLink\" href=\"./license\" id=\"sla_footer\">",
"    Subscription and License Agreement",
"   </a>",
"   <span class=\"sfInfo\">",
"    <span class=\"pipeSpace\">",
"     |",
"    </span>",
"    Release: 21.6- C21.56",
"   </span>",
"   <br/>",
"   <span class=\"sfInfo\">",
"    Licensed to:",
"    <span class=\"emphasis\">",
"     AsanBook Dig. Med. Lib.",
"    </span>",
"   </span>",
"   <span class=\"sfInfo\">",
"    <span class=\"pipeSpace\">",
"     |",
"    </span>",
"    Support Tag: [0604-61.234.146.186-4E1BBEB838-S244013.14]",
"    <br/>",
"   </span>",
"  </div>",
" </div>",
"</div>"].join("\n");
var script_f21_30_21991=[""].join("\n");
var outline_f21_30_21991=[" <div id=\"toggleOutline\">",
"  <a href=\"#\" title=\"Collapse Topic Outline\">",
"   <img alt=\"\" src=\"./../images/orange_arrow_left.myextg\"/>",
"  </a>",
" </div>",
" <div id=\"innerOutline\">",
"  <h1>",
"   TOPIC OUTLINE",
"  </h1>",
"  <div id=\"outline\">",
"   <ul>",
"    <li>",
"     <a class=\"sr_button\" href=\"#H12\" id=\"summRecButton\">",
"      <span>",
"       SUMMARY &amp; RECOMMENDATIONS",
"      </span>",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#H1\">",
"      INTRODUCTION",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#H2\">",
"      DIFFERENTIAL DIAGNOSIS",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H3\">",
"      Airway",
"     </a>",
"    </li>",
"    <li class=\"dashItem\">",
"     <a class=\"outlineLink\" href=\"#H4\">",
"      - Endotracheal tube",
"     </a>",
"    </li>",
"    <li class=\"dashItem\">",
"     <a class=\"outlineLink\" href=\"#H5\">",
"      - Large and medium-sized airways",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H6\">",
"      Pulmonary parenchyma and vasculature",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H7\">",
"      Problems outside the lung",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#H8\">",
"      EVALUATION AND MANAGEMENT",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H9\">",
"      Initial stabilization",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H10\">",
"      Focused assessment",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H11\">",
"      Respiratory mechanics",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#H12\">",
"      SUMMARY AND RECOMMENDATIONS",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a href=\"#references\">",
"      REFERENCES",
"     </a>",
"    </li>",
"   </ul>",
"  </div>",
"  <h1>",
"   <div class=\"openRelatedGraphics\" id=\"PULM/1633\" rel=\"outline_link\">",
"    GRAPHICS",
"    <a class=\"graphics_icon\" href=\"#\" title=\"View All Related Graphics\">",
"     View All",
"    </a>",
"   </div>",
"  </h1>",
"  <div id=\"relatedGraphics\">",
"   <ul>",
"    <li class=\"plainItem\">",
"     <div class=\"openRelatedGraphics\" id=\"PULM/1633|FIG\">",
"      <a href=\"#\" title=\"FIGURES\">",
"       FIGURES",
"      </a>",
"     </div>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"graphic graphic_figure\" href=\"UTD.htm?30/43/31409\" title=\"figure 1\">",
"      Dx resp distress on ventilator",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"graphic graphic_figure\" href=\"UTD.htm?29/53/30559\" title=\"figure 2A\">",
"      Endotracheal tube positioning",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"graphic graphic_figure\" href=\"UTD.htm?17/23/17776\" title=\"figure 2B\">",
"      Endotrach tube neck movement",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"graphic graphic_figure\" href=\"UTD.htm?24/62/25582\" title=\"figure 3\">",
"      Auto PEEP effect",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"graphic graphic_figure\" href=\"UTD.htm?42/50/43822\" title=\"figure 4\">",
"      Peak and plateau pressure",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <div class=\"openRelatedGraphics\" id=\"PULM/1633|TAB\">",
"      <a href=\"#\" title=\"TABLES\">",
"       TABLES",
"      </a>",
"     </div>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"graphic graphic_table\" href=\"UTD.htm?25/5/25692\" title=\"table 1\">",
"      Causes of distress on vent",
"     </a>",
"    </li>",
"   </ul>",
"  </div>",
"  <h1>",
"   RELATED TOPICS",
"  </h1>",
"  <div id=\"relatedTopics\">",
"   <ul>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"UTD.htm?20/17/20761?source=related_link\">",
"      Abdominal compartment syndrome",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"UTD.htm?10/16/10505?source=related_link\">",
"      Acute respiratory distress syndrome: Clinical features and diagnosis",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"UTD.htm?29/15/29945?source=related_link\">",
"      Acute respiratory distress syndrome: Epidemiology; pathophysiology; pathology; and etiology",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"UTD.htm?36/1/36889?source=related_link\">",
"      Acute toxic-metabolic encephalopathy in adults",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"UTD.htm?34/36/35399?source=related_link\">",
"      Airway foreign bodies in adults",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"UTD.htm?5/57/6042?source=related_link\">",
"      Diagnosis of acute pulmonary embolism",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"UTD.htm?15/11/15545?source=related_link\">",
"      Endotracheal tube management and complications",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"UTD.htm?37/15/38135?source=related_link\">",
"      Flexible bronchoscopy: Indications and contraindications",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"UTD.htm?2/42/2730?source=related_link\">",
"      Mechanical ventilation in acute respiratory distress syndrome",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"UTD.htm?13/1/13336?source=related_link\">",
"      Overview of mechanical ventilation",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"UTD.htm?33/8/33925?source=related_link\">",
"      Oxygenation and mechanisms of hypoxemia",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"UTD.htm?39/61/40920?source=related_link\">",
"      Pain control in the critically ill adult patient",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"UTD.htm?25/32/26119?source=related_link\">",
"      Physiologic and pathophysiologic consequences of mechanical ventilation",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"UTD.htm?1/12/1226?source=related_link\">",
"      Placement and management of thoracostomy tubes",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"UTD.htm?32/10/32934?source=related_link\">",
"      Pulmonary barotrauma during mechanical ventilation",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"UTD.htm?9/32/9736?source=related_link\">",
"      Pulse oximetry",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"UTD.htm?15/29/15833?source=related_link\">",
"      Sedative-analgesic medications in critically ill patients: Selection, initiation, maintenance, and withdrawal",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"UTD.htm?42/44/43720?source=related_link\">",
"      Use of neuromuscular blocking medications in critically ill patients",
"     </a>",
"    </li>",
"   </ul>",
"  </div>",
" </div>"].join("\n");
var title_f21_30_21992="Ultrasonography of the hepatobiliary tract";
var content_f21_30_21992=[" <noscript>",
"  <div id=\"javascriptDisabled\">",
"   It seems to us that you have your JavaScript turned off on your browser. JavaScript is required in order for our site to behave correctly.  Please enable your JavaScript to continue use our site.",
"  </div>",
" </noscript>",
" <div id=\"printHeader\">",
"  <div id=\"printHeaderLogo\">",
"   <img alt=\"UpToDate\" src=\"./../images/UTD2_masthead.myextg\">",
"    <img align=\"right\" alt=\"Wolters Kluwer Health\" height=\"40\" src=\"./../images/logoWKH.myextg\" width=\"175\">",
"     <br>",
"      <div id=\"printHeaderText\">",
"       Official reprint from  UpToDate",
"       <sup>",
"        &reg;",
"       </sup>",
"       <br>",
"        <a href=\"file://www.uptodate.com\">",
"         www.uptodate.com",
"        </a>",
"        &copy;2013 UpToDate",
"        <sup>",
"         &reg;",
"        </sup>",
"       </br>",
"      </div>",
"     </br>",
"    </img>",
"   </img>",
"  </div>",
"  <div id=\"printHeaderLinks\">",
"   <a class=\"TOPIC\" href=\"#\" id=\"printHeaderPrint\" rel=\"2\" title=\"Click here to print\">",
"    Print",
"   </a>",
"   <span class=\"pipeSpace\">",
"    |",
"   </span>",
"   <a href=\"#\" id=\"printHeaderBack\" title=\"Back to normal view\">",
"    Back",
"   </a>",
"  </div>",
" </div>",
" <!-- TC:TOPIC_PAGE -->",
" <div id=\"topicContent\">",
"  <div id=\"topicTitle\">",
"   Ultrasonography of the hepatobiliary tract",
"  </div>",
"  <div id=\"topicContributors\">",
"   <div>",
"    <a id=\"authors\">",
"    </a>",
"    <a class=\"contributor contributor_credentials contributorType\" href=\"UTD.htm?21/30/21992/contributors\">",
"     Authors",
"    </a>",
"    <br/>",
"    <a class=\"contributor contributor_credentials\" href=\"UTD.htm?21/30/21992/contributors\">",
"     Umaprasanna S Karnam, MD",
"    </a>",
"    <br/>",
"    <a class=\"contributor contributor_credentials\" href=\"UTD.htm?21/30/21992/contributors\">",
"     Jonathan B Kruskal, MD, PhD",
"    </a>",
"    <br/>",
"    <a class=\"contributor contributor_credentials\" href=\"UTD.htm?21/30/21992/contributors\">",
"     K Rajender Reddy, MD",
"    </a>",
"    <br/>",
"   </div>",
"   <div>",
"    <a class=\"contributor contributor_credentials contributorType\" href=\"UTD.htm?21/30/21992/contributors\">",
"     Section Editor",
"    </a>",
"    <br/>",
"    <a class=\"contributor contributor_credentials\" href=\"UTD.htm?21/30/21992/contributors\">",
"     Sanjiv Chopra, MD",
"    </a>",
"    <br/>",
"   </div>",
"   <div>",
"    <a class=\"contributor contributor_credentials contributorType\" href=\"UTD.htm?21/30/21992/contributors\">",
"     Deputy Editor",
"    </a>",
"    <br/>",
"    <a class=\"contributor contributor_credentials\" href=\"UTD.htm?21/30/21992/contributors\">",
"     Anne C Travis, MD, MSc, FACG",
"    </a>",
"    <br/>",
"   </div>",
"  </div>",
"  <div id=\"disclosures\">",
"   <a href=\"UTD.htm?21/30/21992/contributor-disclosure\" target=\"_blank\">",
"    Disclosures",
"   </a>",
"  </div>",
"  <div id=\"reviewProcess\">",
"   <span>",
"    All topics are updated as new evidence becomes available and our",
"   </span>",
"   <a href=\"/home/editorial-policy\" target=\"_blank\">",
"    peer review process",
"   </a>",
"   <span>",
"    is complete.",
"   </span>",
"  </div>",
"  <div id=\"literatureReviewDate\">",
"   <span class=\"emphasis\">",
"    Literature review current through:",
"   </span>",
"   Oct 2013.",
"   <span class=\"pipeSpace\">",
"    |",
"   </span>",
"   <span class=\"emphasis\">",
"    This topic last updated:",
"   </span>",
"   Jun 28, 2012.",
"  </div>",
"  <div id=\"topicText\">",
"   <p class=\"headingAnchor\" id=\"H1\">",
"    <span class=\"h1\">",
"     INTRODUCTION",
"    </span>",
"    &nbsp;&mdash;&nbsp;Ultrasound is the least invasive radiologic modality for imaging the liver and biliary tract. Unlike computed tomographic (CT) scanning and magnetic resonance imaging (MRI), the technique is portable, quick, and can be used to guide interventional procedures. Ultrasound uses no ionizing radiation to create the image, and is therefore the technique of choice in pregnant women, in patients with contrast allergies, or in those in whom MRI is contraindicated [",
"    <a class=\"abstract\" href=\"UTD.htm?21/30/21992/abstract/1\">",
"     1",
"    </a>",
"    ].",
"   </p>",
"   <p>",
"    This topic will discuss the role of ultrasound in the evaluation of the liver and the intra- and extrahepatic bile ducts. The use of ultrasound for the evaluation of the gallbladder is discussed briefly here and in more detail separately. (See",
"    <a class=\"medical medical_review\" href=\"UTD.htm?28/33/29208?source=see_link&amp;anchor=H18#H18\">",
"     \"Pathogenesis, clinical features, and diagnosis of acute cholecystitis\", section on 'Ultrasonography'",
"    </a>",
"    and",
"    <a class=\"medical medical_review\" href=\"UTD.htm?30/62/31722?source=see_link&amp;anchor=H11#H11\">",
"     \"Uncomplicated gallstone disease in adults\", section on 'Transabdominal ultrasound'",
"    </a>",
"    and",
"    <a class=\"medical medical_review\" href=\"UTD.htm?14/46/15082?source=see_link&amp;anchor=H19#H19\">",
"     \"Gallbladder cancer: Epidemiology, risk factors, clinical features, and diagnosis\", section on 'Ultrasound'",
"    </a>",
"    and",
"    <a class=\"medical medical_review\" href=\"UTD.htm?12/57/13209?source=see_link&amp;anchor=H17#H17\">",
"     \"Gallbladder polyps and cholesterolosis\", section on 'Ultrasonography'",
"    </a>",
"    .)",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H2\">",
"    <span class=\"h1\">",
"     TECHNIQUE",
"    </span>",
"    &nbsp;&mdash;&nbsp;Ultrasound relies upon the transmission of targeted sound waves of varying selected frequencies through tissues, with subsequent computerized conversion of the signals from the reflected waves into anatomical images on a screen. The degree of reflection of sound waves depends upon the interface between tissues with different acoustic properties. The degree of echogenicity depends upon the ability of the tissue being evaluated to reflect or absorb the ultrasound waves. A fatty liver will attenuate the ultrasound beam somewhat, limiting full evaluation of the liver parenchyma. Similarly, waves are not transmitted through air; liver lying below interposed loops of bowel therefore will be poorly visualized [",
"    <a class=\"abstract\" href=\"UTD.htm?21/30/21992/abstract/1\">",
"     1",
"    </a>",
"    ].",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H3\">",
"    <span class=\"h2\">",
"     Normal measurements on ultrasound",
"    </span>",
"    &nbsp;&mdash;&nbsp;Measurements of components of the hepatobiliary tree depend upon the skill of the ultrasonographer obtaining the measurements, and there is variability in terms of what is considered \"normal.\" However, some general estimates are available regarding the expected sizes of structures in the hepatobiliary tree:",
"   </p>",
"   <p>",
"    <ul class=\"bullet-block\">",
"     <li>",
"      Gallbladder: The gallbladder wall should be less than or equal to 2 mm (in a distended or fasting gallbladder). Collapsed gallbladders, seen when the subject has eaten, typically appear thickened. The maximum dimension of the gallbladder is 5 X 10 cm.",
"     </li>",
"     <li>",
"      Common hepatic duct: Common hepatic duct (inner wall to inner wall) is usually measured at the level of hepatic artery. In the normal fasting state it should be &lt;7 mm in patients &lt;60 years, and &lt;10 mm in patients older than 60.",
"     </li>",
"     <li>",
"      Common bile duct (CBD): The normal CBD diameter increases with age and in patients who have had a cholecystectomy. In patients in their 40s, the normal mean diameter is 4 mm. The normal mean diameter then increases by 1 mm every decade [",
"      <a class=\"abstract\" href=\"UTD.htm?21/30/21992/abstract/2-5\">",
"       2-5",
"      </a>",
"      ], and authors have proposed that in elderly patients the normal upper limit of normal be set at 8.5 mm [",
"      <a class=\"abstract\" href=\"UTD.htm?21/30/21992/abstract/6\">",
"       6",
"      </a>",
"      ]. The CBD is commonly up to 10 mm in patients who have undergone a cholecystectomy.",
"     </li>",
"     <li>",
"      Liver: The span of the liver in the right midclavicular line should be less than 16 cm [",
"      <a class=\"abstract\" href=\"UTD.htm?21/30/21992/abstract/7\">",
"       7",
"      </a>",
"      ].",
"     </li>",
"    </ul>",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H4\">",
"    <span class=\"h2\">",
"     Color flow Doppler ultrasound",
"    </span>",
"    &nbsp;&mdash;&nbsp;Vessel patency and flow direction can be determined by assigning color flow properties to the ultrasound image. The transducer detects moving blood and is arbitrarily assigned a red or blue color depending upon whether flow is toward or away from the transducer, respectively. Much variation exists in flow velocities, which are further influenced by fasting or eating. The range of normal velocities in the hepatic artery and portal veins is 30 to 60",
"    <span class=\"nowrap\">",
"     cm/second",
"    </span>",
"    and 20 to 30",
"    <span class=\"nowrap\">",
"     cm/second,",
"    </span>",
"    respectively [",
"    <a class=\"abstract\" href=\"UTD.htm?21/30/21992/abstract/8\">",
"     8",
"    </a>",
"    ].",
"   </p>",
"   <p>",
"    Color flow is an important tool in evaluating the vascular supply of hepatic masses, although no sensitive or specific flow features have been described that allow the lesions to be differentiated [",
"    <a class=\"abstract\" href=\"UTD.htm?21/30/21992/abstract/9-11\">",
"     9-11",
"    </a>",
"    ]. Most hepatocellular carcinomas have internal vascularity that can be detected by color flow Doppler, although a number of metastatic lesions also have internal vascularity, limiting the usefulness of this technique for distinguishing between these two entities [",
"    <a class=\"abstract\" href=\"UTD.htm?21/30/21992/abstract/11\">",
"     11",
"    </a>",
"    ].",
"   </p>",
"   <p>",
"    Color flow Doppler imaging primarily is used in the following circumstances:",
"   </p>",
"   <p>",
"    <ul class=\"bullet-block\">",
"     <li>",
"      It is very accurate when evaluating tumor-induced occlusion of major hepatic vessels, and is quite sensitive for documenting the direction of flow within the vessel being interrogated [",
"      <a class=\"abstract\" href=\"UTD.htm?21/30/21992/abstract/9-11\">",
"       9-11",
"      </a>",
"      ]. This is particularly useful in planning surgery for patients with cirrhosis in whom flow direction may be reversed in the main portal vein.",
"     </li>",
"     <li>",
"      It is routinely used to evaluate patients prior to liver transplantation, since portal vein patency is an important technical issue for the transplant surgeon.",
"     </li>",
"     <li>",
"      Color flow is used to document the flow direction and patency of surgically created portosystemic shunts.",
"     </li>",
"     <li>",
"      Color flow is frequently used to demonstrate lack of flow in dilated intrahepatic ducts, thereby distinguishing dilated ducts from adjacent intrahepatic vessels.",
"     </li>",
"    </ul>",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H5\">",
"    <span class=\"h2\">",
"     Duplex Doppler ultrasonography",
"    </span>",
"    &nbsp;&mdash;&nbsp;Duplex Doppler ultrasound converts an audible signal reflected from a selected region of interest on the ultrasound image into a continuous waveform that includes data concerning frequency, amplitude, and flow direction [",
"    <a class=\"abstract\" href=\"UTD.htm?21/30/21992/abstract/12,13\">",
"     12,13",
"    </a>",
"    ]. Thus, flow rate can be accurately measured, the characteristics of flow demonstrated, and flow direction determined. These features may be important in the following circumstances:",
"   </p>",
"   <p>",
"    <ul class=\"bullet-block\">",
"     <li>",
"      Flow rate is particularly important in the follow-up of patients following a transjugular intrahepatic portosystemic shunt (TIPS) insertion (see",
"      <a class=\"local\" href=\"#H12\">",
"       'Follow-up of TIPS'",
"      </a>",
"      below) [",
"      <a class=\"abstract\" href=\"UTD.htm?21/30/21992/abstract/14,15\">",
"       14,15",
"      </a>",
"      ].",
"     </li>",
"     <li>",
"      Flow characteristics, such as increased resistance to flow in rejecting livers (with peaking of the systolic wave and lack of antegrade diastolic flow), or characteristic waveforms associated with hepatic artery stenosis (the Tardus-Parvus pattern), are used to evaluate the newly transplanted liver.",
"     </li>",
"     <li>",
"      The duplex to-and-fro waveform has a characteristic diagnostic pattern in suspected arteriovenous fistulae following liver biopsies.",
"     </li>",
"    </ul>",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H6\">",
"    <span class=\"h2\">",
"     Vascular indices and ratios",
"    </span>",
"    &nbsp;&mdash;&nbsp;Attempts have been made to document different vascular indices and ratios for differentiating various hepatic lesions, including hepatic metastases, hemangiomas, and hepatocellular carcinoma [",
"    <a class=\"abstract\" href=\"UTD.htm?21/30/21992/abstract/12,13\">",
"     12,13",
"    </a>",
"    ]. These flow indices are not widely available at present, and are currently used in experimental settings only.",
"   </p>",
"   <p>",
"    <ul class=\"bullet-block\">",
"     <li>",
"      The Doppler perfusion index (DPI) is the ratio of hepatic arterial to total liver blood flow. DPI is elevated in the presence of intrahepatic tumors, and may therefore be useful in screening patients with suspected metastases. DPI is also increased in patients with cirrhosis, probably due to elevation of portal pressure and augmented hepatic arterial flow; this limits its diagnostic potential in evaluating mass lesions in patients with cirrhosis.",
"     </li>",
"     <li>",
"      The portal vein congestive index (PVCI) is the ratio of cross sectional area of the portal vein to time averaged velocity of blood flow in the portal vein. The PVCI is higher in cirrhotic livers when compared with livers containing metastases. These findings have been explained by data from animal studies in which there has been an increased hepatic artery flow and decreased portal vein flow in the presence of liver metastases.",
"     </li>",
"     <li>",
"      Tumor peak systolic velocity (TPSV) is another criterion used to characterize hepatic lesions. For lesions larger than 2 cm, a tumoral peak systolic velocity of &gt;0.4",
"      <span class=\"nowrap\">",
"       cm/sec",
"      </span>",
"      has a moderate sensitivity and specificity in distinguishing malignant tumors from hemangiomas. However, the TPSV is not helpful in distinguishing hepatocellular carcinoma from metastases.",
"     </li>",
"     <li>",
"      The hepatic tumor index (HTI) is the ratio of tumoral peak systolic velocity to peak systolic velocity in the right or left hepatic artery. The HTI has potential use in determining the nature of a liver mass. The HTI of masses &gt;1 cm has a moderate sensitivity and specificity for distinguishing hepatocellular carcinoma from metastatic lesions and hemangiomas. When both TPSV and HTI are used in combination (TPSV &gt;0.4",
"      <span class=\"nowrap\">",
"       cm/sec",
"      </span>",
"      and HTI &gt;1.0), there is a high sensitivity (91 percent) and specificity (83 percent) for distinguishing hepatocellular carcinomas from metastatic lesions and hemangiomas [",
"      <a class=\"abstract\" href=\"UTD.htm?21/30/21992/abstract/12\">",
"       12",
"      </a>",
"      ].",
"     </li>",
"    </ul>",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H7\">",
"    <span class=\"h1\">",
"     CLINICAL USE",
"    </span>",
"    &nbsp;&mdash;&nbsp;Ultrasound is very sensitive for differentiating cystic from solid lesions, and for delineating septations within cystic lesions such as biliary cystadenomas. Ultrasound will identify solid lesions, but the imaging characteristics are usually nonspecific, requiring careful clinical or biochemical correlation, additional imaging studies, or biopsy. Certain lesions, such as hemangiomas, have a characteristic sonographic appearance and require no additional imaging when identified. Similarly, focal fatty infiltration or sparing is easily identified on ultrasound [",
"    <a class=\"abstract\" href=\"UTD.htm?21/30/21992/abstract/1\">",
"     1",
"    </a>",
"    ].",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H20554370\">",
"    <span class=\"h2\">",
"     Detection of pneumobilia",
"    </span>",
"    &nbsp;&mdash;&nbsp;Pneumobilia, or air within the hepatobiliary system, may also be detected on ultrasound. Causes of pneumobilia include [",
"    <a class=\"abstract\" href=\"UTD.htm?21/30/21992/abstract/16\">",
"     16",
"    </a>",
"    ]:",
"   </p>",
"   <p>",
"    <ul class=\"bulletCompact-block\">",
"     <li>",
"      Incompetent sphincter of Oddi (including patients who have had a sphincterotomy)",
"     </li>",
"     <li>",
"      Biliary-enteric surgical anastomosis",
"     </li>",
"     <li>",
"      Biliary-enteric fistula due to gallstones or peptic ulcer disease",
"     </li>",
"     <li>",
"      Emphysematous cholecystitis",
"     </li>",
"     <li>",
"      Acute cholangitis",
"     </li>",
"     <li>",
"      Liver abscess",
"     </li>",
"     <li>",
"      Bronchopleurobiliary fistula",
"     </li>",
"     <li>",
"      Congenital anomaly",
"     </li>",
"     <li>",
"      Whipple procedure",
"     </li>",
"     <li>",
"      Percutaneous transhepatic cholangiography",
"     </li>",
"    </ul>",
"   </p>",
"   <p>",
"    This section will briefly describe some of the major clinical uses of ultrasound in patients with suspected hepatobiliary disease. The use of ultrasound and other imaging studies in the individual disorders is discussed in detail on the appropriate topic reviews.",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H8\">",
"    <span class=\"h2\">",
"     Evaluation of right upper quadrant pain",
"    </span>",
"    &nbsp;&mdash;&nbsp;Ultrasound is the diagnostic procedure of choice for imaging the hepatobiliary system in patients who present with acute right upper quadrant pain [",
"    <a class=\"abstract\" href=\"UTD.htm?21/30/21992/abstract/17\">",
"     17",
"    </a>",
"    ]. The sensitivity of ultrasound for detecting gallstones is &gt;95 percent (",
"    <a class=\"graphic graphic_diagnosticimage graphicRef58844 \" href=\"UTD.htm?23/43/24255\">",
"     image 1",
"    </a>",
"    ), and other adjacent structures can be simultaneously evaluated [",
"    <a class=\"abstract\" href=\"UTD.htm?21/30/21992/abstract/18\">",
"     18",
"    </a>",
"    ]. Microlithiasis and small stones seen on ultrasound may be described as sludge and gravel, respectively. (See",
"    <a class=\"medical medical_review\" href=\"UTD.htm?30/62/31722?source=see_link&amp;anchor=H11#H11\">",
"     \"Uncomplicated gallstone disease in adults\", section on 'Transabdominal ultrasound'",
"    </a>",
"    .)",
"   </p>",
"   <p>",
"    Ultrasound may also identify gallbladder wall thickening and localized tenderness over the gallbladder (Murphy's sign), findings which are consistent with the presence of acute cholecystitis (",
"    <a class=\"graphic graphic_diagnosticimage graphicRef55116 \" href=\"UTD.htm?27/1/27664\">",
"     image 2",
"    </a>",
"    ) [",
"    <a class=\"abstract\" href=\"UTD.htm?21/30/21992/abstract/19\">",
"     19",
"    </a>",
"    ]. (See",
"    <a class=\"medical medical_review\" href=\"UTD.htm?28/33/29208?source=see_link\">",
"     \"Pathogenesis, clinical features, and diagnosis of acute cholecystitis\"",
"    </a>",
"    .) CT scanning is not as accurate for detecting gallbladder wall abnormalities or gallstones; cholesterol stones can have the same density as bile [",
"    <a class=\"abstract\" href=\"UTD.htm?21/30/21992/abstract/20\">",
"     20",
"    </a>",
"    ].",
"   </p>",
"   <p>",
"    Ultrasound has similar sensitivity to CT for detecting choledocholithiasis (75 percent in the presence of dilated ducts, 50 percent for nondilated ducts); gas in the duodenum can obscure visualization of the distal common bile duct [",
"    <a class=\"abstract\" href=\"UTD.htm?21/30/21992/abstract/21\">",
"     21",
"    </a>",
"    ]. Cholangiography or magnetic resonance cholangiopancreatography (MRCP) may be preferred in these circumstances. (See",
"    <a class=\"medical medical_review\" href=\"UTD.htm?39/62/40936?source=see_link&amp;anchor=H972627986#H972627986\">",
"     \"Approach to the patient with suspected choledocholithiasis\", section on 'Transabdominal ultrasound'",
"    </a>",
"    and",
"    <a class=\"medical medical_review\" href=\"UTD.htm?22/51/23351?source=see_link\">",
"     \"Magnetic resonance cholangiopancreatography\"",
"    </a>",
"    .)",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H9\">",
"    <span class=\"h2\">",
"     Evaluation of obstructive jaundice",
"    </span>",
"    &nbsp;&mdash;&nbsp;The sensitivity of ultrasound for the detection of dilated bile ducts and biliary obstruction ranges in various studies from 55 to 91 percent [",
"    <a class=\"abstract\" href=\"UTD.htm?21/30/21992/abstract/22-25\">",
"     22-25",
"    </a>",
"    ]. The sensitivity increases with the serum bilirubin concentration and the duration of jaundice [",
"    <a class=\"abstract\" href=\"UTD.htm?21/30/21992/abstract/26\">",
"     26",
"    </a>",
"    ].",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H10\">",
"    <span class=\"h2\">",
"     Screening for hepatocellular carcinoma",
"    </span>",
"    &nbsp;&mdash;&nbsp;Ultrasound has been used for screening patients with cirrhosis at three- to six-month intervals for the presence of hepatocellular carcinoma. In a study of 164 patients with cirrhosis, for example, ultrasound identified hepatocellular carcinoma in 26 of 34 cases (76 percent) while the lesion was still single and small (&lt;4 cm) [",
"    <a class=\"abstract\" href=\"UTD.htm?21/30/21992/abstract/27\">",
"     27",
"    </a>",
"    ]. However, all imaging modalities remain insensitive for detecting small hepatomas in a cirrhotic liver since tumors may be infiltrative and not differ from surrounding abnormal parenchyma, and are indistinguishable from regenerative nodules. (See",
"    <a class=\"medical medical_review\" href=\"UTD.htm?34/10/34986?source=see_link\">",
"     \"Clinical features and diagnosis of primary hepatocellular carcinoma\"",
"    </a>",
"    .)",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H11\">",
"    <span class=\"h2\">",
"     Evaluation before and after liver transplantation",
"    </span>",
"    &nbsp;&mdash;&nbsp;As mentioned above, ultrasonography provides important information regarding the patency and size of the portal vein. It can also detect spontaneous or surgically created portosystemic shunts, which could affect the outcome of the transplant.",
"   </p>",
"   <p>",
"    Doppler ultrasonography is an accurate, noninvasive modality to screen for vascular complications after orthotopic liver transplant. Hepatic artery thrombosis should be considered in patients with fulminant hepatic necrosis after liver transplantation and those with bile collections and recurrent bacteremia. Impending hepatic artery thrombosis can also be predicted based upon the Doppler wave form [",
"    <a class=\"abstract\" href=\"UTD.htm?21/30/21992/abstract/28\">",
"     28",
"    </a>",
"    ].",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H12\">",
"    <span class=\"h2\">",
"     Follow-up of TIPS",
"    </span>",
"    &nbsp;&mdash;&nbsp;A transjugular intrahepatic portosystemic shunt (TIPS) is a percutaneously placed intrahepatic shunt between the hepatic and portal veins designed to decompress the portal system (",
"    <a class=\"graphic graphic_figure graphicRef72311 \" href=\"UTD.htm?3/10/3239\">",
"     figure 1",
"    </a>",
"    ). The shunt is being increasingly used for management of bleeding varices and intractable ascites. (See",
"    <a class=\"medical medical_review\" href=\"UTD.htm?22/61/23514?source=see_link\">",
"     \"Treatment of active variceal hemorrhage\"",
"    </a>",
"    and",
"    <a class=\"medical medical_review\" href=\"UTD.htm?34/40/35465?source=see_link\">",
"     \"Treatment of diuretic-resistant ascites in patients with cirrhosis\"",
"    </a>",
"    .) Ultrasound is the modality of choice for evaluating shunt patency following TIPS insertion [",
"    <a class=\"abstract\" href=\"UTD.htm?21/30/21992/abstract/14,15\">",
"     14,15",
"    </a>",
"    ].",
"   </p>",
"   <p>",
"    Doppler ultrasonography is very sensitive and specific for measuring blood flow velocity within the stent and for predicting stent stenosis; it is the procedure of choice for follow-up and surveillance for complications associated with TIPS. (See",
"    <a class=\"medical medical_review\" href=\"UTD.htm?15/5/15448?source=see_link\">",
"     \"Complications of transjugular intrahepatic portosystemic shunts\"",
"    </a>",
"    .) Sonographic criteria for stent stenosis include [",
"    <a class=\"abstract\" href=\"UTD.htm?21/30/21992/abstract/14,15\">",
"     14,15",
"    </a>",
"    ]:",
"   </p>",
"   <p>",
"    <ul class=\"bulletCompact-block\">",
"     <li>",
"      Low velocity flow (&lt;60",
"      <span class=\"nowrap\">",
"       cm/sec)",
"      </span>",
"      within any portion of the stent",
"     </li>",
"     <li>",
"      Low flow velocity with a focal velocity increase, usually identified at the hepatic venous end of the stent",
"     </li>",
"     <li>",
"      Flow gradient increases greater than 100 percent from portal to hepatic venous ends",
"     </li>",
"     <li>",
"      A temporal change in peak flow velocity of &gt;50",
"      <span class=\"nowrap\">",
"       cm/sec",
"      </span>",
"      from the post TIPS baseline sonogram",
"     </li>",
"     <li>",
"      Identification of new hepatopetal flow in the left portal vein or a newly recanalized periumbilical vein are indirect evidence for stent malfunction since left portal venous flow usually reverses towards the stent",
"     </li>",
"    </ul>",
"   </p>",
"   <p>",
"    In one report, nearly all complications of TIPS were detected by using three criteria: no flow for thrombosis, a temporal change in peak stent velocity greater than 50",
"    <span class=\"nowrap\">",
"     cm/sec",
"    </span>",
"    for stent",
"    <span class=\"nowrap\">",
"     and/or",
"    </span>",
"    hepatic vein stenosis, and reversal of flow from hepatofugal to pedal in the contralateral non-stented portal vein for hepatic vein and stent stenosis [",
"    <a class=\"abstract\" href=\"UTD.htm?21/30/21992/abstract/14\">",
"     14",
"    </a>",
"    ].",
"   </p>",
"   <p>",
"    However, the previously reported high sensitivity and specificity of duplex Doppler ultrasonography was questioned in a prospective double-blind study of 38 patients who had undergone TIPS [",
"    <a class=\"abstract\" href=\"UTD.htm?21/30/21992/abstract/29\">",
"     29",
"    </a>",
"    ]. In this report, ultrasonography correctly predicted shunt occlusion or stenosis in only 11 of 31 cases, incorrectly suggesting patency in 21 instances. Compared with venography, ultrasonography had a sensitivity and specificity for predicting TIPS stenosis or occlusion of 35 and 83 percent, respectively.",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H13\">",
"    <span class=\"h2\">",
"     Liver tumor staging and treatment",
"    </span>",
"    &nbsp;&mdash;&nbsp;Assessment of portal vein patency is important for staging patients with hepatocellular carcinoma [",
"    <a class=\"abstract\" href=\"UTD.htm?21/30/21992/abstract/30\">",
"     30",
"    </a>",
"    ]. Doppler ultrasound is a sensitive technique for distinguishing between tumor-induced thrombus occluding a portal or hepatic vein and tumor thrombus invading a vein. The neovascularity of tumor thrombus is detectable as an arterial signal within the thrombus; ultrasound can also be used to guide biopsy of these thrombi, if indicated [",
"    <a class=\"abstract\" href=\"UTD.htm?21/30/21992/abstract/30\">",
"     30",
"    </a>",
"    ].",
"   </p>",
"   <p>",
"    Ultrasound is used to identify and localize tumors to specific liver segments, facilitating surgical planning if resection is being considered. Similarly, the size, number, and exact location of liver tumors is easily determined with ultrasound. Extracapsular spread of tumor, or diaphragmatic invasion also are well evaluated by ultrasound. The sensitivity of ultrasound for detecting metastatic disease to the liver is similar to CT scanning, around 85 percent [",
"    <a class=\"abstract\" href=\"UTD.htm?21/30/21992/abstract/31\">",
"     31",
"    </a>",
"    ].",
"   </p>",
"   <p>",
"    Biopsy of hepatic lesions can be performed under ultrasound guidance. In addition, in some centers, ultrasound-guided cryoablation or radiofrequency ablation of tumors is now being performed.",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H14\">",
"    <span class=\"h2\">",
"     Diagnosis of ascites",
"    </span>",
"    &nbsp;&mdash;&nbsp;Ultrasound easily detects ascitic fluid in the peritoneal cavity and is commonly used for guiding paracentesis. Unlike CT and MRI, ultrasound provides useful additional information concerning the nature of the fluid, such as the presence of septations, loculations, hematoma, and peristalsing loops of bowel. Bedside guidance can be provided for the sick patient unable to come to the radiology department since ultrasound is mobile. No imaging technology can differentiate between a transudate or exudate. (See",
"    <a class=\"medical medical_review\" href=\"UTD.htm?18/44/19145?source=see_link\">",
"     \"Initial therapy of ascites in patients with cirrhosis\"",
"    </a>",
"    .)",
"   </p>",
"   <p>",
"    Doppler flow patterns in the portal vein may help determine the cause of the ascites. Normally, flow in the portal vein is continuous in a hepatopetal direction, with slight undulations due to respiration and cardiac activity [",
"    <a class=\"abstract\" href=\"UTD.htm?21/30/21992/abstract/32\">",
"     32",
"    </a>",
"    ]. In patients with portal hypertension, portal venous flow may show mild to severe deviations from normal. With increasing portal pressures, flow within the portal vein slows and progressively becomes more hepatofugal. In patients with portal hypertension due to right-sided heart failure with tricuspid regurgitation, flow within the portal vein may appear pulsatile. In addition, the hepatic veins become enlarged and are easily visible in the presence of right heart failure, a finding that would not be expected in the presence of primary hepatic disease.",
"   </p>",
"   <p>",
"    However, the portal wave form cannot be used to definitively diagnose cardiac ascites. For example, the portal wave form may become flattened in the cirrhotic liver, a finding that may also be seen in chronically congested livers due to right heart failure. Clinical signs of heart failure or chronic liver disease should be sought. In addition, there should be additional features of liver decompensation when hepatic ascites is present.",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H15\">",
"    <span class=\"h2\">",
"     Intraoperative and laparoscopic ultrasound",
"    </span>",
"    &nbsp;&mdash;&nbsp;Intraoperative ultrasound of the liver is a versatile adjunct to surgical inspection and palpation; it is being used with increased frequency to identify small (2 to 5 mm) metastases in patients undergoing segmental liver resections [",
"    <a class=\"abstract\" href=\"UTD.htm?21/30/21992/abstract/30\">",
"     30",
"    </a>",
"    ]. Specially developed ultrasound probes are used on standard diagnostic ultrasound machines. The technique is more sensitive than CT, MRI, and regular ultrasound, routinely detecting unexpected tumors in approximately 5 percent of patients. In clinical series, the surgical procedure is modified in 51 percent of patients based upon intraoperative ultrasound findings alone [",
"    <a class=\"abstract\" href=\"UTD.htm?21/30/21992/abstract/30\">",
"     30",
"    </a>",
"    ].",
"   </p>",
"   <p>",
"    Diagnostic laparoscopic ultrasound has extended the role of standard staging laparoscopy by being able to detect small peritoneal and hepatic lesions easily missed by other staging methods [",
"    <a class=\"abstract\" href=\"UTD.htm?21/30/21992/abstract/33\">",
"     33",
"    </a>",
"    ]. It is particularly well suited for imaging the biliary system. The technique is not widely performed; it requires separate insertion sites to evaluate the left and right lobes of the liver unless the falciform ligament is resected. A complete scan of the liver is performed to exclude small lesions using small (&lt;1 cm) flexible transducers incorporated into the tip of a fiberoptic endoscope; biopsy guidance can also be provided if necessary. The porta hepatis is easily imaged to identify enlarged nodes for staging purposes.",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H16\">",
"    <span class=\"h2\">",
"     Contrast agents",
"    </span>",
"    &nbsp;&mdash;&nbsp;Ultrasound contrast agents modify the basic physical interactions between ultrasound waves and body tissues and amplify the signal produced by flowing blood. These agents may be useful for detecting subtle flow abnormalities and for distinguishing areas of abnormal flow relative to normal background parenchymal perfusion. As a result, they may improve the detection of neoplasms, tumor vascularity, vascular stenosis and focal liver lesions [",
"    <a class=\"abstract\" href=\"UTD.htm?21/30/21992/abstract/34-38\">",
"     34-38",
"    </a>",
"    ].",
"   </p>",
"   <p>",
"    Three contrast phases can be differentiated due to the specific blood supply of the liver:",
"   </p>",
"   <p>",
"    <ul class=\"bullet-block\">",
"     <li>",
"      The arterial phase (hepatic artery) starts 10 to 20 seconds after intravenous injection and lasts for 10 to 15 seconds",
"     </li>",
"     <li>",
"      The venous phase (portal vein) extends from 30 to 35 seconds and lasts up to 120 seconds",
"     </li>",
"     <li>",
"      The late phase starts at 120 seconds and lasts up to five minutes post-injection with the disappearance of bubbles",
"     </li>",
"    </ul>",
"   </p>",
"   <p>",
"    Several agents have been developed to enhance sonographic differences between tissues and to improve the characterization of vascular flow of liver lesions.",
"   </p>",
"   <p>",
"    <ul class=\"bullet-block\">",
"     <li>",
"      Carbon dioxide microbubbles injected into the hepatic artery of patients with small (&lt;3 cm) hepatocellular carcinomas enhance most tumors, with a greater sensitivity for hypervascular lesions than conventional ultrasonography, angiography, or CT [",
"      <a class=\"abstract\" href=\"UTD.htm?21/30/21992/abstract/39\">",
"       39",
"      </a>",
"      ]. One commercially available contrast agent (Levovist, Schering, AG, Berlin) consists of microbubbles adsorbed onto galactose particles and palmitic acid. Delayed post vascular scanning with Levovist has shown promise in detecting liver lesions (especially malignancy) [",
"      <a class=\"abstract\" href=\"UTD.htm?21/30/21992/abstract/40,41\">",
"       40,41",
"      </a>",
"      ]. Levovist is available in more than 60 countries, but is currently unavailable in the United States.",
"     </li>",
"     <li>",
"      Perfluorochemicals are promising compounds with a high sonographic density and compressibility, which allows them to act as highly reflective ultrasound contrast agents [",
"      <a class=\"abstract\" href=\"UTD.htm?21/30/21992/abstract/34\">",
"       34",
"      </a>",
"      ]. They are normally phagocytosed by the reticuloendothelial system and remain in the spleen and liver for a least two days, resulting in a rim-like region of increased echogenicity around tumors. A preliminary clinical trial demonstrated that a large quantity of these compounds was needed to produce adequate tumor enhancement, and that they may cause allergic reactions and transient elevation of liver enzymes. This presents a potential problem for their future clinical use.",
"     </li>",
"    </ul>",
"   </p>",
"   <p>",
"    Additional agents now in clinical trials rely upon the targeted sound wave to disrupt small contrast-containing vesicles, thereby enhancing the signal produced by flowing blood. Additional imaging techniques that are contrast-specific (eg, harmonic and pulse-inversion imaging) are also in development.",
"   </p>",
"   <p>",
"    Patterns seen with common hepatic lesions include the following:",
"   </p>",
"   <p>",
"    <ul class=\"bullet-block\">",
"     <li>",
"      Hemangiomas have peripheral globular contrast pooling in the early phase (a cotton wool appearance), with the globules becoming larger and more numerous (centripetal fill-in).",
"     </li>",
"     <li>",
"      Focal nodular hyperplasia has centrifugal stellate branching in the early arterial phase followed by an intense homogenous uptake (spoke wheel pattern). Rapid washout occurs thereafter and an iso- or hyperechoic lesion is seen in portal venous phase.",
"     </li>",
"     <li>",
"      Hepatocellular carcinoma shows strong enhancement during the arterial phase and one or more feeding arteries can be seen entering the lesions periphery. Intense global pooling in the late arterial phase is followed by a rapid washout in the portal venous phase.",
"     </li>",
"    </ul>",
"   </p>",
"   <p>",
"    The accuracy of contrast enhanced ultrasonography compared with other imaging modalities is incompletely understood, although it appears to improve sensitivity and specificity compared with standard ultrasonography in patients with a variety of liver lesions [",
"    <a class=\"abstract\" href=\"UTD.htm?21/30/21992/abstract/42,43\">",
"     42,43",
"    </a>",
"    ], and certain sonographic characteristics appear to correlate well with specific tumor types [",
"    <a class=\"abstract\" href=\"UTD.htm?21/30/21992/abstract/44\">",
"     44",
"    </a>",
"    ]. In a prospective study of 67 patients with a focal liver lesion that was confirmed to be benign or malignant based upon other imaging studies",
"    <span class=\"nowrap\">",
"     and/or",
"    </span>",
"    histology, the sensitivity and specificity of contrast enhanced ultrasonography for discrimination of benign versus malignant lesions was 100 and 63 percent, respectively [",
"    <a class=\"abstract\" href=\"UTD.htm?21/30/21992/abstract/43\">",
"     43",
"    </a>",
"    ]. These values were better than for standard ultrasonography (sensitivity 85 percent and specificity 30 percent). Sensitivity improved from 94 to 98 percent and specificity improved from 60 to 88 percent in another study comparing contrast enhanced with standard ultrasonography for detection of hepatic metastases [",
"    <a class=\"abstract\" href=\"UTD.htm?21/30/21992/abstract/45\">",
"     45",
"    </a>",
"    ]. Contrast US detects more liver metastases than conventional US [",
"    <a class=\"abstract\" href=\"UTD.htm?21/30/21992/abstract/46,47\">",
"     46,47",
"    </a>",
"    ]. It is especially useful to detect small (&lt;1 cm) lesions, lesions in the subcapsular or ventral locations, or those around the ligamentum teres. Findings appeared to be complementary to CT and MRI, since one imaging modality or another appeared to better characterize lesions in individual patients. Contrast enhanced ultrasonography had good concordance with MRI in diagnosis of hepatic hemangiomas in another report [",
"    <a class=\"abstract\" href=\"UTD.htm?21/30/21992/abstract/48\">",
"     48",
"    </a>",
"    ].",
"   </p>",
"   <p>",
"    The utility of contrast US is markedly reduced in patients with severe steatosis or deep seated lesions. In those with multiple liver lesions, arterial and early portal phases cannot be investigated simultaneously.",
"   </p>",
"   <p>",
"    Noninvasive assessment of hepatic fibrosis and portal hypertension by transient elastography is an exciting newer application of ultrasound that needs to be explored further before widespread use [",
"    <a class=\"abstract\" href=\"UTD.htm?21/30/21992/abstract/49\">",
"     49",
"    </a>",
"    ].",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H142044133\">",
"    <span class=\"h1\">",
"     SUMMARY AND RECOMMENDATIONS",
"    </span>",
"   </p>",
"   <p>",
"    <ul class=\"bullet-block\">",
"     <li>",
"      Ultrasound is the least invasive radiologic modality for imaging the liver and biliary tract. (See",
"      <a class=\"local\" href=\"#H1\">",
"       'Introduction'",
"      </a>",
"      above.)",
"     </li>",
"     <li>",
"      Ultrasound relies upon the transmission of targeted sound waves of varying selected frequencies through tissues, with subsequent computerized conversion of the signals from the reflected waves into anatomical images on a screen. (See",
"      <a class=\"local\" href=\"#H2\">",
"       'Technique'",
"      </a>",
"      above.)",
"     </li>",
"     <li>",
"      Measurements of components of the hepatobiliary tree depend upon the skill of the ultrasonographer obtaining the measurements, and there is variability in terms of what is considered \"normal.\" (See",
"      <a class=\"local\" href=\"#H3\">",
"       'Normal measurements on ultrasound'",
"      </a>",
"      above.)",
"     </li>",
"     <li>",
"      Vessel patency and flow direction can be determined by assigning color flow properties to the ultrasound image. (See",
"      <a class=\"local\" href=\"#H4\">",
"       'Color flow Doppler ultrasound'",
"      </a>",
"      above.)",
"     </li>",
"     <li>",
"      Ultrasound is very sensitive for differentiating cystic from solid lesions and for delineating septations within cystic lesions such as biliary cystadenomas. Ultrasound will identify solid lesions, but the imaging characteristics are usually nonspecific. Certain lesions, such as hemangiomas, have a characteristic sonographic appearance and require no additional imaging when identified. Similarly, focal fatty infiltration or sparing is easily identified on ultrasound. (See",
"      <a class=\"local\" href=\"#H7\">",
"       'Clinical use'",
"      </a>",
"      above.)",
"     </li>",
"     <li>",
"      Common clinical applications for hepatobiliary ultrasound include evaluating right upper quadrant pain, evaluating obstructive jaundice, screening for hepatocellular carcinoma, evaluating patients before and after liver transplantation, and evaluating shunt patency in patients who have a transjugular intrahepatic portosystemic shunt. (See",
"      <a class=\"local\" href=\"#H7\">",
"       'Clinical use'",
"      </a>",
"      above.)",
"     </li>",
"    </ul>",
"   </p>",
"  </div>",
"  <div id=\"topicAgreement\">",
"   Use of UpToDate is subject to the",
"   <a class=\"licenseLink\" href=\"./license\" id=\"sla_in_page\" target=\"_blank\">",
"    Subscription and License Agreement",
"   </a>",
"   .",
"  </div>",
"  <div class=\"headingAnchor\" id=\"references\">",
"   <h1>",
"    REFERENCES",
"   </h1>",
"   <ol id=\"reference\">",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?21/30/21992/abstract/1\">",
"      Bennett WF, Bova JG. Review of hepatic imaging and a problem-oriented approach to liver masses. Hepatology 1990; 12:761.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?21/30/21992/abstract/2\">",
"      Bowie JD. What is the upper limit of normal for the common bile duct on ultrasound: how much do you want it to be? Am J Gastroenterol 2000; 95:897.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?21/30/21992/abstract/3\">",
"      Perret RS, Sloop GD, Borne JA. Common bile duct measurements in an elderly population. J Ultrasound Med 2000; 19:727.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?21/30/21992/abstract/4\">",
"      Wu CC, Ho YH, Chen CY. Effect of aging on common bile duct diameter: a real-time ultrasonographic study. J Clin Ultrasound 1984; 12:473.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?21/30/21992/abstract/5\">",
"      Kaim A, Steinke K, Frank M, et al. Diameter of the common bile duct in the elderly patient: measurement by ultrasound. Eur Radiol 1998; 8:1413.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?21/30/21992/abstract/6\">",
"      Bachar GN, Cohen M, Belenky A, et al. Effect of aging on the adult extrahepatic bile duct: a sonographic study. J Ultrasound Med 2003; 22:879.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?21/30/21992/abstract/7\">",
"      Kratzer W, Fritz V, Mason RA, et al. Factors affecting liver size: a sonographic survey of 2080 subjects. J Ultrasound Med 2003; 22:1155.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?21/30/21992/abstract/8\">",
"      Kruskal JB, Newman PA, Sammons LG, Kane RA. Optimizing Doppler and color flow US: application to hepatic sonography. Radiographics 2004; 24:657.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?21/30/21992/abstract/9\">",
"      Reinhold C, Hammers L, Taylor CR, et al. Characterization of focal hepatic lesions with duplex sonography: findings in 198 patients. AJR Am J Roentgenol 1995; 164:1131.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?21/30/21992/abstract/10\">",
"      Tanaka S, Kitamura T, Fujita M, et al. Color Doppler flow imaging of liver tumors. AJR Am J Roentgenol 1990; 154:509.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?21/30/21992/abstract/11\">",
"      Nino-Murcia M, Ralls PW, Jeffrey RB Jr, Johnson M. Color flow Doppler characterization of focal hepatic lesions. AJR Am J Roentgenol 1992; 159:1195.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?21/30/21992/abstract/12\">",
"      Numata K, Tanaka K, Kiba T, et al. Use of hepatic tumor index on color Doppler sonography for differentiating large hepatic tumors. AJR Am J Roentgenol 1997; 168:991.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?21/30/21992/abstract/13\">",
"      Leen E, Angerson WJ, Wotherspoon H, et al. Comparison of the Doppler perfusion index and intraoperative ultrasonography in diagnosing colorectal liver metastases. Evaluation with postoperative follow-up results. Ann Surg 1994; 220:663.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?21/30/21992/abstract/14\">",
"      Dodd GD 3rd, Zajko AB, Orons PD, et al. Detection of transjugular intrahepatic portosystemic shunt dysfunction: value of duplex Doppler sonography. AJR Am J Roentgenol 1995; 164:1119.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?21/30/21992/abstract/15\">",
"      Foshager MC, Ferral H, Nazarian GK, et al. Duplex sonography after transjugular intrahepatic portosystemic shunts (TIPS): normal hemodynamic findings and efficacy in predicting shunt patency and stenosis. AJR Am J Roentgenol 1995; 165:1.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?21/30/21992/abstract/16\">",
"      Sherman SC, Tran H. Pneumobilia: benign or life-threatening. J Emerg Med 2006; 30:147.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?21/30/21992/abstract/17\">",
"      Weltman DI, Zeman RK. Acute diseases of the gallbladder and biliary ducts. Radiol Clin North Am 1994; 32:933.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?21/30/21992/abstract/18\">",
"      Cooperberg PL, Gibney RG. Imaging of the gallbladder, 1987. Radiology 1987; 163:605.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?21/30/21992/abstract/19\">",
"      Simeone JF, Brink JA, Mueller PR, et al. The sonographic diagnosis of acute gangrenous cholecystitis: importance of the Murphy sign. AJR Am J Roentgenol 1989; 152:289.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?21/30/21992/abstract/20\">",
"      Brink JA, Kammer B, Mueller PR, et al. Prediction of gallstone composition: synthesis of CT and radiographic features in vitro. Radiology 1994; 190:69.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?21/30/21992/abstract/21\">",
"      Laing FC, Jeffrey RB, Wing VW. Improved visualization of choledocholithiasis by sonography. AJR Am J Roentgenol 1984; 143:949.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?21/30/21992/abstract/22\">",
"      Pedersen OM, Nordg&aring;rd K, Kvinnsland S. Value of sonography in obstructive jaundice. Limitations of bile duct caliber as an index of obstruction. Scand J Gastroenterol 1987; 22:975.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?21/30/21992/abstract/23\">",
"      Pasanen PA, Partanen KP, Pikkarainen PH, et al. A comparison of ultrasound, computed tomography and endoscopic retrograde cholangiopancreatography in the differential diagnosis of benign and malignant jaundice and cholestasis. Eur J Surg 1993; 159:23.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?21/30/21992/abstract/24\">",
"      Lapis JL, Orlando RC, Mittelstaedt CA, Staab EV. Ultrasonography in the diagnosis of obstructive jaundice. Ann Intern Med 1978; 89:61.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?21/30/21992/abstract/25\">",
"      Salem S, Vas W. Ultrasonography in evaluation of the jaundiced patient. J Can Assoc Radiol 1981; 32:30.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?21/30/21992/abstract/26\">",
"      Gold RP, Casarella WJ, Stern G, Seaman WB. Transhepatic cholangiography: the radiological method of choice in suspected obstructive jaundice. Radiology 1979; 133:39.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?21/30/21992/abstract/27\">",
"      Zoli M, Magalotti D, Bianchi G, et al. Efficacy of a surveillance program for early detection of hepatocellular carcinoma. Cancer 1996; 78:977.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?21/30/21992/abstract/28\">",
"      Nolten A, Sproat IA. Hepatic artery thrombosis after liver transplantation: temporal accuracy of diagnosis with duplex US and the syndrome of impending thrombosis. Radiology 1996; 198:553.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?21/30/21992/abstract/29\">",
"      Owens CA, Bartolone C, Warner DL, et al. The inaccuracy of duplex ultrasonography in predicting patency of transjugular intrahepatic portosystemic shunts. Gastroenterology 1998; 114:975.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?21/30/21992/abstract/30\">",
"      Kruskal JB, Kane RA. Intraoperative ultrasonography of the liver. Crit Rev Diagn Imaging 1995; 36:175.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?21/30/21992/abstract/31\">",
"      Clarke MP, Kane RA, Steele G Jr, et al. Prospective comparison of preoperative imaging and intraoperative ultrasonography in the detection of liver tumors. Surgery 1989; 106:849.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?21/30/21992/abstract/32\">",
"      Wood MM, Romine LE, Lee YK, et al. Spectral Doppler signature waveforms in ultrasonography: a review of normal and abnormal waveforms. Ultrasound Q 2010; 26:83.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?21/30/21992/abstract/33\">",
"      John TG, Garden OJ. Laparoscopic ultrasonography: extending the scope of diagnostic laparoscopy. Br J Surg 1994; 81:5.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?21/30/21992/abstract/34\">",
"      Goldberg BB, Liu JB, Forsberg F. Ultrasound contrast agents: a review. Ultrasound Med Biol 1994; 20:319.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?21/30/21992/abstract/35\">",
"      Balen FG, Allen CM, Lees WR. Ultrasound contrast agents. Clin Radiol 1994; 49:77.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?21/30/21992/abstract/36\">",
"      Bartolotta TV, Midiri M, Quaia E, et al. Benign focal liver lesions: spectrum of findings on SonoVue-enhanced pulse-inversion ultrasonography. Eur Radiol 2005; 15:1643.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?21/30/21992/abstract/37\">",
"      Choi BI, Lee JY, Han JK, et al. Contrast-enhanced sonography for hepatocellular carcinoma. Intervirology 2004; 47:162.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?21/30/21992/abstract/38\">",
"      Nicolau C, Br&uacute; C. Focal liver lesions: evaluation with contrast-enhanced ultrasonography. Abdom Imaging 2004; 29:348.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?21/30/21992/abstract/39\">",
"      Numata K, Tanaka K, Kiba T, et al. Nonresectable hepatocellular carcinoma: improved percutaneous ethanol injection therapy guided by CO(2)-enhanced sonography. AJR Am J Roentgenol 2001; 177:789.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?21/30/21992/abstract/40\">",
"      Blomley MJ, Albrecht T, Wilson SR, et al. Improved detection of metastatic liver lesions using pulse inversion harmonic imaging with Levovist: A multicenter study. Radiology 1999; 213:491.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?21/30/21992/abstract/41\">",
"      Bertolotto M, Dalla Palma L, Quaia E, Locatelli M. Characterization of unifocal liver lesions with pulse inversion harmonic imaging after Levovist injection: preliminary results. Eur Radiol 2000; 10:1369.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?21/30/21992/abstract/42\">",
"      Leen E, Angerson WJ, Yarmenitis S, et al. Multi-centre clinical study evaluating the efficacy of SonoVue (BR1), a new ultrasound contrast agent in Doppler investigation of focal hepatic lesions. Eur J Radiol 2002; 41:200.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?21/30/21992/abstract/43\">",
"      von Herbay A, Vogt C, H&auml;ussinger D. Late-phase pulse-inversion sonography using the contrast agent levovist: differentiation between benign and malignant focal lesions of the liver. AJR Am J Roentgenol 2002; 179:1273.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?21/30/21992/abstract/44\">",
"      Furuse J, Nagase M, Ishii H, Yoshino M. Contrast enhancement patterns of hepatic tumours during the vascular phase using coded harmonic imaging and Levovist to differentiate hepatocellular carcinoma from other focal lesions. Br J Radiol 2003; 76:385.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?21/30/21992/abstract/45\">",
"      Albrecht T, Blomley MJ, Burns PN, et al. Improved detection of hepatic metastases with pulse-inversion US during the liver-specific phase of SHU 508A: multicenter study. Radiology 2003; 227:361.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?21/30/21992/abstract/46\">",
"      Dietrich CF, Kratzer W, Strobe D, et al. Assessment of metastatic liver disease in patients with primary extrahepatic tumors by contrast-enhanced sonography versus CT and MRI. World J Gastroenterol 2006; 12:1699.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?21/30/21992/abstract/47\">",
"      Konopke R, Kersting S, Bergert H, et al. Contrast-enhanced ultrasonography to detect liver metastases : a prospective trial to compare transcutaneous unenhanced and contrast-enhanced ultrasonography in patients undergoing laparotomy. Int J Colorectal Dis 2007; 22:201.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?21/30/21992/abstract/48\">",
"      Lee JY, Choi BI, Han JK, et al. Improved sonographic imaging of hepatic hemangioma with contrast-enhanced coded harmonic angiography: comparison with MR imaging. Ultrasound Med Biol 2002; 28:287.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?21/30/21992/abstract/49\">",
"      Rockey DC. Noninvasive assessment of liver fibrosis and portal hypertension with transient elastography. Gastroenterology 2008; 134:8.",
"     </a>",
"    </li>",
"   </ol>",
"  </div>",
"  <div id=\"topicVersionRevision\">",
"   Topic 669 Version 10.0",
"  </div>",
" </div>",
" <div id=\"footer\">",
"  <div id=\"supportFooter\">",
"   <span class=\"sfInfo\">",
"    &copy; 2013 UpToDate, Inc. All rights reserved.",
"   </span>",
"   <span class=\"pipeSpace\">",
"    |",
"   </span>",
"   <a class=\"licenseLink\" href=\"./license\" id=\"sla_footer\">",
"    Subscription and License Agreement",
"   </a>",
"   <span class=\"sfInfo\">",
"    <span class=\"pipeSpace\">",
"     |",
"    </span>",
"    Release: 21.6- C21.56",
"   </span>",
"   <br/>",
"   <span class=\"sfInfo\">",
"    Licensed to:",
"    <span class=\"emphasis\">",
"     AsanBook Dig. Med. Lib.",
"    </span>",
"   </span>",
"   <span class=\"sfInfo\">",
"    <span class=\"pipeSpace\">",
"     |",
"    </span>",
"    Support Tag: [1004-118.195.65.247-FCC50AAECF-S244013.14]",
"    <br/>",
"   </span>",
"  </div>",
" </div>",
"</div>"].join("\n");
var script_f21_30_21992=[""].join("\n");
var outline_f21_30_21992=[" <div id=\"toggleOutline\">",
"  <a href=\"#\" title=\"Collapse Topic Outline\">",
"   <img alt=\"\" src=\"./../images/orange_arrow_left.myextg\"/>",
"  </a>",
" </div>",
" <div id=\"innerOutline\">",
"  <h1>",
"   TOPIC OUTLINE",
"  </h1>",
"  <div id=\"outline\">",
"   <ul>",
"    <li>",
"     <a class=\"sr_button\" href=\"#H142044133\" id=\"summRecButton\">",
"      <span>",
"       SUMMARY &amp; RECOMMENDATIONS",
"      </span>",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#H1\">",
"      INTRODUCTION",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#H2\">",
"      TECHNIQUE",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H3\">",
"      Normal measurements on ultrasound",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H4\">",
"      Color flow Doppler ultrasound",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H5\">",
"      Duplex Doppler ultrasonography",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H6\">",
"      Vascular indices and ratios",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#H7\">",
"      CLINICAL USE",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H20554370\">",
"      Detection of pneumobilia",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H8\">",
"      Evaluation of right upper quadrant pain",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H9\">",
"      Evaluation of obstructive jaundice",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H10\">",
"      Screening for hepatocellular carcinoma",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H11\">",
"      Evaluation before and after liver transplantation",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H12\">",
"      Follow-up of TIPS",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H13\">",
"      Liver tumor staging and treatment",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H14\">",
"      Diagnosis of ascites",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H15\">",
"      Intraoperative and laparoscopic ultrasound",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H16\">",
"      Contrast agents",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#H142044133\">",
"      SUMMARY AND RECOMMENDATIONS",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a href=\"#references\">",
"      REFERENCES",
"     </a>",
"    </li>",
"   </ul>",
"  </div>",
"  <h1>",
"   <div class=\"openRelatedGraphics\" id=\"GAST/669\" rel=\"outline_link\">",
"    GRAPHICS",
"    <a class=\"graphics_icon\" href=\"#\" title=\"View All Related Graphics\">",
"     View All",
"    </a>",
"   </div>",
"  </h1>",
"  <div id=\"relatedGraphics\">",
"   <ul>",
"    <li class=\"plainItem\">",
"     <div class=\"openRelatedGraphics\" id=\"GAST/669|DiagnosticImage\">",
"      <a href=\"#\" title=\"DIAGNOSTIC IMAGES\">",
"       DIAGNOSTIC IMAGES",
"      </a>",
"     </div>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"graphic graphic_diagnosticimage\" href=\"UTD.htm?23/43/24255\" title=\"diagnostic image 1\">",
"      Gallstone in gallbladder US",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"graphic graphic_diagnosticimage\" href=\"UTD.htm?27/1/27664\" title=\"diagnostic image 2\">",
"      Acute cholecystitis US",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <div class=\"openRelatedGraphics\" id=\"GAST/669|FIG\">",
"      <a href=\"#\" title=\"FIGURES\">",
"       FIGURES",
"      </a>",
"     </div>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"graphic graphic_figure\" href=\"UTD.htm?3/10/3239\" title=\"figure 1\">",
"      Transjugular intrahepatic portosystemic shunt",
"     </a>",
"    </li>",
"   </ul>",
"  </div>",
"  <h1>",
"   RELATED TOPICS",
"  </h1>",
"  <div id=\"relatedTopics\">",
"   <ul>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"UTD.htm?39/62/40936?source=related_link\">",
"      Approach to the patient with suspected choledocholithiasis",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"UTD.htm?34/10/34986?source=related_link\">",
"      Clinical features and diagnosis of primary hepatocellular carcinoma",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"UTD.htm?15/5/15448?source=related_link\">",
"      Complications of transjugular intrahepatic portosystemic shunts",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"UTD.htm?14/46/15082?source=related_link\">",
"      Gallbladder cancer: Epidemiology, risk factors, clinical features, and diagnosis",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"UTD.htm?12/57/13209?source=related_link\">",
"      Gallbladder polyps and cholesterolosis",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"UTD.htm?18/44/19145?source=related_link\">",
"      Initial therapy of ascites in patients with cirrhosis",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"UTD.htm?22/51/23351?source=related_link\">",
"      Magnetic resonance cholangiopancreatography",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"UTD.htm?28/33/29208?source=related_link\">",
"      Pathogenesis, clinical features, and diagnosis of acute cholecystitis",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"UTD.htm?22/61/23514?source=related_link\">",
"      Treatment of active variceal hemorrhage",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"UTD.htm?34/40/35465?source=related_link\">",
"      Treatment of diuretic-resistant ascites in patients with cirrhosis",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"UTD.htm?30/62/31722?source=related_link\">",
"      Uncomplicated gallstone disease in adults",
"     </a>",
"    </li>",
"   </ul>",
"  </div>",
" </div>"].join("\n");
var title_f21_30_21993="Side effects of androgen deprivation therapy";
var content_f21_30_21993=[" <noscript>",
"  <div id=\"javascriptDisabled\">",
"   It seems to us that you have your JavaScript turned off on your browser. JavaScript is required in order for our site to behave correctly.  Please enable your JavaScript to continue use our site.",
"  </div>",
" </noscript>",
" <div id=\"printHeader\">",
"  <div id=\"printHeaderLogo\">",
"   <img alt=\"UpToDate\" src=\"./../images/UTD2_masthead.myextg\">",
"    <img align=\"right\" alt=\"Wolters Kluwer Health\" height=\"40\" src=\"./../images/logoWKH.myextg\" width=\"175\">",
"     <br>",
"      <div id=\"printHeaderText\">",
"       Official reprint from  UpToDate",
"       <sup>",
"        &reg;",
"       </sup>",
"       <br>",
"        <a href=\"file://www.uptodate.com\">",
"         www.uptodate.com",
"        </a>",
"        &copy;2013 UpToDate",
"        <sup>",
"         &reg;",
"        </sup>",
"       </br>",
"      </div>",
"     </br>",
"    </img>",
"   </img>",
"  </div>",
"  <div id=\"printHeaderLinks\">",
"   <a class=\"TOPIC\" href=\"#\" id=\"printHeaderPrint\" rel=\"15\" title=\"Click here to print\">",
"    Print",
"   </a>",
"   <span class=\"pipeSpace\">",
"    |",
"   </span>",
"   <a href=\"#\" id=\"printHeaderBack\" title=\"Back to normal view\">",
"    Back",
"   </a>",
"  </div>",
" </div>",
" <!-- TC:TOPIC_PAGE -->",
" <div id=\"topicContent\">",
"  <div id=\"topicTitle\">",
"   Side effects of androgen deprivation therapy",
"  </div>",
"  <div id=\"topicContributors\">",
"   <div>",
"    <a id=\"authors\">",
"    </a>",
"    <a class=\"contributor contributor_credentials contributorType\" href=\"UTD.htm?21/30/21993/contributors\">",
"     Authors",
"    </a>",
"    <br/>",
"    <a class=\"contributor contributor_credentials\" href=\"UTD.htm?21/30/21993/contributors\">",
"     Matthew R Smith, MD, PhD",
"    </a>",
"    <br/>",
"    <a class=\"contributor contributor_credentials\" href=\"UTD.htm?21/30/21993/contributors\">",
"     E David Crawford, MD",
"    </a>",
"    <br/>",
"   </div>",
"   <div>",
"    <a class=\"contributor contributor_credentials contributorType\" href=\"UTD.htm?21/30/21993/contributors\">",
"     Section Editors",
"    </a>",
"    <br/>",
"    <a class=\"contributor contributor_credentials\" href=\"UTD.htm?21/30/21993/contributors\">",
"     Nicholas Vogelzang, MD",
"    </a>",
"    <br/>",
"    <a class=\"contributor contributor_credentials\" href=\"UTD.htm?21/30/21993/contributors\">",
"     W Robert Lee, MD, MS, MEd",
"    </a>",
"    <br/>",
"    <a class=\"contributor contributor_credentials\" href=\"UTD.htm?21/30/21993/contributors\">",
"     Jerome P Richie, MD, FACS",
"    </a>",
"    <br/>",
"   </div>",
"   <div>",
"    <a class=\"contributor contributor_credentials contributorType\" href=\"UTD.htm?21/30/21993/contributors\">",
"     Deputy Editor",
"    </a>",
"    <br/>",
"    <a class=\"contributor contributor_credentials\" href=\"UTD.htm?21/30/21993/contributors\">",
"     Michael E Ross, MD",
"    </a>",
"    <br/>",
"   </div>",
"  </div>",
"  <div id=\"disclosures\">",
"   <a href=\"UTD.htm?21/30/21993/contributor-disclosure\" target=\"_blank\">",
"    Disclosures",
"   </a>",
"  </div>",
"  <div id=\"reviewProcess\">",
"   <span>",
"    All topics are updated as new evidence becomes available and our",
"   </span>",
"   <a href=\"/home/editorial-policy\" target=\"_blank\">",
"    peer review process",
"   </a>",
"   <span>",
"    is complete.",
"   </span>",
"  </div>",
"  <div id=\"literatureReviewDate\">",
"   <span class=\"emphasis\">",
"    Literature review current through:",
"   </span>",
"   Oct 2013.",
"   <span class=\"pipeSpace\">",
"    |",
"   </span>",
"   <span class=\"emphasis\">",
"    This topic last updated:",
"   </span>",
"   Mar 27, 2013.",
"  </div>",
"  <div id=\"topicText\">",
"   <p class=\"headingAnchor\" id=\"H1\">",
"    <span class=\"h1\">",
"     INTRODUCTION",
"    </span>",
"    &nbsp;&mdash;&nbsp;Androgen deprivation therapy (ADT) is the main therapeutic approach for men with metastatic prostate cancer. ADT is also frequently used in patients whose only manifestation of disseminated disease is a rising or elevated serum PSA and as an adjuvant or neoadjuvant in conjunction with initial treatment of men with intermediate or high risk prostate cancer. (See",
"    <a class=\"medical medical_review\" href=\"UTD.htm?1/20/1353?source=see_link\">",
"     \"Initial hormone therapy for metastatic prostate cancer\"",
"    </a>",
"    and",
"    <a class=\"medical medical_review\" href=\"UTD.htm?21/26/21930?source=see_link\">",
"     \"Initial management of regionally localized intermediate and high risk prostate cancer\"",
"    </a>",
"    and",
"    <a class=\"medical medical_review\" href=\"UTD.htm?29/48/30470?source=see_link\">",
"     \"Rising serum PSA after treatment for localized prostate cancer: Systemic therapy\"",
"    </a>",
"    .)",
"   </p>",
"   <p>",
"    Despite the potential benefits associated with its use, ADT can cause a range of side effects that negatively affect quality of life. The side effects of hormone therapy for prostate cancer and their prevention and management are discussed here.",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H2\">",
"    <span class=\"h1\">",
"     SEXUAL DYSFUNCTION",
"    </span>",
"    &nbsp;&mdash;&nbsp;The vast majority of men receiving continuous ADT who are potent prior to therapy develop sexual dysfunction. Loss of libido in men receiving GnRH agonists usually develops within the first several months, and erectile dysfunction follows. Sexual dysfunction should be anticipated and couples counseled before ADT is started. Sex therapists may be helpful in managing these issues once they become problematic.",
"   </p>",
"   <p>",
"    Recovery of erectile function is possible after discontinuation of short-term ADT (eg, in men who receive neoadjuvant and adjuvant ADT with radiation therapy for high-risk localized or locally advanced disease). However, it may be delayed and incomplete [",
"    <a class=\"abstract\" href=\"UTD.htm?21/30/21993/abstract/1\">",
"     1",
"    </a>",
"    ].",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H3\">",
"    <span class=\"h2\">",
"     Alternative hormone strategies",
"    </span>",
"    &nbsp;&mdash;&nbsp;Because one of the major disadvantages of ADT is sexual dysfunction, efforts have focused on the development of alternative hormone strategies that may permit sexually active men to retain potency.",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H5\">",
"    <span class=\"h3\">",
"     Antiandrogen monotherapy",
"    </span>",
"    &nbsp;&mdash;&nbsp;Antiandrogen monotherapy has been advocated as an alternative to ADT as a way to avoid some of the side effects associated with medical or surgical castration, but this approach is not considered an accepted alternative in current management guidelines. (See",
"    <a class=\"medical medical_review\" href=\"UTD.htm?1/20/1353?source=see_link&amp;anchor=H347804711#H347804711\">",
"     \"Initial hormone therapy for metastatic prostate cancer\", section on 'Antiandrogens'",
"    </a>",
"    .)",
"   </p>",
"   <p>",
"    Antiandrogen monotherapy was compared with castration in a number of randomized trials. A meta-analysis that included 2717 patients found a trend toward shorter overall survival with antiandrogen monotherapy compared with castration that approached, but did not reach, statistical significance (HR 1.22, 95% CI 0.99-1.40) [",
"    <a class=\"abstract\" href=\"UTD.htm?21/30/21993/abstract/2\">",
"     2",
"    </a>",
"    ]. Antiandrogen monotherapy may be a reasonable option for carefully selected men with well-differentiated tumors and a PSA-only recurrence who wish to minimize side effects during therapy. (See",
"    <a class=\"medical medical_review\" href=\"UTD.htm?29/48/30470?source=see_link&amp;anchor=H8#H8\">",
"     \"Rising serum PSA after treatment for localized prostate cancer: Systemic therapy\", section on 'Antiandrogen monotherapy'",
"    </a>",
"    .)",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H261290306\">",
"    <span class=\"h3\">",
"     Intermittent androgen deprivation",
"    </span>",
"    &nbsp;&mdash;&nbsp;Intermittent androgen deprivation (IAD) refers to cyclic administration of GnRH agonists with temporary withdrawal of therapy once a response has been achieved. Treatment is then reinitiated when there is evidence of progression.",
"   </p>",
"   <p>",
"    <ul class=\"bullet-block\">",
"     <li>",
"      For men with metastatic disease, a phase III trial found that IAD could not be considered noninferior to compared with continuous ADT in terms of overall survival [",
"      <a class=\"abstract\" href=\"UTD.htm?21/30/21993/abstract/3\">",
"       3",
"      </a>",
"      ]. However, a preliminary analysis of quality of life suggested an improvement in sexual functioning; additional analyses are ongoing [",
"      <a class=\"abstract\" href=\"UTD.htm?21/30/21993/abstract/4\">",
"       4",
"      </a>",
"      ]. Based upon the available evidence, IAD cannot be recommended in this setting. (See",
"      <a class=\"medical medical_review\" href=\"UTD.htm?1/20/1353?source=see_link&amp;anchor=H261287591#H261287591\">",
"       \"Initial hormone therapy for metastatic prostate cancer\", section on 'Intermittent androgen deprivation'",
"      </a>",
"      .)",
"     </li>",
"     <li>",
"      For men whose only evidence of disseminated disease is an elevated serum PSA, a phase III trial found that men treated with IAD had more disease-related deaths but fewer unrelated deaths compared with continuous ADT [",
"      <a class=\"abstract\" href=\"UTD.htm?21/30/21993/abstract/5\">",
"       5",
"      </a>",
"      ]. Patients treated with IAD had a reduced frequency of hot flashes, but there were no other differences in adverse events. IAD cannot be routinely recommended and patients must be fully counseled that there are limited data to support a benefit for this approach. (See",
"      <a class=\"medical medical_review\" href=\"UTD.htm?29/48/30470?source=see_link&amp;anchor=H7#H7\">",
"       \"Rising serum PSA after treatment for localized prostate cancer: Systemic therapy\", section on 'Intermittent androgen deprivation'",
"      </a>",
"      .)",
"     </li>",
"    </ul>",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H7\">",
"    <span class=\"h1\">",
"     OSTEOPOROSIS AND BONE FRACTURES",
"    </span>",
"    &nbsp;&mdash;&nbsp;Androgen deprivation therapy (ADT) increases bone turnover, decreases bone mineral density, and increases the risk of clinical bone fractures in men with prostate cancer [",
"    <a class=\"abstract\" href=\"UTD.htm?21/30/21993/abstract/6-8\">",
"     6-8",
"    </a>",
"    ]. Loss of bone mineral density can be detected after six to nine months of ADT, and longer therapy confers a higher risk [",
"    <a class=\"abstract\" href=\"UTD.htm?21/30/21993/abstract/6,9-11\">",
"     6,9-11",
"    </a>",
"    ]. Osteoporotic skeletal fractures occur in up to 20 percent of men within five years of starting ADT [",
"    <a class=\"abstract\" href=\"UTD.htm?21/30/21993/abstract/6,7\">",
"     6,7",
"    </a>",
"    ].",
"   </p>",
"   <p>",
"    Other factors contributing to osteoporosis can include reduced intake of calcium, low vitamin D levels, alcohol abuse, smoking, and chronic use of corticosteroids. (See",
"    <a class=\"medical medical_review\" href=\"UTD.htm?31/45/32473?source=see_link\">",
"     \"Epidemiology and etiology of osteoporosis in men\"",
"    </a>",
"    .)",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H8\">",
"    <span class=\"h2\">",
"     Diagnosis",
"    </span>",
"    &nbsp;&mdash;&nbsp;Baseline measurement of bone density is appropriate in men treated with ADT; subsequent retesting is based upon clinical judgement. The diagnosis of osteoporosis in men is typically accomplished using dual energy x-ray absorptiometry (DXA). Indications for quantitative computed tomography (QCT) are discussed elsewhere. (See",
"    <a class=\"medical medical_review\" href=\"UTD.htm?35/23/36213?source=see_link\">",
"     \"Clinical manifestations, diagnosis, and evaluation of osteoporosis in men\"",
"    </a>",
"    and",
"    <a class=\"medical medical_review\" href=\"UTD.htm?10/55/11128?source=see_link\">",
"     \"Diagnosis and evaluation of osteoporosis in postmenopausal women\"",
"    </a>",
"    .)",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H9\">",
"    <span class=\"h2\">",
"     Prevention",
"    </span>",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H261290808\">",
"    <span class=\"h3\">",
"     Lifestyle modification",
"    </span>",
"    &nbsp;&mdash;&nbsp;Beneficial lifestyle modifications include smoking cessation, moderating alcohol and caffeine consumption, vitamin D and calcium supplementation, and regular weight bearing or resistance exercises.",
"   </p>",
"   <p>",
"    We recommend dietary calcium intake (food and supplements) of 1000 to 1200 mg daily and supplemental vitamin D 800 to 1000 international units daily for all men receiving ADT. We also recommend weight bearing exercise, decreased alcohol consumption, and smoking cessation [",
"    <a class=\"abstract\" href=\"UTD.htm?21/30/21993/abstract/12-15\">",
"     12-15",
"    </a>",
"    ].",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H2165880127\">",
"    <span class=\"h3\">",
"     Osteoclast inhibition",
"    </span>",
"    &nbsp;&mdash;&nbsp;Osteoclast inhibition with either bisphosphonates [",
"    <a class=\"abstract\" href=\"UTD.htm?21/30/21993/abstract/16-20\">",
"     16-20",
"    </a>",
"    ] or",
"    <a class=\"drug drug_general\" href=\"UTD.htm?20/53/21335?source=see_link\">",
"     denosumab",
"    </a>",
"    [",
"    <a class=\"abstract\" href=\"UTD.htm?21/30/21993/abstract/21,22\">",
"     21,22",
"    </a>",
"    ] can decrease bone turnover and increase bone mineral density in men receiving androgen deprivation therapy (ADT). Osteoclast inhibition is recommended for men with advanced prostate cancer and bone metastases. (See",
"    <a class=\"medical medical_review\" href=\"UTD.htm?36/8/36999?source=see_link&amp;anchor=H19250956#H19250956\">",
"     \"Management of bone metastases in advanced prostate cancer\", section on 'Osteoclast inhibition'",
"    </a>",
"    .)",
"   </p>",
"   <p>",
"    The addition of an osteoclast inhibitor therapy (bisphosphonate,",
"    <a class=\"drug drug_general\" href=\"UTD.htm?20/53/21335?source=see_link\">",
"     denosumab",
"    </a>",
"    [60 mg every six months]) in men without bone metastases who are treated with long-term ADT is indicated when the 10-year probability of hip fracture is &ge;3 percent or the 10-year probability of a major osteoporosis-related fracture is &ge;20 percent [",
"    <a class=\"abstract\" href=\"UTD.htm?21/30/21993/abstract/23\">",
"     23",
"    </a>",
"    ]. Estimates of fracture risk using the",
"    <a class=\"external\" href=\"file://www.shef.ac.uk/FRAX/\">",
"     FRAX algorithm",
"    </a>",
"    with or without bone density measurements may provide guidance in consideration of osteoclast inhibitors to prevent fracture.",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H10\">",
"    <span class=\"h4\">",
"     Bisphosphonates",
"    </span>",
"    &nbsp;&mdash;&nbsp;Multiple small randomized trials have demonstrated that bisphosphonates can prevent the decrease in bone density associated with ADT [",
"    <a class=\"abstract\" href=\"UTD.htm?21/30/21993/abstract/16-20\">",
"     16-20",
"    </a>",
"    ]. As an example, in one trial,",
"    <a class=\"drug drug_general\" href=\"UTD.htm?9/1/9241?source=see_link\">",
"     zoledronic acid",
"    </a>",
"    (4 mg every three months for one year) was compared to placebo in 106 men initiating ADT for nonmetastatic prostate cancer [",
"    <a class=\"abstract\" href=\"UTD.htm?21/30/21993/abstract/17\">",
"     17",
"    </a>",
"    ]. At one year, mean bone mineral density in the lumbar spine increased by an average of 5.6 percent in men receiving zoledronic acid, while it decreased an average of 2.2 percent in those given placebo.",
"   </p>",
"   <p>",
"    The role of bisphosphonates in men with castrate-resistant prostate cancer in preventing progression of bone metastases is discussed elsewhere. (See",
"    <a class=\"medical medical_review\" href=\"UTD.htm?36/8/36999?source=see_link&amp;anchor=H19250956#H19250956\">",
"     \"Management of bone metastases in advanced prostate cancer\", section on 'Osteoclast inhibition'",
"    </a>",
"    .)",
"   </p>",
"   <p>",
"    The risks and complications of long-term bisphosphonate use are discussed elsewhere. (See",
"    <a class=\"medical medical_review\" href=\"UTD.htm?38/43/39610?source=see_link\">",
"     \"Risks of therapy with bone modifying agents in patients with advanced malignancy\"",
"    </a>",
"    .)",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H11\">",
"    <span class=\"h4\">",
"     Denosumab",
"    </span>",
"    &nbsp;&mdash;&nbsp;",
"    <a class=\"drug drug_general\" href=\"UTD.htm?20/53/21335?source=see_link\">",
"     Denosumab",
"    </a>",
"    is a humanized monoclonal antibody that specifically binds to the receptor activator of nuclear factor kappa B ligand (RANKL), which is a key factor in osteoclast formation and function [",
"    <a class=\"abstract\" href=\"UTD.htm?21/30/21993/abstract/21\">",
"     21",
"    </a>",
"    ].",
"   </p>",
"   <p>",
"    The utility of",
"    <a class=\"drug drug_general\" href=\"UTD.htm?20/53/21335?source=see_link\">",
"     denosumab",
"    </a>",
"    for the prevention of osteoporosis in men with nonmetastatic, hormone-sensitive prostate cancer was demonstrated in a double-blind, trial in which 1468 men were randomly assigned to denosumab (60 mg subcutaneously every six months) or placebo [",
"    <a class=\"abstract\" href=\"UTD.htm?21/30/21993/abstract/21,22\">",
"     21,22",
"    </a>",
"    ]. Overall, 912 patients (62 percent) completed the three year trial.",
"   </p>",
"   <p>",
"    All subjects had undergone bilateral orchiectomy or were receiving a GnRH-agonist on enrollment and were expected to remain on the GnRH-agonist for at least 12 months. Patients were either &ge;70 years old, or if &lt;70 years, had a low mineral density (T score less than -1.0 at the lumbar spine, hip, or femoral neck). Patients receiving treatment with bisphosphonates were excluded.",
"   </p>",
"   <p>",
"    Key results included the following:",
"   </p>",
"   <p>",
"    <ul class=\"bullet-block\">",
"     <li>",
"      At 36 months,",
"      <a class=\"drug drug_general\" href=\"UTD.htm?20/53/21335?source=see_link\">",
"       denosumab",
"      </a>",
"      significantly increased bone density at all measured sites (lumbar spine, hip, femoral neck, and distal third of radius) compared to placebo. For the primary endpoint of the study, the bone mineral density in the lumbar spine, the increase with denosumab was 5.6 percent, compared to a decrease of 1.0 percent with placebo. The increase in bone density was progressive over the course of time at all sites and was statistically significant beginning one month after the start of treatment.",
"     </li>",
"     <li>",
"      Treatment with",
"      <a class=\"drug drug_general\" href=\"UTD.htm?20/53/21335?source=see_link\">",
"       denosumab",
"      </a>",
"      resulted in a statistically significant decrease in the incidence of new vertebral fractures at 12 and 36 months (cumulative incidence 0.3 versus 1.9 and 1.5 versus 3.9 percent, respectively). The incidence of fracture at any site was also decreased, although the difference was not statistically significant (5.2 versus 7.2 percent, relative risk 0.72, 95% CI 0.48-1.07).",
"     </li>",
"     <li>",
"      The overall rate of adverse events was approximately 87 percent in both the",
"      <a class=\"drug drug_general\" href=\"UTD.htm?20/53/21335?source=see_link\">",
"       denosumab",
"      </a>",
"      and placebo arms, with approximately equal rates of drop-out due to side effects (6.7 versus 6.5 percent). Cataracts developed more frequently in patients treated with denosumab (4.7 versus 1.2 percent), although these were not attributed to the study drug. Serious adverse events were slightly more common with denosumab (35 versus 31 percent). Deaths possibly related to treatment were observed in three patients treated with denosumab and four treated with placebo.",
"     </li>",
"     <li>",
"      Metastasis to bone was diagnosed in three patients (0.4 percent) treated with",
"      <a class=\"drug drug_general\" href=\"UTD.htm?20/53/21335?source=see_link\">",
"       denosumab",
"      </a>",
"      and ten (1.4 percent) treated with placebo.",
"     </li>",
"    </ul>",
"   </p>",
"   <p>",
"    The risks and complications of",
"    <a class=\"drug drug_general\" href=\"UTD.htm?20/53/21335?source=see_link\">",
"     denosumab",
"    </a>",
"    therapy are discussed elsewhere. (See",
"    <a class=\"medical medical_review\" href=\"UTD.htm?38/43/39610?source=see_link\">",
"     \"Risks of therapy with bone modifying agents in patients with advanced malignancy\"",
"    </a>",
"    .)",
"   </p>",
"   <p>",
"    The role of",
"    <a class=\"drug drug_general\" href=\"UTD.htm?20/53/21335?source=see_link\">",
"     denosumab",
"    </a>",
"    in men with bone metastases from prostate cancer is discussed separately. (See",
"    <a class=\"medical medical_review\" href=\"UTD.htm?36/8/36999?source=see_link&amp;anchor=H19251250#H19251250\">",
"     \"Management of bone metastases in advanced prostate cancer\", section on 'Denosumab'",
"    </a>",
"    .)",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H12\">",
"    <span class=\"h3\">",
"     Selective estrogen receptor modulators",
"    </span>",
"    &nbsp;&mdash;&nbsp;Selective estrogen receptor modulators (SERMs) have also shown a protective effect on bone in men receiving ADT for prostate cancer [",
"    <a class=\"abstract\" href=\"UTD.htm?21/30/21993/abstract/24,25\">",
"     24,25",
"    </a>",
"    ].",
"   </p>",
"   <p>",
"    The most extensive data with SERMs are from a phase III trial with",
"    <a class=\"drug drug_general\" href=\"UTD.htm?29/30/30181?source=see_link\">",
"     toremifene",
"    </a>",
"    [",
"    <a class=\"abstract\" href=\"UTD.htm?21/30/21993/abstract/25\">",
"     25",
"    </a>",
"    ]. In that trial, 1284 men who were receiving ADT for prostate cancer were randomly assigned to toremifene or placebo. At two years, there was a statistically significant decrease in the incidence of new vertebral fractures compared to placebo (2.5 versus 4.9 percent), and statistically significant increases in bone density in the lumbar spine, hip, and femoral neck. Toremifene is not currently approved for this indication.",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H13\">",
"    <span class=\"h3\">",
"     Antiandrogen monotherapy",
"    </span>",
"    &nbsp;&mdash;&nbsp;In two randomized trials, antiandrogens alone increased rather than decreased bone mineral density in two randomized trials:",
"   </p>",
"   <p>",
"    <ul class=\"bullet-block\">",
"     <li>",
"      In a randomized trial comparing",
"      <a class=\"drug drug_general\" href=\"UTD.htm?4/41/4760?source=see_link\">",
"       leuprolide",
"      </a>",
"      versus",
"      <a class=\"drug drug_general\" href=\"UTD.htm?30/2/30758?source=see_link\">",
"       bicalutamide",
"      </a>",
"      (150 mg daily) in 52 men with advanced prostate cancer and no bone metastases, the mean change",
"      <span class=\"nowrap\">",
"       (+/-",
"      </span>",
"      standard error) in bone mineral density of the posterior-anterior lumbar spine from baseline to 12 months was significantly different between the two groups, decreasing by 2.5",
"      <span class=\"nowrap\">",
"       +/-",
"      </span>",
"      0.5 percent in the leuprolide group, and increasing by 2.5",
"      <span class=\"nowrap\">",
"       +/-",
"      </span>",
"      0.5 percent in the bicalutamide group [",
"      <a class=\"abstract\" href=\"UTD.htm?21/30/21993/abstract/26\">",
"       26",
"      </a>",
"      ]. Mean changes of the total body, total hip, femoral neck, and trabecular bone of the lumbar spine also differed significantly between groups.",
"     </li>",
"     <li>",
"      Similar findings were noted in a second trial in which 103 men with localized or locally advanced prostate cancer in whom initial hormone therapy was indicated were randomly assigned to",
"      <a class=\"drug drug_general\" href=\"UTD.htm?30/2/30758?source=see_link\">",
"       bicalutamide",
"      </a>",
"      (150 mg daily) or a GnRH agonist for 96 weeks [",
"      <a class=\"abstract\" href=\"UTD.htm?21/30/21993/abstract/27\">",
"       27",
"      </a>",
"      ]. Bone mineral density was maintained during bicalutamide monotherapy (+2.42 and +1.13 percent for bone mineral density at the lumbar spine and hip, respectively, at week 96), while castration was associated with a progressive loss in bone mineral density",
"      <strong>",
"      </strong>",
"      (-5.40 and -4.39 percent at week 96, respectively).",
"     </li>",
"    </ul>",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H15\">",
"    <span class=\"h1\">",
"     VASOMOTOR SYMPTOMS",
"    </span>",
"    &nbsp;&mdash;&nbsp;The majority of men who receive ADT for prostate cancer experience hot flashes, including up to 80 percent of those receiving GnRH agonists. Although not life-threatening, hot flashes affect quality of life, particularly if there are associated sleep problems.",
"   </p>",
"   <p>",
"    Hot flashes are usually described as an intense sensation of warmth in the face and upper part of the body. They may be associated with nausea and sweating, and may occur during sleep. Assessment should include duration, frequency, accompanying emotional or physical symptoms, and the degree of associated sleep disturbance.",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H16\">",
"    <span class=\"h2\">",
"     Treatment",
"    </span>",
"    &nbsp;&mdash;&nbsp;Numerous approaches have been explored, similar to those used in postmenopausal women [",
"    <a class=\"abstract\" href=\"UTD.htm?21/30/21993/abstract/28\">",
"     28",
"    </a>",
"    ]. (See",
"    <a class=\"medical medical_review\" href=\"UTD.htm?24/53/25434?source=see_link\">",
"     \"Menopausal hot flashes\"",
"    </a>",
"    .)",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H17\">",
"    <span class=\"h2\">",
"     Medications",
"    </span>",
"    &nbsp;&mdash;&nbsp;The success of various agents for treatment of vasomotor symptoms in men ranges widely, and benefits must often be balanced against treatment-related side effects. The available evidence suggests that the pharmacological approach to the management of hot flashes in men being treated with ADT is similar to that in women. (See",
"    <a class=\"medical medical_review\" href=\"UTD.htm?24/53/25434?source=see_link\">",
"     \"Menopausal hot flashes\"",
"    </a>",
"    .)",
"   </p>",
"   <p>",
"    Potentially effective agents that have been evaluated in randomized trials include progestational agents,",
"    <a class=\"drug drug_general\" href=\"UTD.htm?14/2/14374?source=see_link\">",
"     cyproterone",
"    </a>",
"    , selective serotonin uptake inhibitors, and",
"    <a class=\"drug drug_general\" href=\"UTD.htm?19/19/19768?source=see_link\">",
"     gabapentin",
"    </a>",
"    [",
"    <a class=\"abstract\" href=\"UTD.htm?21/30/21993/abstract/29,30\">",
"     29,30",
"    </a>",
"    ].",
"   </p>",
"   <p>",
"    <ul class=\"bullet-block\">",
"     <li>",
"      The most extensive data on the treatment of hot flashes in men come from a trial in 311 men who had been treated with a GnRH agonist for six months and either were requesting treatment for hot flashes or had a minimum of 14 hot flashes per week [",
"      <a class=\"abstract\" href=\"UTD.htm?21/30/21993/abstract/29\">",
"       29",
"      </a>",
"      ]. The men were randomly assigned to medroxyprogesterone (20",
"      <span class=\"nowrap\">",
"       mg/day),",
"      </span>",
"      <a class=\"drug drug_general\" href=\"UTD.htm?14/2/14374?source=see_link\">",
"       cyproterone",
"      </a>",
"      (100",
"      <span class=\"nowrap\">",
"       mg/day),",
"      </span>",
"      or the serotonin uptake inhibitor",
"      <a class=\"drug drug_general\" href=\"UTD.htm?21/45/22233?source=see_link\">",
"       venlafaxine",
"      </a>",
"      (75",
"      <span class=\"nowrap\">",
"       mg/day).",
"      </span>",
"      Symptoms were reassessed at 4, 8, and 12 weeks after therapy initiation.",
"      <br/>",
"      <br/>",
"      All three regimens significantly reduced hot flashes compared to baseline, but medroxyprogesterone and",
"      <a class=\"drug drug_general\" href=\"UTD.htm?14/2/14374?source=see_link\">",
"       cyproterone acetate",
"      </a>",
"      were significantly more effective than venlafaxine (84 and 95 versus 47 percent reductions in symptom scores one month after starting treatment).",
"     </li>",
"     <li>",
"      <a class=\"drug drug_general\" href=\"UTD.htm?19/19/19768?source=see_link\">",
"       Gabapentin",
"      </a>",
"      was evaluated in a phase III trial in which 223 men who had at least 14 bothersome hot flashes per week while receiving ADT were randomly assigned to gabapentin at doses of 300, 600, or 900 mg daily or placebo [",
"      <a class=\"abstract\" href=\"UTD.htm?21/30/21993/abstract/30\">",
"       30",
"      </a>",
"      ]. Gabapentin 900 mg daily was well tolerated and associated with a significant reduction in the frequency and intensity of hot flashes compared to placebo (46 versus 22 and 44 versus 27 percent reductions, respectively, at week 4 compared to baseline).",
"     </li>",
"    </ul>",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H18\">",
"    <span class=\"h3\">",
"     Alternative strategies",
"    </span>",
"    &nbsp;&mdash;&nbsp;Alternative or complementary therapies are increasingly popular as \"natural remedies\" for men who have side effects of ADT:",
"   </p>",
"   <p>",
"    <ul class=\"bullet-block\">",
"     <li>",
"      Acupuncture may be some activity in ameliorating vasomotor symptoms due to ADT [",
"      <a class=\"abstract\" href=\"UTD.htm?21/30/21993/abstract/31-33\">",
"       31-33",
"      </a>",
"      ]. In a small phase II study, 60 consecutive men receiving a GnRH analog were treated with acupuncture to the ear lobe; of these, 95 percent reported a significant decrease in the severity of symptoms [",
"      <a class=\"abstract\" href=\"UTD.htm?21/30/21993/abstract/31\">",
"       31",
"      </a>",
"      ].",
"     </li>",
"     <li>",
"      Soy products, vitamin E, and herbal remedies have also been used with variable success in women with hot flashes. However, in a randomized, placebo-controlled trial of 199 symptomatic postmenopausal women, flax seed (a lignan) was no more effective than placebo for relief of vasomotor symptoms.",
"     </li>",
"    </ul>",
"   </p>",
"   <p>",
"    The lack of well organized prospective double-blind placebo-controlled trials makes it difficult to determine the true efficacy of any of these approaches.",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H19\">",
"    <span class=\"h2\">",
"     Recommendation",
"    </span>",
"    &nbsp;&mdash;&nbsp;The best treatment for hot flashes in men undergoing ADT is unclear. Megestrol and estrogen appear substantially more effective than",
"    <a class=\"drug drug_general\" href=\"UTD.htm?21/45/22233?source=see_link\">",
"     venlafaxine",
"    </a>",
"    . However, the side effects differ between these agents (estrogen - breast symptoms, megestrol - increased appetite and weight, venlafaxine - dry mouth). We typically start with a selective serotonin reuptake inhibitor and reserve hormonal treatment (estrogen, megestrol) for refractory cases.",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H20\">",
"    <span class=\"h1\">",
"     CHANGES IN BODY COMPOSITION AND METABOLISM",
"    </span>",
"    &nbsp;&mdash;&nbsp;Several prospective studies have documented the effects of GnRH agonists on body composition, lipoproteins, and insulin sensitivity [",
"    <a class=\"abstract\" href=\"UTD.htm?21/30/21993/abstract/34,35\">",
"     34,35",
"    </a>",
"    ]. Reduced testosterone levels are probably responsible for loss of lean body mass, increased body fat, and decreased muscle strength.",
"   </p>",
"   <p>",
"    <ul class=\"bullet-block\">",
"     <li>",
"      GnRH agonists significantly decrease lean body mass and increase fat mass [",
"      <a class=\"abstract\" href=\"UTD.htm?21/30/21993/abstract/36,37\">",
"       36,37",
"      </a>",
"      ].",
"     </li>",
"     <li>",
"      Most of the fat accumulation is subcutaneous adipose tissue [",
"      <a class=\"abstract\" href=\"UTD.htm?21/30/21993/abstract/35,38\">",
"       35,38",
"      </a>",
"      ].",
"     </li>",
"     <li>",
"      The decrease in lean body mass (sarcopenia) and increase in fat mass appear to begin within the first year, although some further decrease in muscle mass may be seen for at least three years [",
"      <a class=\"abstract\" href=\"UTD.htm?21/30/21993/abstract/37\">",
"       37",
"      </a>",
"      ].",
"     </li>",
"    </ul>",
"   </p>",
"   <p>",
"    Treatment-related changes in body composition are accompanied by important metabolic changes including reduced insulin sensitivity [",
"    <a class=\"abstract\" href=\"UTD.htm?21/30/21993/abstract/39,40\">",
"     39,40",
"    </a>",
"    ] and increases in serum LDL-cholesterol, HDL-cholesterol, and triglycerides [",
"    <a class=\"abstract\" href=\"UTD.htm?21/30/21993/abstract/35,40-42\">",
"     35,40-42",
"    </a>",
"    ].",
"   </p>",
"   <p>",
"    Similar changes may be seen following orchiectomy [",
"    <a class=\"abstract\" href=\"UTD.htm?21/30/21993/abstract/43\">",
"     43",
"    </a>",
"    ].",
"   </p>",
"   <p>",
"    These metabolic alternations may be minimized by use of the selective estrogen receptor modulator",
"    <a class=\"drug drug_general\" href=\"UTD.htm?29/30/30181?source=see_link\">",
"     toremifene",
"    </a>",
"    . In a phase III trial, 1389 men with prostate cancer were randomly assigned to toremifene (80",
"    <span class=\"nowrap\">",
"     mg/day)",
"    </span>",
"    or placebo in conjunction with ADT to assess the frequency of bone fractures [",
"    <a class=\"abstract\" href=\"UTD.htm?21/30/21993/abstract/44\">",
"     44",
"    </a>",
"    ]. In a planned interim analysis at 12 months, the use of toremifene blocked the increases in serum LDL-cholesterol and triglycerides and prevented the decrease in serum HDL-cholesterol seen with placebo. Additional studies and longer follow-up are required to assess the impact of toremifene on cardiovascular outcomes. (See",
"    <a class=\"local\" href=\"#H12\">",
"     'Selective estrogen receptor modulators'",
"    </a>",
"    above.)",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H21\">",
"    <span class=\"h2\">",
"     Recommendation",
"    </span>",
"    &nbsp;&mdash;&nbsp;Men who are receiving ADT for prostate cancer should be encouraged to maintain a moderate exercise regimen. Greater intensity of screening for diabetes and elevated cholesterol may also be appropriate.",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H22\">",
"    <span class=\"h1\">",
"     CARDIOVASCULAR DISEASE AND DIABETES",
"    </span>",
"    &nbsp;&mdash;&nbsp;The rates of incident cardiovascular disease and diabetes mellitus in prostate cancer patients treated with ADT have been studied in both large observational series [",
"    <a class=\"abstract\" href=\"UTD.htm?21/30/21993/abstract/45-51\">",
"     45-51",
"    </a>",
"    ] and in retrospective analyses of randomized trials [",
"    <a class=\"abstract\" href=\"UTD.htm?21/30/21993/abstract/52\">",
"     52",
"    </a>",
"    ]. Although some of the data are conflicting, the results are sufficient to support counseling and risk reduction measures for men initiating ADT. Although these risks are incompletely defined, the potential harm from ADT should be balanced against the potential benefits for men in whom ADT is being considered.",
"   </p>",
"   <p>",
"    No randomized trials have prospectively addressed the risks of cardiovascular disease and diabetes associated with ADT. Retrospective analyses of randomized trials, however, have consistently demonstrated no increased risk of cardiovascular death. A meta-analysis incorporated data from 4141 patients who were enrolled on eight multicenter randomized phase III trials with median follow-ups ranging from 8 to 13 years [",
"    <a class=\"abstract\" href=\"UTD.htm?21/30/21993/abstract/52\">",
"     52",
"    </a>",
"    ]. The incidence of cardiovascular death was not significantly different in those assigned to ADT compared with placebo (11.0 versus 11.2 percent, relative risk 0.93, p = 0.41). There was no increase in risk of cardiovascular death in those who received ADT for a short (6 months or less) or long (3 years or more) duration. Furthermore, the meta-analysis found that in 11 trials with 4805 patients both the prostate cancer specific mortality and all cause mortality were significantly decreased in those assigned to ADT compared with placebo.",
"   </p>",
"   <p>",
"    Men with prostate cancer who are treated with ADT appear to be at increased risk of thromboembolic events (deep venous thrombosis, pulmonary embolus, arterial embolism). In a Surveillance, Epidemiology, and End Results (SEER) database study that included approximately 155,000 men, 38 percent of whom received ADT, there was a significantly increased risk of thromboembolic events compared to those not on ADT (15 versus 7 percent, hazard ratio 1.56) [",
"    <a class=\"abstract\" href=\"UTD.htm?21/30/21993/abstract/53\">",
"     53",
"    </a>",
"    ]. A Swedish study that included approximately 77,000 men with prostate cancer found that the risk of thromboembolic events was increased in all men with prostate cancer, and that the risk was greatest in those who were treated with endocrine therapy [",
"    <a class=\"abstract\" href=\"UTD.htm?21/30/21993/abstract/54\">",
"     54",
"    </a>",
"    ].",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H692236399\">",
"    <span class=\"h1\">",
"     COLORECTAL CANCER",
"    </span>",
"    &nbsp;&mdash;&nbsp;ADT, using either a GnRH or orchiectomy, appears to be associated with a modest increased risk of colorectal cancer in men with prostate cancer. These risk estimates fall below those qualifying for special attention in most screening guidelines. The data supporting this observation and the proposed mechanism are discussed separately. (See",
"    <a class=\"medical medical_review\" href=\"UTD.htm?41/25/42394?source=see_link&amp;anchor=H19181667#H19181667\">",
"     \"Colorectal cancer: Epidemiology, risk factors, and protective factors\", section on 'Use of androgen deprivation therapy'",
"    </a>",
"    .)",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H25\">",
"    <span class=\"h1\">",
"     FATIGUE",
"    </span>",
"    &nbsp;&mdash;&nbsp;Fatigue or lack of energy is a highly prevalent and often annoying side effect of ADT. In one study, fatigue was severe in 14 percent of men after only three months of therapy [",
"    <a class=\"abstract\" href=\"UTD.htm?21/30/21993/abstract/55\">",
"     55",
"    </a>",
"    ]. The extent of fatigue does not seem to correlate with anemia or emotional cognitive issues. The benefit of regular exercise in maintaining functional capacity and reducing fatigue is discussed above.",
"   </p>",
"   <p>",
"    Two randomized trials have demonstrated the benefit of a regular exercise program in avoiding or reversing some of the changes associated with ADT [",
"    <a class=\"abstract\" href=\"UTD.htm?21/30/21993/abstract/12,56\">",
"     12,56",
"    </a>",
"    ]. In the larger trial, 155 men undergoing initial ADT were randomly assigned to 12 weeks of resistance exercise performed three times per week or no exercise [",
"    <a class=\"abstract\" href=\"UTD.htm?21/30/21993/abstract/12\">",
"     12",
"    </a>",
"    ]. The group receiving resistance exercise had significantly better fatigue and quality of life scores, as well as improved overall muscular fitness.",
"   </p>",
"   <p>",
"    Issues related to fatigue due to cancer are discussed elsewhere. (See",
"    <a class=\"medical medical_review\" href=\"UTD.htm?10/62/11242?source=see_link\">",
"     \"Cancer-related fatigue: Prevalence, screening and clinical assessment\"",
"    </a>",
"    and",
"    <a class=\"medical medical_review\" href=\"UTD.htm?26/29/27098?source=see_link\">",
"     \"Cancer-related fatigue: Treatment\"",
"    </a>",
"    .)",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H26\">",
"    <span class=\"h1\">",
"     ANEMIA",
"    </span>",
"    &nbsp;&mdash;&nbsp;Anemia develops in up to 90 percent of men receiving long-term ADT. It is usually mild to moderate, normochromic, and normocytic [",
"    <a class=\"abstract\" href=\"UTD.htm?21/30/21993/abstract/57,58\">",
"     57,58",
"    </a>",
"    ]. The relationship between anemia and fatigue symptoms is unclear.",
"   </p>",
"   <p>",
"    Anecdotal evidence suggests that the anemia associated with ADT is highly responsive to erythropoietin (EPO) therapy. However, EPO is rarely necessary, and we reserve it for symptomatic patients.",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H27\">",
"    <span class=\"h1\">",
"     ISSUES RELATED TO BODY IMAGE",
"    </span>",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H28\">",
"    <span class=\"h2\">",
"     Gynecomastia",
"    </span>",
"    &nbsp;&mdash;&nbsp;Gynecomastia is caused by an increased ratio of estrogen to androgen activity. Gynecomastia is common in men with prostate cancer undergoing androgen deprivation therapy and it is particularly prevalent with antiandrogen monotherapy. Gynecomastia causes significant alterations in body image and is often associated with breast tenderness as well.",
"   </p>",
"   <p>",
"    Both drug therapy and radiotherapy (RT) have limited benefit once gynecomastia is established in this setting; as a result, prevention of breast development is the goal of therapy. Strategies that have been used for prevention include pharmacologic therapy (antiestrogens or aromatase inhibitors) or radiotherapy. (See",
"    <a class=\"medical medical_review\" href=\"UTD.htm?0/47/760?source=see_link&amp;anchor=H16#H16\">",
"     \"Management of gynecomastia\", section on 'Prostate cancer'",
"    </a>",
"    .)",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H29\">",
"    <span class=\"h2\">",
"     Decreased penile and testicular size",
"    </span>",
"    &nbsp;&mdash;&nbsp;A decrease in the size of the penis",
"    <span class=\"nowrap\">",
"     and/or",
"    </span>",
"    testicles is a common side effect of ADT, which may be distressing to the patient. Men should be warned of this potential complication.",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H30\">",
"    <span class=\"h2\">",
"     Thinning of body hair",
"    </span>",
"    &nbsp;&mdash;&nbsp;Thinning of body hair is another unexpected and disconcerting side effect that should be discussed with the patient before therapy is started. Although facial and most body hair are decreased, bald men may regrow some scalp hair.",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H31\">",
"    <span class=\"h1\">",
"     EMOTIONAL AND COGNITIVE CHANGES",
"    </span>",
"    &nbsp;&mdash;&nbsp;Circulating testosterone levels have behavioral and neurologic effects in humans, and both testosterone concentration and cognitive function decrease with aging in normal men. Some reports note a decline in cognitive performance in men undergoing ADT for prostate cancer [",
"    <a class=\"abstract\" href=\"UTD.htm?21/30/21993/abstract/59-68\">",
"     59-68",
"    </a>",
"    ], although the data are conflicting in men undergoing short-term ADT (less than 24 months) [",
"    <a class=\"abstract\" href=\"UTD.htm?21/30/21993/abstract/62,63,69\">",
"     62,63,69",
"    </a>",
"    ]. (See",
"    <a class=\"medical medical_review\" href=\"UTD.htm?4/13/4314?source=see_link&amp;anchor=H13#H13\">",
"     \"Overview of testosterone deficiency in elderly men\", section on 'Cognitive function'",
"    </a>",
"    .)",
"   </p>",
"   <p>",
"    At least some reports suggest that age, comorbidity, and advanced disease stage may account for much of the depressive, cognitive and constitutional disorders seen in these men. In a report from the Surveillance, Epidemiology and End Results",
"    <span class=\"nowrap\">",
"     (SEER)/Medicare",
"    </span>",
"    linked database, claims for 50,613 elderly men receiving ADT for prostate cancer were compared to those of 50,476 men without prostate cancer [",
"    <a class=\"abstract\" href=\"UTD.htm?21/30/21993/abstract/65\">",
"     65",
"    </a>",
"    ]. Of men surviving at least five years after diagnosis, the incidence of at least one depressive, cognitive, or constitutional diagnosis was significantly higher among those with prostate cancer compared to controls (31.3 versus 23.7 percent, respectively, p&lt;0.001). However, after adjustment for age, comorbidity and tumor characteristics, the risks associated with ADT were substantially reduced or abolished.",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H32\">",
"    <span class=\"h1\">",
"     SUMMARY",
"    </span>",
"    &nbsp;&mdash;&nbsp;Androgen deprivation therapy (ADT) is the main therapeutic approach for men with metastatic prostate cancer and is frequently used in combination with other treatments in selected patients with locoregional disease. (See",
"    <a class=\"medical medical_review\" href=\"UTD.htm?1/20/1353?source=see_link\">",
"     \"Initial hormone therapy for metastatic prostate cancer\"",
"    </a>",
"    .)",
"   </p>",
"   <p>",
"    <ul class=\"bullet-block\">",
"     <li>",
"      Sexual dysfunction: Most men who are potent prior to therapy develop sexual dysfunction when treated with continuous ADT. Loss of libido in men receiving gonadotropin releasing hormone (GnRH) agonists usually develops within the first several months, and erectile dysfunction follows. I would also add here that antiandrogen monotherapy and intermittent androgen deprivation are in general NOT used to mitigate this side effect (See",
"      <a class=\"local\" href=\"#H2\">",
"       'Sexual dysfunction'",
"      </a>",
"      above.)",
"     </li>",
"     <li>",
"      Osteoporosis: ADT increases bone turnover and decreases bone mineral density, thereby increasing the risk of clinical bone fractures. For all men beginning long-term ADT, we recommend dietary calcium intake (food and supplements) of 1000 to 1200 mg daily and supplemental vitamin D 800 to 1000 international units daily, as well as weight bearing exercise, decreased alcohol consumption, and smoking cessation. (See",
"      <a class=\"local\" href=\"#H9\">",
"       'Prevention'",
"      </a>",
"      above.)",
"     </li>",
"     <li>",
"      Osteoclast inhibition (bisphosphonates,",
"      <a class=\"drug drug_general\" href=\"UTD.htm?20/53/21335?source=see_link\">",
"       denosumab",
"      </a>",
"      ) can decrease bone turnover and increase bone mineral density in men receiving androgen deprivation therapy (ADT).",
"     </li>",
"    </ul>",
"   </p>",
"   <p>",
"    <ul class=\"hyphen-block\">",
"     <li>",
"      For men with castrate-resistant prostate cancer and bone metastases, we recommend an osteoclast inhibitor to reduce the risk of skeletal complications from progression of bone metastases (",
"      <a class=\"grade\" href=\"._grade_1?title=Grade 1A\">",
"       Grade 1A",
"      </a>",
"      ). For most patients, we suggest",
"      <a class=\"drug drug_general\" href=\"UTD.htm?20/53/21335?source=see_link\">",
"       denosumab",
"      </a>",
"      rather than",
"      <a class=\"drug drug_general\" href=\"UTD.htm?9/1/9241?source=see_link\">",
"       zoledronic acid",
"      </a>",
"      based upon it&rsquo;s superior efficacy in a large randomized trial the results of a large randomized trial (",
"      <a class=\"grade\" href=\"._grade_4?title=Grade 2A\">",
"       Grade 2A",
"      </a>",
"      ). For patients in whom cost",
"      <span class=\"nowrap\">",
"       and/or",
"      </span>",
"      reimbursement are important considerations, zoledronic acid is an appropriate alternative. (See",
"      <a class=\"medical medical_review\" href=\"UTD.htm?36/8/36999?source=see_link&amp;anchor=H19250956#H19250956\">",
"       \"Management of bone metastases in advanced prostate cancer\", section on 'Osteoclast inhibition'",
"      </a>",
"      .)",
"     </li>",
"     <li>",
"      For men without bone metastases and those receiving their initial treatment for metastatic disease, there is no consensus as to the optimal timing of bisphosphonate or",
"      <a class=\"drug drug_general\" href=\"UTD.htm?20/53/21335?source=see_link\">",
"       denosumab",
"      </a>",
"      therapy in men without bone metastases who are treated with ADT. Our approach is to use an osteoclast inhibitor only when osteoporosis becomes evident on serial bone mineral density studies, or in men who present with an osteoporotic bone fracture. (See",
"      <a class=\"local\" href=\"#H2165880127\">",
"       'Osteoclast inhibition'",
"      </a>",
"      above.)",
"     </li>",
"    </ul>",
"   </p>",
"   <p>",
"    <ul class=\"bullet-block\">",
"     <li>",
"      Cardiovascular disease and diabetes: The results of multiple, large observational studies suggest that there is a statistically significant increase in incident cardiovascular disease and diabetes but no significant increase in cardiovascular death. However, the potential benefits of ADT for men with prostate cancer appear to outweigh the risks, when ADT is used for appropriate indications. (See",
"      <a class=\"local\" href=\"#H22\">",
"       'Cardiovascular disease and diabetes'",
"      </a>",
"      above.)",
"     </li>",
"     <li>",
"      Decreased muscle and increased fat: Reduced testosterone levels associated with ADT result in a decrease in lean body mass and an increase in subcutaneous adipose tissue, most of which occurs during the first 18 months of treatment. (See",
"      <a class=\"local\" href=\"#H20\">",
"       'Changes in body composition and metabolism'",
"      </a>",
"      above.)",
"     </li>",
"     <li>",
"      Other quality of life issues: ADT may result in a number of other changes that can adversely affect quality of life. These include:",
"     </li>",
"    </ul>",
"   </p>",
"   <p>",
"    <ul class=\"hyphen-block\">",
"     <li>",
"      Hot flashes. The optimal management of vasomotor symptoms is unclear. We typically start with a selective serotonin reuptake inhibitor and reserve hormonal treatment (estrogen, megestrol) for refractory cases. (see",
"      <a class=\"local\" href=\"#H15\">",
"       'Vasomotor symptoms'",
"      </a>",
"      above)",
"     </li>",
"     <li>",
"      Lack of energy, which may only partially be related to anemia or emotional and cognitive issues (see",
"      <a class=\"local\" href=\"#H25\">",
"       'Fatigue'",
"      </a>",
"      above and",
"      <a class=\"local\" href=\"#H26\">",
"       'Anemia'",
"      </a>",
"      above)",
"     </li>",
"     <li>",
"      Changes in body image, including gynecomastia, decreased penile and testicular size, and thinning of body hair (see",
"      <a class=\"local\" href=\"#H27\">",
"       'Issues related to body image'",
"      </a>",
"      above)",
"     </li>",
"     <li>",
"      Decreased cognitive performance or depression, although these changes may be related to aging and disease rather than ADT (see",
"      <a class=\"local\" href=\"#H31\">",
"       'Emotional and cognitive changes'",
"      </a>",
"      above)",
"     </li>",
"    </ul>",
"   </p>",
"  </div>",
"  <div id=\"topicAgreement\">",
"   Use of UpToDate is subject to the",
"   <a class=\"licenseLink\" href=\"./license\" id=\"sla_in_page\" target=\"_blank\">",
"    Subscription and License Agreement",
"   </a>",
"   .",
"  </div>",
"  <div class=\"headingAnchor\" id=\"references\">",
"   <h1>",
"    REFERENCES",
"   </h1>",
"   <ol id=\"reference\">",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?21/30/21993/abstract/1\">",
"      Wilke DR, Parker C, Andonowski A, et al. Testosterone and erectile function recovery after radiotherapy and long-term androgen deprivation with luteinizing hormone-releasing hormone agonists. BJU Int 2006; 97:963.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?21/30/21993/abstract/2\">",
"      Seidenfeld J, Samson DJ, Hasselblad V, et al. Single-therapy androgen suppression in men with advanced prostate cancer: a systematic review and meta-analysis. Ann Intern Med 2000; 132:566.",
"     </a>",
"    </li>",
"    <li>",
"     Hussain M, et al. Intermittent (IAD) versus continuous androgen deprivation (CAD) in hormone sensitive metastatic prostate cancer (HSM1PC) patients (pts): Results of S9346 (INT-0162), an international phase III trial (abstract #4). J Clin Oncol 2012.",
"    </li>",
"    <li>",
"     Moinpour C, Berry DL, Ely B, et al. Preliminary quality-of-life outcomes for SWOG-9346: Intermittent androgen deprivation in patients with hormone-sensitive metastatic prostate cancer (HSM1PC)&mdash;Phase III. J Clin Oncol 2012; 30: (suppl; abstr 4571)",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?21/30/21993/abstract/5\">",
"      Klotz L, O'Callaghan CJ, Ding K. A phase III randomized trial comparing intermittent versus continuous androgen suppression for patients with PSA progression after radical therapy: NCIC CTG PR.7/SWOG  JPR.7/CTSU JPR.7/UK Intercontinental Trial CRUKE/01/013 (abstract #3). J Clin Oncol 2011.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?21/30/21993/abstract/6\">",
"      Smith MR, Lee WC, Brandman J, et al. Gonadotropin-releasing hormone agonists and fracture risk: a claims-based cohort study of men with nonmetastatic prostate cancer. J Clin Oncol 2005; 23:7897.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?21/30/21993/abstract/7\">",
"      Shahinian VB, Kuo YF, Freeman JL, Goodwin JS. Risk of fracture after androgen deprivation for prostate cancer. N Engl J Med 2005; 352:154.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?21/30/21993/abstract/8\">",
"      Smith MR, Boyce SP, Moyneur E, et al. Risk of clinical fractures after gonadotropin-releasing hormone agonist therapy for prostate cancer. J Urol 2006; 175:136.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?21/30/21993/abstract/9\">",
"      Saad F, Adachi JD, Brown JP, et al. Cancer treatment-induced bone loss in breast and prostate cancer. J Clin Oncol 2008; 26:5465.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?21/30/21993/abstract/10\">",
"      Diamond T, Campbell J, Bryant C, Lynch W. The effect of combined androgen blockade on bone turnover and bone mineral densities in men treated for prostate carcinoma: longitudinal evaluation and response to intermittent cyclic etidronate therapy. Cancer 1998; 83:1561.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?21/30/21993/abstract/11\">",
"      Krupski TL, Smith MR, Lee WC, et al. Natural history of bone complications in men with prostate carcinoma initiating androgen deprivation therapy. Cancer 2004; 101:541.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?21/30/21993/abstract/12\">",
"      Segal RJ, Reid RD, Courneya KS, et al. Resistance exercise in men receiving androgen deprivation therapy for prostate cancer. J Clin Oncol 2003; 21:1653.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?21/30/21993/abstract/13\">",
"      Ross RW, Small EJ. Osteoporosis in men treated with androgen deprivation therapy for prostate cancer. J Urol 2002; 167:1952.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?21/30/21993/abstract/14\">",
"      Bae DC, Stein BS. The diagnosis and treatment of osteoporosis in men on androgen deprivation therapy for advanced carcinoma of the prostate. J Urol 2004; 172:2137.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?21/30/21993/abstract/15\">",
"      Saad F, Olsson C, Schulman CC. Skeletal morbidity in men with prostate cancer: quality-of-life considerations throughout the continuum of care. Eur Urol 2004; 46:731.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?21/30/21993/abstract/16\">",
"      Smith MR, McGovern FJ, Zietman AL, et al. Pamidronate to prevent bone loss during androgen-deprivation therapy for prostate cancer. N Engl J Med 2001; 345:948.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?21/30/21993/abstract/17\">",
"      Smith MR, Eastham J, Gleason DM, et al. Randomized controlled trial of zoledronic acid to prevent bone loss in men receiving androgen deprivation therapy for nonmetastatic prostate cancer. J Urol 2003; 169:2008.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?21/30/21993/abstract/18\">",
"      Greenspan SL, Nelson JB, Trump DL, Resnick NM. Effect of once-weekly oral alendronate on bone loss in men receiving androgen deprivation therapy for prostate cancer: a randomized trial. Ann Intern Med 2007; 146:416.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?21/30/21993/abstract/19\">",
"      Klotz LH, McNeill IY, Kebabdjian M, et al. A Phase 3, Double-blind, Randomised, Parallel-group, Placebo-controlled Study of Oral Weekly Alendronate for the Prevention of Androgen Deprivation Bone Loss in Nonmetastatic Prostate Cancer: The Cancer and Osteoporosis Research with Alendronate and Leuprolide (CORAL) Study. Eur Urol 2013; 63:927.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?21/30/21993/abstract/20\">",
"      Choo R, Lukka H, Cheung P, et al. Randomized, double-blinded, placebo-controlled, trial of risedronate for the prevention of bone mineral density loss in nonmetastatic prostate cancer patients receiving radiation therapy plus androgen deprivation therapy. Int J Radiat Oncol Biol Phys 2013; 85:1239.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?21/30/21993/abstract/21\">",
"      Smith MR, Egerdie B, Hern&aacute;ndez Toriz N, et al. Denosumab in men receiving androgen-deprivation therapy for prostate cancer. N Engl J Med 2009; 361:745.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?21/30/21993/abstract/22\">",
"      Smith MR, Saad F, Egerdie B, et al. Effects of denosumab on bone mineral density in men receiving androgen deprivation therapy for prostate cancer. J Urol 2009; 182:2670.",
"     </a>",
"    </li>",
"    <li>",
"     file://www.nccn.org/professionals/physician_gls/f_guidelines.asp#site (Accessed on August 20, 2012).",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?21/30/21993/abstract/24\">",
"      Smith MR, Fallon MA, Lee H, Finkelstein JS. Raloxifene to prevent gonadotropin-releasing hormone agonist-induced bone loss in men with prostate cancer: a randomized controlled trial. J Clin Endocrinol Metab 2004; 89:3841.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?21/30/21993/abstract/25\">",
"      Smith MR, Morton RA, Barnette KG, et al. Toremifene to reduce fracture risk in men receiving androgen deprivation therapy for prostate cancer. J Urol 2010; 184:1316.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?21/30/21993/abstract/26\">",
"      Smith MR, Goode M, Zietman AL, et al. Bicalutamide monotherapy versus leuprolide monotherapy for prostate cancer: effects on bone mineral density and body composition. J Clin Oncol 2004; 22:2546.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?21/30/21993/abstract/27\">",
"      Sieber PR, Keiller DL, Kahnoski RJ, et al. Bicalutamide 150 mg maintains bone mineral density during monotherapy for localized or locally advanced prostate cancer. J Urol 2004; 171:2272.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?21/30/21993/abstract/28\">",
"      Frisk J. Managing hot flushes in men after prostate cancer--a systematic review. Maturitas 2010; 65:15.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?21/30/21993/abstract/29\">",
"      Irani J, Salomon L, Oba R, et al. Efficacy of venlafaxine, medroxyprogesterone acetate, and cyproterone acetate for the treatment of vasomotor hot flushes in men taking gonadotropin-releasing hormone analogues for prostate cancer: a double-blind, randomised trial. Lancet Oncol 2010; 11:147.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?21/30/21993/abstract/30\">",
"      Loprinzi CL, Dueck AC, Khoyratty BS, et al. A phase III randomized, double-blind, placebo-controlled trial of gabapentin in the management of hot flashes in men (N00CB). Ann Oncol 2009; 20:542.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?21/30/21993/abstract/31\">",
"      Harding C, Harris A, Chadwick D. Auricular acupuncture: a novel treatment for vasomotor symptoms associated with luteinizing-hormone releasing hormone agonist treatment for prostate cancer. BJU Int 2009; 103:186.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?21/30/21993/abstract/32\">",
"      Beer TM, Benavides M, Emmons SL, et al. Acupuncture for hot flashes in patients with prostate cancer. Urology 2010; 76:1182.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?21/30/21993/abstract/33\">",
"      Ashamalla H, Jiang ML, Guirguis A, et al. Acupuncture for the alleviation of hot flashes in men treated with androgen ablation therapy. Int J Radiat Oncol Biol Phys 2011; 79:1358.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?21/30/21993/abstract/34\">",
"      Saylor PJ, Smith MR. Metabolic complications of androgen deprivation therapy for prostate cancer. J Urol 2009; 181:1998.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?21/30/21993/abstract/35\">",
"      Smith MR, Finkelstein JS, McGovern FJ, et al. Changes in body composition during androgen deprivation therapy for prostate cancer. J Clin Endocrinol Metab 2002; 87:599.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?21/30/21993/abstract/36\">",
"      Alibhai SM, Breunis H, Timilshina N, et al. Impact of androgen-deprivation therapy on physical function and quality of life in men with nonmetastatic prostate cancer. J Clin Oncol 2010; 28:5038.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?21/30/21993/abstract/37\">",
"      Smith MR, Saad F, Egerdie B, et al. Sarcopenia during androgen-deprivation therapy for prostate cancer. J Clin Oncol 2012; 30:3271.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?21/30/21993/abstract/38\">",
"      Smith MR, Lee H, Fallon MA, Nathan DM. Adipocytokines, obesity, and insulin resistance during combined androgen blockade for prostate cancer. Urology 2008; 71:318.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?21/30/21993/abstract/39\">",
"      Smith MR, Lee H, Nathan DM. Insulin sensitivity during combined androgen blockade for prostate cancer. J Clin Endocrinol Metab 2006; 91:1305.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?21/30/21993/abstract/40\">",
"      Braga-Basaria M, Dobs AS, Muller DC, et al. Metabolic syndrome in men with prostate cancer undergoing long-term androgen-deprivation therapy. J Clin Oncol 2006; 24:3979.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?21/30/21993/abstract/41\">",
"      Braga-Basaria M, Muller DC, Carducci MA, et al. Lipoprotein profile in men with prostate cancer undergoing androgen deprivation therapy. Int J Impot Res 2006; 18:494.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?21/30/21993/abstract/42\">",
"      Yannucci J, Manola J, Garnick MB, et al. The effect of androgen deprivation therapy on fasting serum lipid and glucose parameters. J Urol 2006; 176:520.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?21/30/21993/abstract/43\">",
"      Reis C, Liberman S, Pompeo AC, et al. Body composition alterarions, energy expenditure and fat oxidation in elderly males suffering from prostate cancer, pre and post orchiectomy. Clinics (Sao Paulo) 2009; 64:781.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?21/30/21993/abstract/44\">",
"      Smith MR, Malkowicz SB, Chu F, et al. Toremifene improves lipid profiles in men receiving androgen-deprivation therapy for prostate cancer: interim analysis of a multicenter phase III study. J Clin Oncol 2008; 26:1824.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?21/30/21993/abstract/45\">",
"      Alibhai SM, Duong-Hua M, Sutradhar R, et al. Impact of androgen deprivation therapy on cardiovascular disease and diabetes. J Clin Oncol 2009; 27:3452.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?21/30/21993/abstract/46\">",
"      Keating NL, O'Malley AJ, Smith MR. Diabetes and cardiovascular disease during androgen deprivation therapy for prostate cancer. J Clin Oncol 2006; 24:4448.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?21/30/21993/abstract/47\">",
"      Keating NL, O'Malley AJ, Freedland SJ, Smith MR. Diabetes and cardiovascular disease during androgen deprivation therapy: observational study of veterans with prostate cancer. J Natl Cancer Inst 2010; 102:39.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?21/30/21993/abstract/48\">",
"      Saigal CS, Gore JL, Krupski TL, et al. Androgen deprivation therapy increases cardiovascular morbidity in men with prostate cancer. Cancer 2007; 110:1493.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?21/30/21993/abstract/49\">",
"      Tsai HK, D'Amico AV, Sadetsky N, et al. Androgen deprivation therapy for localized prostate cancer and the risk of cardiovascular mortality. J Natl Cancer Inst 2007; 99:1516.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?21/30/21993/abstract/50\">",
"      Nanda A, Chen MH, Braccioforte MH, et al. Hormonal therapy use for prostate cancer and mortality in men with coronary artery disease-induced congestive heart failure or myocardial infarction. JAMA 2009; 302:866.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?21/30/21993/abstract/51\">",
"      Hayes JH, Chen MH, Moran BJ, et al. Androgen-suppression therapy for prostate cancer and the risk of death in men with a history of myocardial infarction or stroke. BJU Int 2010; 106:979.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?21/30/21993/abstract/52\">",
"      Nguyen PL, Je Y, Schutz FA, et al. Association of androgen deprivation therapy with cardiovascular death in patients with prostate cancer: a meta-analysis of randomized trials. JAMA 2011; 306:2359.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?21/30/21993/abstract/53\">",
"      Ehdaie B, Atoria CL, Gupta A, et al. Androgen deprivation and thromboembolic events in men with prostate cancer. Cancer 2012; 118:3397.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?21/30/21993/abstract/54\">",
"      Van Hemelrijck M, Adolfsson J, Garmo H, et al. Risk of thromboembolic diseases in men with prostate cancer: results from the population-based PCBaSe Sweden. Lancet Oncol 2010; 11:450.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?21/30/21993/abstract/55\">",
"      Stone P, Hardy J, Huddart R, et al. Fatigue in patients with prostate cancer receiving hormone therapy. Eur J Cancer 2000; 36:1134.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?21/30/21993/abstract/56\">",
"      Galv&atilde;o DA, Taaffe DR, Spry N, et al. Combined resistance and aerobic exercise program reverses muscle loss in men undergoing androgen suppression therapy for prostate cancer without bone metastases: a randomized controlled trial. J Clin Oncol 2010; 28:340.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?21/30/21993/abstract/57\">",
"      Beer TM, Tangen CM, Bland LB, et al. The prognostic value of hemoglobin change after initiating androgen-deprivation therapy for newly diagnosed metastatic prostate cancer: A multivariate analysis of Southwest Oncology Group Study 8894. Cancer 2006; 107:489.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?21/30/21993/abstract/58\">",
"      Joly F, Alibhai SM, Galica J, et al. Impact of androgen deprivation therapy on physical and cognitive function, as well as quality of life of patients with nonmetastatic prostate cancer. J Urol 2006; 176:2443.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?21/30/21993/abstract/59\">",
"      Green HJ, Pakenham KI, Headley BC, et al. Altered cognitive function in men treated for prostate cancer with luteinizing hormone-releasing hormone analogues and cyproterone acetate: a randomized controlled trial. BJU Int 2002; 90:427.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?21/30/21993/abstract/60\">",
"      Salminen EK, Portin RI, Koskinen AI, et al. Estradiol and cognition during androgen deprivation in men with prostate carcinoma. Cancer 2005; 103:1381.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?21/30/21993/abstract/61\">",
"      Salminen EK, Portin RI, Koskinen A, et al. Associations between serum testosterone fall and cognitive function in prostate cancer patients. Clin Cancer Res 2004; 10:7575.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?21/30/21993/abstract/62\">",
"      Salminen E, Portin R, Korpela J, et al. Androgen deprivation and cognition in prostate cancer. Br J Cancer 2003; 89:971.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?21/30/21993/abstract/63\">",
"      Jenkins VA, Bloomfield DJ, Shilling VM, Edginton TL. Does neoadjuvant hormone therapy for early prostate cancer affect cognition? Results from a pilot study. BJU Int 2005; 96:48.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?21/30/21993/abstract/64\">",
"      Cherrier MM, Rose AL, Higano C. The effects of combined androgen blockade on cognitive function during the first cycle of intermittent androgen suppression in patients with prostate cancer. J Urol 2003; 170:1808.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?21/30/21993/abstract/65\">",
"      Shahinian VB, Kuo YF, Freeman JL, Goodwin JS. Risk of the \"androgen deprivation syndrome\" in men receiving androgen deprivation for prostate cancer. Arch Intern Med 2006; 166:465.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?21/30/21993/abstract/66\">",
"      Holzbeierlein JM, McLaughlin MD, Thrasher JB. Complications of androgen deprivation therapy for prostate cancer. Curr Opin Urol 2004; 14:177.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?21/30/21993/abstract/67\">",
"      Pirl WF, Siegel GI, Goode MJ, Smith MR. Depression in men receiving androgen deprivation therapy for prostate cancer: a pilot study. Psychooncology 2002; 11:518.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?21/30/21993/abstract/68\">",
"      Nelson CJ, Lee JS, Gamboa MC, Roth AJ. Cognitive effects of hormone therapy in men with prostate cancer: a review. Cancer 2008; 113:1097.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?21/30/21993/abstract/69\">",
"      Alibhai SM, Breunis H, Timilshina N, et al. Impact of androgen-deprivation therapy on cognitive function in men with nonmetastatic prostate cancer. J Clin Oncol 2010; 28:5030.",
"     </a>",
"    </li>",
"   </ol>",
"  </div>",
"  <div id=\"topicVersionRevision\">",
"   Topic 6927 Version 22.0",
"  </div>",
" </div>",
" <div id=\"footer\">",
"  <div id=\"supportFooter\">",
"   <span class=\"sfInfo\">",
"    &copy; 2013 UpToDate, Inc. All rights reserved.",
"   </span>",
"   <span class=\"pipeSpace\">",
"    |",
"   </span>",
"   <a class=\"licenseLink\" href=\"./license\" id=\"sla_footer\">",
"    Subscription and License Agreement",
"   </a>",
"   <span class=\"sfInfo\">",
"    <span class=\"pipeSpace\">",
"     |",
"    </span>",
"    Release: 21.6- C21.56",
"   </span>",
"   <br/>",
"   <span class=\"sfInfo\">",
"    Licensed to:",
"    <span class=\"emphasis\">",
"     AsanBook Dig. Med. Lib.",
"    </span>",
"   </span>",
"   <span class=\"sfInfo\">",
"    <span class=\"pipeSpace\">",
"     |",
"    </span>",
"    Support Tag: [1004-122.72.76.133-F7325097AE-S244013.14]",
"    <br/>",
"   </span>",
"  </div>",
" </div>",
"</div>"].join("\n");
var script_f21_30_21993=[""].join("\n");
var outline_f21_30_21993=[" <div id=\"toggleOutline\">",
"  <a href=\"#\" title=\"Collapse Topic Outline\">",
"   <img alt=\"\" src=\"./../images/orange_arrow_left.myextg\"/>",
"  </a>",
" </div>",
" <div id=\"innerOutline\">",
"  <h1>",
"   TOPIC OUTLINE",
"  </h1>",
"  <div id=\"outline\">",
"   <ul>",
"    <li>",
"     <a class=\"sr_button\" href=\"#H32\" id=\"summRecButton\">",
"      <span>",
"       SUMMARY",
"      </span>",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#H1\">",
"      INTRODUCTION",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#H2\">",
"      SEXUAL DYSFUNCTION",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H3\">",
"      Alternative hormone strategies",
"     </a>",
"    </li>",
"    <li class=\"dashItem\">",
"     <a class=\"outlineLink\" href=\"#H5\">",
"      - Antiandrogen monotherapy",
"     </a>",
"    </li>",
"    <li class=\"dashItem\">",
"     <a class=\"outlineLink\" href=\"#H261290306\">",
"      - Intermittent androgen deprivation",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#H7\">",
"      OSTEOPOROSIS AND BONE FRACTURES",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H8\">",
"      Diagnosis",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H9\">",
"      Prevention",
"     </a>",
"    </li>",
"    <li class=\"dashItem\">",
"     <a class=\"outlineLink\" href=\"#H261290808\">",
"      - Lifestyle modification",
"     </a>",
"    </li>",
"    <li class=\"dashItem\">",
"     <a class=\"outlineLink\" href=\"#H2165880127\">",
"      - Osteoclast inhibition",
"     </a>",
"    </li>",
"    <li class=\"bulletItem2\">",
"     <a class=\"outlineLink\" href=\"#H10\">",
"      Bisphosphonates",
"     </a>",
"    </li>",
"    <li class=\"bulletItem2\">",
"     <a class=\"outlineLink\" href=\"#H11\">",
"      Denosumab",
"     </a>",
"    </li>",
"    <li class=\"dashItem\">",
"     <a class=\"outlineLink\" href=\"#H12\">",
"      - Selective estrogen receptor modulators",
"     </a>",
"    </li>",
"    <li class=\"dashItem\">",
"     <a class=\"outlineLink\" href=\"#H13\">",
"      - Antiandrogen monotherapy",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#H15\">",
"      VASOMOTOR SYMPTOMS",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H16\">",
"      Treatment",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H17\">",
"      Medications",
"     </a>",
"    </li>",
"    <li class=\"dashItem\">",
"     <a class=\"outlineLink\" href=\"#H18\">",
"      - Alternative strategies",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H19\">",
"      Recommendation",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#H20\">",
"      CHANGES IN BODY COMPOSITION AND METABOLISM",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H21\">",
"      Recommendation",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#H22\">",
"      CARDIOVASCULAR DISEASE AND DIABETES",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#H692236399\">",
"      COLORECTAL CANCER",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#H25\">",
"      FATIGUE",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#H26\">",
"      ANEMIA",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#H27\">",
"      ISSUES RELATED TO BODY IMAGE",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H28\">",
"      Gynecomastia",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H29\">",
"      Decreased penile and testicular size",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H30\">",
"      Thinning of body hair",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#H31\">",
"      EMOTIONAL AND COGNITIVE CHANGES",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#H32\">",
"      SUMMARY",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a href=\"#references\">",
"      REFERENCES",
"     </a>",
"    </li>",
"   </ul>",
"  </div>",
"  <h1>",
"   RELATED TOPICS",
"  </h1>",
"  <div id=\"relatedTopics\">",
"   <ul>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"UTD.htm?10/62/11242?source=related_link\">",
"      Cancer-related fatigue: Prevalence, screening and clinical assessment",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"UTD.htm?26/29/27098?source=related_link\">",
"      Cancer-related fatigue: Treatment",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"UTD.htm?35/23/36213?source=related_link\">",
"      Clinical manifestations, diagnosis, and evaluation of osteoporosis in men",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"UTD.htm?41/25/42394?source=related_link\">",
"      Colorectal cancer: Epidemiology, risk factors, and protective factors",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"UTD.htm?10/55/11128?source=related_link\">",
"      Diagnosis and evaluation of osteoporosis in postmenopausal women",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"UTD.htm?31/45/32473?source=related_link\">",
"      Epidemiology and etiology of osteoporosis in men",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"UTD.htm?1/20/1353?source=related_link\">",
"      Initial hormone therapy for metastatic prostate cancer",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"UTD.htm?21/26/21930?source=related_link\">",
"      Initial management of regionally localized intermediate and high risk prostate cancer",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"UTD.htm?36/8/36999?source=related_link\">",
"      Management of bone metastases in advanced prostate cancer",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"UTD.htm?0/47/760?source=related_link\">",
"      Management of gynecomastia",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"UTD.htm?24/53/25434?source=related_link\">",
"      Menopausal hot flashes",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"UTD.htm?4/13/4314?source=related_link\">",
"      Overview of testosterone deficiency in elderly men",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"UTD.htm?29/48/30470?source=related_link\">",
"      Rising serum PSA after treatment for localized prostate cancer: Systemic therapy",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"UTD.htm?38/43/39610?source=related_link\">",
"      Risks of therapy with bone modifying agents in patients with advanced malignancy",
"     </a>",
"    </li>",
"   </ul>",
"  </div>",
" </div>"].join("\n");
var title_f21_30_21994="Pemphigus vulgaris bullae and erosions";
var content_f21_30_21994=[" <div id=\"graphicsToolbar\">",
"  <div id=\"graphicsCopy\">",
"   &copy;2013 UpToDate",
"   <sup>",
"    &reg;",
"   </sup>",
"  </div>",
"  <div id=\"graphicsLinks\">",
"   <a href=\"?imageKey=DERM%2F53425%7EDERM%2F51868&amp;source=image_view&amp;view=print&amp;elapsedTimeMs=2\" onclick=\"\">",
"    <img alt=\"Print this page\" src=\"./../images/icn_print.myextg\" title=\"Print this page\"/>",
"   </a>",
"   <a class=\"icontxt textLink\" href=\"?imageKey=DERM%2F53425%7EDERM%2F51868&amp;source=image_view&amp;view=print&amp;elapsedTimeMs=2\" onclick=\"\" title=\"Print this page\">",
"    Print",
"   </a>",
"   <a class=\"etacLink\" href=\"#\">",
"    <img alt=\"Email graphic(s)\" src=\"./../images/icn_email.myextg\" title=\"Email graphic(s)\"/>",
"   </a>",
"   <a class=\"icontxt textLink etacLink\" href=\"#\" title=\"Email graphic(s)\">",
"    Email",
"   </a>",
"  </div>",
" </div>",
" <div class=\"graphic\">",
"  <div class=\"figure\" style=\"width: 524px\">",
"   <div class=\"ttl\">",
"    Pemphigus vulgaris",
"   </div>",
"   <div class=\"cntnt\" style=\"width: 504px; height: 378px; background-image: url(data:image/jpeg;base64,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);\">",
"   </div>",
"   <div class=\"lgnd\">",
"    Flaccid bullae and erosions on the skin of a patient with pemphigus vulgaris.",
"    <div class=\"footnotes\">",
"    </div>",
"    <div class=\"reference\">",
"     Reproduced with permission from: www.visualdx.com. Copyright Logical Images, Inc.",
"    </div>",
"   </div>",
"  </div>",
" </div>",
" <div class=\"graphic\">",
"  <div class=\"figure\" style=\"width: 524px\">",
"   <div class=\"ttl\">",
"    Pemphigus vulgaris",
"   </div>",
"   <div class=\"cntnt\" style=\"width: 504px; height: 378px; background-image: url(data:image/jpeg;base64,/9j/4AAQSkZJRgABAQAAAQABAAD/2wBDAAYEBQYFBAYGBQYHBwYIChAKCgkJChQODwwQFxQYGBcUFhYaHSUfGhsjHBYWICwgIyYnKSopGR8tMC0oMCUoKSj/2wBDAQcHBwoIChMKChMoGhYaKCgoKCgoKCgoKCgoKCgoKCgoKCgoKCgoKCgoKCgoKCgoKCgoKCgoKCgoKCgoKCgoKCj/wAARCAF6AfgDASIAAhEBAxEB/8QAHwAAAQUBAQEBAQEAAAAAAAAAAAECAwQFBgcICQoL/8QAtRAAAgEDAwIEAwUFBAQAAAF9AQIDAAQRBRIhMUEGE1FhByJxFDKBkaEII0KxwRVS0fAkM2JyggkKFhcYGRolJicoKSo0NTY3ODk6Q0RFRkdISUpTVFVWV1hZWmNkZWZnaGlqc3R1dnd4eXqDhIWGh4iJipKTlJWWl5iZmqKjpKWmp6ipqrKztLW2t7i5usLDxMXGx8jJytLT1NXW19jZ2uHi4+Tl5ufo6erx8vP09fb3+Pn6/8QAHwEAAwEBAQEBAQEBAQAAAAAAAAECAwQFBgcICQoL/8QAtREAAgECBAQDBAcFBAQAAQJ3AAECAxEEBSExBhJBUQdhcRMiMoEIFEKRobHBCSMzUvAVYnLRChYkNOEl8RcYGRomJygpKjU2Nzg5OkNERUZHSElKU1RVVldYWVpjZGVmZ2hpanN0dXZ3eHl6goOEhYaHiImKkpOUlZaXmJmaoqOkpaanqKmqsrO0tba3uLm6wsPExcbHyMnK0tPU1dbX2Nna4uPk5ebn6Onq8vP09fb3+Pn6/9oADAMBAAIRAxEAPwDjWRgVAYgBccZPHr7ikVlZCnmjIBHIwR6cU9WyMb8qp4JB6Ht7CpTEok/efeJwzKMgH/PavIR9ARZUOm4iIAc5BI46fXNOVBE6jaBkYbOcnPUEfyppUKoy6jAGQ7ZKj1zjp71MSFDICCR972fnofQjmmSOmlIEhjkPTOW6ke/5CoGmYKBIpYfwg9RSEyO4UKdvVfb2zUp+bchUhj6Nx09KkoZGysAVk+ZMghsD/Jp7QqRv3ttb1GMimqnl7eBgnIOM49z6ipSrbGDMBjkEdAfSgCr5Y8vykO3acde3bNSQuylSRuK9yDyf88U63AbOAQ3XLDqPrTnG0mRAQCdrFfftQAFA6kogJ64I5Uf57VHcGVEJQLuXt7VKZQNqkKxxlSe/4+1I02MhNqkdVU9BQBTjnYsfM5XvjtVpJg6n94uRwAaGkXcpx7HIyMUriKSM7QpOM7femmKwvluuHKnpuyBxTGUTLh13KOh7n8as2jOY2EecgEnI4GOtNExk8zoBnB6AH/CjqDSK32cImVJ47GnAvtzjYQM5XirTRlojvUEL3z0NVWVoSMqWPXAJyKq/YlwuWrbVb21GElaQA/dcZrQt/EkwGJrZSemQcVhsVbJIYsOCTxTPLdQQACRzy1aRrTj1Mp0It7HY22u2khAkJhb+63+NaSzIyhkdGB6YOa88dQqgyKCv9akt5QoYozh/4Qtbxxb+0jnlhV0Z6GMEckfzpcfkK4ZL+7gI8qYgHs3I/KrK69exDB2uPpWscVEzeHkjsVJPPp70uBkDsa5mDxEFhPmx/OOynrUkPiOMyANC3lkZz1OatV4PqZ+ykdF0z6Ug+mPesuPW7RsbnC89D1qzHqNq7MFmXFWpxfUnkl2LQ79+abg55pFuICOJUx9aDNGTnzFP41V13Js+w4g8enekpRIjLwykUY/lQtQaaGkY+lJTx7c0mAeegNADfUenWlI4+tLR79PrQA0kkelIMA8CnZzyRSHJGDQwGnIFJjg+9OH54o/T2oQgHpig9Dmg8cjJo4oGIFwBgDFL7c0fzoOcf4VIhvb/AOvSEnt09RTsDPPNB4Ix0oAbxwOeKTvS4OTS4B6UANxRjNKRxzyfSkHpQAcA8+tNHPTFOPT3owBnJp3JG9RS0EflRSGkNzS9sg80YH40GgGJ0FNIxz2p3Xr07Yo4HQUCE9M9TzS0ds9c0DmgA6D2pCOOelL2NJnj0oAawwOnXpRSCNVLFRgscn3NFAHIiJGRhswxXBAOCDn/AApxjZ1mWQMzDkq3AJBHX0NPjDSIQwJyAqlo8njOB9OtMBVUH7tCdpyrdWxjI9Qf6V4tj6AqtE5OyNT5eMMOmef/AK1PVGQoI13kDlQcgqfSp5IVIYLkMoGPl6g9j/jURGx1dCw7kjluex/+tTuKwjAYUE5GflOOR/TNRsXDbyzNuww9x60pGFbIYr0+YZwD356HNPUDcVCbzjngjj1xQIi81vMA3gFTlFzwMnpU1ujygCEEsSQFJx1PSmKOQZhxgZI/r7inu5WQgvjPOBwOe/40DHzwnBVw/nK2OO4xzTd48xwoIV+CAePrQzfu8wHadudoGfyp4bMZyASQrEqCQ3b04wcUAI7RgbZFAOAMk/e/wNVWQhwByF79DVwodw3FGVgD0+ZeeQaZNuUqgfJz0IyPagBgeR1DK+AD9Dj0pmZPMBTGVYkcfeJ9anQbjlmxk9l4z9KDFJJIptlIYcnDD8TVJCuLF9mmjxN50Mij5vL53EeoPT6ioodm7MLK+47QdpXp6g1O8SrFKzwus5JUvvyoB747ms9LdocNhtuMAE02Kz3NeDJZUI+Yg8EdSPSiWVY3iclSgOWBHcdvpWert56mN8nIwoOQP8KtnZJvTazdevH4GpRVyBys0pMeSGJIGBgUwxAOJH+UdetEcCkYVnAz61OoVAEyHAGMY5P4UbA7srSxsSeSwxTYEIyHJHTBxip4l27WgImQdVxjB9KluFH7mRioGMgkdO/NFxcpVZkORnDA4yKTzE3bTv3Z79DV69hQneufNILFSm3cT3HtVW3i81QojJKjdwM8dzTYco3aH5BAX8uaY5XdjIU9MDIqdoYzKrR5V3GdoHFPkWRiGJLn/dz0pXJcSBomYAoRkdd1IN4PG4dvY1dRXY4G3d9KqX0/2ZljdfMBGT/WruyWkhnzMTwx+hpPOIKguw/WmxyROAIXaJ8/dLUpt3LHcFBzzz39aZNrEq3E33opDkdwatJqNwVKGZwTxjNZ4gk6grkUOuMlkHHXA607tbMXKuqNOPULq3JCSs2fU5xU8WsXbcFuT14rHiMQ+719KmMjc+g/u0KrNbMPZwfQ2v7ZulTGVb14qyNWleAsGj8zjCGueUOxGCdo55qRduCGLr9DVKvNdROhB7I2v7Vu41JeKP5eT81RjXpWK4iHPXtiseRHXrnaehx2pYlyck54o9vPuL6vE3Brhz80PH1pia3NvAWJMGsd4kLqRlWx97PBoaPHMcgyBjp1pqvPuH1eHY6WLXrcRxrdQsrk4dlxgCh9ZsgxKF/L7E1yzxsRwST7UisQV3puHTNX9akQ8NC51Y1izMe8yHb6YpYtVtH5EhH4VzK9QAp25PWoru2d2LrIcdNoprFSE8JG10dkt5bseJF9qlWWI5ww4964KFZInCt8wJ4NWjbGaVZXldGX+FTgGn9a11RLwnZnZNImQPMUH2NKvJJ4/OuQjt2bIR5PlGTzUvnSiP8AdTtT+tLsJ4N9zqwuTkYzSFSDjvXJC8u0JdZBkDHWmQXl4lw1zJI21eCnb60/rMexLwj7nYY9qT+VYKa6QBvjxxVpdXjK5MZ9+a0VeD6mbw81sjV47jNNJz61nf2vFnlWAPFK+pwoF28n86pVIPqL2U10NFFaQ4Tr3prfyqP+0LeNQu75nGR7GnCRWIAZT6YNVzR6MiUJLdCk5X5aUDpmmqVOdpBFP65/pTIsNIz34o7fpSheeKTOOvHanYLMXHvSDkChmUdSPzpiyxI6lyGXvijQfKxxHYDB9aKYJ4ZCfKYbc8c0UrruPkZycYbynVHXy+xycHABz/8AXpQVVsAMAwA3DHIznkd8/rTUbaEwGU53EscAP0IP4Dj1qRAFDFSRuG3djOzPbntj8q8Y95DUbYys2Aytu3EnAHXbilcMC5DxfJkhv0/HtTlDNMC4KloyqsOCRjCn0x1FRmYiM7UQsQSAeew4APTnvSEK8QCyCMFlOZFwOMZ5Pv8ASq8pw29QWkUY3eg6j8KkuHjjZlRQwU8nsM9xj60iEyRYQbyFyMYLADr/AIj8aYiEfOpYDCkglf8APNOeMAIwUAYyAy4OQeR9B15p+F2kh2JVScZzn3HHb/CkLKXVlwpBA+7kZ+p/UGmA7DNJhQ2ODwPlz6+1SxsrOT5mCD937uQev06Uzc45LIAnHT06j+eKdKN8Xmx7mj2nEjADIHHT+8O9IBVBebJbgNtAU7T/AJ96ZOrhkKqwTp15J/pSqdlurksQpAz24HUevFNn8xFfftXjoy8n2+tAXGRxs7mR2y/JAB7njJrVtJ0jcr5YZXXBYj7vtWKkr5bngjucc+3oatQurZJcbu4bgA/XvxWkSepossluztK0ixsv93gqenHp9KzL3AKlGySMj0Na7Xk0ttawcpL5ZGQeSvOP8D9Kq6jZymITlFVG6bjyfUqO9KzbN525TMQb1Ytz/ePv71fhjKTKCFBbA55GSOxz0NUokLIdpOFGSoHze+farEW/bgMWwcDBwNuOMH1BpGKJHRvKyhKnHII5P/16ms7K3nsjcTCQmN1EkWQNwJ42n+eaYXVsMxVW4OfX8Oxq19qCKUZgIyd3Hc4/nRexaSKsYzJtII5456+x/wAabPLlSItrunzKeoHrxTbhGcmUn5iMZA/LrUKAgDKMVIzyOlTcTRfeSOZFkZXDsSHG4nD/AN4egPHFQ3QJVBIHBxy2OCfWmRFlHAxgcYFSK6niRimOhJ6fXPam3ca0VmNhUmJhjK5yGHGD6U2ZsN8pGQeferfkS7d62zlWI7fKTj34+lU54ZSEkZSoOQOOWpEqxCwzu3K3bHtUdzErx7pY96gccZxg/wAqnQSbQUyYyckY9KbIizNGWdkI+XPQMB600xSjfcprpMj3kcSwssh/vnAUdc57j3q5EYo12SESsTjOenuDirXnSywpDLKxUA5IOOPQmomwSQMbQTtx6f41fMZKnYgnUxI6ufmBwCORn0pocMNrDgc4PX/69VJku1l3xTGRG7t0HsasWzmVAHXb7g9DSuMlMcZYGXoRkc4qOVI0O6Bzz1B6CnG3SRtrNknp3IqF7Z1dSpwCcbf60BYc7gKN5IXpkGkOcKUfP1NHlOGbY3y9weRTVQZ3OQrk9jwaYmmieGaRQQQQfTPapVmwwDJz3I7iq8jwvCYhLtGTyOuf8KrZuIOknmD0xmhIXMzSuJVhjT5oyx6Kp6CoZEimBcSEZ6YqmxW5DOv7uQcADpRb2zuw3ZyRkY707BzGjboyqMvv5qS4SOQDeTkHj2qG3wgBJzgdD61JI6CPJAyBnjvUmgRoUUAPjPYigoWO4E5/lVe3uBOSqk7TzgjNWGLo6+WFwBj3oKTTQ9ELHIIJHY0+Io6nOQfQ9aYrMXIK9f4hxTFZlkxjgHvSsBdIKwFh16EDuKpDezkgYX0qZ3bGBkemKkDDGAQcetA1Yzmfa5Bzgdc0xLrkgkHjoDVq5ti6uY/vnjB9KyJrWYMWKFQp54oJa7Gw12JYY4BEAyZ59c1JEuY+PmI7Y5/Cs22gutwOz93n73p9avWkxjmwMfL37VTuyFoxzo7AndjHahS3KswUimylm3EHdnn602GTc4BUhu9SUToJJSASPpT2WaAjeMc9QabdShAUQFl25LDgioYbhnOd3mYOOf61SbCxY86VZAI33Kc8jNWvPmTCsxXI4OetQzuu7eFCtj+GkMrMBhx0x83UU+Z9xezT6FwXsuzbvw3qKYRcSvjzNwIzjvWeJ2ywIyR1IqbzHjVWVslulCm3uxckV0JWK8q7OPY06PbFkK2VI596jVxK+ZSenemMPLckk7f7vp9KmTuaJRRYgxa7miUEHnk0U2FxtDYz7DvRR73cfulBIwqNkj5F3ZJHOMcex7VXnkQXO0LxyHYkH2/KnlkijD8FD1yOpznA5/8A11Gyh4w7B3cZxgA5IA6/hWa8xvyJYHRIVfCsBkAE43KeGz+PND7XlZIvLYAELnqeRwT6j1pkCrkGM8LkE5wFBAP4fSmSxCUKz8uwO7Ye3r7k+1MQl/E5uFkUuxVNu3gHrkqfoRS2s5WaOEjaBzkZ4Izxj0IJp8m5ypkU7ioYnZ93gDOe/SnmEmRlRkBxkso4XHPX0p3FYhjRkdQQemABx34x3xUkpbIaXKtHkkFgMfNn8etJH+8lHzMrqNozyOAcHdTSshVSmN0q5QDljzyf0o3Alh+eWMkEo5xk4AU5yc/09qZsCuVB35BBZW6e4z16dKHXDneF+Y4fC4IHY+xJFO8qSUqPkwMMrZ69uCf88UxXFXD7hIfk3fxNkuD3H+e9Q8yrh+Dwp46+4J6VPKqoyMd5H3eVOCBxnH6YqGWN8fuycdBzgD0pgRgFWJQjKt1AGCe+c1q6f/Z9xCIJ5ZIJs/I4UMgz/C2T93361kKN8hwT0wMD061ft4lELsCP90jnHtTvYcVc1rhdMtBKhvZJ5QAyBUwu8HGQw7VizX88q+UGLQmTKqozk4xkenHamSumQY2wxHyk9jT4V2lmddoI5U9Sf8cUuYrV7j7dFWFnfLS7WwO6rjBJ9aYEEaHau4nBBOQfTAX171ZUqkZ42KUynO7jP6ZqlehoZtr/ACkDkbskH096BE6xLO42NICBnb1Oe44606L5oBvJdsnBBoiO9o5liIwAwIJHAHUZ6+hFAl3llRCU3AkY+59P6VDGlqWraIXJEZj25wCcdce9E0TRNskXcFOHznPsfTNXLeeKJQFGck4OOG9arzyZQTAbkXJBxnJ6Z9TS1NW0RRKdybto4JIx+p9DUsKQSMd8hAxuA2b/AKjA7d6qWkkZKxN5Z39Gc4zz159TxUgG2WSIxvHznBXkE+vqKaM27mbqC3zOZY7rzFIwCZCvQdCpPHFWYVkNrEk12ZNpLIm08E43c+nv3qyFKOfmJTI5IA57g9v8aZJGyyDIyoz14xz0xVcxmoFW5lMXl/eJZevTj6UQmVN/mI44zhsHjscVLPtnDI+wFSM/7JqSOIpvwq5xyOB7cfhUlkO37uRhVz90j8jTYiZD2LD5Rxj86jupjay4Kjym4B65HfHvUoBWIyLnZ0B/vc9qBWHKYyrKORn5cf4VWWJhGWjEYkDZJYdR61LcBWjbZJtyMB+Oceo/rUNrOzJyuG3dqBNEykGIs68ryWHTHqKsf2jLFp8n2V9krY2yAc9eVzUaOqbWB3BTnHfHekliMgVcggthkzjjsc1SZMkYN5czuxbzG3H36/Ws67knk2By5PQcYroFitAdssEu5Tkndj8CPSmG1zIGMSbCc7Qx4HrWiaMXFsxIxKG9+4/lUi3E8T/LIwOOR3rb8tIwcAAEYOR1pZIYcgv8oxndRzXFyDIiyW6TtFyRn04pJEkaPzbd2KHnBOCPaollcS7SVKryAD0FXgY2IHzocccZ5/wpNlJFL7RP8odtu48bh/WpJzPANzSrvB2kBgccdDUbzPCdtym0A8E81O5jmjB3KT0z2pgMhuVYKdhSQenINXWOGALkZXPAyAfWqlvJtyJVjQDpg0+GdBjZIr5Jwc0mNMtRyvGm1zncP0pWcBTk7xjqKhwobBBVu4J6VLbvt2427gcc9GHcUiriwbpcnd8386DKEckqQckEGo2+R3IBx6DtSu+UBIxzwT3pWHcljnYKCw6HrVyK7DIVZEYeo6mqCFiBhcDkfNUK4Uny/lPbNFilJo6CG/VrWS3jG1W6rjr9aypY1ikJRcqwyVqGN2RuPv8AentL5kWHB3Z6+tK5fMmtSvEvlS74Jcox+6e1SjNrceYeSOx5pMCOYbiNyn5cdDUn+tb/AGSMD3pmTjfYnSdGaQyLuLLxjtTI4osOYcgjtUFwJEIKcnGD7VHHchxhsKx4z0z7UDL0LNg4Ib2NQ3GGIWMdeWwelNLYPysPMx0Bp4jYLvAVXz0z1phcakixEiMgEjnNSq8kgx5mzA4x0NMk3CNgFVj64quoURsS7L/jS2E2XlljZsEldvB29qkXg7g29ffrVS1uFEm8EA4wcjg06VskmPsOQtNIOhfe7R2iQRorLycDr9aKzpXIUEgcD73rRRZjuVxcSNGqxbThSCqoDv8AYZHFNDRqhRw5ZSCzKeB65z3zinSCU+W7MkpWI4AOFXk8Y79acEDJujQq74IDqQACeTU2GiQYDSYVHTasbFW5znOfxAqLcdzYZipxtKqOFPB6+1PncmZ027drDhB/COOPX1prFdsiFcEnA2AnAPp60mUVsuZFQNuGcAA7gADk4PSr8Jkdg0RVFZ9odk4J5wcn64PpxUMhdgc7VjIII7sAOp9zx9aYgDSRruDR4JAZeBnqMflSAWJxGFJK4C4Xf1PY4z0P86EUZZAwyy7BgY7cZ9M96deQMdPMkCb23HzgOWjAPyse4HUE0kLebp8cRWRpQzOcYIKg5A9frntVJEXuOLM8UoRlQcMVJJKjtn23evrUjHbOziNRmMsUI+U8YPHOAD3pt2srlWBQG4d2Ozo7ZxtJ9PSiCUm2mN6SmZlEjqOoORj0BznI70wJ0lZrpYZn+YEQpJ0MbHnHuOaju7ZoS6sSiklR33kHkE1Ss5k+3+dIDgdAP4D/AFro7qBZtPgijUs0O6QyAgAqwzu5P6U7D9TJtrZpJQEBG0YG4cVNMn2MoG5JPBJxg+1WXvI7aJArKxP3VOQD9Pxqld3JuTGZdojJGQOT7AUjVySWhDGpaJ5VHHTPAwcgY5781NEC8rs+HIGcou5uO/p+FaOnWcDT3H9qCRZmVfLIYIBnByxyMcdKq22snT7mI2cdr5H/AC0CZy4yQMk9u/FHL1Mee+w6N4pVLEhlZV3ooPDY+6Rj2OR78VRntzLeocmSHO4orYYJnoCf0JqwokLKxDlJ3Lqwydy55PP8PfmppkmK5cKQS3TrwcYx2HekaRXMNR3cwpk7II/LiUgYUAk8+p55IqZFO9TEn70clSwA9cgdhg8Z6c1LFbAQJKX2svzEbs4yM/kfXtVO5yI9kCu0pLb1Toqjr+nrS3Ka5VqRXNyqjYFUp9wlj3B9f8OKIbiIRhJ2YEnerE5xj37H2qnc7oyN6bZGJZVUcke9RRR7slwAw5YDnPHc0WI5jRNsSuLjD4yoIPBOOFz+tQNFLJJukd3kkAHck9vXjjFNt5JHZFRxjhQAPm/H0rTkjTzCq7Tuw+4NuIb0z+tIEiBIyEji2fKqDcBk5bOd3opxjj2p0jLt/eDJcj5vc+/U/SrE+ELK525O4rjGPc+v09aYJEUR+WQSCWznkc8nb34oNEmRCJFkJjcEMpUnuPc5qGNhHIS7Exg5XcME/wD16eI/LyHKsCpX5uc5PQHsaFC5Vg+5B8oJ5ZSPUe9AWElKvCMqVDk4CgEcjr/jTDCuxPLUlF+6w52HuDU6ZKfMCB3AGeT/ACqK/IjCwAgM/DDkBeeMf3vrQJpFSREityfLADkqcEthh3qohlbhMHPBzxk1blEjRM7EiMYyVHKt7n/OajMRkTfEoz2Xkc9/rQQOSU3NskkLBXU4IJGD9PSnC8GNk0YRxgjJ6D096nhjaJjKB5YUgFtgIXI4yKqvbbSzrESrckseF9/pTQmTuzZ5AZGBxxnjrimkMyKUQM23OOvT6dKZEDAwJUiJsbW6AD/GllLF3K58tjxzt9/8imSSSYLHaflK5yeCB9KhRFa2kSZvMAwckdvenqpIR2VsFvlI5HTOKGU+aSMRyFeS3emJlOGzaC4/cPgNwyMOKmVgAkhICkkDew/EetWo02kqyhuignk89yKqXdmWj32owMiRk4OSOv8AkVSVyJe7sPlEEsQdzhtvBx09veoFRPMYRsM9uwNNinEdwxbY6v8Awx8YPt/hVryoIrYyyB2RfnIJ6+oFOxLfUbIOApCleowR9KrpaBWUrnDk4OOKgubq8kZzYlUiK7AdvBHscU21uGa5YTyv9nAABcZAPpVONiFK7sPlt2t9zNIysDyc8g1dgcPbbyuY3GFJbHPqKUmKW2aNhvHOSP4h2qnYqlreukbsLXG7CkMyn2BpJJlOVi/CJDHt3ruBGQxxxildzvVTEVB5VafdRIrI9k+9HXLqw5Ht9aowzNOPORjhMkK5wcdMVNiuYuqSUbMW0r/COfxqLliCOy7mGOcVHECdwEjB/wBNv4U9QeApBBJCsG7elFhqRIWUoTGrDbzjPakLMVB2nZ6g1WW+t5nkjEhzGdpyMHPoaseWfLHzHOeVpWZXN2JB84YFeg49ans1jMqLI+yPOCfeqoQJyBgkbl5p+9VIIBwT+ncUik7k07+XKcD5c44NNkiDzoq9HYZz2p0U/lyDy4xx13cgg0yaGOQFVkKt19Bx2oDqJIgLMpADL3FOIfy9rYbjjIxj3qlMLm1OMkITwev51b0mdJbpFuZtsB+8Txtz3pgER2uFbpjin+YAzElRjHFTzqDGVR0kCk4G7nBPWqQUxs5MRMi8HdzgUzOTJGbdhdu4HngVNDJGFYHJbHy4ql52HUg+WfUHPNSnDgENyPTpQK5OzFkICjB65oqJCxiAyO+M96KYETKDI4MilYzuIODkD6dqkVXRBKJGQjgnbgHPTvz9KUyPHC3lrGiyRtkFj90HOPocVGqyBA7cIXUgseAc/wBMisToGBsHbEzBjwzg8N7ew44qcvGxVEZsEs6r02/3fpTWjKPJkdFJUk4Jy3696Q7d8W6RTHnqwyyjtx+lNEsWZAtpHMJA6TfKTGCNj5OFx/e9+mDTIQpf5G81twVQxI3Png8dR1p/kEx+ZAufKZYmTzAd7EZ+UdT0/Cm2gWKTkYhkKEsR/F1I9v8AE0ybloyMRG8crYPmMpZ9hAH3kJHUcfpVW3RVt5A2cLJtJUbiy4y2O3pT5w6xxx/KwRBvKjLcEjbz15xSbd7O7ESKDl2UEbfYfT2pjSJSMRBjJskdOEGADhhgj265FOmRTH5TBzuYnbnaoI9P1/GnOcyT4lVy29wAMlvr6E5+nFMfMbKMxjy+ZAuThs9vp0/OlcpjI0CPGxVBwCgA4cHrx2471ac+XC5UhPN3Rqd5YNH7AflmqjOYgzFwFXAdcdT1BB/nVpf3UQEifvTuBGwcKRnPp9KaFa5RSGRkH3nAPPbbx0A9a07KOXS7U3lzD5U4faokH3F7sB1zk9as6MDbWl3qMiK8ltgRq2cIzfxE+w7VgapfSS3bywsSCMbm47cnHYe1VayIlI1Luez1C2uoibiK6wWjjQAqx64LdcHn5aykh3RghRKy8sNv4Z9gOBUEYVPJTZvUsCGKnMuc4bPp6D2rTsph5afLslhhcFjjmTPDH1OP5UmTHcsBmQ4nVMOOijknGCMDvx0qe3lCISmH34X5gOPwqOeCSRWjtSqS4KRgnlFJy7Me3FZwu/sqGC2LSJgFzx8+PXvioaOiMrbGxKSQxMe5VBaRlPXnj61RkefHnWzBBISQQ3U5GeOu71IqSyuFlilRDGTxzjHfJA/PHtUdxCY1LRBfKU52dAgIxz75/PrTSsDfMJdG1eMMZHig2ncrEuWbn7h/IfhmqcELtDIjZghcbWY8sfp/nipxafvAEXFzH/HIcrGRzx2Bx+dWHUOVB8xQoyISPmdjjlj+f4VTszOKaZBYQlIwsSKZOcgtnJ7ZNbLqobzCoPG1yOBy2CR26dKzl3sSZPLbILRsh4OAeOegq8XkSMKXDKoBYggBWHp+NQzZIrzndLJjdthIGDxuxwOe1L5JknYmRcngAnYpyeefcVYUMsgLKySFskMfvHrz68+vamEBwobBDc8LkMewz6DpUlWKd7G7Rq8TeWiN8yAjHJxwPXjB/CgMI12Nn5UG5iSc+3vUiqCFY52kjDqeBn1HueKkkhMathl4UMQD93n17mgOUTcgDeXtJxuAUZZDjsPQg4xUckQdVIXbOi7FcAndnPJ9CBmnsQzjOVxs4UYK+vA65pHy6qjA9MKWGRgnr9c96Lg0Z0yO/wC4keJIR8y+Uc8jv9TUp2+dt3SHPXnJ9CPY1bmR5D8ofG/G0qCwPfb69KiU5yqgFx1LgqBn+In14p3IaEiCxyLKcH5dwVuRgdVxn071HcQxSQSxvIQw+ZCQRx7juPanhtqZb92mCyt1yOnHNOaMlztIYKBkowwe3r1poTRThjeRTHI2QFyMjJOPT3qMSG3j2KGG5Tyerf4HNXDEy703eXhM89D+NQNc4TLRlwp+foCPXjp+NUkQRQCN7cPlQXOfn5ZMcYPsfapNgdCy8FSqjc2M9v8AJprxxLIUQdjnOCQceoqZoyFwpk8zOCScgD0z607EsVycDltwI6NnpUYUxMirITIV3BU4xnrk1GsodgAQMgkJ6Hpj6Y71YgG6ItFHGcfOFfkbQeg9aaE5XK7NmORgickjcVwQfb196a3nQ71UBnAEqsCHAGP5+1PbL3BKxM7E52R4259QPTmkmlSVAohjUAEgxtgA9DketMhgTGJYz5SyRKCSqtt+vT86gJg815It6xMcASJj8ePwq/DNYrbwRLZtKTy8obP5KcVV8lGkjuY2zhgGBG0cHPze2KZmxs8qRNDEuBvGWYHOfYe9OR7JrnbKwjRmK7wp24/nnvQrRrdGNnRywwsRA2AHnGarRs63TxTW8Xlyny1aQZAPt7+maaswOgubJ9LtxeW6o8LExrJnKtjsRWOix3bSOVEMrOSyg7UPrj0x6VejM1sjRSPkHJ8lhxkL1x2qlLcoykeQqk9GAwwpPc1vFx8yq26N5EOGI4GOd3oPofWmWty4mKzRbHiHIwD+H1q2diqzRn94qEZYnpjpWeIWnMM0sSwyoxUtv3bx747igzJ2igdmlTBLsSSRgkds1PExjQgMVJ68dqqO0cTbi7L5n+rVuKsI2SwOcj7m89BSY0yRpQrGJAM44UnkfSnFgSoxx6E1ASGO7lsdM/zp5bPzYySeT1596k0TJ1cApkArwQAalTlz5udqD0zn61XIwQoHUg5AqWNAQxkYhcdTzg+9Isl3qylNpIY/xcmoWtEDF0JAGMgd6eEKlSI94zjg4wcUgkVoWLE56g55FAEdxbMpEofvjA7VJayOs2VViR/dGefpSQyOAuJM4PzDP61p6LeQ6fdvc+XvJRlwDwPeqi9SZK5nrp8M1tI5mUlP3rR4+4M0+wXybhZJYWktypDKOMe9QSW7TSsZrkPk5ATjI6496fDJqFpM/wBnnJt5CC8bjJqjFprclMasiujsSxI2gdBRV/UJLaTyrm0kiEjZEsQBVs+uKKdikZcsRWUq+3dt2lt2c7c5wfTP8qdJHiLYQ7YYFSBn5iuSR9elNViiICpy67UUY4GcZx+dP3yCJZQhDRsTIc9BwPz4rnOkhnmKYbfISu3avGAMHgn69qhjlcqzFg2NxCMTnnuPX3FPWWNpiOUhOSQgyRxxj0OeKJI0cSgMyQxZZRjoTgcn1JNUkS2WJJdt0xbyWfIIYHbjAz1xwMelV4PkjaKIBieVBzuLE4BPHvTpQ8dsisFy74AA9Bjn6Z7VKqFLrcPmjjbAA3E55x+tMRHOPIuDazszAlVLZO4jrkn696sWyOfOeZDJMJSmAchFUZ3epHbHeoIi0kwLEuy/K7KeMf4+lSRtJCoeVDtKkhTgFtx4A98r1pFIUuUeIEOI3IDSAYOMnGfrREA1m5MkvngACPYT5gOcMD7dMH1qGORzFumPzK25VODls+g7HkVJHG8UP7t3JP7xiZOBt9v9np70yWQQRStEwkO5QCyIDk8Y79s5/Sr1q7TSbz5ZcKqhSpCoO5Oev/16js2VBG1wJVg/5aNGPmQE9/c8YzUtvK0e2UxhkY7dpOMtjnB9O9A0ie3ZliZ9xVvLOckgcHHOPvdfryKytbty9+UDR78ByFOFXPOCe+K1pVUSAq23YRweSG2Z3A+5OKzJ4FZ900qxxABidpIOewA5P407ikiJLmC2VhDDujKfLJL9+QggkA/wL6Y5rTnjTc0lsDJb7AVdwcjO0jA9QTWfNPDbOUgtlkmwAss67trnoFj6dOOckVqXd1Jd6U1pMQdXaeL94VCCNRnKHAxxwxP4dqa2IW+hYt3eOdJEB+bK89x0KkenJJrM1Wx8homi5t5OUKryv1/EnFWozGjbopmJidUQkYD8kl8eh/8A11af5oiojJjG4sGBGF9W7evTvUbG1r6mHpsggluGaNCs0LxBGOMcDBB7HIrV8xwqsrh/mO4FcgA9D7c8D3qSGGASK5KmLeAu/g7cHp6DP60bx57bCpEXHCjDAc4x1OOKSY1EiaJnjk2YG1hvzgFsD88jNRvFLLLiQhY1cAKvLEE9W9T6CrtvGGysTguTwehYD7xz2xnFSOSuxQw27RuwNpHIyc9vw60XK5SK3SNCMxAAjIXhty9OvYe3rTUkRyfP6DJIBwSc9ef1qwqhLpkaPcWb5kZcnGOFPp1/Cq6QZuGZyXA+UrGMBhnp6n6ijcoeZXt5pEbezbgM5zg5zn6dfwqPzwlyEVkDfdDbvlBPf8qmncJdBplkCsN2487l24x7fXrTJItjo/ysVYgrjOenf0pWC5CHw0bxIxXdkMx5Bzn6du1I7O6A/Jk87sbQTznr65/SmuAoJ3ZAO3CnIL9c49O1TqFDbkcEqMFiDlcDGBnrSYRI8OAdm52wAHxwB+PX/wCtQhjUIWbEKHDPy2fYge9LKqF5VjONwOQTxgdz7UwuZHDAAkDds429OvsKQ2RFwVVg3KEAHkbQen45qQoNjyRy52nBJI5A7Y74zQ2xW2hzvKbW7ZGMgfgadFko32ebygG3KwwADgZHPbvVxs9zOd+hUuSbeSVZCVdW5Pr+HpTdjHIIw4PyKT0OPb2p9zm4nklHyLn7qD7i5zncevtn1ppO3IUBN2AQeCCT19uxptEptrUivJZFUlCpikcbiyZOAOpPbvVKP54lglZEcMQGjTcXBPQercdfStadQ25FwCpOVI2huecevXFUhFHG+4MsbM23aMj8KuLRnOF9hxhubVEMjrGZHYRxYwVC4yT6D6+9DB2UFUdizH5VGQAQO348GmuBM+5jhmOVO3jI6Z9u9N3TI8vlkmOUNlQeAhPoPfkelMjVIkkjDtG6iMFhu2HgAjjnPrjpUUUytdFEzvyMM4wBxg9Pc0GNxNtzuIIBycBsDqD9R+OabcAGYMH/AHr4VmwVOMcEiglkzSFUKgbNv3pCvIHrj0qqI0RgSxbcPvDv68dqmvSpOELBRhZAvOT3Ge/rUET/AGgxK0gVYwSFxw3frRYLkrgvvkAX5Au7GeP/AK1JEJIVV0LKwUEMWz19R6U23kd4Yi2NzjBGMAgnHPrjip4za/bJLaS5EsipvZQSGIH3lHGCaauJkskjyTNLJEzQyReXsBC4bHDZx61GqwzIq3LhYnY4bZkZA498VLKz+SwEf38LsXA+UDuPoBzVeSYv5MQmDPKSTvT5VHXj0/Gmrk2H5ijmLxYeAoYyeMsT3I9KqSzIsRi3BnDcMQemOap29yJLlGnT54SwYAYDjPUgdPSrbq7yFYWMZV2Cr1CjGep9qppiTGeYjwzLIVjGFBVehIOAQO9RMyqFViVfoyqMnP8AnvVi3ACyHKBPLzjGCeccVFIrBy7RkgjChQcjBxmpSHciCrcRlJQsgyCM/wAOPSpYsGJgDzjbzz+tEeEBBX5N2eeCas6gbeO5ZLVyyqAA2Mg9/wA+1NoLkZI8pyQwH+z3PSljf5xzjjDZGB9ajBJiRmbC7jx1pEY4G1stnIz6c1NirlhD8vJJJP1HXGRUzt8pw3U7dpHAPfNVYH3pkDK9PoTzU4ZyjDzMqx5A45HapaKUiZcDaUYFt2Rn+HjvSsgjT5gVOOcjr+NNTMirtbPOTgjjjofWlRmjUoQevY5we1Jo0uSY3Kd65HQEfyzTrWCScqkGCwbaPQe9EcioRhNoK9d2cHucVtWkcGy4aOQmUBQm3G1QOpJoirsd9NDMlsZYYWModWiOPu5z7VBJDlNwYIcZAP3sf4V2+r3ccejC3s4BLuTMk7sM56ngelcbqdkFu4rmJjErKDy25V9cn0IrWUIpaMyi3J2ZEvyozn/Vkj6/hRT7iCNxuicMmcjYOD7+1FTYTbRTl8orAoDGUgqSRwwycf8A66Zd7tiuc/NzkDjg4A/ChcvCrXDkrGCFXPPr07DJpk2950UxgszADJyM/XtgVlY3uPvYl+026wIXEjZ8vfncQR6Dv606zYh5POG9pFLbS21Uz0yfUelRo0f2rMQIOP3Q34yScZz6daJkAEr/ADQRISAitnO0YGPyxmqSJHtGVXdufZjMRbu2MjBH581ZleUyMJEBkjBDbBjneMkgc9/zqKMvMscHmM1tGhcDOQrsMtj64x+FNQuLqOVMsWdCqpyWYnIB/rSYy5AhinI3pLlXK7uRuU9eeAcDNJAm60MIJfneVYjlT0Oc5B9qiDKkTqhBUFniYgbwTnP6/WphtCQEiQFn3hSOCuMfN9Rn8KRSASs0dtIBHtgTCrwo256Ad+3JpYIlSQKGWZhHwofaC+0kD8CePcUy3DtDdDADPtcDPzf7g9Bk/pTpWYRPwH2Jn5RgYGeR6AA4+tWkSyCZ90ghhdmLBS+7gn+8Rn0PNSQDEYjkmQxrtwnQAE5yPfvmsyUThV2h1OcLk8g+n1qS5QtOXV2yRja3Y9x9KkpGsH8sxPg4kbcCeCRuIUn2PX8qbeoXULHG25I1jV2HK4JI6+3NFvESXj3q7BjGhA64Xj8M5p4kCLGGChJIxIASfmUnA9f1oBq5n+WskSPEpBWQjeq5LFsFeT1PX6VPPFOpRo2bPLPJIchmzgtn17cVJBEiFRlYwoLcEkk5wcHr0q5MqQhS5AEeQiqOpIyDz9cY7YJoEokccchAKnfIclsrkZA/M4/wq9MhkeTyXUhYxIRtOOAMrjpnnpRpIZp/KMZeQkIZOjKMHGwepP6VXG+GeQrlYzIQ0Z/ugZJz3zzUmsRkE/72NXUmTB4c5CjHB+uBmnXMbQuqgEPswBsyVzz82e545qW1h86527yPM3OVyOQRxk+gBHTmnkG5lMeBKD8xOcncWPze3I6UIZEzxu0a4JiZQAuzIUjrnp1OceuKnkjP2NZWj/dnEZLEbhzz+HvRJmOYK7H5NrA7c7uo3t75PSnyIYoo0LllwjvtG7IOQoJ6jPXFIogZXDMmWfD567Rg8AEd8461bgAmVNpEpyI9o4YsPu4Ht61TlIkvIpAzuJcqVc8vhsc+mcVcgEYilkLnAJK442nIOcjnGePrTQehaVmudNW3ii8wAFQUXLOxI3sxH8OMCq1wphsobNpiypI0hgCgNubjg44GAucnvVhAVtZAZFkkV9wJJUAkEFuD1GenSs/UEmmMLNEMK43nkF14xn+VV0Jadxr7pJFkY/wbwy84OMZPtU2kxRXV7HDOWMDHOOnGOv5+tFssIkklkcxqinZhc5bHQgfe5NQxlSxaFdsiKS5K9QP5f/XpJWYeRZ8V2lpFDJJbSNI8Z4Ib7wJ71kAb7ZnkjJZslCOQAOo29fSrVxFHNOiZZRgKzDvg5y3bAFOMVvJFiWRI3fqd2TGvYKo747nrmm1divZFbcRgOCD3B4bcOgz24pv+skyqx9eSBnJ7j69eKbcMDEjxcFhmPP3toJA/H606Jnm5CyOrv84A598e/GPxpcrDm0I5U2oxJUMR93HBU85OPwoaKQxea6sg2lcnA9gPfjvViI/Y3E2oQlA3LJIvMeHHJ6ZBXIz6jpXQ6TdjxFHd6KLiGCF4sW6GJVIlJDAbv4W65+taxp6amMqqTOd02yS+uovn8hWkWN5upUY5b3HeqV8kFtdyW4mEqo2BIp+Vj9f1rSktbqJrqxtICSxUmaAZQqfRsfdyeo64rUsvC1nqkeyR3tbyKBzciFQyM6k8AZHtnH1pqk3oiHVSd7md9gC2EbGEPIXZ3lHIZeMfhisKd4pLuWODIcDLOVyB3JP4Vdh1aays5oIoJJIwNqyDgKo525+pHvWRp/mNNNLMgLSSlzuORgjp+FElbQL3LboEVXUAKTtQjB/HHaprZwqytMGeTAjRiODg85H93HpTSrSQskh3JuyRjkn2/Tiop5A0qMFG3G0ggkE4PPYcY5qRPQZcOTIIjsiZjknjgH+lQ20PlTskaYQoUYlgOD3+vcYqy0E11mRIwE4BYD5Q3oO+KtLD9pthFOAgb5yRyBhTtTPXnpmmiGVFtgfJCLHtjAdUaTow4Ib1PtV1tNa2nlvb7TGYhNgNwjqGOOq4xn8ans1eO8tZBH5m9VCJAM7WA4ck9ACMfWman41vHbzNRd5Y0lCywk7EVc9QOhNUkxGfdtI0cMPkMCgLeYi4LR46H6f1qhIH2gSKnncRlV4wP/r9OK2tRe31C0iksJAI4wzPLktvjY4Tj26Vi3dtiYrLJIVPUg98Zxjr7U7CuNl/1xgOVYnpuIIHcdOKdF5YlOxm4JVcHLFT9fT1p2VAU7S0Q+U/PtBfGT744piZRMqHlkJG4nsD1GPrQxCkP5oQnJYbU3nGAfftx3q3qN7e3E8JmkjEkAMO2JRkrjAPv0xmqLkSPubAjIwe/foPapRAnlEruIDBRg4bGc9PxpJWGRFgcMzLISVzg9BQ7E72wAM4+Y9PTNOYl4RhUU7duTjg56U35PNJj+U5znoTjoM0xXGEMOhUgNnKvwfUCnhSodQjHAIHf86VhufJVMAE8dFHXp60oQb9wxg5JB7jjBz6+1AMkjYGNW25AAU+5/z3qVH3+WqMpkAwcckjNMXKHJAGBjJGaR9gBC5ADkbcDGO/vUWKTLB2BU4AIYrlRzj0qYP8gjMalkcHdjBx2z7VXgYOdu0FiflxzjH8zVuN1eRpCiAN1KenQE+9ItMCqwoclmkGQSBgMT6D+tXYyD5aK2UbgHgj6fWqXneaVkILrg4PA2nPXFPtzJEX8t5CisHwgHHqR7Y5oLTsbek6ktvM0c6hg5WL514A9vQkDrUusXtsYWbT4lVWDRvGedy5/wAKwHGxiFlUpgFwvJAB4K/nn9KdHcNMFWICWVXDKT9Mf5FPm0sJ73NC4spbeU3dtMqKyDcqx5QemfbHftRWdFeSOsquirEqFmjYFRweB65zRQ9dhe0fYzWQosbqvzNlYyTyxx0A+nBPanorwxtvbIdscDlyBxj0HI5qG2dYpond1AT5x1PuVPoc8VJcOIoInEW1njKNg4IAb5iR2JOMY7CkXcrxxys2xFypJK5GN3GCPp1qV8PHNcj935UUQjXcSXbPYdh1PoMVDullhjaDhYnZZHOe7ZVmHYc4qZIHa3MhUSoigSyMQUQE/IBz1IzxQK5ZillSFZCOWBGWUfL14GevBJ9jUUSP8uHaJwWcE5GAo6j/AHqS2nYSL8hbYFG518zcQcgH+WKSFS93BLK+6FzzjPAz0HuM1DKRYg6Q7M+YyggMOCOgP4mrCsVEf2XeWYDAA53bSM/nmoU2mRm/emJRtI6MoB4yemMj9aWRUZgAoCuGIVSeMnPP58fSpuVYnWJW8vhMAjYM8E9Tz3wT1/pUqqWdVj8zcyfxk4b1P1PpUDbVKuoPk9MoeAB0C+4FXrYiOQ5SJiJC/mFeQ5H15AGTj1qr3BLuUbiJnjWFJAgdQ0mScIccnB6H+H8MVAqsxSM5UNkSkLwo3fdA9OlaeuW0X2pYoVdo5Nu8P/y0PXJx+vbOcdKq3kX2e5aKSYOpzvlgBCgkAsuD6DFAr2IA7Nc3BQqpiXKopJ3t7HrgZzj0FSXS+ZiGDam3kE/LkcYOeuPSkSADezJlc7lOeSCcAE+mcdO9WZGLDdHgyhiXOcliBnOewHpSGnclheJLY25VAWCrHIRjaoznoONx6UTOJFkEu/OwKEVegBwAM9Ce/XvUCPKZViRwOFcHOSwznJqXyGadWydwfIx82FB9PXPr7UDLMW8faGMvluzkkscg9Ofwxj68UxlDjzShZowTtc4Jbscd/XH4CmnaIdzSI7Bm3Atxwc7ie4HYdzQkhkcBkcqcAOeSxOcPjtj9OPSmUhbUyRopUKp38HcMhsZHP+eauWx2gs6ho2BZ8DlgOw9c1QsYTFhX+cfM2OfvYIUD19ans2JkicK7MBuLMPLGeQQPYD0HtQUmOuDJDcxzOS7jgIr/AHmOfmbjAHO0DrxSwN9nkRJwWcfeweHAGM57AY/SrUXl29m091cRQRIEZjIp+cluAKoXM8DxpPbtcSxyONzTx4Kc9MjjB9KfL1BySdiwVaRnaTY20lh1BAx0A/xqfy0+RGBBAxv24VV6kepyTg0lg0fzFn+Yk7fdsZ3E9gAentVkrcOm2NFkkjQ7hjJwG547k5zx6CoSuaNpbkEkitGFkYIRuZn28Aejfj29ajjI2nDOhJDsp9AM5z6+1Lrn+jWQkYASsm5Sw2kAcBsdifeqhlBt0Jyquo+boAoBwPU5z+VPYi9x7LCZpFjysRO9BnGCwz17f1NWzbzLa293II0ikO5JCcZUcEBfTOeaqI/mvBuycON4Y4AIxgj3Apt27zuwVnkjDCNNx4Cn+L3pia1HIIpbaQxhRIFMaIcgsc5yfyOKbEyzKBIqkSDJ2D5hz1BP1xU9tGn2mKJ3HlNwdp+8McZP+eKk0zZNbXcRVFErBAxHHBOAPTGCeKqKuyJaIz7k6g8Fi2msLa3VXgV0IAaT7zKW9fxrY03xFPo4uUtAJJwqtK0hV1thg/dA4yR1Ix17mqbfY7awla4uZ4IUCyRPtyEuSCoKqOCNoPXFZ3haBZNHu3KNGYFLIJFD7mXncQeuMkHr610xj1OGUrysy55Nxrd1FexrPd20ZEE80sZOMgkZ/u4Pf3q74XtfsF5B5pht5zukR3t/NKqASzBc9xwTnpirmsNBpujn7FHK91eRItygPy4PPyBeCeM98VHoIV7oXCyia2tEAd4eIVYqAFGQOc5BB4646U0J6oXxhaXUNvJKuoNH50P+jW8RYKUADYK9UAU/c59KwNJ8QrapY2s9tbPb2zAySBcSSDOQVJ5wR3rcvbfyGME9zAslkWmhSVyqZJy0ZwOpBA5POeK5a80x7XULhItszLtYIpLbYjkgFT0x784q0yGl1Oj17ThqOly3X2KOz8iXzVaB1KujjAyoPHIOe4rmCqreCKLl48oWBDBecZB9OtdXZiCPRZ5JTD9oS1ljW3JCIkknIWVySe+ea5fRI77VooLKDal5cSJC7A/JcgDK5GOMY6jHQVEoqTHGTirmlJYLYwpFdmRNz5nDHBU5wAo65x396oa94qmt5fs8dvpt6EAHmJFtiXPRVBxjA4P4mty+0ZdMFxLrF7aNfSsjG3hZpGi4yxJOcsDjpxXP3vh/fpM13cQzLbyR/wCjzHgyvk8gHHGBzVOnZaCU7vUxdQ1S/jnMkZhty+Q0Ma/LEPoe3cHmul8PkXulS3FwoEjMsG7OFKgZZz34yPzrEnWdNP0ixuH802W8YGSUyQw+nTp6VvaNLBG5t4rSBRqE2x53Y/IB8x2+gyPzrGyvobNtocvmWDNJkMCY1lUnHBI9OmcVFZ6VDczrIjQmZpdyGZMsrEE7QemQOeRVi9mVtv2dmaSXG8lcfIBhS3+0TjiiSeVNHtlU5Mrrl1YOEYk847Njg0xGFeXpjs7i3s4oyzsC0rEL8isD07c46VQvGkmmhXLCYqVlkJBLNnPH61v63PptnHqlrbwOmpi+wxkUGNIggZdvfJJOcVjiAyRmPmX7OhdnAzuIGSMjoMGggaI1R1lKmZEK5jIPzDB6KP8APFRBtoEY8pSWBVgT1HUk/Q1MwkRHBA3oqlI1bpkk5+opssPkgJvYbQD8qkbi3YZ74pFXGq0HUI/l8xgEAHGM8DrUspeWRLdJll2jahAxjJ7f41GNg814vMe3UsvHuf1AxzSSFv3gUkSZCJtIwo6g4osFx0bdH8pn3rlNrDoBj8DUUYGDvPRepGSWPSpCq4d+q7lyRjBXB5+uaZHGpKhlCRlfkBPVgB19PxoJLELxsgWRMuGCswHbBz+tQs2T82GJfoG4WmLxNGsTlhxwo4Y9wR7Ug2rImAVUZGVG3HYmgCTc7lhK+ASoOT39QPpTowTEMhQxDENnJ9OlMiEaNGY8gZIy+eevIz7Yp6q6HqVYHZgDJ6cGk1cdyeIqSeSMYUAAZ9asp5hEqMSryDocetUkfPmKFDKgI5O09s1ZQjLFgyoqbcA84IyDz1qWi0ywXCSMQCwC8ll69Oc/WkRAS8gTJUbW29G4/lxUUDHeXA2OY9xUjAI6cD3pwY4Ksm4quS3XIPGfwNTYq4sbGLEmwH5CrZO0hj/X0pxnKqFBwGCrv2jO4HjGP50ttC0s0VuFAnc+Wd7cEk4HH9atXNlaW2rLZTXWyKP5XuUi+644IA9AR1p2C5nTKVkdJy6zquWLgls59+/tRVrVIrqLUroXrtLcJIRLLnO7PcfpRTJvczmJZWRwp4bbgc7hg/jx3pyOIis0a58sAfMwbJbqOeo96ijZsgkjcw3Lgfxf3frzUkSbZGVgqqVyB6c8/THrWdzUSGKQAjazKw5HmYUAZI3N+fPTtTLVts20/vRC24Rs2N3HX6cikaMt5rZ3NEyBVXHzKeuD0x3/ABqRLN/LlZMSKG8suxySB3A68DHNNDSHOjCIwxMHZxG26N8DBPOPSpZpjKTIQA7fKjR8KvsPwqCHejbnX5kkDAZ2ndjAz7ClNqQgdgdyr0z1bPIBqWUi2hK7XgXYpYsm45II45H0zS26qzIgc4LgAZI56nr2NMAVZSuQrl9x54HGeParCFWaNkjyGIAVj3A657euahloarxJNGRyWy6nbhuoBzj0qynlyNHA83kFnAYueFG4YGO2R396gKsHjZFAVyFVsdsgjcadM6b5HaMKA+3gbQ2CCRj2zxTQE/ikvBcRWtszOsUWTsz0HJCn15PINZcd3d3F5HBcSspO7fG3QZPRsdDwBn2q2ylZVEMsyxqRzvPy/L149jimoxjuHWbcY5eCOMkbcg+/NWmZWZZMTxose+IOwMZiRwSpyCCR6c5GKTMZclVdlbCjp83Pf06VDAx87EjBSH3EHgbh1Oew4FSCKSTCqwCnABHAAwTkn/PNJlx2CKNE8pHwCuXMYU7m54BPfsT7VPJJMUBYGbOMk4XO3oPpzkmqplUwSyTEqoXJBOC3Yfh34p8NzE0h2u+U6lh94HHAXsfWkUPkKxyjIYoVZSD0OWycH3xipjIUmlK7ncx5kfIxvPG0e2OB34zQSWtpCXOF+QMeMDd1A7knNPikURoTtKq/mbTwMLnoPTGPxp3KJEzCFJjMmwFgw4BIA+6Pbpn2pYSsk7SQMSzEjcX4Bx8xA9efwrUF4s2n+VdtGvlKqRKyjIAPIGORjr71i20qWwnmkZYVYnyDIhYHjBIA74z1p2swT7mhfSW8fmQxRwXayKVcXKZ8kj7rKw5ViASfrzUmntE3hYWxdraee6BVTGNrBIwdu7PByxPQgn0rnY2iB+1SzNNIzHfEwLGXj5XPfHbn0rSlubaeexa9lS1VlCR+VliIWb78iEEg5B57kg1tHY5573JIyLSPymZ8uCMbQpHPJJzxzW9oOo/ZY3e38tZIyG3uuNwI5XPbGcjH0pms6tDeummaLNapFD80cDQ4BVRuZmkOcEYPXrU+lat5pFzpOjwMsjN5btD5jseNznOeQe+MHtTVOzVmH1i6s0Y2vadfajaz3iWtxJaRy5mkAIVV69T1HPQVmuf3qqpUBAGYryB/h2FegWtxfJ4S1G/mZ72yhhLRR3cmzcCxQZH8OMnGRknHSuEc/wCjYZ0ScScrkEyKOrkjg4IqZ0tLlU6/M7CSxhIixcKw+YqB0z2/THNT22Fe3baQxfaoY53DGcY7Y5/nUUwjdwAAzfKxwMMB1JJ61YEjWMqhWxMSB83GAW5/H19qxtqdHNZEk2+zi3SRvGJdoiUgFihOcD0yatwWyxT2kVvbrcTrt3QMOZAoJck/w8j73XtT20+e8u7We4cYZvOHlsOMNhQT744rR8NfZJtBuRdWTJqN2SkW0nzHgLfOB9CMHHTNbU4O5zVZq2hy/jbT7czW1jYSTyxTMJWCMhbfjhCp5G3ng9eCM1mRXM2mWi/ZpQs29tzKPur2BYHAB9+ec1t+PrZLDU9OaMpJcTh4wkrFsocYZv8AZHPPUVxUzeSskVrPgyjMjRsWikAH8Qxg8ZOevNdEk76HJDe7Os0lrzVdTcxanDbRshkkCTkbNpAIGAPmPGD35zXa6zLYnT1to2ihgUrcyWdjH+8uJckHex4wBz7V574d0+5sIzfQsVlIVyrybfLj42jcDwxyPfpVHVLa7hupI7xJmdc+Y7jJOeB8w65NCdlew2rvct2mowXOoOlvbzAFg6QPJ5jl1BO7J7e1R6iECykWpMrAlg0hJJBwXLA/NjPTvVCGJbWG3ktpD5ryARyxjuRj8wSRityws4BqDPJMjQ7HYrECRGvQhmJ4wQOMZ5pJthNWItGa40bT5rtrg3DXzvEiEK6XJwdxOeVCjv1ycVW0m+utMmj+wStbXTXCOdsn7ssOVAB7Zzxx1qwUkuJQFWFLfTkkjDEBS7n5m+b+IHI+nStM6Diy08XkTPeXke7CMAsQHKq3Xrzz2OKlthG1ix4y1SXR5Vk0t1+23LG9uohH5iMxwcAn+DAJyOh4rz241zUNcv2uNUuDcuowCV2BQBwAo4FdNrttLDo1nFbzGN7hZI2lBBXywM4GTheCFyPvEHtWLpGnbEke9zCII9zkYPzbsKuc4HJ61U22TEv6LFc2l3JdXJiMk8SxiVzkYcZBX3GOvsRTtGt5WlsppxE8M0joVLFQBg7gx7Z45qe+hmgtJ/LbeYrYtEjsVCA8ZA6dDVa0eE30MVlK7RwRY83oHbGSeODWZoti3cJNDaSwSSt5kyLjAG0kH5Bu74B/GrZeL7EyrbqW/cxtGvJjBJJbPUnd396y/EFlbavNNBcxlI4Yxjy32mLjORng9/zFFneIt2rx3XlbUEaTTNhxjuR6Gi/QTuihrtrBLdtKtwZ3njExuAmxYsNtx/tfUetQEybPLndhM8o2KQFZwe579BxV22NxK6tcWjbY3yYp1OAjfKoUdOeScd6W4SNVnlHmxx8RwF2DcRjBOcckZ6j0osRdEN1cSTyPM7K5LBmKYQbsYGR3PHJ981XSUJBM8sjhhGSgP3S+ccZ5zj0qWYO1mrAxvHZx+akRJBZySWYqev8ATionQ7VicZWFFyN+5t5P5d6BpjkhWN4wZA+5WSMbuFIAPOPp370w/L5e5MsuJMFhkDbjOfenTwyTzyAeWsssZVsEfLtPP4nP1NI8ysTcDyxGxCxkELvK4BOPyoBMilQI7mZPnTCJlt2OjZ49Ae9BURELM0mNjDsGXjC/nx71YSHybmOGV9rMxDspABDA4YnnuQKjLFIZGZj5gXDMDyAvqO5z3FAXGy71T7jNNkLjphyQdw9jxRJIEdsuz8/KpXAw38u9F3kb0L7Qm1grknB459T1zmn3m6O9kUuXEeCowfmGc4/n+dAJ3GOXjlRnfaysyEjpzxkdselKGYMHACEk7VzzgY5474oni3rGIj5ccT/8CGTnB9ueKVowwmUBgylFO1gG5zk46c4oBMUvhHAPmSErli3HXrVi98rzWECsQpbLFsMyjGFx0yOfrVG4KGWQxfI0aLkxjcmQSOD6dPxqcIPs1zHvAMRDZI4PYjNIZcXHmYdxIDzx82QDzn6ZFSROsaIN7qRCwZgePvdD2wcdfemQzETIAN8ih1EgbOB1BzjryKqw5WP52w4GTtbGCScoR6Ui0y1bSSw3izxHYIyJEHqCeOD6/wBK65rKV5jdyeHJ1vWYuVEwWN2PUleoB54965XTW8rULbmNtoUDzG4OG+6T2rb1Kzt7rULiWPXbRo5ZVcJI7cAnp7+lCQpMx9We5Op3X2pNl3uzIUb7oxwMdMUUyREM80EcolKF9joMq469/TkYNFA0VBGDFEVPPDDJz6jIH4dKdcBI94GU2EkZ/iPGcenepXQZXaeisVbAICehHrx0qCUKFZm+WFwOfvdBkA/jmsDpsREySkQR45O9UGBkgZ4J9RnipIQ0nlSRoxjJbaX/ALo4I9j60TSAyqrYGFBAX+ADkEAdv5Usb72lY5f5QWTOdxHX6evpTFccsTGWaKQK6gEKQ2cY6EeoxxUhRixZV2syjKHoSOi475xnNV0VVA81t+zcXOMkgg4OPbA/OpYZ9xExBlXaCGCkbW2jjn24+lIaZOoVZxGn3AQo38+vH86e7KJoi/yqVUtHn7nBByMdP6VFbuPkdIzkjIYj5XXcc8diB2p4yGbkELjOVwWXt9T9O1Joq5JMSJR5flsEOQvIUkjCn6cfpTIfMdF85VLozE/7uOB+fenKUKIxULkqGBb5Qc9B7dDSTgqrSMykqnUHknqcD054oQmT2+JZRFvaPzGVN7Zxk84OOwINQsTv+6DuACBh0H/6+Ki3PtkkDAAk5JOeeo/M1aaN9ltdjb5dyhwAMhHXh1/UEfX2pjZF914yV3FixBXp0wc/hzT3RULGUSDam8KACSVHf0HI/GoSpRYy2AC5Q7c5wep/PH0xUwQhZWMm04GG7q+R/MU0SQvOJoZljxxGPk5LELjjNVLWRlSSQEL8pyT6kjGPfNaEMAS5/dpgDbwe5z82f8aiulD2qiHs4YrjAOOjH8qVh3L0wQSTDdujGIwme3Iz7VLG7srhlXGQV5zjock+n9aqXDtcXU0/UmMbQeeSeTjtgVdBRSrKdzM7B93THBBPvwMelBSLFyscUO5TvkJPCk4QEZ/Pj6VT8YRCyu7WBmYyxwxf6OyEbCy5JOT83JHT+dWbSSO4ukivGAgdv3hLFTgnBGfcZrE1a+N1fSXdyv2i3HMSq/MSjATJPIA4yAcE1pBe62TJ+8kS2Ku87zeT5kESnMe4xqCuMSOe+TkgVZTUbi61JrqS4+1TfZ/J3uMs2PQ4+727Eis6Bs2SOLtzJ5uNsrHjj7w6g+nNTxMF2iJVjjfkZH3eP61MqllZHRToRnvqIkkyR3FtEtvCbgkME+QlccoD2B7Cn2niDVtKtLmztboxpzG0jRqZCT91Vfr06dcVDJEhiQFySRxj0z0NCW7yXNvIW3PHmQAnO444JPtTjWezKqYCPxRNe/8AER1Hw5DY3pliDrGJDH9xwpx68kY7+9ddoV5ba5pkqzaaZYorQW0DSKHNqW6EZ424GS3WvLwIrW3uxMpZ3Cl2CDIVWyFXsTn2rW8PeIFsXmMscrzyQk4C8+pA5A6YB4J9K6eZSR5kqcouz0N7TtFljtp5PtdvNdW6KdqIT5gbBzgnOMcc12OixaVql/Ml3ZIzSKUmcT48qMdCgH8Wc5OelZEFrpt5Z2k+tyTWk10SYXDhZlRRwoGOUJwRnBPNZwj0/Tr+xtbO7t5Ghmci5BIiBYdWBOV44I9RUpKLuht86F1fVrw280Ol2yw6YFbF4DgSIML+79MY5HXJyTTNAvbfTtfuZLq+Fp9rhhhEhJkT5fvZI5UnI5APQjNVoLV0kZr+WH7AspWeXfuRlDH5VK5xwR2Bycdqh1oW1rcRR25nZZAsytMoDKHY8cADAK5Gatvl1M4py0On1yCSS1ilnlsbuwNy2+YygSZzjzEYcgbeCp6k1y2t+HbGyvdSmt9QW0063G54GieQpu4UovfOOucVWktgxkmOTPOTt+XIAwMnj69KvJLFc21jZyI2+NCDPNNthKglkCqem3PQnBoVZNhKlZXHWzaTFDDaXJvpoPK3TSuoSSRtuQQBnAPHB9KreKL9obOxt5Apd+UVoiJEixgZB5b1PpiqKL500jSyiAv8pUxnjHOQR296NTZJrIy2+pyT3IeRVWWH94ADgBWbnDEkf0pxqtlSglYj8OiGSea5IlnaOUYt40ON2OCT0HPqOlaV5ObW4N1dOZbqQIkDMCcAn/WNg8cdj2HNc3oM7Q2F6ZFbdAGaTyRz5bfe5zhl69c0yS4a6WK5mL/vGLAufnCHH3h9AMe3SpctCHDoaEF3NLJajzVnkt1kEnyFd+5icnB53NgnpWlYeImtpo4bi3t1Owwu5TDbSCwyw/hz+IrJtHmhiupIZFCOpDkn5Xx2H04ocOu6RfnnOAAoJ5PXA9gBWfMy1T7EslumqRzXxtpcW8arFaW0ReCMZADfLyc846cd6r+KCllo7W0kKQteugc7BkBBuYDng5P58VKbyeC2aGykaBrnezSCTaxTGDn9ePesgWJvNNjtogEmRvOQyHAY8Dn2xjNVzXIUeVmvok0l7b29ghNyzxk4VskIpyyMSOQevsaBavYQX8AiYeSMI+7aFTOSAO7dqx9Jtr+yvIbi5heCxhbzpnEgDsvoMHOD7dq1P9K1Az/L/pWoBniLv8qrySfbjHWp6Fyte50VrpsN1o9nPIBLNsUOUGFC4yO3Poc1j3cES+KGGT5626NAqQiQO7cYOTgDnOe2K0L95bDRr28spLi3QRqYNz53IOCCvpnjNcYranfXEl00j5mKySGP5lRVz27DHGOtNLUznLoa0vnCBXjkVpHlZlRG4V0O3aOTnk9qgvZIfskixiMxxR7IQYslSxwRz0I2kg9ealxIEsZE3RRjCRMrAAAfPlcjqDn3qi254XVZfJDt55D5ztXkZ9Sc/rTZmPupRcXbTSksxlSaaTyx8wJwAB0xkZP1p8sLyvOsyhXMnzhCGVFUEEk+uSKhuSxtbmWVnSOWQBYwcMVIG0467juz6cVd1G2a31ZoBHh1kZXikwB5YTg5BIJPXHrigaZVkKR2ztDJFHsiE5AJGHwFIz345xSyx+dIgiA3I8MaggqhwuWOemeO9RtOv2RSATaRzAnC/fCgZTHQfTHNTz5Vp7d5W8xryFhGoJUsRwSo7AcUh9SGNARKcyGSdDsLAYO1sk46HjjikfBhldECAl9shyCynGcL0wG/nU05klmkvJLeIxfat7hTncep+U/dUH0pl3beTBM8cReBJtjTNxkfKW57cdKdg6Dpm6GdjHChWNYgCXU7eM+vpn2pkcIDJCjMJBFsduVdW5OO/oRn0oT57ouxDwJPv3knDKOBj3XimMWe3kaUSO8hI+YcOckgg9higLkbksjCGQsrIjBVBwx4wc9sVOzu0ksbZKyXIADDDMSRuyR64/Chw6CCUsn2be0KY+U4CjIx3wegqJ2jKxqrNlG2yzMSAwZt3GOmB/OgLliWUyQXjxPEoiCoItxOd5yAB3AIJqcwu1zu+YOAygMPvBlJBAH41UVirSnbuhiZGRB1wSfTnoangUQ3SSSyMphKW57cEHJJ6ccUhpj4HMBgaIuQEGZEOSysACMeoOfzpN/MSfN2j3t1RA3DevTimSGMR7n3F442jOxQApxn5fbNLBE3mJ8kokhmUFVUEDJBGPwOcUFJl/T9STT2uUNpZzRSMu4zoWKtg4x/Orn9viCMsmlacVXI+WHB4APSsIN8zSFFbDkhgCD1xn/630pGwkcyzM0cW/KkjPpk/wD1qQy5eTpdX8kyxRoZNrkJ8qgHHT9aKfqa21tM5sr4znzlIKxlOvbB4IPp7UUrDTInJEWGIVGPmcev96orwMbY7AAxb5to4bj9O9SN0VCmGGSMe55U+1Rq/JXOxQ21ucbhj/EZrA6rlRVEoA8tY1dcjAyAeh/AnH0qYx/MMnyyAAwTHynnue3anldwjI2yO671Qtjdz8w+pxkGki/eSCQD5g0i4Yckkbgrfr/SnYgHCyllLYUKQuRjIPTP8jTo1VSsoUMAwJXJA3f3T+FR8T2wIwFYbWz04PU/mKnRGDoNoIZDgdiAOn1HPNBV+hMiFXUOMBv4c/MB6D3wfxzUf3I4QYyAADjGc84X6Ag08Rs7b7fLyKrbScqT0OT74FNkOyOQFwAqlQSuMgjIH4GkMawk8mN0fAUlFDNyAR3H5jPtRBciZyhH3AQpbqyg5Az603D28pDxqXYAbG+cIxPH1B6g1LFLG8r4ZUG/apPynqcjP16e1DQJjsB5EYrzhuOitnoPxJp8aOWbJd9oO/sM47+n/wBaiCYFoyxAGer9cDt9QaJZgjIxQAFmfYD8zdRj696dgHzbDJIAzAsGbdnBYEZwO3alhl+eMKR8xCso56jnn0/xqAFrRcI+ZCzBMHIU9D+JBFFsq28rjB2oQPLxjHPQ5+v6UhvQl5U7ombG0jLHGCDzknn0qVk5KFlOBscHrwOB/hUEkvyJIx6jLcZbPQ5HcnrT4mAmSU71VNgDuvJznkjuM9KYrkwZ44S6gM4XzGHTJJK/y/Khm8kOkoeRUXbjP3j1z+gqSaJoElW4X99CCShH8ecN9OtRENBDN5YEgGCM/MOcAn6YosVctaKYrm9SORVLTPhmI3DbtYkY9+me3Wuc1Gc3Mts8UQthNBkRoSQCOOM88YPfmuh0qQabqMM5RWWHbIAP4skcfXG4flU3jfw/DY6gxy8Ngzu8caIzFDjcFB/g6854NdFKN4tHNWlaSOXXYX8v968aQ7d0eACw55B6dR+FT208smPNH75sFsng4FZ1tKxvPLuUm3q5D5+ViOMZx16VdklSS+lCL5eTjy8n5fbntWVaDsdmDqJTNa22uibtmSeBnoK0fsnkW8j7ix4+VR0qvZyRRSIcKY2XPynOP8K6IQpLBnaQXwd+cEHtn2rCMe57mlrmEdOS5i3OpzuUIvds96zNV04xzL9ozIpLLheF3Z65H+eK3IokWYyyy5VomXI4KN2I7E1Dc2bSu8aOcbfMxzjjAyPT/wDXW8GkjixEOd7D4ryFv3tw9zNdxKE8yYfJE2AoUjdwcYwR+IrQtNTlSUamLGCKFcQLdCPDSHkCPaDtJHfIGetc88DIstoY/wDWLsXK7uQQcIfU8jJ44qg9zJbwW8sDFUgYuyDMbbyAFJzkE8fhmt4zTPIr0pU3ud1d6Xbazp97cRotrcCX7Rbm3IRGTaQUlXOCxbJB6jNYf9mXciRywMbqJdkbImdw2nBPzYzyTyO5qDwxe2SagJ9QkJsrzdDIduWlIG5MpnH3wOa6XxhJBBZ2k91I93cTKJLdYsR52H7z44xnjaOtVKKktTnhNp2MeKKKMwh5U3+YrIsal1c44HHT0P0zVG8+cMUjYIZNkTMxJB3HAz0I7VYt7xLq5cxukUqybnlPCOxBLMvHBxwB+NN1ERJd3cMMhMMKh4GJ6jHBI9uTn3rBqy8joWu5PoVw2midlhRrjaLeASnOxpGKs39a5pVSzkNm8olcsxWZQShycDPrkZrSuomneWSQgswDowfDMA+CMfkTUOoaZLJcQF0dZmkMskjKFUjG4nOOABxnpRFkys9Dp/AOhw3Qu4zJHJB9naN5GG1Y85UKAOjYBOPf3rn9aktby5nTT4Fj063kCAE5kJxtUk+nH4VZuvEOqTQRabpUsdlZbXY7IgGnz1b1A4AFYYvyLwQ3h/c8W2QMBMchi3qD1z64rS6aMtmLayRqiyNGXkBKkfwl87Rn25z9RWhHAltdIkZBkDkh343KwwF65GcGs+3mhur+eNmIRpHUkYBGOcY+tWZ4tltbXE7DzLnfHtAz82flz6Dkc1BfMV5N0MzRogBkyi4PIxx+p579KighCRrnYNz+WSSd+0DOQfzzVgQxyRXoEvlMjrHnAPbGB3JzmmpKGmuZMbYUbYoztYFuOB9BQSytIS8im5wqsjMVXJIH/wBfjOKtO/kSXU+1RcxxhGPO3kjJ9jjjFOs0K3cgRl8tdsS7OdoIyxAPXtn610GqWtrYwQLKJyL9oVuI4vnYluQCO/rjimiZHKeJLtm0OCxtJC9uUDT7VO4NnOCT/DyKS7tpdOsHs5ooZXQ+ZkDLEsoAG7uK6PV9N8LQanfQf2xqcxKsTH9myxOQPvBsHAHTrWBqTW9xMlxbXEgEjJGkskQAjwMJlQcgADr1zVtWM2yLzN91aAQl/LYuGXDBNucAE9skZ4psQc2EZkLBpllth5Zyd27JG3uPfuRgUl15UV3PHagJCkW2MsSCWyARnvyCSR61NGwjnhSMMEgn/dYHyhzhic+o68eppCEuQGjmmjZ4xI7WyBQeAoA3c9znp2ptvcLBdpPEzmCO3ZsHBBLja3GOe/0qWxhmv7ZYBK5HkvPthIIjZnwRyeox25qKF/tFxM53Isqqdq/8s9p5wCOjHOBQBTs1WG+hSSWB4zKMc5Vhg4LH8vb1qzbbre4tJZppIVSWTe8Y2lML8nJ68kUnmFPDdxcRR+XcNcLuD8/uCp2/QZB/OoJoGNtf7i0iu0ThySh2sufu9C3+AoBu5KglLXCRlla8tsjL8E8b9w684BxUl8TeCBZS6Q3zxhZXOGaMAKCB0OMMKfOssuoRmGd5DPFKImbaPMAbkHHf5ckVBuBiPzSfZ4ztRigHz7t209jgcccZx60XYDrlpp7y7aWaRTKDGTgFDIozx6ZA7U2SbcITCTHPHaoSGj/dgqDuz/tfpzTCQIowibIIxHdSJjG/DYz6DI7io3MkitCAoL+cd3mY4bBwPU8cfWgQ6WcSTTYC7I2WdCoICcgfrTXDTPMh3KqzmYs3O5cAAj6Gq43G1fKRpE0SIp5BUgn9eAfSrGoFYHYDzI5NjBHlJ5dgDhj9M0WC4RuskiOFMnnmSRw/U5yNvH0zipsmSO2WIMPM8r55RwW7qR07fpUX3XiR4443Mh4Dnao2YC/Tj9abZypHbQbEcKkgDJk5wG5OD65oAtGRB9rkCMHKsxCg/u93HHqDg/TIpzo0lvOzMY8eSMg5G8jg+p4qJVwlyuWEhKR7EOBsOSc+uDxU9pKs01sYVedXkhX+4WA4K59jQVzDrHy59RMcxWG0uHjc9iqE4I9snmuruLWS0NxMmmwi8u7xYLW3kTeNq/eYZ67hjJ9641Iml1LTbWJlmjMgimJbGS0hH4gcV015/Z9vDaSJJqMi2t7LYPO0p3BSvJQfwjsKBt3MfxCkVrrd9BbDECzKfl5Cjqw/CiodRtpLC/nsWkZ/JcRySEEBwQdpI7HB5opDTQsqokMLrzuLBge/ODj/AIDiq7RmTzGDFpBlst14OBj3xniplYSFSijAySv8RHGR9etPyIwJDIAFYBG2kKARj69c/jXOdjIpYmb/AFeGTJDEfgc57eoNJOoUo4BEhDbh/EGH3Rn88fWnSSN5bocACPaVLcHnOP8ACkieURBMEs2WQE9QevPrx0ouSLFCYsqAHhbC8c7/AJc/gcDp7VLErvDuJbeT0bqWAzj6kfnTFlGHcExsQrOq8jIPDL9R1/GpBgxukirlSBgjGARw3sQcUFIVHHkttDHy23Aj7xGen4ZqRI3QOc+YVXDYGduMEMP50hcojnaqgrkE9ScDAz79qghaR7gKp24JK4PJx0XH0pDJTJIVkJjVPLyT/tozZxjpweR+VLlQ5V1RVXIbaMZ6kr+pqZIskjO6QrwvfA5x/nvSeWJGjV3yqkgEruBOOD/n1phYhLh8E+Wg4Z15xgZGRUsSi4dSVMilfmJ68grke461DIqohRwwABJXGGC8E4Paq8935FuY12glAwboCeh/AjHNAti0rPGJoMwsWUkuuSQQPuY/AHPvUwQO3meY7O7DYZBkk8ce/pTdekitdTkSJ98flxsCB1crn8R15qNJpJYQwwXlw4G/lWBxx2GRinYL3LLNE7o54iJLsxPKruwwPuCDj60qIrvMFuAyFXCNuwNowQSPf0HvUCPCod8B41fJ29dpPUj1GT+VTQwi3Nysa7xEGKAfxKPf2yD+lLqCC781XXywy7wrBXHUZzkevrSLGUT5t7hl3R7eOCc5z68VPHEQ1u+2Q5cMMjJHH6c5FWZIbW2jt47u/EnKsEtVJKRsTjlsBW5GByKdiilLzcDgFdww3QjLd66vVJLvVLeztp/3u5FiVkcDzEUZ6dcFTg/Q1z+m25utQtLS6nkigt9zTyFMyKqEnAA7k4rUv/FMWnXVtbxmZEgYrNtiQvKzNyCzfcxnnHTJrooaPU5q2tkcpqmnKb29W3DqibPLaRwEyeAgbOcY53e1ZgZmuJd8XlyIwZwuSMjgnPbr24Neh+KNLt5LhYtJvYLm0vJvP8uNi4JQcKx/hbqMd/SqHiHTf7GK3aWcISK2jeSLALMxyCFYc5HUiumrDmV0Y0qjpsxNIuI2lDEocYGK6z7T5cLLESY0U4yed319K4XTozOJjboX/drI8cq7STzzx97p26Vbu5JIbM488suG2Mvy5PRQc88c5rg9m47Hu0cbGUfeOoLI8CSSYIzu5HUe9IrRvNulCIXXazen+1x7etct/aTxTOnzZAHyE449easDVJQXUkK3IY5x/n1qL6nXzwnG6Zd1BpVHmCY795UDPIB9/TGa5vU4njig+zlG3Lk5QE5PY5rZnv0migBUPj5uRz1/kaz5Fy2QwyvGMdc+lOM+VnLXpqcSfw3BHqF5DbyCSGRSVlxJtSElepB6njt0rpNZni1bXZIYZY7nS7Zo0hCq2ZYQM5/FgRkdq4xmayuzPEVDzKyNJgEgNkHB7HoTRp9zcabextI2JYn+SQFSPlzgDPUeg75rpjUvGx5MqPI7nXb1hsIRENjsyjYc/uzx93jpjjJptnEtzdn/AFUfnSyLuYACKNE/lTI7uGW4hyFjMql5rdCBtIBIIBzg57e1JdTLBe3ERWTYULjPGVYDGevHfj1qJBF3WhXnj8s28UoEhKkbgM7lx2P+eKqTrLJGWZnkdv8AWKTwxB6j2wO9PYhPs+6TzNo2oQ2M7hwT9KkuB5l18xlbICZbjjA4z7E1BQtlva7mZGbZBbMgXPAfggAmobm5nmS3uI7OxFnbuFELp5hdmYbnIPGcjkg4Aq5aB8LkqwZC7/Mcc9Bn9ap6tZ7I7Io5ZHTdkj5UQOQu7n+fNXGSSsZyiZEzxtctPCjp/rMsCMAhiFYY574ArXupledIZEkihto0XYM4DE5z7f8A1zVazgjkS2GxjAjFi23Ib/J28Va04N9oSXcWeVmjXC+2Mg/U8UrhYIlZIpJIYwiCTcq43EMwwMDqOBTbG3kmtJw5iiWIorO2N2R82B3780SiOIQLG4Rt5JJbOxzkH5u/SrFtZxf2XMWZmupiH3E7hsIwWK+vsOlAmQeHljd5Zbl9kca5y3IaQnOCO/yitXVr6W2iNzJayx3Kp5i+WuVaTGBg5PAXkjiquksbq3mgWKGMvd+ZvjXaGRRtPfgYUk1dmvItU0WeeDLMkgMuCpGPXJ5x0GKpK6Jkzz63uZ7q9tp5VVIV3qPmOTnktn29K0rYhrFpowTDEOABgmTaf3hyORz09ah0uNEeOI5zA0oKkZCBckAemQRVm5QxJfR4lyY0SR/UgZxnOMc4psy3HyoY3VG3BIoceWCdxyQWXk9TURlmjt283JRVfzVyGxvGQAOucAAH6065YujlUCospRFZSNoZfUdweBUkkazSw25KiWS+XbxtThQGDe3BAoAtWk8umrI1nDCktpZKu/bksWOC6Z53DpWbcKVeK3Cs08tts+XJERyGAPpV21kH2i5hZjGt5C8aluFUh8BjxkDk8cZ4q1eabb296jyzMzrbOshZsAHO04HQ5/rSbSKS0sZCGYrcxSSqrm3XkRZ2FCQF46EjpUUEKwQXTyJvM03lxF2JbcFAB9vvY6UgWFkuiok2FI3+ZsbSr4xntkdBVryZZrq4O04uCJokdsEgPtJJ/oPTJpk2IoAS9sXRiGhNozhf9WyqCRgcg5HXrTXESafCltE7+bFM0yKDgMZNvygntx9c1Ze4L2cc6uSjzTTOygsEcZVfwxiq6Rt9nAjDs8lqxYZHyMrB8j09aAGXJ8id0kVIXULDsjztXGTgMMgjOPWqtrJlrNHAAiL+aISQCBnGOuTzk1ZaWI28xkWSGKSUMMHJ+ZcE8dAarRvuaGWZdlwC/msFGEPICkd88c0CFnh/0aZWlSXiTeBwAvBXb7c0t5NiO4mj3SNNHDkMcEDqSMcZwAPwqsFP2e8gcbBGG5ySYzkEfgasNJKLxkCxxCJ4y6E5BYlufp6U0Ie0gk1aRzCnlTFlBPXJ5DADjkDFKNz2TLv3SXEfn5kw20fxYI+g/Cq8Xy28KIp8yKZyMnlhnPPp1xUiy7LexZM5WPAiGPmVuMfXJ5oaAtSuxt5JSAsjxIrx4ycsw5B7YGMCnOB9rjiMhj2XL5BUkKoHp9ev1qGYbdQWxCqpKLvjY7shOoPp0IqN5DMkdy7sgV8Y3H95ltuM+47+1ILlhGllubPyVEYhuFSIkgEFjuznv9T7V2yQ6k6Rxy+HrSadrg3DN9qCgzcgNtzzxj2rhw6wTyTTQ+aILlJFjPGAo5B9emK6K7srOXXZr8eIYI43PmnzCfOTBB2hR3A4GPamhtlHWYdVt5PtOpw7ZLx1MjA71kk5HGDwR6UVPq+qW0ml31zbzYmuLlLuGAfK8GMje3YE5PFFDQXKDRSeT5jsNpGduRnjqP5VHOA8H75ioOBuI79zj1weRUhbD/KgAAwF9upHv3+lTICYgzNlSNyjHB/h6+uMDNc1zvKvkCORCDy6hgFOcg5BxnuCOnpSgbogs2QFXaCO3PB/mPoaecxj5T8wGQvTGe+O3PBFPCBsGMDA3EbuRzztz645oAjSPaodiRuyCPRhz+VSK6oCqMqPja3cbW7n8QOO1JkeVtdUCvlHK5JDL0bn2PQdvemiNIy7MvzH7y9SABzQFxGKsjIxO1sbi3Oz5eVI+uDToFXczKysE2gsSAwGCcgdeCOtJtjdVDylsEAN6kcj9PzFWIrcIsjHGSSGXtg8gA+xx+lSPclPyAyOPnj2vuA6EnG7FSsGWDKqFQttyW5znB/X+dRoN6DbIjkBRuwOQac6/IMkg4wDnlQD0wewI+tBRCxLKw3Lndhdx46cfrxVC+tQv3HUqUJUEnchHVfrkHjuK0I3R/MeY74CTvCjO1SPlZfowpt3IzTvzG6ugLFlxvJwQR6HvVkMge2y9mG+9napz1+bpg/5watw25WCAKNyGNgnzZKncflHvgE1XYsQzKTsHOSM7XAHB9sCpSFYxJGf9azRt6q4bIz/AI0gRJGEAKuEYjAWTp0B598j+VWoYzvXOMMQAAvXKn09+M96qxEFQyKSzRgKxXHQnB/Ug1ZidlA2kr+7Csx5AwflP4f1pFk80sYtpHADv5e6fZuJTgfyIzx3NVL8m9jtp5GOIwU3gE/LnIH68VckmVFnafzWhupPMaOM7VRhgDHrwTnPtVKJks7YNH+9SERo+4YYHcc49uF/Ona2w4tXNjTruNDPcBZoLCeFoFmi2t5ZIGcjI7jIzggnvWdeaWqS2v2iYy5j86JEIeTnlWOTxnqfes/S1P8AaUxcHZcREMTwACyn8RxjFb6zywxyxQvHFbvGzsrxqzdMDax569R71qtUYTjZnHaqWe3hubhn3RyrhGz2bofzyDXql851DSks2Vrm88vLWxRXbcQCWJ/3c4B69e1cZrtkz6fpkm1cXM0jqkaAZ2gAjHp7+taFpJc216j27TRzKj4XzCrHAGBu7nG7BrWnU5XZmU6fMjYg063u54I542sY5WMJe5jLMpVTtbzB91vpweAa88vIrmO6jW9eXzQzsWYCQFQT84CjjOOg+lepxatAhhSKeaV0LO6m0fcwUgYbt05yB2NYk2n2+qajIL6KS0liBSSRmIWTd8wdSB/Du5PvXU1CcbJ6nOlKLucdbbdVW3aJN09w7wq3d8jIXOR0x0qC2t2DvFGyOIxnLthto+8Pcj06kU/xVoF94VSzczpJZMyTKUOJA6t1weQf9qr2qTMk980Ili/feaMrlo95zkn1Irhqw5HaR6VKq5L3TK88spMTJsztIyeT2wO9PAnEk0cu9RE2HIXoMdfp7UkzxpNG0LCMQoxVgxKu3t9ev1o3G33ywzSkltqvnkgrznPv3rJxV9DoU5PcLv5iW6REllReQOatxugh2AbGVSOOpB7CoGnMqoSuSBg4UfNjoaSOUiTcDw3IP6VjzNPQ6VTi1aRLHfGOZVCpGbc5EgQBmIGMnscAkY6Guoaa0vfDw3BHe2t0IlUlcqcqwA6kcjjsRXGSjdxtPzDORzn/ACa30jFjoswhjwkqxIx2tlmckEPnoR7Yz17V10puW552JpqnblEnLS2kKLtwqPJ0GQ44K+w9jVmYiCaKSMuhmRnUE7iAAMDjg/N0qBJbmWGGKV0eNQ6ZRQMDhizev1OasHzVlYOWRn2Myq3HJyeh6AAc0NLoYptkaRSPbCPyifMKR7iCDnOCfaq2vWkk17ZpvEUKruk2A5JVsDA+oq5av+7aVyhOd/Pbac59dx59qbcOW3lQ/mAhwA2QDksRn3GPyqNimrjbSBftCRSArCsoSMD5TIcFjnHQ561Ws2aNSYxlkXy1Cc/NnOPYgn8asxFoPJdWUPIu3cVyd2eCAP4s/nmm6ZCzSgshBSXc3HCDdnH0zk5/CqIKZ8qDz5Y0kkWDiOMnJY4PJOMdTTorhRcwuwP7uPEi5xvJUkZ9D9OuKmtHzJLBcgmImQKowDv3E5z0xgd/Sqt0PN1HndiYxbmkUfMATzx0GBQJlrw/d/2czu7SEbDBtVefnzlge3Bx64NTtanSvDt8J7ne9y5G1eiAD77Med59M8VVfzms5JBGwE0u+NiAqng7QMcg4x1p02mvfKEu28tWMkxjjcsWIxhCRxknH61UXoTJLc5vRI3RHuzko4LlCcFt2EwB1rbtYXmu44gQYo4lZskbi4zjPqD/AEq7b6aC1srp5duXMplEW3DrGRx3IHBPrmsnSbkC3ldcCUkMW64VOPu9iSxxRci2oy2A+3WpYGXypAsiMQMO4PAPTJJ4pbdJUu7cGNkmilkZndM5cAkLtPbHb8akWRjq0bMy7muWmUf3Qg+8T0ycVYsWZJ5blQDIEEjBn4JkIHHcZWgVtSS1tZp9F1OeLaG+0ojj/lpt2Dgc9AW6d6eNStPsQS9jSSY3B3NwFjO8DAHp04NPuEb+wi0SN5CyzRkgHLBWyOT0rI1a5WbUAyROpdA2OgLDB79xyPwoG3YruQ0t35duQX2o0TjBcliFxz68+1Wkt4pEhtJZEVYPJidmG1gpdg2Me5IJ9hVeVf8AR9RDjczTRfNINxAzuznt979K05bcW+tQ2TySSRzXG8yryXUjcAP+BCglasdep5Ul9ZzR7XZmk8ncNoPABx67RWdCGMVreSSiXY+9k2jLYPlkD2+7x3zWn4nuVuJmmMkr3c4Z5WbB4JHIrBhudmj7Sqjy5iVKHO8K/Q+mM/jmgbRovbSw6vcw3jBysLeWowA0qEDnt0Jqi9xvsdS+TDvKCzBMY2p93Pr3/Wr/AIiuE+3TuELmSRGBHTbz+uTyPas+3fEl1FjiORJvvcZKkYC++Bk+1BLRm3iTJJJIQ6q6ksCAdzEZyfwNTqWL+afKaRZY2d9wG7joSeBzzUN9dZ0+EhAyqXYp7gngep6Uy3Vma1glH76aDLYbbyFz/I9KpE3LRgLSXEE0JDtGZgz8iBj8pP1OBUM7iSwjRRsTZGolVACrZwRn3OaeCiC1Q7lZ4mXuWGVzwO/I6VEqvFZFD8xW5Dldud5yGC4+n86YF+6m2Xk8gVDIjh2XP38kqfpUdzEsKyxZHm2zbyRyAoYfh6jNJcNiO8iKLMjSBl2E4wxGeeoHb8afcOjaq0bysxeORV56bcEA+uMYpMCzZok+rTQzncs0qM4I5CscEZ/KuzvtVlt11CSPTLZ57O4RGthb5JicEDt7DmuJsIGm1JoJSoV1VVlP3lBcAbvp6d66GS/02x1GNUv9aN1HGbeSeORV3BMjac88dqaBmP4qiaPXrqGZgzs7LuCgZUqGHHbb0orOvrlXka5s5pn2tuAuMlyRwQSPUZopNAaNqTKGCgAZ3defpz+YP1FWChIJ/iaMsNvRgPb1yOlRQbAAp2BeSO/OOh9qlAUxiQEmRXznOMccEfyrkPRWxUklkaJcAOCfkYj065+ueamUhjtAiXJD/NnJ7bc/r9aGIlkAeQLlwMt1z7/55prRo/3/AJQu4j2Ocnn+tNMNx8bNCN0b/IHDLvPAYZ4PoR6+9MdUZW8vcSerKPmx6/Uc/UVKWQkiSFtufmHQ49R/SopMLuRX3jJ2Kx+YDPB/pRcCVpd6h/kAIztVMYHTAH5H15qRDtZCrOAvUqegPr7g1EgBjYICCX3o3Q9MEfXpUiFo8EbTlyeOpXGDx+IOKQLQmSXbbuAQXUEAg47fyHYetQXStKclCpcchm7nr/8AWpJCiqrj5s/Lgjg5pERhu80bg5JYMOvHUelAyQ+XFDEAxEihlRsDnB+YY79+KjjWTeQ4SUHEfzcqT/CQe3BH4cVK0LPI3lkCRcENjHzjPXsNwA/GluEE0jBcrC6jYVONmcYOOmM/lzVIkhSRChBLkZ2srHjaRjafcVN5hVWVuduWY7cFsAYJ75wOntULfJIXVNscysZFyDhsfNjH8OQcfWpGmD+W7Hc2MFeoO0c4/wCA0SBFtwGhwqgbGY9ecMBlffB5FS3JDRnI+ffkqDzjow+uRn8qrGXaZPkVlRfnPJDLtxux9Me4xU7wlVCq5bDBGI+Y4YZUn1FTa5TdiwYYb2yllLKs9oHHlxsdzqvJkZfTGORz+FMsJnECbtuyMosobow7Me+NrfpUVvdNFcQXCIhZP3yPsOM4w2R/FzwQferFsYYppllCpBITG+wcLGwBXb7AkHir9BJlWQmDUIGWNkJfe5K8As3XHpmrNvMu1pIjIUZRlQpbazA5+g6jn0qvPNtkDyjEixrHnORlWHIPr9fWoropbuFBC/umxwSUUk8EHqCD+FNXRMt7l2+uJgtosaKqpB5O1Dndjk/7pOc59asxSDyJRNEzvlSGzk8MR36fSsy2EZONqlN5IbPBHQge/pUtlPsmVTLuRnUFzwpU4+b68ZouPQ3vtmoIiXNhqU9pNGPLZshcjjtznOeQetVn1C8vZFW+uZLq4djGGD8blPAOR0wTx9KigeOfybZ5IV8lWJz1ZugYDoe350XKGLU5l+zSWzuRcWys5YHBG7nHIBGeK0V7XI05rFu7ubfUorW1u/KUFTbufJ5beOcN3AHfqO3SufvNKubG7uYkKXjQIdyREmVo12hdykZLDOcir1w4naVoWO4rt/1mPKblSSO4wQM9q3tAvHa7+23GYWlj8qS4LECQ/dKYHAGBkkcnA71rGSqaSM3Fx1iecX0x8yOMrhhuRgcgqQR1z35GaIsSfu3cKmMnbzj0rc8V6bFcXEtxIsqSWaANPbhnW6HZs8lc8KSR161T8MacLzSJDC0fnxO8p8xRhQADnPU8jAHvmsp0ddDaliFbUr2kTzWm6DexRyHOflAxxx9e9VciKUiRA/UnbyR27dh1xV7/AI99Mumt/OBnlwE/gZf4gT/eB7dDWjodlFPafabqeSF2YlV2hixxjCjgD8T6VmoI1lWk76keneHLmaya4eNgsE6Qs0jBUV25BPqMYP14q1q7usMVnDcOi2iNJcDGBLLnC8dyAenarYjjhsHieJIoLhI5YlY8ptOAB9cEk9+azdz/ANmQB4jKZmbLBTlcHJ3D6Y/CtVpojmcnJ3ZFFh0ZTGFYlWC7s7eOhPXH+NaLJ9oupfLcoZpF6/wgE8E47Yx71VhgHmQMEaVWxKFGR8nJzk9+nFXrRdqmaWRV3+b80vHbAx/tZycVCKSGgsiq/lqq7VV8kAndzkn3GRntVWciKR4o23RhmOyUAPGmeA3vj8qXT7233NMJXS1KhE3w7mkBwCQO45IxUs6+ZOsweIqcbAAQM5HyqCM454NJsZJFIFuEiYkvHK0wYHp8pzz/AHuc1Qsd0kexJl8yWNl3BSCMsCTn/PSprvfGHeR12FxyRkMc5+73ORzUVsC10VyGdxllJOMbvf8AAmmmQRx26spRTn5ZPlccJhsbm/U0+N86jaF4y9uGIVUbCnaCOvcd6tacLNIL2S6XfL5YFuF43ne2+Q/7IAAx70qeWl7NIFUtAY41jDYySM7cdT1HvQw3Ldzp9/pUVsUtTM3lErGWxuRlx+Bx0780ujtm/wAWt4Eu7SE5gCkgtg/OrDgtzzxyfpW/5ce5ZIpmlQ4B3cMkg+8pHYiuR0rWZtJ8U6zDBCkltJ5qhmG3DbQRhgOxzx9aaa5rESRPfusKxyXcjB0YRBDyAxXq2e/Q8dutcvYxONPuEC/6wfNH3I3NtA9Tkirl5Dc3elO7+Y1pC6puOfmaTofrj9KlcGPVH/ePuRkHXBYYI7ewFUxWHtbyKxiK2wS1iHl/3pN/94jrwOVPrT1SJrtPLMkVxJcGMw4yMBeiEcYz69KW18ua88hY2aeWOMSMTneQckDHTkgfgaigMyyfaXjYSW7G5CkFdwaTAx9RmgLDtVm8zw9p1n5kqkyZJKty0kmcY7+9UNQAudZldgogHmQocfdc4GQOvTNaWsyxQahDFxsjmQRsTgDBJyxHboM1kWyz3F3BJcttZrgIQ6/KBgtwMflQRIkh5aM4leM3hkdkwFMahTn8vw5qUTPNd2EmHMwud0eFyxRQeOfTGTVxNOmfTLK4jU5AKu+SBGpO3BHccZrN1G2udD1Ozs5HkEsQdFnTLBgytyPz5+tHUVraj4yjahDLMNwMEkpQNjccjCn2z/Kq86EaS5kYPJuE+VXaACc4HfORTbZlmnn5wqWe9wowAH2gAcemfxqK/utj3KDa8S2+1SPRTxn8DQNu+pMqvdQ30hHmA7I029Rk7iwz9QKhuWdHLeUwLsyMzLztxgEHt64rVsWezs7uYKCylJIQVBVigAY++Dj8646fUr+fUnkllQSSSj9xtwHLdcfzqlG5LfUtwITDGjIxdy8KIcnDZzke5BqvCqQ3KRvtd1L2xJ+9t2/Ln1NWYD5WqwwuCAs4LkHIVyp6egzVe5DpdTTIMBbqNWxxnA/+v1qkidyxE/7iyuI5G/0dUyOQ2SdpH5Z61ZMi2vmKHHmrfI2OGIwFHGKoXD7NOcqEUFpskHoQcirl8ih2dAmFeF+VwpkJHbqKGhXEPE16hPzxW5EYH3mLN39elTNF5l+rbdsVxbucYzjIB3EdjUbBYL28lEJHkSxybmOOTlcfWpG2xXMClTvWJ0w5xuUnjn16VIyXTmSS6tpWZniaJBKicjBcD6546iuu1ibV49amhXQLaS3hDNDN9k8wunYE9ScevNcvp1tppswt/qD2UsN2V4gLblBBGSOnWtcvZhnY+K7rMTlVzFIAwxj15xmmkSzndVmlmutSS5iFtKZo18pV2qny8kL296KRysWtaii3D3cZmRfPbKl8KTkg9PSigpGp5pAwFY9snjBHPJqrPceWymIlc9SR0JHP4VZQ5XG7Hy/eHT2/P1qG6iQrtfjJJDAcE9wR2rjiehIqjU1EjJcMVAGAVTryOAPWrsL+XKCdpPbcfvA8Yx7dKyruyETRt82SMj256VoPM11M8zEjzWyCexPb8atpEK5OpwoiYyH5SQWP3uf0YVLvLFUZgQQeccj1x9KrPuRNoyjjBDsT1/x96mYtGN7FVkDryD/F/e9gakokbY0aMFPPzkscEHocdueKbu+Y4I8rJyS3qO3fjNNVgAUYfKRlwF6c5H1FRKXywb5mClPl6sMd/wAKLBcssyBEJTdtwSAcYHQg/l1pqx7GIds8NgOMbvb6Ef0qONx8oBdWUZJBznnrj26GrG7bggjpuz1xjsT/ALv+eKCkyW2kAk2YkYkHI2g54wGHvwPyNSSTIGQmNCxDMFPAJIzx6AHtVCWRUlDKfLABCsfnyp/hPqRjikune7lidM+eGJYbhjd/s+g7/jVEiJIZIpIyiHzVOCBjPI/L0qffCWPlKQq5fD8nA7j14JB/So7UCJVkjKrKxIxgHKsB83I4GRj2NPuZBbszwMOMSAKOMHrj36g0DJpEaMRQs6neFOQehxlWx9D/AENTRbo7tGjIV0dVHfaeu36ZAqpKGNwEklJDLthz2UfMnPr29806MHaSeCzYkKjjPBGPcjP0oC5bN0I5TPgiIyeZJHu5UZ557c5/OnROY3KrIoVQbdycFtpBCnHpg4P0qkzEkxpKcTBhjAyoDZAz6kAH8akRwFifACYaE+pBwVzQIfc3axyGKZMNjbI6jndjqB3zhTT7h0N6l03keZGuJF++GHBLD15qrqrKtw874HmBSoHOSByaiSPyphulQq+0hl5PGcj6YJ/Ki5TjdXLSxrPBFFOAEik3MynBI64z2PWrayIGHlghFlICddoCnGfqCOfaq8O6NFlbHl42Op5bngn8MdfQ08ALbjcflQIHOOmOAwHoOKL2JsPtnls5xm52ySoqTZG8qnXBB68/mOK1fEdyp1BFtruK6tGt98ajopBGQO46jjJNZzxTII3d3TMaFWIPr29s9Kjn2o8ER8xHjZwwYdScDP5Gr5tCeXW5ei/0i7OGEjT5yB1XcBuA4AOSDSK7ubYAsVEeWU8ZOTyP04qKB3DqGEkqLGhdFXkheT/MGpLl0EUICBZI9iup+4D2YHrzwfrURfU18hEbVIkf+z7hZBcQNbOssm3auQflyOeeMk9OKls9RntbaOxs47Z5hHskBH7tm27j8o4IHt1PtViK2DweUkyeUZNsecgtjA7fXPuayLhBHcIyuVJBZnUng9Aw9PStfaMz9mnsSa/I9ldXYuVhlt7iTzC3dGYAlW/2gOnetM239n2qWSQyNKsJlSUYkQRsM7lOOW5GR2NZaz+dPD9oiL3AdXBmHQgcEg/1q/qdxcXj3uou8hbzUTJGFBxkgAcDgL0HakpLdi5WtCC8eOSyFs+4s7RQR8cYjYlmYdic/jmo3jd5EIOSib32EkAMxGCPYZqG9CJcpGgJTyYw+7kk8Z9u/wClRxsFllICDe2VDseOPUdRgnilzCtYlW4eBrWHKnyoADgFcBzyD68Usa+WtvudW+zRsVRxlVI6tgdW54pthEJlM1w2xF3ud3zf6tOmPrUil2+yLKAEePDgggMSNwPH0FSUivdK8gt5YSzTyKzEH5tnJwPp3qXT2ZrqwjY5tkHyo/O7aCWPXjocUsENy0E6Wo3x5QLjG4hT279CKiaJlmtUcny8y7+eoB52n65yaEO46AvdAqMbFKFHZv4SevqcY5qKRwxEqrmUkMRng/Nn73U8YNPJSRGd+UiILYJG1fLJGPbJA/Clsi0WmTSKg3JAWdk/h3MPyFMgiVT5d7HHIU2JkN94cdsjv8xqykssc0RQmJnljkAI+ZevzD146mqVmkpjiXj99DI5CkZIznn0yfxq9I/k7vKd9kCq64wSgZcA+3JOaQMjkubyOyijtJW/fRec4B+YZJJYZ9zjua5/Td5bcz7mjj3Zz82WbByCecc1rwzMlpAYOHlUgqTwBswTnsM5NZjW5mMhDDLQorNnG3LYB4pol6l2Uq63JZ9oYx7cMdoc9vwFEM2JnuGJVcyOSRnC4KgD35Jpk0oYMsRjZvOZ8jJDbBjjP+eaijdhaXSr5ZfyVAJ6gZLEnPHtmqJL2n3bpqlnNIF3mMt833XbC9SOnHHtVWa/N9dXNxKx2jjIztCjnn15x9KRuLmTeGRYXQeUG4JLDcPr901EoZ7bySxMbTOjMRyMnJI9B1FMC3LHI11BLOSZNxnIA4GFJ2jI6DgVf8MWr6lqen+dO5RopHQ9SHxwB9M49s0k8vnWtmjIcmR0KMw3ebt7/wCyc9ql8Pqttr2n2UfEtuswyxHJKggY7jJNHUmx1sYXTdEeydcXk05VoeCNvq/PJOe3cGvO/Hcx06/0hZzv2zSk5bOcrjOfTJrufDvmyFbmXLTB3wSRtx7D8+a87+Kz/bNY0oqrByXTGPTHSnu0KXwso2tzJJY30j5ISSNsHnIIIH5EVUnZLqxLDPmrujZgcHH3lPv3H4U/Rs/2RqUxR2bz0TJJ+6Mkk9upFSadAI9N1OctH5HyqxJAVdvJ/E5xx61o1qZrYt3WoBxawHBjFtjeTjqucEfXFYFjHNcXjRW6gP5bZJAIVR1IJ6YrTu7V7e202ScOrSQbHwBwdp25x0PAFU7BXU3ZX5XaDBXOG+Zu35c0W6gMtYvJube2Vlb/AEpCG77T60moORb38OW/4+VbAGcDAP5DFTadbt9rE4BeJJI4l2nC+a68k/QVDAfM1nbJg/aHk6ZAIVCOn1oIFnUmyuVTBWCVygPHysOv5mrl2S+nXZC4crDMQ3HO3B/lWeQseorC4GJ4A7hz/Go/r0q9IANNmilG1Hso2XB9AeM+4zT6CQ694vLhZN5F2FQHOMsGBHHryakuHSKW6jzgqixb+7Bn4b68c+9MaXY4uNxKxXELop67So5+uT+lI0T77WUgFkuyowcb1UnOfz6e1SM0bLSL/Vl1IWcHmZlMbfvACxCjHXGfqKsyeGdcfTQJbNHcukpAlThhgN39qzdIjjuNUtrZJcfaL1jnv0AP/wCqukez8Mtp7Zs9Q8m1vWtZj55DAjJ8z6HHSmkBzN/HLZXOrpcPtlgcEqcEA7TkHH0oqTxHGLLVNdkeIxBCh8vJZRkHHPvmiiwF8kEqAHAHOemeamMbZYrzkZI6ZHr/AIipYrXeUfgp0OeMH0qZo/nO3IZRkg8EVw3se77FtGXNETFGPlG4gqc8Y54zUUSAFQOEH9a0zD90KoYMC4QDocYyPyNMkZpbO3tvKRjCzHdnBIbBP8qq9znlFxZX3YCgjAXgZ5471K8KyWRO9yTIP3aqDuXHJ3eoPQe9SNEiRZkcbgobGQOpx+FJdGJWEFm6NLIpAckeW/Az7g+9Uoszm7FJZBFIPKaR0QBVL4DgZyVNOWQMWeQybMfeReT6E/jTtUkSUJOjLIh/dS5JJV14HJ5PGBnuKjQ55z8jYBA6g9x/X3oehKV9hYkkRiZVKyM3XspB5/Q1M2An3gQp27R09jnuM0m0J1fawPz7edvPB6/hSnajAEqFBBIGMgDng+vPSla5SViVnWV3YqoLsQQegPv6deKqGNlUtGBlOhxzkcjP4ZqywJRyhJZDkbsKNp6H/wCtSFgjB48hcKAD2Hp+HI+lIZEJNzIuVQZyHHODnOeOx6fhT8M8YKkoXbG1j8oPUr7UEIkQAblcnaRkdev4inggsxdtwIGWUghsD5fx56+1O4WFij2wBSpKhiwDHJxjn+XX8KdKZEcDqUCkMOjZ7n8v51E5GSC5EeRuI/hPqM9ualeZThJNwYKwK7cYbPb/AD3pbhaw6MyxuZIy4ZUGAgx6Aj2470kbIJJixZlkALA9WA6YH6UtrDLOkpjO0wxvMFU/eUZ+Ue+ai3MVW5iyP743ZKdBk/niqQm0X7yxa3hP7yK5iRVlco3zQHHO4EdOgyMjNMHlqFYqAcksOmRj5sfTOaLGea2kIjlwr4jcbchl6gEHt14p8cYVJPOJUeXlSqk5IOMKewzgfhQ2nsEbrcAnlOdg3pIoLcdyP5f1qVB+7ZWBXcqfNjvkjH1NQXEijILPkMQSeE29sD6mlR33PFIoCk4diclgDwfYg1DL0NCLctu67TJGOADjII5bGR046Uk0MD4c+YItw5xggMvT69DSF1luVWR+XAUNjhTxn/8AXSOdkEm0tuU7cBuCMEEHj8jV30G1Ysn935DNHt85Tl92W5XHHpyMe9EEyKxUuESQb0Zhjaw9ce9VHZjbCPKl4x94N2OCvHT1HFOuJC8r5BJJVhtXaD707gaFn9rWSC4sl8plXcDuxuZmIA9ycY+nNRXPkxGWZVJQqzIhAXaxf5geuBkcGoLdppYplSVxHERtQ+nPTv8A4Ut7P50L28CBH3lwE5AQrjaM+p5NDVlcd1sRTSzywpLI8xdIsOSd2X34B5OeePyqV5pFt7uIuCpO8LnuUAHsSOeKoXBkOnhJAWBbAfqMD5v54HNXJ3USzpDEFgkVWKrnDEfXoOeM0IzloygGEUqtgna2wEcj5eTweuKlQNGqQrkOFdsDGCW+6ee3rSTsjajlAwLsxJfhg2M9OgxT7U77tTI2+SQkbZc4P97IHAPPQUeRDJJIyivHCQV3lEZBwQxweD7k4qEyoVKiX99uZMgHCnoGz7jPFWYovKurpJnj/dcqgOVABLcnu3b8aq2pVr+diMqJ8ujDBOFOB+BIp2sC1LUCNJPsC4jRZNoAx90gjJ+lJpkgN5HcSZkWOKTIwMNnHC/99fnUamXzJRE5GLV9m7AYN0LH8untVMzvHZgR/KJGAD7cfNyQfblf1pASSvJLPdW77IVjQRABsAY5/U4FWrsvPLdWyBXkkVUyVxlUTJ9O4plw5KOyr5buTnB5U7RweOTlc/jTDPEbeS5RfmkRiqsMMMAAc+5z+VBLEtEBWK4lJEX2VjtHAVs4/PH60puA9lcoDkli7F+qhE+7u75/SpYmtY4bKG6fEDIjy44wDubjHXJ2j8Kyo4ZpgJBGoa4imZcnO4D5Qcdjn+dCDyJprQWzw24dpBJbkjkAhSgJUYOMk/yqGUuLwrhR/q0IUc7sBucd+AK1nhtWvGUR7dkflgqcmQEYXHvnIx+NVNaiEc6zwkRQtJjzT1ikXAI9xg9fan1EzOcGS1u42Q+YD5YOTw5bdkH0zipHBle6UbslY8A9Cc+nYHGDTvNcWl02wrAbhSoB4AUgEY607Do0jhlJZJoVPJAVche3bk+lUSQxEyKEgCLI8zhnLDjjKnnvgYFI+97FGj8xTKxl3Efdd3KgZ+mfypxBjQhnDwo6kPtzgeWQM+g+UUlqha2toRkEtAhQA5yzbsj3Az+BpgXLCMXWrW0ELuYzLMQx/vKOh9DVmefyfEE0owWiSIAlSuw7txH5DGfeobqGaLVpEU7hH5khVeQS7bT056Z5pqXEE0mozzviQjyopU/h2jJznt04oQM9A0+2jltLeSyZWEi5VD97nnGO/fmvF/Et22peKpYkZQtqJIlLfLubBJ+nbH0r0HRb+PT9HluZpnR7SMhlEYVkyOAffJzx2rzaK6Emrpe22G3u7kgfxeX90g9xzWid2Yz0RNol62nwQwXMfmJdykPH907WUANu9c9sVK9vt0jyXYvCL7bKSMDAK5GPWqUqyXF1bxHClAkXmknb/vA9+P1FaV2iT6ZFaRBlMtxIGLkjb83LH0+UUeZJSvJJv7WCu2F8/DLjjlsdKXa8Dao8hVm8tQpIGO+ffOO1W/EJ83UkQxrI4nDZDYZlUA5JPU4HfrVS5hlu21G4ibCERtll42kHGD2HbFNagxIp0sNKsbaJUklumWaQtkDGOFHpzjmmGS3l1/SJYYnjgijImbqGYA5b8yBUF0zSW9jOkcvl+Wqxlj8xIG1v1BqrCyGK5KN+8IEaZb5lx1GPckflTSuIdekPOlyVMavIUjV+yAHn8zV28kIsZlkyrNZxYAXO1RwBn8f1qlcwpO0S5JTzBGq7ScDIHX61cnUTanDuc8SEFU7BRnnPvijyJLFyFk+3vOrRjZExVTnZjORx0OBRZkrPp6OS/lx+e+R/e7Z/H9KhQut2ysczXEQWIEHBJYnB9wvOadZSoJQsp3xJbiKRmBODk4I9+P1pWGiS2mk863e1BDy3nmwLF94DOM5711a3lxaeMrm1uptKcXMWbkSIfI81cbSSOj54J6c1zdgs9veWNxbxMxtoeyfKrHG1cj1redNOup7nUZtN1uOR4t0tmLfcpbPzKH7An2oQM53WTc+ZqbaptW8urgmVc8fe2j8MdPaipdZuXvdd3XMRhuVfzWRh/q8KML/KincDr7iMRyzxQyeZHIR82OvfIqjdFoSvzB1Y7uDyCB0P+FN81mBWUqG6bjxj6Cql1cMWyzhiONx7Adq81p3Pp3Xiok97deTBYSwsBMELbiBjkn+lSabIk0X25iqWqMcu/AbABK8d+cY71m3sSjSraZWR2MhBjbjaAf1HP61Yt1F3A1rNdW8MQffDGRtBJOOeMnvyeldEIdzyq1a+o+7Yfb7gw2s0Ul7hnVkGJYj224+UjAwRyK0dfk086bCba3QSiJWEka4kQDrknrzk5qqsQk064aaZ4ZrGbYsoY70ypxgc5G4EEio5mMqwNKo3SxEONvysBznA54J6euK6lojjbu7IqQQxDT7m5tJpJbNpUjiSZQr7guScenbNRqAscvVnA+X/AGumPpUuoSo0iiKRmhVBGoI2/XIHqeaqXW52QsvT72eBx61zTab0N43SJFlMgMhG0OfnUcbW6Hn/AD1p0h5jDNtUgYyPTpmqYIDkr91wdyn07EVNEGC4ZSeOcngj/wDVUlotwOhVgM5HOSc4Oeo/z3qZSJVJVe3yk9cc5X8aoMQAOe2M47VOjfJs+7nDZ/kagpE0GTOu5mMZbrnBI7gH1xUcyAzO1uylCBt3HHHUZ9/601RvXDBgM5LD/D+tShfKVRjaATnbz1HUfzxSuUKkhCgsTIoUr83Gc9vw5pCMkl8bmGArcYbH5jpkU9mfay5wQhGB0JPXHr1z9ag81TKWIAIABZeqjjBpolsupMIrhzE7RDI4yd54zg9uTyKgdi8QZwcyfMCR8xwec+opcYliLZ25CuTzhQeP0qNGdrhlcnDcAE8qe3555qiWydZQdrEbAclsEnIzx+FXYpPMgMERwRKSu8YK55x+YNZkSIoMY3AtwFOflxnj2xVmC6byHcgFlAbhsHOe3rnJpbFRd2LdlTHIE4JIZCST/wDroSRAQyFXBQ5UN6jkH36/lVSSTey75FXqAO6DPUfypYydjYwQpDYxgj0/Pmiw27GtawyzbxaSxtcKr7Yy4BkAxlR6mno7TozLxH5QcnHUA+n6VlRSzRS7sb5DIzg8A5xj6j+tW7FjFKonfcgYhmUZx6/nnNPYXM29S+yfu1TYnkplAFzwOoyf89Kjln88RKW2hEKgt1OMZH6cVK7rvjitXEokAHyBjlh0baeQfUdPSqTZjfZMGRlBJU8c55A/z2plF2KWMSQPwpZslnPDccZ9OR071FIjEF0ZiWYoQvBDfe+Uenao1jC6Y92zBgsiwLHjBlJBPXttGOfWo1udpjYgsOWRMYIY9RnsfemyYuzJY1VU+ZFyzK5cnIAx0A6dTT5HDRpCgXzS7KXbPQ88+1NhfE0hL7QWDBUOSCMnvxj39qI41eGeVbiGNoiN/mSBTkjqo6HPv6UIG0yvvlM8cjkfcGMAcjocflzSGUjdK7qBICAQepUDmiyLXT+W0cZz8wQH7u7BGD7HPHrUMc4lkigkcsscpKNtw20H9DTWpm5FyI7Z7FAAF+0mRsHJ5Gf096bY7d0kkbCRZ5PvgA5yQM896guWiS2t5UbfMSJSFTkPnBGfTBq5PKEmtoYF8pNmVCYwDtHJ/Gk9BJtiwqSZHiACybo5TnPBbKnnv8pqlGBNaws+WjViJPLPJOOuO3BqxbvhBFvP7mRyS33nGRjI9evFQX00UcMk24mR5WZogpChSRyfzxxQURrcq7q4XIWViyt2IXH3e44zU0kAht1E4fEMURGCdpZmB7dOM5plkpSSGIsC6ykYXnDMefrwAPxpJ5sSOfKfYG3SPu9CeCOnQdKdmiE9SWBFnmkilZQqhmY4ycoMKPpzn9adYwqksj25ObdXjbd1+Z8Lg9jg5/CqkqtD9tEgkeMooUNlSd2CPw4qzZmRLi88snElyqRDI3E8Acn0z17U7ATXUps54HicyvFChIB6upbnP49u9Nu9S3xeUVRrGwYMXZeZWYcrx16E02Oefy7iad5i9vcBFUPtARRjAI7jj64qrYxtNp88aJGs+4jl8M5Kkj5e4AB57YpWsFwaORGsrZd4nDDdg5LHG78O1MWOSW1KQvlpGm3c87cZbH1JNa2i3EbSy/aBukkVHLHkNuGAo789fwrHVZo9NS4UnysXBVuMquSuKEtdREVx5Zhu3R1LyIiR4OAxbHB9uavQAzanEkYaFY5WuS2TlNg2g57DJP4EVVmQS6jFCwOzzETLLlggXJ49h29qjhkZmaRHfmOV9+eEBYAsMevp71aJbL1lcFY9RuD5r7rQtg5Zm2ydj2APU1HJEWvraKSFV82YFwy/Kd6HH165zUcM5gsph5aKjRTW4Y5GBu3EDPrirF68ltqWheaWhYNCWAIOAQAQD34OTnmmJsq3V9cWMUdm6oxut0kzFCXBA4B59ABXLQRSPJujj4uJxCVEfzK2eNp7HBro9Qlin1qMWQaSKMSYO08Eg9B3FZEYRo2nbcBDdoZmB5VRgggdM4zxVR0Mpa6Fk2+7UJ7nywoh2kLnJYvkAn/ZwOvrUEyRvolkxw8su8ZYdP3hUYPfjvV60Jl1/XSpDJJa+YruuGEYcEEAd8HpWYmD4dii3ndBJLHx1A3bkx+dVb3SSzcySvNqMs4QtbqbcSKf4/p6lR1qJ9g0pLeJG/0q2heQhssh9/YnNRPcO2kTXMmS81wxcgdSFAyfemySHTx5Uyl7mKDAyOAT0BPqq/rSQxLuMW/h/T5ck5d5EGc5HmGoLSFvLiXylDG4dnc8hhjP14qa4jCtawq8romwfKvTjJGB24NQqyRWjMgUFVbIAzjeeMHsfeqQmKikWNu0ZwwYFADkEB+MnqDS3DLbXMkm7CMJIAxyQzH0P1xzVq+RIrdo5pUBWNEIfj3YnHfiqFxIjRxrbOnltcFh8vAIwQP0pCZdUpHf2yROcxqwBfLHOzGKqhnC3MTNthnV5V+buMKfzoeUybrmOTYxjdlC+rHGD78GpJkb7eIgEJWIBS3IUAjOf8KBXNGynmkvhH50vlNJEGEZOMjoyr0zyMV0ckttBcHT5PF+qmWa6KNMIjgEcbSd3QYOT71xdjM8ZgmUqJzJ5qvjuD8o+nHSu4h08Of7Sfw3ObtVM32cXaqrs3JxGfmA77e+aaAw/EWlCEX1+NQmvZ4rkWswlTZKj9Qepzn1oqDUNWa5tZ7SWALdTTm6ups8l84SML2x09eKKQF5Y5HDHfEYmYgl2wfUn/69V5Fki8tZwQDyrjBDKegz6/rQ67g4zlSMZA7e1RwyOkJgEjeVnlD3rkbR6jck7EiZZCSmYlP4j1NNsrH/AE66bULyGK1lY7JEbfIOMqcemSM80bBnJcZ6e4FGCTzjH6VUKjiZTpqW5qWWYbF/tl2kqtMHjRAPM3bcFskcLiq811J9l+zRkiHjKBt2Me/5VRXc24BSVXlsdvwp8Kg5ycZ4x0xTlUbHGCWwoQurEMPmHRRURVDlmJI6AZx/kVIY/m4XgHOM0rDaoBAJzms7l27kccW3qhz1J6kirsMDOvXheCV7Cq4OOvzLng+lWYiduVOCDlW7/SkONrjJI8DrlVBH09/pTEYqiltir2b39Knn2BANuZ92GAbtVR1/eAuSFzjBPA9v/r0DlpsWFdYwMA7uFz3HPT6/0pFkRQhMmySQ5QsMZA7/AE6ioRktyfm7A55I9+xqCWMMyPtGFB+buBnjP600iLsuLJ5igZKdCMnODUaJtdlZMuTg9io6jGPWkQ7ZArk4YAcDHHqabG7yFCyBSecE+h/lSD1JF3KgHBB4/HkAn3p0EecDBxgg84OSP50kuNxZjmPnjPT1PvQzgKTleOCOucd/rTQhwzK3zSfMRwGPPA70qsIlwqhsbgBjqO4x685/Cm7RIV2lgRgpgcZ7g/402NVbaS6hgBjjuPf6ZqhGgbUzQ3EimNREodvNcKTzg49e3FVWeKBY2EsUmTkgEk/ifbqMVF5zSsQwD/Kcls44xx9B+tNSMvGxZvkD5XaOgz1x69vpRoF2y5C43FW6N91sYAIOOfXjFTRybPLOVAZiMY6HoBn9KquFIjbOGPGAc4B/+vipAonj2NLyMupGT83XHtzSHctpGGgWRJNrFyAg5dD2b6dKkiUTLCY/3su4I0Tnlsngrj3yCPeqr3LoHMbZ8wAle3+eKgVsiQZ+XhiDyAD0/WmPoX5ftEOnXtrLGI/JIKPt64IOMnucHn8KqMS5+UkhnDZzzzgjn2qzJIZIZTJPI0bDOWfdtwcZxVC5QvaooBWSN94O7BAHNPQlpommn+X5l2xEjzChwSvHA9v1NXbAK9m0ojPmIcSn73mMAeCPfg1UlcSByMlWUuNp5AGMAn2o0GV4lu57guCx2IV43cDJ/LvTsidSpGSNTjjgwrSny9qc5PUHFNmaWG4bcjo6KW27uv8A+sc/hTJf+Q1azohMcZ5GcZAHy/j2q3N5k+qSPgJCrLG7AhjnBHGOvf6YpCEEUpgcxsAUjLNuYDPOOn4CrrTSNd+cm6PyRlSCASf69cVnK0AilkuHKxomCByW9AM+uKltPnhhWRZQrBSAOCAc9++SBQ0NEiMiTkPuZFZtmMHlhwSc881FIxUiWKQGMMQN+ccMCeOw7YoiIjZi6lSrIflXBGP/ANVRr5t3AYyuZncttQ/dyp4x9RmhIGx927W8KuWkj8mb7UijOdxyB+HHHpU+sXPHnmNY7eJdqRIoKqMjIb1J65NNIEl7HInmSNcKjMirgLtIwBnrk/pR4k8v5bJxulln+ePlXYgruA9CM45rSCuZSdkRzPM8AVpWjJt4ZfLOQQuNo/Ajn8aktZA19GJjgh1kXBOFO7/AVV1vUG+wPJE4d2mZdzLywUgKD64AAFJYHdHFJM4837PukC8dCM8fjQ0NF6JJZLcvdBU893miZiBuO9c4/wBoBcioUu3lju3JGwvIyttw5Yrg8+w7e9MnlEtnbW8u392SysSfvM2cH2waVwxS7WAEJK64UDO0HsfrjOfakUaYEM1reMJWhKpFbiPqCx/iBPoMYNVEnC3SrJ8lmZwdr8lFz831zgfiabJMyq+BJhI0KDGSMMTuH+FMuXaScyLggSqBjny2IJ2j8hSuIteKpbSfUkudPYl0d2+Y9EION2KpI8UELs8CkfYRsyxUhictx3PaqjIZYow5I87duwPmQMDkD16D6VPDI84maTlHaOHqCQuCcZ6g4xzVJaEtk1zC32ILGhkmluVJ2vlpAACR7Dqc+1T61qaT35uEKgxSqxIXGUwDk55zVSzuGK2czOwcwtAqhtuScjPIx2xVeOBri4XeyoLthEZGONpDEZ+mOKYCiOO2XTJdgDPueQk5zuU8+3GP8msyMYspFERxNcCNwTksuRjA9etXNbUJqy20DTtEsuNxIJKj+nH6VSmlCRLPEWDrKZUMYODtxnHr0xTZk9ydpBLrLZZsTk25ZSAVQHJ5I44A5qrDDGfMZXVRvdgGPCBAMNx65qaRit59oR2VY42l3DnLMMYx6nNNdQEhbbGixLtbnPJ7n6mncCMRBbGPbIAZJQhxk7SMcnsfXil1Apcr5yEfv2BX1GOM/iTQ7yqLeLkOm5GIOcjbg4Ppg1HDI32W3hQDaX2I6nnJJwcdsDPFFxELxubhnBbAV/MbPVTxz9asuoini81MhTEuzPEjBc4wOp5HFNhmV5SkuWVp1U44yozx6dTU9s7Peh2A8lGM7k4G3HA2+oziq2E9RuoWEJ1GYXnmvCkfmOqRgtzwAP8AaLDGewrE1Q+VrEX2dRGp2E4bIZuh7cY6fhWzcnzisk8QkMgUMpblVJyTjvn0NZz2Qlvi6FY1+4nPz46Zb6VpzKxm07hYxeZHDHKxKygnK8Mqgk8H6n9akWVZY5N5zKGZCeoIUZ/M5qSMf6O/2ZGjZv3SBx9zkcfjSP8ANLOZE2rs2ApyMY7e/Spuiixp08VteWUk8bPFZqkpj7vzkn8s10FxpJu9autQh1yy+xyzrci5e4w8eexQ85A/lXO2Vjd3MCi3huJioJl2Rluw+Ukew4qwdL1JXbzNLuiZGDE+QxwScDt6UgG+JL2G91bUL+33eVcuXjAyGYKMBvbOM0Vb8XJHF4tv41CLGJWUqny8BV6CikBP1UAknnA4puzA56DofSmIy4OSc9qUEsAvGM9TXCercezEBjjcB2I5pQdysCOB1AHSk5x6gHIOP0+lJJEsyKspbruGDjn60xWHRKQpYMdu3LYNAO5Qu1lf0PXNO3EHLN1OTzyajlCFS6sVPU0mGxKpI3Bzknrmm+ad5yp5JwBwMf4UgbABJ3P1HPalLkgswzjj8aA3IwG5XGTn72eKkH3iSCEPTPf2zUUo3ckYBH8J59zW7pOrs+6C78sjYVhYoMseyt9exqlqQ3Yynck7WYEdvRv8amjuVtJYpI40MboQRMA8c2OGBXqAM/Udaqz6qVW8ihhjgEkrEhhvwoPCrnkEevvVJJlkikjW2ikkY/Id20KR1OfXt6VSRDnctExmZvI3iMHASQ5IHt61Kqlhk4UDoGGT9Kl0+xmu7R7i08mYKQrJE+WB7g5/n0NV9TmktVhCFCswYpKh3DI7dOD6ip5Wyk0S/KDxjHv2pzEFhhQexx3+tZ0d0T/rBg4AcenvV1ZQqqucE+vQj1o5WWmhyH5iwJWQdPTp396bhWJIJ5A/SovtUbhfLIIJzkjuPapUdD8xDdSche/vQF0PCccj7vGF9TTM5ZhkqTwwx0+lNW4JGAxAHAY8UkknBO7AH3gOoFNEtWHxpjL/AHQOc5/XFSu6YIkDEDBwT36fiKr2gzJEhO0YO7C5z/kVZl8lJGSMvtB+VmAB2+/rSBDVlPlPH/C5yAOOD7/WpQm9G2swYgd8Zx7/AKVHtTJBO5V+7j09QKepBJHGV/i6kn3PtRcaRMGDRtEiFTxjkfKSP15qKF5Ui24UMeGPoecg1FO43Ky4IIJI9PUUSAAg7mYbduCec9iadwLIl3KQVO584C8DI4P0qu4ldoCoKqvysQRzSwDADc+YnIyeSR6+tODus28kAOOM8jmi47XHRQqEdWyo3bWOcYBpyuYUdGzjbjbngnPJPvQGZ1AXOCuCD04/rSgjcuHAAVtoPAHYZPfmi9ydgUtGeedrZJJ9Rx071X3yvqVuoRlgDMwJwTyCMn8v1qVDJJGC5CqxA3FuBk8D65prhVkZCSjrknAznP8Ak80yWQRqz537cSYxzkhBkAmrNrIVaJVLFgOEHIyOg57cfrVctEUyRwVIyp5GOn8qR5i8ilA7bSHfIwR2z+tBJtW8cLW6zscFoVwqgkytu5UeuPWs25HkyL1jaMhhtGNoLY/lUsbDdFGHKiPOMZU7SMg57c1BdSxyBSmQWba5U9OnTNBQI3ksd4ZTEVxg+/OKn1GSGfUH1Fpbgaksm4EABCMn5ueSc1VXdI7sFT51yQFJB57D8adbQvlY0Ubigk4XPC5JJ9qpSsQ0R3C/aZlWcDryuB8p6n/Ip8JLyxABmXAQbMZI545/CkIcpGU2/NhzgcLk8/yptm+btRGCWYqwU8DIz+lFwL2oRgsVUZmMseCWyQpUDOO3JNVGYi6dd4Vo8AN1BB+UAD6E0jOy3Uq3AkkRckcht3fJPpmom3l1GDGzSjJB+4O2Poe1UncTdixqDiWW6aNEi3NHFtRTg4B9eRk81HMXSJUXa8jFlQg8sQAoBB796imkke9jSEEuV3Be5bOOvfj+dQtzfWoAYIs28sT8pAXoB9apESkXxIqqEilSOC3w2/nc5K7cY7Hrmm6VA13KIl3C2VpJiwOG2A9Pxxj2qrFIv7lJANzBiDtwW5wFqzDOBp6BF2yxlnLo2GDFtuR6hQPu++aaRF2WFYgKjIije0qwlPMKAjOQOwANZnmLvdICJ0eQI/H3WPUfQ9QR3qsWuJN2oSvuVkMIijBDMNuNoHv3OavW8hhieztkyDCnvtUHO0e2enoPrTcbCuQXIVrwPbQgWkc3kxo2eDj1J685qsHVreVkEpAVolfbkHPLAcd+KXe0emINqiJ2LhnB3Zzkke/GM0XLyotrFErLKhLFW4O9j37dMCkBJbFjcRyFAwEO4IxxwcBefrzSww27W0ML4V8ZnkPPAzluO3QYpmxYpjEsi5jQLyDncTkn6DkUixxJFG7LviVe49Wwo+mcmgCo4crcGSPzBgxocDJY4OPwxUgJP2RMjylJcY6twdxx69s+lJJG0lnORnCu3zb/AJug6U64t5Fd2RFKwRbcEHKE4AwaaAgthxCrKyRlpJI1UAllxgfqMZpA+5VAVxJKAo4yFI6gfkaFID27sSVVRIVB2gduD9TSwvsEgJ3BE3bmHTLZPP4dfeqepOw53IOI+EjfGCPvHHAyPQVEV8wNhstIwG4Nn5QOT7d6FkRXto5lARwzMw469z6nHGar20vn6hE3lSvbLEd0aHAIH3c4p2ZJdkYpG0k5HlsMx7iMjHQj1z0GaqrIiBGkaTDtucr91e+Mfhikmh+2ahFbo37tQWO1ckY5PHpxVX7O8gfy/lCsQzk8Af3R7k1SSEzXs9SvbcP9jvJYopXV2aOQoCo6kjuaujxDq4uk26rfHgsW8w46cYpfC+l6dqs72t5PfRTxRBYRGFKu3XZz/EQKS9h8OXE5BvdXRzx/qkB9x+FLdgZzyvdSie4meZ5Jv3khPzZxjBPvRTHjtLe3jFnLI6PNugM2FdgD1YDjsaKVhmshIbAxjOcDuKdkD7ykEnjHT61AqYJ3EAj9aer/ACqecHnn19BXCelcnMXOeD3B71BMzApk/IeQBU8bgHAHsPY1AbmOS5kgwd6EMQR29RQlcHJCrIShQvuBB6DkU1hhfnDfKfvfhUhWIOq5G45wM805sAjbhiMZzQA2JlaP5vu9MMD+lPlkUsQXycdu9RSvgbkUZHrVWRAxJIXf0OKLBcu4BwS457D+VO+VO3zHgH0qrCWCAkfKc4Ur+tS7933zhD696BFgtvWAXSC4gDEkHAYe4b/Gq8cNq4XKTDZkD5gAfoO1K8nlqCCpBGcLzxUYZz2UL655p3YWiaWnPDZQ3iCHzXmj2Zc4CjPbHOemKqHcAR8zhxgjPX3+tVy+1ydxz256/Spp52liURIVPAYAcmi7Cy6FdImWUHCKF4K9fx96shEmjKSHy1ccORkjA6GhI2JXeQCOeOmKYZMEBVV2+vQe9F2KxGbEJGg89GRuGXoy+hI96sAArjLZU4yB1H1pQqqDuJLZyBSx7MkIMMPXilcdgcqzAcDk59/8aYAjn5GyvUHHUdOKWTDALIc54OKGmiilChVzjBGOMdqYWZICxZlGMgZAzjIojPmKCVBbPUcnioDMhDLKh47DpSxy442MCTx2yKBlgSYYHOGB54pEfDHb93ofQ0BJJGAiDO7cgKOTxUROBjPzYyfQU0JsmZl3Nu+4SGwORUYLMuAAVztK5/LFOyRH0AGMnPr7e1RKm2QHt6+n1osCZYhwrY3fMeMjnOelKxwhjBwOo9RVcKW4Uj5TwFHepLm5ihB3uFbso5z60rDuXF3GNA5wS2Q+eOnIx61InIZ5DjBJwD147Vn29yk5KxvkAkHI5J7fjVly4BKhAz9cD0GOvY0Ilsq6jtmLxJ/CwkUr0wec47Hiknk3XELJnMgWFnOeQCcEiprgMoBiQEjbyPXvkelRO0bN+7JZt5OMfd7H8qpEMeLiOWZ4Y1wQcgkdeeopExIhJZxu3biPXqOO/Qmq8bBJS6BSxBXJGSMnrUSTXFvdOqAtERgMy9Me/bvVtdhXL4kdZCVIIkH7zK9x2/KlUzYIyAVAcLwcL15qpHckylXGWwSD1AU9M+tWRgK8aBl52kY6jHb8agdyae5htUlkklREKHDnuSe3vTbTUCrPLbESxSRmPDjn1P8AKo2Jd038Ky4YEcHjpioY0iAiULGijK4B5BPf9KaSFc1LZmnMNusqrAwwwb7oB5x7VRmKK8YhcMfMKAgcnOc/QVA87okIZtiK2BgYGN3Jz3pyqC+SGaMZOCMHuMU1uS2SQTNmWRDhPl3A8DI7mo9gWSFPvyCQkNHyWYZ7Ht61HcypDbStcJnhW2r144I47VHYSTNaBgq71+ZdoxksOnPerS6kORPuYyNK7Av5e5Mrkvng/r0+lRwLLFcW0eSzRLlsdemP51PE+J5YwrlmITCMGKY5PJ6f40y5Zo5Wa3kaQlC2HYZxnkA9z60yWLNJs+0ylQNkGIiDkEn73PrTI3KCLHyxmMrG7DO5jg5H6ikDiGJt4MkSfOiqCASTyBnv9KYkkKSrbRxBZXUspyWKknkZ7YHUUxDBuWLzigwWK5jODgHsM1JCGlh82M7mcDeRnhuqj/E1gytOHwHZjEAv3jxz/Wta2QppaxbWJ5mJ6EMPlBx9OKbXUCaTLWxWb77HYir0Ycc59M/yp8gEsnlzEqgHzZOeBj5s96gludyo1oxjKR4O44AOMAfrUEZaZTvCpuXy8scAnIpAWLbJll2sRvG0SHqqg5J/HpSsyrp8BG7zAwYjPQfw4zUFkqw+ckhHJALg7sBe3vSnaltEpQF423cnoCeKAGNGpk8rdhAF8yReQe7fWknn85J0t2dywO7sqKP605gTI7OAykYkHJwf88U2MHap2EeYSWBHQdl+lCERQxFLS32yFQ5U5IByOc4B/PmnFmuZ57eNVKEAOxOMIpJO73JpNQniglBLFpznheBkjr7AVXVmS4Noqh1KCSd+wyOnv9K0QmRSmRzGbdWaR0LMzH5Y1z2/nVyW4js4kVAhkO1twOM8c4A7Zyaz7kyDzHACqzjcF9MZ249e5q7IiSyINhDSx8nsg6nFMkZC0gvbeWI7X5kRmwTtIx0/M4qSf7NEZvIG9IEY7m/5aOTgfKe9KsjRxyTWrKYk/dQt2bHB5po8pWDbWeH7kRfje/8AEfz6UCNTSdL1S7024a0h8263ebMUYKYmI4HJH50638H63G8kjWRfyQWx5qYZm6kfNWbob351VzpkLzz7jEbbBZXjOSwcenPXtV678Paxb6XcO2lXREuSUQ79gHCjg56VVtCdTK1K3eweCK5VheQZQxn5tpIz1HHGaKcNpkiiT5hHFk8YGcAUVNyzRLM5Iy25eOxFOGDglgMjGfeohNwAVYAenHNRiWRmJAVWzghjz+Vcdj0C4Ap+QMo9MnmolSNJCylEdh8zL1PsTVdkY5yyBupx2p5c/KAi5GOS3NCVhMsrIoDMyHJxlu9KQgJKghD1IHWqqyjJwrA5zjqDUyltu7nPoRSaHctRyQCKTertIMbH3bQP8ajIR14UEjJFRbQyqGBA9c8GhmAcgKSD3B4qQuPkEhACsqgYz6mkwzfK6ZHXcOlABcjYxOexoPyylXWQMvPzDGaAEdSMbMKG685wacNw3FiGOcc1CR5zMHZlOeNjCnqSzDdgjHJ9T6UwJN+SNoC+uBn8qVmCPwzlc46Bc+v0qC4mkjwG249h09qj+07kAcEqeOKLAWt2/czDCseBnoKUKgwF2rzyAOaZGApOFwRxyaczhkztHp70hiyOTIHAbPoaV5FDLllUdMLUbyui8R5PoDzSbydrbBkjOB1X600JthIzFmKfMDwaYTKF52lewP8ASngjG4IwYZ464qANyxeUHvlO34VViW2TSgMm7aVbAzzToyAUdhyAD9KjiYYO0n6GpYQcg8kZyM9//rUBdsntZnjlzFJJExBOYjgjj+VRAKpL7hu7gnrTHBII2kPkk545pDnAZiflORxzQK5MWEgBLDeD0weakjlkaR8rx2O2qsJjSVZGVnRj8yBtpb8e1MWaSOQKhYrjBJ70WHcsJMyBi6the+DgfWmlN5c3EaSKBlSg5p1tdbSySE49+v41JK0KqPnAOPu5PI9qYWFgeIA7PlK4GCPyq1FJExVQ4RnGVI7nuKzUC7snaOSMk9B6GpI54pCyKyvzwB2NIVy98skW7fExOVJUjP8A+uoZWijj81EZgRyMd+hqlJBLId8X7lgc/T0I9auK0gQFmBGMNtosBThvGF6mUQo44+XOKiguRF58cishjY5ZWyTzwfwq3JJKGMjR2qRJzuB+ZvenExh1kKIyYOXHUnsRVxIaI4rhn3KWTGC3AAB9cH+lSySGVFXLkBepGcH/AApl/PZQQqftCyzlQTEsR2hcevrUAup1H+jAlTkpJnkjGKLAmPvLwwwqqKCxG04U/L9Pes9i0wePeWmGGUg8jJ5H1rQijkKqJgEQjcejbqiLvH923jUIMnk4/H3ppAxsUPyEFmYAFvmHJb/Gi9knKr9mJWR8HzB1A9MU9k+ZvIK7iN654+v1zTt8QRmK/KVI+Xnn/Gns7ktXGorxM8bYbaQQO4J4IP1qwxG5kIJfJZlBHQYwAPWqTSbuD/FHnHPH+JqVH2+WxzvxtYZx17ijzII4RKInjuH8kvLzsGcD3NII2tpZxKS6IuVQEsMeuakkV0UI/I2sQrjpk8GqzgFGeUyMHCrtB+7gc1QmWmT93HLNIDIoXdkZAyOn16VXE0c04aB8OsgxnnPqPrRt8793EwjcliDu4AxinW6BGjjuN0SFSGCkZ47jPWgQ+XiO42xnBIVsH/WN3yfSmLfXJnkaa3KxnOXbnoMDmkbzXkZo3+6mzBwR7DHbipAFkjWSf51UAMR0JHRadwIL1Eihjgu3MGCJJFX7xBqxNsW5V4lURiIOsYVuOMD6n3qr9ltzIszpuYPvYHkYBp+RKZJHYJGzZJz0weAKQE4iVWjiwwk5aRR8xVTyAD/OmSEfu5N0hLlm5x2qN5PKkd42UdFXA5569KWYYnJkL5VSDx09sUABP7llUESONxKHPXsKTZ96Q5JCKMAc7uuQKjaTCy7gQSpKn+79Pep4J5obq3kUDKAPtC5zgcE09guQXyhWcBE+0Mn3Ry2O/wBKV8pNJOp+ZVChQB1PU/gKJnMYu7u4f99Ocyv7k/KoFUrWQySMsR3zHHAwPl75rRbXJfYWDc1nHG7jyzIzKCcFyTkjPfpSTSNJAzwjY1wTCqrxsXOKkigL3YVlASOPfyvBb29KitLdTKkw3rFGG3E9eD0H507kkl3C2bWCFEEUciogUnqOTV3UBvnjZ3VQoOBt4TA4J/GqV5dusqyxY3wr+7IH3WPHP4VTM1z5bRQSvJJcgJLxu2j+7TtfUV7HSaLfw3GkXumG/t7Ge4mRzMWKrKoBDIXHIzU8Ph+8iu0un1rTrZYQCkqXe4qM9QB1NQ+GdAs7DQ7vWNat4rpkkSNLd2O1AwJLMB344qaeC0vrAanoFkYEhdftGnk7iqk481e5T27Un5DK+tXFve6pqNxZqPsk8u5MjG4euO2Tzj3oqz4gsorTxBfw28aQw+eSqLwAMDpRWbkWZBuGwPlzkcE8Uhmdm5A47gdKrCU9ASfrTyXK8sVx0xWXKdKbJS7SNgj2zim/KSMnbzzioFdlJO5if0NHmZyWLZPXPenYLlnckbZUrjOcHIxSrKCx2SuPrVQSce4oMhPTr9KXKFzREwOBuGe+TxmldwEBX5mX+6azzLvIBAx3wKGcpzGwHHTFLkDmL6zMyZUEYI5PB/OlkkfezOwIPPPJB+tUDclQNwGaleVZFyeO/NHIO5KpIyynnNIsjoPlHrk4NQLJsUk8kj1xSrO+4Me3cGjlAs+arjBycinRwooDDLHPTPSq/nnO48igT4wRjHXGKTiwNElF+8c+vNMM0fPBB9M9ao+cW4CD6k9aaJtwABGO+aOQdzS89OkfUfw0SSFSAARnoaoFmbAO1hjjNBkIwSQB0+U9aOQHItSS4J3JwOpDdaY8sKkERgnOOKgLjr1HuaGkIUlSFI5p8pNyxvHJBIFSwTBW+VhketZyOBkqWVm4POc0/wAwbfvBmHQGjlBM0BMyzcE+pU9BT5rqB0X5SHI6DpWX544PcelI8m088A++aOQHIvNJnLcdah8zDAHoT3PUVVWfbuXHA5zT43DlfMCbv5e9PlFcto2Hzjf2JHpUi/MXGzIU9xjHvVQSEEq2CBx2oebK/MCMjn0NHKJS6FpZ18zZGhK9C6kEZ9D6U7LROcwAhuwFVIpFVGaNFV8dgKIrmbaWLjngqRik4j5maDyICRmRQTkHkingktkMjqRg+9UzdMowke5gM/e7+lPiluGgSX7K4V2IBBB5HrS5R8xJIoYqTIqgHOO5+tMdjtKRqT3Bbke9DZZ2ZxuUjG1lxzUaxCOQGNyFPUGhXQbimUpIDJZxXCEBS3XAqh/pBnlZoikKOdm3japPStRxweNx754yKgZbqSRds6ogOMSdAPc+lUmSyJrmYADKPJ94Iqk7cHjJp6zXD3JlVFKKvzDpn/H6VbMgiZYmmhyeCUGAR6c1QunuxK3ltE0QOQoXHFNEtonQMzPknySQVI/h9s+5qvLcWsd08LSnzM+hwGNJJMkUaoZip6sEG406S53PFP5fmoBjOOVHv61SJv2JHWVSXOAY1yAvJ9OfWj5TJhejLwc5x7VWa5keXEceNpzn0HpSbyrCSFx5jZ3B24z6YpCLjTmRlJx5mNuMZOO1MA3blOAd/wA2e1UIzKMMu7ehB2M3506N5C8ru6v/ALKjHfrTsBoDBQyBgCp4wKYYFkjbzikrLnCtwST9fSoAWj3AnAc8H04pY3IRVMiljjnOelAizCyCJguVXcSWUcD6VKREAHZd45IbGMHHTmotkjxfuwrBjwABzTZZo7ZSt5I0EmAFAGc+4pAWGIjVWCnJA4yGBOO9V2VFjxJ85BwAV6ZpJ0WM7UmWRD9wg4GD3I9ad5ghaRCTkYDMRgc+g9vWgY8QqHEkafMnHIxmmc7GRM5DZJI6ev406FvMMiF1REBJ3NgH8PWqq3isRHbh2CjqeN2e9OwhZQ7LvZmZSoQYOOhqyu2Fjxzt3N1OPbNKJFTzB8rDGcYp0m8hckJkBFP9TQMpCaK4VldQ0AO47hjntxUduIrchYYFjLnJCrnj0rSmtTFNbiBNwZT3zntn/wCtUl5ZmztDcc7s7kXHzHNCl0E0Y8sm6V0tlkeWUgLx8qkf0qy0UXkJFKmyNG5YkneeppZpltVEkpVmxlEL85PXIpvkvcyiOKYBgNzY6A/jVCaCK3jWImSIBnOFIzkjtVuO4tbVVziWQjBSMgbeepNU7NIra5YS3RdgclSaqFVa8d1hhCpIV3YyW9h/jTd9xGjHLq8Us8mnXcMSyK0ckTAEFT/ez1+tM0mCXTPs0lpeNFNExZnjP3s9FPsB2710ug6aZlNzNFHJukFvDFISqbsFmd++1V5xVqymOpR3Qnjsri2txuKxQCJjGOC8bAcEdcHrScmkFjA1XUGv7uW4nGZJWyzjgHjsO3SijWdNexnuYT+8MTEAj+Jeob24xRUaPcs4ltQDNk5z6mnLqC85yTWZQOtdXIjD2su5ojUQDnnmlOps33ufwrNPakp8iJ9rI0TqRPQ8/SnDUyByKzjRRyIPasv/ANpEHKij+02wRgfWqFJQoIPasv8A9oHpjAHpR/aLgYB4+lUR92gUckexSqNlxr6QH60gvpPU1UpDRyR7A5y7l3+0JfU0n26XPWqYpaOVdhc8u5bF/KO9K2oSk54+lU6TvT5V2Fzy7lz7fL6k0n26X1qrRRyrsHPLuW/t83rR/aE2CM5BqpRRyrsHO+5bN9MR96j7dKcZPHpVSlo5V2Dnl3Ln9oSjuKP7QmyM8+9Um7UCjlXYam+5e/tCb2pr38rgBhxVSijlXYfM+5cW+kUfKAKHv5XADc4qnRS5V2Dmfc0rTVWgfc0KSjGNrdPrUh1lyT8oI9O1Y70vYUuRC52jWGrHcT82COlWBrKspyCrdD6GsLtSx8rzTdJFe0kjpW1SCWPas7IRj3qa2u0JGZfM5yDnpXLMOKaSRjHHHaodFFRqtnZTTOycScfXJoM5VTkF/l4JOa5NHdWj2sw+hq7byyZ++/fvWfskWqhru6SAGX94Dzg8bRQMGJQv7oYxlTnP41Tjdi3LMfmHf2qrGx8wjJxk1CWhUmaTNbWpz+8ct2GWxVdtRj3MMOrMQMEVACQG5NMflyT1x1raEUyOY0H+ViGzn1B5H400yJFnG4993Tms12OepqtKx3LyfzoUCXOxqiZzJmQq2egPWpI7gQrhnPPp1rCcnJ5NPYnYpzVeyRHtX2NwT2wxJ5rkHgqeOlQm9RS7bdwPTIHFYykk8mmnvT9khOqb66pGsGxgFbqCDULagJI9krFwOm7t7isRv4qaego9kg52zctJI/PUJMEY/wAbHI/HNTrdOqSt5wYt8pYnrzXPL/7LSv3/AAp+zQc7R0EUiyOVwGL9smrMNvKHZo413Y4GCRgetc9YEi9t8E/6wV6LqTMuiyFWIOeoNRKFi4zuYcLShk80BQTnhePyrQldXkb92ZAfuuq7Qp9awklkMMhMj5HTmuosCTpCEkkkDk/WsGaFFZ1ysUsrFl56c1fgu7Rpw0shMDZVSuSwI9R71UuwA2QBmsec7fM28fSqiSzQ1Gztjei6Vk2HG09Rn0xVK8uYlKHz/n7hf8ayxI/9mXA3tjzF4zWfN90fSqUbsnmNPNstw0hUuxzy5yDSx3zE8KgA+6I+DWY33B/u10+nxR/2dE3lpuz1wM1o46Epmt4UubxleK7n+zhZRcWzuCyK4BUq4/uMpwa6WytLOwinaX7HZpcDbL5F0bh3Tuka9s9MnpXGKxEkmCenrXR+Do0fVl3orYHGRnFYy0ZZc1DQtS1wTSki1S5OdoPKL0A/Kiu5/iP4UV0QpJoiU2j/2Q==);\">",
"   </div>",
"   <div class=\"lgnd\">",
"    Erosions and small blisters are present in this image taken from a patient with pemphigus vulgaris.",
"    <div class=\"footnotes\">",
"    </div>",
"    <div class=\"reference\">",
"     Reproduced with permission from: www.visualdx.com. Copyright Logical Images, Inc.",
"    </div>",
"   </div>",
"  </div>",
" </div>",
"</div>"].join("\n");
var script_f21_30_21994=[""].join("\n");
var outline_f21_30_21994=null;
var title_f21_30_21995="Epidemiology of HBV";
var content_f21_30_21995=[" <div id=\"graphicsToolbar\">",
"  <div id=\"graphicsCopy\">",
"   &copy;2013 UpToDate",
"   <sup>",
"    &reg;",
"   </sup>",
"  </div>",
"  <div id=\"graphicsLinks\">",
"   <a href=\"?imageKey=GAST%2F51820&amp;source=image_view&amp;view=print&amp;elapsedTimeMs=3\" onclick=\"\">",
"    <img alt=\"Print this page\" src=\"./../images/icn_print.myextg\" title=\"Print this page\"/>",
"   </a>",
"   <a class=\"icontxt textLink\" href=\"?imageKey=GAST%2F51820&amp;source=image_view&amp;view=print&amp;elapsedTimeMs=3\" onclick=\"\" title=\"Print this page\">",
"    Print",
"   </a>",
"   <a class=\"etacLink\" href=\"#\">",
"    <img alt=\"Email graphic(s)\" src=\"./../images/icn_email.myextg\" title=\"Email graphic(s)\"/>",
"   </a>",
"   <a class=\"icontxt textLink etacLink\" href=\"#\" title=\"Email graphic(s)\">",
"    Email",
"   </a>",
"  </div>",
" </div>",
" <div class=\"graphic\">",
"  <div class=\"figure\">",
"   <div class=\"ttl\">",
"    Epidemiology and modes of transmission of hepatitis B virus infection",
"   </div>",
"   <div class=\"cntnt\">",
"    <table cellspacing=\"0\">",
"     <tbody>",
"      <tr>",
"       <td class=\"subtitle1\">",
"        &nbsp;",
"       </td>",
"       <td class=\"subtitle1\">",
"        High",
"       </td>",
"       <td class=\"subtitle1\">",
"        Intermediate",
"       </td>",
"       <td class=\"subtitle1\">",
"        Low",
"       </td>",
"      </tr>",
"      <tr>",
"       <td>",
"        Carrier rate, percent",
"       </td>",
"       <td>",
"        &ge;8 percent",
"       </td>",
"       <td>",
"        2-7 percent",
"       </td>",
"       <td>",
"        &le;1 percent",
"       </td>",
"      </tr>",
"      <tr>",
"       <td>",
"        Geographic distribution",
"       </td>",
"       <td>",
"        Southeast Asia; China; Pacific islands; sub- Saharan Africa; Alaska (Eskimos)",
"       </td>",
"       <td>",
"        Mediterranean basin; eastern Europe; central Asia; Japan; Latin and South America; Middle East",
"       </td>",
"       <td>",
"        United States and Canada, western Europe; Australia; New Zealand",
"       </td>",
"      </tr>",
"      <tr>",
"       <td>",
"        Predominant age at infection",
"       </td>",
"       <td>",
"        Perinatal and early childhood",
"       </td>",
"       <td>",
"        Early childhood",
"       </td>",
"       <td>",
"        Adult",
"       </td>",
"      </tr>",
"      <tr>",
"       <td>",
"        Predominant mode of infection",
"       </td>",
"       <td>",
"        Maternal-infant; percutaneous",
"       </td>",
"       <td>",
"        Percutaneous; sexual",
"       </td>",
"       <td>",
"        Sexual; percutaneous",
"       </td>",
"      </tr>",
"     </tbody>",
"    </table>",
"   </div>",
"   <div class=\"lgnd\">",
"    <div class=\"footnotes\">",
"    </div>",
"    <div class=\"reference\">",
"    </div>",
"   </div>",
"  </div>",
" </div>",
"</div>"].join("\n");
var script_f21_30_21995=[""].join("\n");
var outline_f21_30_21995=null;
var title_f21_30_21996="Rx of adrenal insufficiency";
var content_f21_30_21996=[" <div id=\"graphicsToolbar\">",
"  <div id=\"graphicsCopy\">",
"   &copy;2013 UpToDate",
"   <sup>",
"    &reg;",
"   </sup>",
"  </div>",
"  <div id=\"graphicsLinks\">",
"   <a href=\"?imageKey=ENDO%2F78904&amp;source=image_view&amp;view=print&amp;elapsedTimeMs=2\" onclick=\"\">",
"    <img alt=\"Print this page\" src=\"./../images/icn_print.myextg\" title=\"Print this page\"/>",
"   </a>",
"   <a class=\"icontxt textLink\" href=\"?imageKey=ENDO%2F78904&amp;source=image_view&amp;view=print&amp;elapsedTimeMs=2\" onclick=\"\" title=\"Print this page\">",
"    Print",
"   </a>",
"   <a class=\"etacLink\" href=\"#\">",
"    <img alt=\"Email graphic(s)\" src=\"./../images/icn_email.myextg\" title=\"Email graphic(s)\"/>",
"   </a>",
"   <a class=\"icontxt textLink etacLink\" href=\"#\" title=\"Email graphic(s)\">",
"    Email",
"   </a>",
"  </div>",
" </div>",
" <div class=\"graphic\">",
"  <div class=\"figure\">",
"   <div class=\"ttl\">",
"    Treatment of chronic primary adrenal insufficiency",
"   </div>",
"   <div class=\"cntnt\">",
"    <table cellspacing=\"0\">",
"     <tbody>",
"      <tr>",
"       <td class=\"subtitle1_single\">",
"        Glucocorticoid replacement",
"       </td>",
"      </tr>",
"      <tr>",
"       <td>",
"        1. Dexamethasone 0.5 (0.25 to 0.75) mg or prednisone 5 (2.5 to 7.5) mg orally at bedtime. Supplement with hydrocortisone 5 to 10 mg orally in mid-afternoon if indicated.",
"       </td>",
"      </tr>",
"      <tr>",
"       <td>",
"        2. Alternative therapy is with hydrocortisone 15 to 20 mg upon awakening and 5 to 10 mg in early afternoon.",
"       </td>",
"      </tr>",
"      <tr>",
"       <td>",
"        3. Monitor clinical symptoms and morning plasma ACTH.",
"       </td>",
"      </tr>",
"      <tr>",
"       <td class=\"subtitle1_single\">",
"        Mineralocorticoid replacement",
"       </td>",
"      </tr>",
"      <tr>",
"       <td>",
"        1. Fludrocortisone 0.1 (0.05 to 0.2) mg orally.",
"       </td>",
"      </tr>",
"      <tr>",
"       <td>",
"        2. Liberal salt intake.",
"       </td>",
"      </tr>",
"      <tr>",
"       <td>",
"        3. Monitor lying and standing blood pressure and pulse, edema, serum potassium and plasma renin activity.",
"       </td>",
"      </tr>",
"      <tr>",
"       <td class=\"subtitle1_single\">",
"        Androgen replacement",
"       </td>",
"      </tr>",
"      <tr>",
"       <td>",
"        1. Dehydroepiandrosterone 25 to 50 mg orally in women.",
"       </td>",
"      </tr>",
"      <tr>",
"       <td class=\"subtitle1_single\">",
"        Patient education",
"       </td>",
"      </tr>",
"      <tr>",
"       <td>",
"        1. Educate patient about the disease, how to manage minor illnesses and major stresses, and how to inject dexamethasone intramuscularly.",
"       </td>",
"      </tr>",
"      <tr>",
"       <td class=\"subtitle1_single\">",
"        Emergency precautions",
"       </td>",
"      </tr>",
"      <tr>",
"       <td>",
"        1. Obtain Medic-Alert bracelet/necklace, Emergency Medical Information Card, and prefilled syringes containing dexamethasone 4 mg in 1 mL saline.",
"       </td>",
"      </tr>",
"      <tr>",
"       <td class=\"subtitle1_single\">",
"        Treatment of minor febrile illness or stress",
"       </td>",
"      </tr>",
"      <tr>",
"       <td>",
"        1. Increase glucocorticoid dose two- to threefold for the few days of illness. Do not change mineralocorticoid dose.",
"       </td>",
"      </tr>",
"      <tr>",
"       <td>",
"        2. Contact physician if illness worsens or persists for more than three days.",
"       </td>",
"      </tr>",
"      <tr>",
"       <td>",
"        3. No extra supplementation is needed for most uncomplicated, outpatient dental procedures under local anesthesia. General anesthesia or intravenous sedation should not be used in the office.",
"       </td>",
"      </tr>",
"      <tr>",
"       <td class=\"subtitle1_single\">",
"        Emergency treatment of severe stress or trauma",
"       </td>",
"      </tr>",
"      <tr>",
"       <td>",
"        1. Inject contents of prefilled dexamethasone (4 mg) syringe intramuscularly.",
"       </td>",
"      </tr>",
"      <tr>",
"       <td>",
"        2. Get to physician as quickly as possible.",
"       </td>",
"      </tr>",
"     </tbody>",
"    </table>",
"   </div>",
"   <div class=\"lgnd\">",
"    <div class=\"footnotes\">",
"    </div>",
"    <div class=\"reference\">",
"    </div>",
"   </div>",
"  </div>",
" </div>",
"</div>"].join("\n");
var script_f21_30_21996=[""].join("\n");
var outline_f21_30_21996=null;
var title_f21_30_21997="Features of Mansonella spp I";
var content_f21_30_21997=[" <div id=\"graphicsToolbar\">",
"  <div id=\"graphicsCopy\">",
"   &copy;2013 UpToDate",
"   <sup>",
"    &reg;",
"   </sup>",
"  </div>",
"  <div id=\"graphicsLinks\">",
"   <a href=\"?imageKey=ID%2F66052%7EID%2F70668&amp;source=image_view&amp;view=print&amp;elapsedTimeMs=13\" onclick=\"\">",
"    <img alt=\"Print this page\" src=\"./../images/icn_print.myextg\" title=\"Print this page\"/>",
"   </a>",
"   <a class=\"icontxt textLink\" href=\"?imageKey=ID%2F66052%7EID%2F70668&amp;source=image_view&amp;view=print&amp;elapsedTimeMs=13\" onclick=\"\" title=\"Print this page\">",
"    Print",
"   </a>",
"   <a class=\"etacLink\" href=\"#\">",
"    <img alt=\"Email graphic(s)\" src=\"./../images/icn_email.myextg\" title=\"Email graphic(s)\"/>",
"   </a>",
"   <a class=\"icontxt textLink etacLink\" href=\"#\" title=\"Email graphic(s)\">",
"    Email",
"   </a>",
"  </div>",
" </div>",
" <div class=\"graphic\">",
"  <div class=\"figure\">",
"   <div class=\"ttl\">",
"    Features of mansonella species causing human infection - I",
"   </div>",
"   <div class=\"cntnt\">",
"    <table cellspacing=\"0\">",
"     <tbody>",
"      <tr>",
"       <td>",
"        &nbsp;",
"       </td>",
"       <td class=\"subtitle1\">",
"        M. streptocera",
"       </td>",
"       <td class=\"subtitle1\">",
"        M. ozzardi",
"       </td>",
"       <td class=\"subtitle1\">",
"        M. perstans",
"       </td>",
"      </tr>",
"      <tr>",
"       <td class=\"subtitle2_left\">",
"        Geographic distribution",
"       </td>",
"       <td>",
"        Western and Central Africa",
"       </td>",
"       <td>",
"        Central and South America, Caribbean",
"       </td>",
"       <td>",
"        Sub-Saharan and North Africa, South America",
"       </td>",
"      </tr>",
"      <tr>",
"       <td class=\"subtitle2_left\">",
"        Transmission",
"       </td>",
"       <td>",
"        Transmitted via bite of infected Culicoides species (midge)",
"       </td>",
"       <td>",
"        Transmitted via bite of infected Culicoides species (midge) or by Simulium amazonicum (black fly)",
"       </td>",
"       <td>",
"        Transmitted via bite of infected Culicoides species (various species)",
"       </td>",
"      </tr>",
"      <tr>",
"       <td class=\"subtitle2_left\">",
"        Clinical features",
"       </td>",
"       <td>",
"        Usually asymptomatic, but can cause chronic papulonodular dermatitis, pruritis, pigmentation changes, dermal thickening, and lymphadenopathy. May be difficult to distinguish from onchocerciasis.",
"       </td>",
"       <td>",
"        Usually asymptomatic, but can be associated with urticaria, pruritic rash, edema, lymphadenopathy, arthralgias, fever, headache, vertigo, or pulmonary symptoms.",
"       </td>",
"       <td>",
"        Usually asymptomatic, but can cause transient angioedema, urticaria, and pruritus, and may be difficult to distinguish from loiasis. Other manifestations include headache, arthralgias, pericarditis, pleuritis, hepatitis, meningoencephalitis, and ocular symptoms.",
"       </td>",
"      </tr>",
"      <tr>",
"       <td class=\"subtitle2_left\">",
"        Site of adult parasites",
"       </td>",
"       <td>",
"        Dermal layers of the trunk and upper shoulder girdle",
"       </td>",
"       <td>",
"        Lymphatics and thoracic and peritoneal cavities",
"       </td>",
"       <td>",
"        Pericardial, pleural and peritoneal cavities; mesenteric, perirenal, and retroperitoneal tissues",
"       </td>",
"      </tr>",
"      <tr>",
"       <td class=\"subtitle2_left\">",
"        Site of microfilariae",
"       </td>",
"       <td>",
"        Blood",
"       </td>",
"       <td>",
"        Blood and skin",
"       </td>",
"       <td>",
"        Skin",
"       </td>",
"      </tr>",
"     </tbody>",
"    </table>",
"   </div>",
"   <div class=\"lgnd\">",
"    <div class=\"footnotes\">",
"    </div>",
"    <div class=\"reference\">",
"    </div>",
"   </div>",
"  </div>",
" </div>",
" <div class=\"graphic\">",
"  <div class=\"figure\">",
"   <div class=\"ttl\">",
"    Features of mansonella species causing human infection - II",
"   </div>",
"   <div class=\"cntnt\">",
"    <table cellspacing=\"0\">",
"     <tbody>",
"      <tr>",
"       <td>",
"        &nbsp;",
"       </td>",
"       <td class=\"subtitle1\">",
"        M. streptocera",
"       </td>",
"       <td class=\"subtitle1\">",
"        M. ozzardi",
"       </td>",
"       <td class=\"subtitle1\">",
"        M. perstans",
"       </td>",
"      </tr>",
"      <tr>",
"       <td class=\"subtitle2_left\">",
"        Diagnosis",
"       </td>",
"       <td>",
"        Microfilariae (mf)&nbsp;in skin snips. Differentiated from mf&nbsp;of Onchocerca volvulus by small size (180 to 240 micrometers) and characteristic sharp curve in tip of tail (\"shepherd's crook\").",
"       </td>",
"       <td>",
"        Microfilariae (mf) in blood and occasionally in skin snips. Differentiated from other circulating mf by lack of significant periodicity, small size (170 to 240 micrometers long), absence of sheath and absence of terminal nuclei.",
"       </td>",
"       <td>",
"        Microfilariae (mf) in blood (or rarely&nbsp;serosal effusions). Differentiated from other circulating mf by lack of significant periodicity, small size (190 to 200 micrometers), absence of sheath, and round terminal nucleus at the tip of the tail.",
"       </td>",
"      </tr>",
"      <tr>",
"       <td class=\"subtitle2_left\">",
"        Other laboratory findings",
"       </td>",
"       <td>",
"        Peripheral eosinophilia is common.",
"       </td>",
"       <td>",
"        Peripheral eosinophilia is common.",
"       </td>",
"       <td>",
"        Peripheral eosinophilia and elevated serum IgE are common.",
"       </td>",
"      </tr>",
"      <tr>",
"       <td class=\"subtitle2_left\">",
"        Treatment",
"       </td>",
"       <td>",
"        Diethylcarbamazine (6 mg/kg/day&nbsp;orally for 14 days) is effective against adults and microfilariae (mf) but associated with significant side effects. Ivermectin (150 mcg/kg orally) is effective in reducing mf.*",
"       </td>",
"       <td>",
"        Ivermectin (200 mcg/kg orally) is the treatment of choice.",
"        <sup>",
"         &bull;",
"        </sup>",
"        Diethylcarbamazine is ineffective.",
"        <sup>",
"         &Delta;",
"        </sup>",
"       </td>",
"       <td>",
"        Recommend therapy with albendazole (400 mg&nbsp;orally BID for 10 days) or mebendazole (100 mg&nbsp;orally&nbsp;twice daily&nbsp;for 30 days) is generally inefective.",
"        <sup>",
"         &loz;",
"        </sup>",
"        Doxycycline (200 mg&nbsp;orally daily for six weeks) clears mf for up to 36 months.",
"        <sup>",
"         &sect;",
"        </sup>",
"       </td>",
"      </tr>",
"     </tbody>",
"    </table>",
"   </div>",
"   <div class=\"lgnd\">",
"    <div class=\"footnotes\">",
"    </div>",
"    <div class=\"reference\">",
"     * Fischer, P, et al. J Infect Dis 1999; 180:1403.",
"     <br>",
"      &bull; Nutman, TB, et al. J Infect Dis 1987; 156:662; Gonzalez, AA, et al. West Indian Med J 1999; 48:231.",
"      <br>",
"       &Delta; Bartholomew CF, et al. Trans R Soc Trop Med Hyg 1978; 72:423.",
"       <br>",
"        &loz; Bregani ER, et al. Trans R Soc Trop Med Hyg 2006; 100:458.",
"        <br>",
"         &sect; Coulibaly YI, et al. N Eng J Med 2009; 361:1448.",
"         <br/>",
"        </br>",
"       </br>",
"      </br>",
"     </br>",
"    </div>",
"   </div>",
"  </div>",
" </div>",
"</div>"].join("\n");
var script_f21_30_21997=[""].join("\n");
var outline_f21_30_21997=null;
var title_f21_30_21998="Endarterectomy stroke ACAS";
var content_f21_30_21998=[" <div id=\"graphicsToolbar\">",
"  <div id=\"graphicsCopy\">",
"   &copy;2013 UpToDate",
"   <sup>",
"    &reg;",
"   </sup>",
"  </div>",
"  <div id=\"graphicsLinks\">",
"   <a href=\"?imageKey=CARD%2F54275&amp;source=image_view&amp;view=print&amp;elapsedTimeMs=1\" onclick=\"\">",
"    <img alt=\"Print this page\" src=\"./../images/icn_print.myextg\" title=\"Print this page\"/>",
"   </a>",
"   <a class=\"icontxt textLink\" href=\"?imageKey=CARD%2F54275&amp;source=image_view&amp;view=print&amp;elapsedTimeMs=1\" onclick=\"\" title=\"Print this page\">",
"    Print",
"   </a>",
"   <a class=\"etacLink\" href=\"#\">",
"    <img alt=\"Email graphic(s)\" src=\"./../images/icn_email.myextg\" title=\"Email graphic(s)\"/>",
"   </a>",
"   <a class=\"icontxt textLink etacLink\" href=\"#\" title=\"Email graphic(s)\">",
"    Email",
"   </a>",
"  </div>",
" </div>",
" <div class=\"graphic\">",
"  <div class=\"figure\" style=\"width: 470px\">",
"   <div class=\"ttl\">",
"    Carotid endarterectomy in asymptomatic men",
"   </div>",
"   <div class=\"cntnt\" style=\"width: 299px; height: 462px; background-image: url(data:image/gif;base64,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);\">",
"   </div>",
"   <div class=\"lgnd\">",
"    In the ACAS trial, 1662 patients with an asymptomatic carotid stenosis &ge;60 percent were randomized to medical therapy with aspirin or carotid endarterectomy (CEA) and followed for a mean of 2.2 years.",
"    <br>",
"     (Top panel) There was no difference between the two groups in the incidence of major stroke or death.",
"     <br>",
"      (Bottom panel) The incidence of any ipsilateral TIA or stroke or death was lower in the surgical group (p = 0.004).",
"      <div class=\"footnotes\">",
"      </div>",
"      <div class=\"reference\">",
"       Data from: Executive Committee for the Asymptomatic Carotid Atherosclerosis Trial. JAMA 1995; 273:1421.",
"      </div>",
"     </br>",
"    </br>",
"   </div>",
"  </div>",
" </div>",
"</div>"].join("\n");
var script_f21_30_21998=[""].join("\n");
var outline_f21_30_21998=null;
var title_f21_30_21999="Duodenal ulcer on fluoroscopy";
var content_f21_30_21999=[" <div id=\"graphicsToolbar\">",
"  <div id=\"graphicsCopy\">",
"   &copy;2013 UpToDate",
"   <sup>",
"    &reg;",
"   </sup>",
"  </div>",
"  <div id=\"graphicsLinks\">",
"   <a href=\"?imageKey=SURG%2F57603&amp;source=image_view&amp;view=print&amp;elapsedTimeMs=2\" onclick=\"\">",
"    <img alt=\"Print this page\" src=\"./../images/icn_print.myextg\" title=\"Print this page\"/>",
"   </a>",
"   <a class=\"icontxt textLink\" href=\"?imageKey=SURG%2F57603&amp;source=image_view&amp;view=print&amp;elapsedTimeMs=2\" onclick=\"\" title=\"Print this page\">",
"    Print",
"   </a>",
"   <a class=\"etacLink\" href=\"#\">",
"    <img alt=\"Email graphic(s)\" src=\"./../images/icn_email.myextg\" title=\"Email graphic(s)\"/>",
"   </a>",
"   <a class=\"icontxt textLink etacLink\" href=\"#\" title=\"Email graphic(s)\">",
"    Email",
"   </a>",
"  </div>",
" </div>",
" <div class=\"graphic\">",
"  <div class=\"figure\" style=\"width: 470px\">",
"   <div class=\"ttl\">",
"    Duodenal ulcer on fluoroscopy",
"   </div>",
"   <div class=\"cntnt\" style=\"width: 300px; height: 302px; background-image: url(data:image/jpeg;base64,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);\">",
"   </div>",
"   <div class=\"lgnd\">",
"    Fluoroscopic spot view of the upper abdomen with water-soluble contrast demonstrates a large duodenal ulcer without no evidence of perforation.",
"    <div class=\"footnotes\">",
"    </div>",
"    <div class=\"reference\">",
"     Courtesy of J Pierre Sasson, MD.",
"    </div>",
"   </div>",
"  </div>",
" </div>",
"</div>"].join("\n");
var script_f21_30_21999=[""].join("\n");
var outline_f21_30_21999=null;
